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VOORWOORD
Promoveren wordt veelal beschouwd de bekroning te zijn van een acade­
mische opleiding. Het is niet onmogelijk dat de aard van deze kroon over­
eenkomsten vertoont met de nieuwe kleren van de keizer. Zelf zou ik een 
proefschrift eerder willen vergelijken met een indianentooi, kleurrijke ver­
siering van het afgetobde hoofd van de niet meer zo jonge promovendus. 
Een op het eerste gezicht imponerend aureool, dat bij nadere beschouwing 
slechts uit een facade van 1 rij bonte slagpennen bestaat. De drager van een 
dergelijk hoofdtooi pronkt in wezen met andermans veren. Het eigen aandeel 
is -  zoals in mijn geval -  vaak beperkt gebleven to t de keuze en rangschik­
king van de afzonderlijke pennen.
Gaarne zou ik in dit voorwoord willen uiteenzetten wie allemaal hebben 
bijgedragen to t het onderhavige eindresultaat, en daarbij hen die dat in grote 
mate verdienen, hun veer als pluim op hun hoed willen terugplaatsen. Helaas 
laat het promotiereglement van deze Universiteit het maar ten dele toe om 
een ieder met naam te noemen.
Mijn grootste waardering gaat uit naar alle verpleegkundigen van de 
afdeling Gastroenterologie (hoofd mej. A. M . Th. W. van der Belt; in 
vroegere jaren mej. J. M. T. Dekkers) en van de polikliniek Inwendige Ge­
neeskunde (hoofden mej. Th. Th. M. Hoogenbosch en de heer G. C. Th. 
Delisse), alsmede van de Staf Interne (hoofd mej. L. M. J. Schreppers). 
Door hun gezamenlijke toewijding en zorgvuldigheid konden de vele, vaak 
ingewikkelde onderzoekingen plaatsvinden, en de resultaten ervan gebruikt 
worden. Belangrijk was hierbij de inspanning van vele analisten op de labora­
toria voor Klinische Chemie (hoofd dr. A. P. Jansen), Haematologie (hoofd 
dr. J. M. C. Wessels), Isotopen (hoofd drs. F. H . M. Corstens), Aminozuren 
(dr. J. M. F. Trijbels), Histochemie (hoofd dr. A. G. W. Lansink) en Bacte­
riologie (hoofd dr. G. C. J. van der Ploeg). De resultaten van hun geduldig 
verrichte bepalingen konden pas geïnterpreteerd worden na verzameling 
van controlewaarden door de heer A. A. M. Masclee (student-assistent), en 
na statistische bewerking op het Medisch Statistisch Adviescentrum (hoofd 
drs. Ph. van Elteren), waarbij ir. H. J. J. van Lier erg hulpvaardig was. Voor 
sommige ‘normaalwaarden’ werd gebruik gemaakt van reeds verzamelde, 
merendeels in dissertatievorm verschenen gegevens.
v
Graag wil ik op deze plaats de zeer prettige contacten memoreren met de 
instituten voor Pathologische Anatomie (hoofd Prof. dr. P. H. M. Schil- 
lings), Röntgendiagnostiek (hoofd Prof. dr. W. Penn) en Dermatologie 
(hoofd Prof. dr. J. W. H. Mali). Bijzonder veel hulp werd verder ondervon­
den van de medewerkers van de Medische Bibliotheek (hoofd de heer E. de 
Graaff), het Instituut voor Geschiedenis der Geneeskunde (hoofd dr. D. de 
Moulin), en de dames W. van Deursen en H. Scherpenborg-Hellegers van 
het archief van de kliniek. Waardering verdient ook het aandeel dat de 
diëtistes, mej. H. A. van der Heyden en mej. H. J. W. Lamers, in de be­
handeling van de patiënten hadden.
Voor de verluchtiging van de tekst is -  op een enkele uitzondering na -  de 
heer H. M. Berris van de Medische Tekenkamer verantwoordelijk. Ik heb grote 
bewondering voor de door hem getekende figuren, waaruit veel gevoel voor 
vorm en helderheid spreekt. Aan de vakkundige hulp van de heer Th. C. van 
Hout en de heer A. Th. A. Reynen, hoofd van de afdeling Medische Foto­
grafie, zijn de verschillende fotografieën te danken.
Een grote pluim komt toe aan mevr. B. J. R. Grootendorst-Lieve, die blij­
moedig en accuraat de vele ontwikkelingsstadia, die dit werkstuk kende, 
heeft uitgetypt. Bij het persklaar maken van het manuscript werd zij gehol­
pen door mej. L. W. M. Tempelman en mevr. P. Mey-Fuhlrott.
De vertaling van dit proefschrift werd verzorgd door de heer Th. van 
Winsen. De kosten hieraan verbonden werden ten dele gedragen door de 
Jan Dekker Stichting en de dr. Ludgardine Bouwman Stichting.
Het lijkt mij juist om op deze plaats alle collegae te bedanken, die mij 
hielpen door het geven van adviezen en daadwerkelijke steun, zowel in het 
kader van dit onderzoek als bij het uit handen nemen van andere werkzaam­
heden. De plezierige onderlinge verstandhouding en de grote interesse voor 
elkanders werk heb ik altijd als zeer stimulerend ervaren.
Aan hen, die met zorg en precisie, zo geheel als vanzelfsprekend een bij­
drage leverden, is dit proefschrift opgedragen.
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INLEIDING
Alhoewel er uit de antieke oudheid en vooral uit de 17e en 18e eeuw enkele 
nogal vage beschrijvingen bekend zijn van patienten met chronische diarrhee 
en een slechte absorptie van voedselbestanddelen, is het ziektebeeld darm- 
spruw (coeliakie) niet eerder dan aan het einde van de vorige eeuw voor het 
eerst goed beschreven (hoofdstuk 1). Over de oorzaak en aard van deze aan­
doening is in de afgelopen 20 to t 30 jaren pas enig inzicht ontstaan. Belang­
rijk hiervoor was de ontdekking, dat de ziektemakende factor in bepaalde 
granen, te weten tarwe, rogge, gerst en haver aanwezig is (hoofdstuk 2). Van 
groot nut was verder het aantonen van betrekkelijk karakteristieke afwijkin­
gen van het dunne darmslijmvlies bij spruwpatienten, bestaande uit een ver­
dwijnen van de normaal aanwezige slijmvliesvlokken en een beschadiging 
van de overblijvende oppervlaktecellen (hoofdstuk 3).
Het is op grond hiervan mogelijk geworden om de ziekte goed te definiëren 
en af te zonderen van soortgelijke aandoeningen. Momenteel geldt, dat voor 
het stellen van de diagnose darmspruw er aan tenminste twee voorwaarden 
moet worden voldaan, te weten:
-  de aanwezigheid van bepaalde darmslijmvliesafwijkingen, en
-  een gunstige reactie van de patiënt op een dieet zonder tarwe, rogge, gerst
of haver, een zogenaamd glutenvrij dieet (§ 1.3).
De eerste symptomen van darmspruw treden doorgaans korte tijd na het 
toevoegen van meelprodukten aan het dieet van de zuigeling of peuter, aan 
het licht. Op deze leeftijd heeft de ziekte meestal een vrij heftig beloop. Bij 
het ouder worden van het zieke kind nemen de verschijnselen vaak spontaan 
in ernst af (§ 9.1). Waarschijnlijk als gevolg hiervan is alom de mening ver­
breid, dat darmspruw een kinderziekte is. Men beschouwde tot voor kort 
soortgelijke symptomen op oudere leeftijd als uitingen van een andere darm­
ziekte. Door onderling vergelijk van de slijmvliesafwijkingen en door de 
gunstige invloed van een glutenvrij dieet, welke ook bij deze volwassen 
patienten optreedt, kon aannemelijk gemaakt worden dat darmspruw be­
halve in de jeugd ook op oudere leeftijd kan voorkomen.
Het viel ons op, dat volwassen personen, bij wie de diagnose darmspruw
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gesteld werd, vaak al zeer lange tijd (gemiddeld ruim 13 jaren) duidelijke 
klachten hadden, voordat de arts (en) tot wie men zich gewend had de ware 
aard van hun aandoening onderkende(n). Dit feit was de eigenlijke aanzet 
om een na-onderzoek te doen bij volwassen patienten met darmspruw, met 
de bedoeling om na te gaan onder welk beeld de ziekte zich openbaarde, en 
welke verschijnselen of afwijkingen bij spruwlijders aantoonbaar waren. Dit 
alles met het uiteindelijke doel om enerzijds het ziektebeeld bij volwassenen 
meer bekend te doen worden, en anderzijds om te kunnen aangeven welke 
afwijkingen of verschijnselen de gedachte aan darmspruw bij de onder­
zoekende arts zouden moeten doen opkomen. Bij het verzamelen van ge­
gevens hierover werd geleidelijkaan duidelijk, dat er bij darmspruw ener­
zijds een onderling sterk wisselende, en anderzijds een soms zeer uitgebreide 
verstoring van de absorptie op kan treden (hoofdstuk 7). Aangezien tot 
dusverre slechts weinigen onderzoek hadden gedaan naar de uitgebreidheid 
en de precieze aard van deze absorptiestoornissen, leek het ons nuttig om de 
grote hoeveelheid gegevens, die wij hierover hadden, te publiceren. Het 
was hierbij vooral de bedoeling om enig inzicht te verschaffen in de ver­
schillende soorten mechanismen, welke afwijkingen bij darmspruw kunnen 
veroorzaken.
SAMENVATTING
In ons onderzoek waren betrokken 47 volwassen patienten met darmspruw 
(fig. 6.2), van wie er 36 op het moment van onderzoek nog onbehandeld 
waren, en niet tegelijkertijd aan een andere aandoening leden (fig. 6.1). De 
diagnose darmspruw was bij hen gesteld op grond van de aanwezigheid van 
3 criteria (tabel 1.3), te weten: een abnormaal slijmvlies in het eerste gedeelte 
van de dunne darm, het voorkomen van absorptiestoornissen, en het ver­
tonen van een verbetering op het glutenvrij dieet, of het bestaan van duide­
lijke klachten op kinderleeftijd.
De reden waarom deze 36 patienten met darmspruw naar ons verwezen 
werden, bestond in ongeveer de helft van de gevallen uit de aanwezigheid van 
diarrhee. Bij de overige patienten vormde het optreden van buikpijn, bloed­
armoede of algeheel onwelbevinden de aanleiding, naast enkele minder vaak 
optredende, bijzondere verschijningsvormen (tabel 6.1). Bij navragen en 
lichamelijk onderzoek van deze groep patienten kwamen heel wat meer 
klachten en verschijnselen aan het licht (tabel 8.1). Vrijwel alle voorkomende 
verschijnselen zijn terug te voeren op het bestaan van tekorten aan vita­
minen, mineralen, eiwitten en calorieën, vanwege een gestoorde absorptie 
van voedselbestanddelen door de dunne darm. Als zodanig is geen van deze
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klachten karakteristiek voor darmspruw. De aard van de gevonden afwij­
kingen en de ernst van het ziektebeeld lijken grotendeels bepaald te worden 
door de mate van uitbreiding van de ziekte over de dunne darm, of -  liever 
gezegd -  door de absorptiemogelijkheden van het resterende, gezonde stuk 
dunne darm.
Wat in het voorafgaande gezegd werd over de aard, de uitgebreidheid 
en het wisselvallige optreden van de klinische verschijnselen, geldt in grote 
lijnen ook voor de afwijkingen die bij chemisch onderzoek van bloed, urine 
en ontlasting gevonden kunnen worden. Enkele bepalingen, zoals van het 
haemoglobine-, albumine-, vitamine E-, en folaatgehalte in bloed, of de 
onderzoekingen naar de absorptie van voedselvet, melksuiker of de suiker­
achtige stof D-xylose, zijn bij veruit de meeste onbehandelde patienten 
verlaagd (fig. lO.l.c). De ernst van de waargenomen slijmvliesafwijkingen 
in het eerste gedeelte van de dunne darm lijkt hierbij niet van belang, behalve 
voor wat betreft de absorptie van vet (fig. 7.7) o f het haemoglobinegehalte 
(fig. 7.35). Veel minder vaak worden stoornissen aangetroffen in het gehalte 
aan cholesterol, calcium, magnesium, ijzer, vitamine B12, het enzym alka­
lische fosfatase, of de absorptie van vitamine A  en vitamine B12 (zie resp. 
fig. 8,25, 32, 36, 38,27, 11 en 39 in hoofdstuk 7).
In hoofdstuk 7 is steeds getracht om aan te geven waarom de concentratie 
van bovenvermelde stoffen in het bloed verlaagd is. Over het algemeen ge­
nomen kan gesteld worden, dat dit grotendeels geweten moet worden aan 
een verminderde absorptie van die stoffen door de dunne darm. Bij spruw is 
het darmoppervlak, dat dienst kan doen bij de absorptie, sterk verminderd 
door verlies van darmvlokken en beschadiging van de borstelzoom van de 
darmwandcellen. Bovendien kunnen de resterende darmoppervlaktecellen 
vaak minder goed hun functie vervullen door o.a. afwijkingen in de cel­
structuur. Daarnaast spelen ook optredende verliezen van die stoffen een 
rol, zoals door lekkage van weefselvocht in de dunne darm, verlies van darm­
wandcellen, of verbruik door darmbacteriën.
Tijdens gebruik van een glutenvrij dieet verdwijnen de klachten van de 
patiënt doorgaans snel. Dit is vooral het geval wanneer het klachten be­
treft over diarrhee, tongpijn of mondzweertjes. Symptomen die op een lang­
durig bestaand tekort aan bepaalde stoffen berusten, zoals ontkalking van 
het skelet, bloedarmoede en eiwitgebrek, nemen slechts heel geleidelijk af. 
Verschillende patienten bleven ook na langdurige behandeling klagen over 
moeheid of buikpijn (§ 9.2.3).
Ook de afwijkingen welke door chemisch onderzoek in bloed, urine en 
ontlasting kunnen worden vastgesteld, verbeteren meestal tijdens dieet- 
gebruik. Erg opvallend is deze verbetering voor wat betreft het gehalte aan
IX
cholesterol, albumine, calcium, magnesium, haemoglobine en folaat in het 
bloed, evenals de thrombotest (zie resp. fig. 18, 24, 29, 34, 37, 43 en 21 in 
hoofdstuk 7). Verschillende andere bepalingen laten ofwel een gedeeltelijke 
verbetering, of een groot aantal blijvend gestoorde uitslagen zien, zoals van 
de absorptie van melksuiker, de suikerachtige stof D-xylose, voedselvet, 
vitamine A en vitamine B12, evenals van de concentratie van vitamine E in 
het bloed (resp. fig. 5, 6,17,19,41 en 20 in hoofdstuk 7).
Het heeft er de schijn van, dat de nauwkeurigheid waarmee het voorge­
schreven dieet wordt opgevolgd, van weinig invloed is op de mate waarin 
de absorptie verbetert (fig. 9.5), of op het weer normaal worden van het 
afwijkende dunne darmslijmvlies (fig. 9.6). Het is evenwel niet mogelijk om 
de geldigheid van deze veronderstelling te bewijzen, zolang men niets met 
zekerheid kan zeggen over de wijze van naleving van het voorgeschreven 
dieet (§ 9.2.2).
In de meeste gevallen is het voorschrijven van een glutenvrij dieet alleen al 
voldoende om de patiënt snel te laten opknappen. Het is desalniettemin aan­
bevelenswaardig om de patienten tijdelijk een extra hoeveelheid mineralen 
of vitaminen voor te schrijven, om zodoende de opgelopen tekorten aan 
deze stoffen snel te lenigen. Een enkele keer blijken er uitgebreidere dieet- 
voorschriften nodig te zijn, en moeten ook de hoeveelheden melkprodukten 
of vet in het voedsel beperkt worden (§ 9.3.1). Het kan ook voorkomen, dat 
de patiënt pas enig teken van verbetering vertoont als tegelijk met een gluten­
vrij dieet ook bijnierschorshormon wordt toegediend (§ 9.3.4).
Het niet goed of zelfs in het geheel niet reageren op een glutenvrij dieet 
moet de gedachte doen opkomen, dat er sprake is van een kwaadaardige 
ziekte bij de patiënt (§ 9.4.4). Wanneer dit uitgesloten is, bestaat de mogelijk­
heid dat de patiënt niet lijdende is aan darmspruw, maar aan een andere 
vorm van spruw, welke niet glutengevoelig is (§ 11.4). Tenslotte kan het 
voorkomen, dat de spruwpatient naast zijn darmaandoening nog een 
andere ziekte onder de leden heeft, waardoor onbegrepen klachten of een 
vreemd ziektebeloop verklaard kunnen worden (hoofdstuk 10).
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CHAPTER 1
INTRODUCTION
1.1 H1STORY
The earliest descriptions of diseases of the intestine date back to ancient 
times. The clinical features of malabsorption were described in India as 
early as 15 centuries B.C. (41). The first European treatise was probably 
that of Aretaeus, during the second century of the Christian era (547), 
although his work may have been copied from an earlier author (33). It is a 
general description of patients with chronic diarrhoea, but some passages 
suggest that patients suffering from coeliac sprue were probably among them. 
In this respect it is notable that a female predominance was mentioned and 
that the condition was described as one of a chronic recurrent character, 
manifested by such symptoms as steatorrhoea, flatulence, borborygmi and 
chlorosis. It is also noteworthy that Aretaeus was the first to use the terms 
‘coeliac affection’ and ‘coeliacs’ (547).
The next descriptions of the syndrome appeared during the 17th and 18th 
centuries. They were actually treatises on intestinal catarrh and malabsorp­
tion, and particularly on oral aphthae, and their causes. In 1669, for example, 
Vincent Ketelaer published a detailed description of stomatitis aphthosa 
(called ‘spruw’ in Dutch), and mentioned more or less casually that these 
aphthae could also be found in the intestine and give rise to severe diarrhoea 
which completely exhausts the patiënt (547). In the beginning of the 18th 
century about ten additional theses on aphthae appeared at the University 
of Leiden, which indicates an almost fashionable interest in this syndrome 
and its possible causes and implications. One of those who studied under 
Boerhaave in Leiden at that time was Hillary, who described stomatitis 
aphthosa in patients with malabsorption on Barbados in 1759. Reports on 
the association of aphthae and diarrhoea or malabsorption also came from 
other tropical regions (95,114, 703).
The first accurate description of the clinical syndrome of coeliac sprue 
did not appear until 1888, when Gee published his treatise ‘On the coeliac 
affection’. This description, the accuracy of which has so far scarcely been 
surpassed (305), has since been quoted in full or in part by several authors, 
to  whose publications we refer (164, 234). It seems of importance to note
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that Gee believed he had encountered this syndrome in patients of all age 
groups, although the adults in whom he observed it had nearly always been 
in the tropics. It seems plausible, therefore, that most of these adults were 
actually suffering from tropical sprue. Another interesting point is that Gee 
already noted that in some cases the abdominal symptoms may be of minor 
importance, the clinical picture being dominated by marked cachexia and 
anaemia. Gee also pointed out the importance of restricting the amount of 
farinaceous ingredients in the diet of these patients, and he noted specifically 
that one of his young patients showed distinct improvement on a regimen 
which consisted of the best Dutch mussels.
The contribution which Herter (385) made by focusing attention on the 
growth retardation in coeliac sprue, found its reward in the fact that the 
disease was long known as Gee-Herter’s disease. The name of the Dane 
Hess Thaysen (387) has also been linked with the syndrome as a result of 
the important monograph which he published on coeliac sprue. The cur- 
rently most widely used designation -  coeliac disease -  dates back to the 
1920’s (597).
In the course of the past 25 years, two events have improved and facilitated 
both the diagnosis and the treatment of coeliac sprue. One was the identifi- 
cation of the pathological substrate of the condition; the other was the 
discovery of the importance of gluten. Post-mortem reports on patients 
with tropical sprue had already indicated (114) or described (58, 255, 554) 
morphological changes of the small intestine. For a long time, however, 
these changes were regarded as artefacts resulting from post-mortem auto- 
lysis (387). Paulley (663) is to be honoured as the first investigator to have 
demonstrated with certainty the mucosal abnormalities of coeliac sprue in 
tissue peroperatively obtained from the small intestine. Paulley’s findings 
have been generally confirmed since the introduction of the peroral biopsy 
of the small intestine (185, 779). The knowledge since accumulated con- 
cerning the normal structure of the mucosa of the small intestine and its 
changes in coeliac sprue, has created an important objective method to 
establish the diagnosis and evaluate the course and prognosis of this condi­
tion.
Dicke’s discovery that the cause of the abnormalities of the small intestine 
was to be sought in the presence of a toxic protein fraction from cereals in 
the diet, was published in 1950 (208). Dicke had suspected this for more than 
10 years, but his revolutionary ideas had not been welcomed. The work of 
two other Dutch investigators -  Van de Kamer (453) and Weijers (908) -  
which had actually been designed to prove the harmlessness of wheat once 
and for all, turned out quite deünitely to corroborate Dicke’s hypothesis
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(455). Rational treatment of coeliac sprue has since become possible, and an 
end was put to the wide variety of often one-sided diets used for this pur- 
pose, e.g. the milk-protein diet (423, 749), the banana diet (346), fruit diet
(261) and meat diet (124).
1.2 TERMINOLOGY
A large number of different terms are in current use to refer to the syndrome 
associated with idiopathic steatorrhoea and abnormalities of the intestinal 
mucosa (table 1.1). The use of so many different names would have been
Table 1.1. The various terms in use to denote patients with a sprue syndrome.
Coeliac disease 
Adult coeliac disease 
Idiopathic coeliac disease 
Coeliac affection 
Coeliac condition 
Coeliaca
Coeliac syndrome 
Primary coeliac syndrome
Coeliac sprue 
Coeliac sprue disease 
Sprue
Sprue nostra 
Adult sprue 
Sprue syndrome 
Idiopathic sprue 
Symptomatic sprue 
Temperate sprue 
Non-tropical sprue 
Idiopathic non-tropical sprue
Atrophic jejunitis 
Idiopathic mucosal atrophy
Gluten sensitivity 
Gluten sensitive diarrhoea 
Gluten enteropathy 
Gluten induced enteropathy 
Gluten sensitive enteropathy 
Gliadin induced enteropathy
Steatorrhoea syndrome 
Primary steatorrhoea 
Idiopathic steatorrhoea 
Adult idiopathic steatorrhoea
Malabsorption syndrome 
Primary malabsorption 
Primary malabsorptive disease 
Intestinal insufficiency 
Primary intestinal insufficiency 
Chronic intestinal indigestion
Gee’s disease 
Gee-Herter’s disease 
~ Gee-Thaysen’s disease 
Herter’s infantilism
less confusing had the (usually ill-defined) criteria applied been less diverse 
(736). Fortunately, the tradition of introducing yet another name for this 
syndrome when publishing personal observations seems to have largely 
disappeared. Agreements on diagnostic criteria have greatly contributed to 
this (section 1.3). It has not been our intention to coin a new term for this 
disease in this monograph, but a choice had to be made between two names
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which have long been used by many authors: namely ‘coeliac disease’ and 
‘coeliac sprue’.
The adjective ‘coeliac’ comes from a Latin corruption of the Greek word 
‘koilia’, which simply means abdomen. The significance of this adjective 
is clearly expressed in the anatomical nomenclature, e.g. coeliac artery, 
coeliac ganglion, etc. The designation ‘coeliac disease’ therefore does not 
mean much more than disease of the abdomen.
The noun ‘sprue’ is actually an anglicised version of the Dutch word 
‘sprouw’ or ‘spruw’. In 1880 Manson-Bahr adopted the word as a name for a 
malabsorption syndrome which he observed in patients in the tropics (481). 
In the former Dutch colonies in the Far East, this condition had long been 
known as native sprue or ‘Indische sprouw’ (95, 703). In fact the usage of 
the word ‘spruw’ is due to the frequent presence of one particular symptom 
in this malabsorption syndrome: aphthous stomatitis.
The word ‘spruw’ really means thrush. Etymologically it is thought to be 
related to sprinkling, and the original meaning is believed to have been 
sprinkling or spattering disease (930). The Dutch use the word not only for 
inflammation of the oral mucosa but also for inflammatory changes of other 
mucous membranes, e.g. those of the vagina. It therefore seems to be 
applicable also to inflammation of the mucosa of the small intestine.
In view of all these considerations we have a distinct preference for the 
designation ‘coeliac sprue’. Additions such as idiopathic or primary seem 
to us superfluous, and adjectives such as adult or non-tropical incorrect. 
Further specification such as gluten-sensitive seems undesirable as long as 
the real identity of the harmful cereal protein and its exact role in the patho­
genesis of the syndrome have not been established with certainty (section 2.2).
1.3 DEFINITION OF COELIAC SPRUE
It is difficult to define a syndrome when its true cause and pathogenetic 
mechanism are only partially known. In the case of coeliac sprue the diffi- 
culties are increased because of the many expressions of the condition, and 
the sometimes variable response to treatment. Manifestations of the dis­
ease can occur moreover in early childhood, but also at an advanced age. 
The symptoms may disappear rapidly and spontaneously, or persist and 
become worse. Yet it is evident that agreements will have to be reached con- 
cerning a definition in order to break the deadlock which has existed for 
some time. We need only think of the numerous names now being used with 
reference to various spruelike conditions (table 1.1).
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This definition will have to account for a num ber of features or phenom- 
ena involved in this disease, e.g. malabsorption, villous abnormalities, and 
improvement during gluten withdrawal. One of the major difficulties, how- 
ever, is that we do not know to what extent these features are conditiones 
sine qua non, while on the other hand the above mentioned phenomena may 
sometimes also occur in other diseases. This is evident so far as the malab­
sorption and the villous abnormalities are concerned, whereas some in- 
vestigators have maintained that gluten abstinence can also be beneficial in 
affections of the small intestine other than coeliac sprue (54, 166, 724, 873).
In patients with a classical sprue syndrome, malabsorption is always 
evident and often extensive. Since it has become customary to do a jejunal 
biopsy on patients with dermatitis herpetiformis, it has been established that 
malabsorption needs certainly not be present in all patients with mucosal 
changes of the jejunum (section 10.2). Follow-up studies of individuals in 
whom coeliac sprue had been diagnosed in childhood, have confirmed this 
(573, 776), as well as investigations in relatives o f  coeliac patients (570, 709, 
714). One may therefore distinguish a manifest (overt) and an occult type of 
coeliac sprue.
The presence or absence of villous abnormalities in coeliac sprue, and the 
question whether these are sufficiently marked to be called sprue lesions, are 
rather controversial subjects. In most cases one finds a flat, avillous mucosa; 
but less serious changes (e.g. a pattern consisting of convolutions) can also 
occur in coeliac patients. It has even been suggested that an increased lym- 
phocyte count in the epithelial layer of the intestinal mucosa should be 
accepted as a criterion of abnormality (297). Experiments by Weinstein 
(901) have demonstrated that, in some patients with dermatitis herpetiformis, 
the apparently normal mucosa of the small intestine can become abnormal 
after administration of very large amounts of gluten. Such patients may be 
suffering from an atypical form of coeliac sprue for which Weinstein in- 
troduced the term ‘latent sprue’. A few other investigators have also men­
tioned coeliac patients in whom mucosal abnormalities did not develop 
until after gluten provocation (129).
The response to a gluten-free diet can also vary widely: some patients 
show an excellent response to gluten abstinence, whereas others show only 
limited improvement. Several authors have suggested that this may be due 
to  less than optimal adherance to the gluten-free diet, but no evidence has 
been presented to clinch this argument. Moreover, there are several well- 
documented case histories of patients who required glucocorticosteroids in 
addition to a gluten-free diet in order to produce a favourable turn in the 
course of their disease (section 9.3.4).
5
In spite of the above mentioned uncertainties, the general view is that, in 
principle, the following criteria should be fulfilled to establish a diagnosis of 
coeliac sprue:
a. the presence of morphological changes in the jejunal mucosa;
b. improvement of these changes upon gluten withdrawal;
c. exacerbation after reintroduction of gluten (90, 876).
Paediatricians have already reached agreement about such a definition
(586), and for them the above mentioned definition seems to be workable. 
The situation in children differs from that in adults, however, in that im­
provement in response to a gluten-free diet is always complete. Moreover, 
provocation of jejunal mucosal changes by reintroduction of gluten after 
obtaining a remission is nearly always required in children to differentiate 
coeliac sprue from other diseases which can produce similar mucosal 
lesions. In children, this provocation rarely has serious consequences (876), 
but this does not apply to adults (141, 143). Routine gluten provocation in 
adult patients is therefore generally rejected, and resorted to only in excep- 
tional cases (90, 164). Adults, unlike children, frequently show only an in­
complete response to gluten withdrawal, particularly so far as the morpho­
logical changes of the jejunal mucosa are concerned (section 9.2).
In actual practice, therefore, the above mentioned diagnostic criteria are 
not always sufficiently met in adult patients. In clinical medicine it is not 
always possible or justifiable to collect all the parameters that are to be 
collected. Table 1.3 shows that, so far, no investigator has fully observed 
the above mentioned, so called basic definition. There is in actual fact a 
choice between two alternatives. One is to apply a very strict definition so 
that the number of ‘true’ coeliac patients remains very small and the ‘un- 
classified’ group is very large (736). In that case a discussion about variants 
of the villous morphology, symptoms, or response to treatment is super- 
fluous with regard to coeliac sprue but relevant with regard to ‘unclassified’ 
sprue. This is in fact not much more than shifting the problem. The other 
alternative is to hold the view that coeliac sprue is a disease with a wide
Table 1.2. The different forms of presentation of coeliac disease, and their terminology.
CRITERION PRESENT ABSENT
Mucosal lesions Coeliac sprue Latent coeliac sprue
Malabsorption Overt coeliac sprue Occult coeliac sprue
Previous history Coeliac sprue of childhood Adult onset coeliac sprue
Improvement on diet Responsive coeliac sprue Refractory sprue
Relapsing on normal food Permanent gluten-intolerance T  ransient gluten-intolerance
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variety of expressions (901), which do not always fulfi.1 the above mentioned 
criteria (table 1.2).
The criteria so far applied by the various investigators to establish a 
diagnosis of coeliac sprue amount to five phenomena (table 1.3). As the 
table shows, all investigators have so far held th a t mucosal lesions should be 
present if the term coeliac sprue is to be applied. How severe or how char-
Table 1.3. The criteria for the diagnosis of coeliac sprue, as used by various authors.
CRITERION
MUCOSAL
LESIONS
MALABSORPTION
unspecified
clinical
biochemical
radiological
PREVIOUS
HISTORY
IMPROVEMENT 
ON DIET 
unspecified 
clinical 
biochemical 
morphological
RELAPSE ON 
NORMAL FOOD
unspecified
clinical
biochemical
morphological
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acteristic these mucosal lesions should be, however, is still a controversial 
question. Many investigators restrict the term coeliac sprue to patients 
whose jejunal biopsy specimen is completely flat (128, 164, 182, 553, 601, 
668, 736). In our opinion, this attitude does not adequately account for 
patients with a convoluted mucosa. In any case it is advisable that patients 
with a flat mucosa but without signs of crypt hyperplasia should not be 
included in the group of coeliac patients unless several other criteria warrant 
the diagnosis (section 11.4). The symptoms of malabsorption can be clinical 
as well as biochemical. Radiological changes, which some investigators use 
as diagnostic criterion (247, 724) are in our opinion too unspecific to be of 
much use. A history of a malabsorption syndrome in early childhood has 
to be very typical (section 9.1) to be used as an argument in establishing the 
diagnosis. The effect of introducing or discontinuing a gluten-free diet can 
be evaluated on the basis of clinical, biochemical or morphological para­
meters, or on a combination of them. In our opinion there are no arguments 
to regard patients as non-coeliacs who require other dietary restrictions or 
glucocorticosteroids in addition to a gluten-free diet.
A diagnosis of coeliac sprue is usually accepted if a patiënt fulfils at least 
two of the criteria mentioned in table 1.3 in addition to the presence of an 
abnormal jejunal mucosa. This seems sufficiënt to us to justify presentation 
as such for the time being. As long as our knowledge of the exact nature 
of the aetiology and pathogenesis of the disease is as limited as it is, it seems 
ill-advised to apply excessively strict definitions. It is advisable however, to 
specify in each publication exactly which criteria were applied, and to 
apply strictly the standards chosen.
1.4 INCIDENCE
Symptoms of coeliac sprue can occur at any point in a lifetime. The majority 
of patients develop symptoms at an early age, usually a few months to a year 
after introduction of cereal products (i.e. of gluten) in the daily diet (581). 
In some 50% of the cases the disease is diagnosed prior to the second year of 
life (358, 581). The symptoms disappear quickly after gluten withdrawal and 
often do not return when the gluten-free diet is discontinued after a few 
years (776, 875). Even without gluten withdrawal the symptoms often dis­
appear spontaneously after a few years (section 9.1). Follow-up studies have 
shown, however, that unmistakable mucosal changes persist in all children 
and adults in whom the diagnosis has been made on sound evidence (573, 
614, 776, 936). It can be maintained, therefore, that the maxim ’once a
coeliac, always a coeliac’ (233) is certainly valid, even though some investi- 
gators do not want to exclude the possibility of transient gluten intolerance 
(584, 883). Many patients do get a recurrence of symptoms even after a 
lengthy remission (53, 776).
Careful questioning of patients in whom coeliac sprue is diagnosed in 
adult life, reveals that some 25% indicate having had symptoms suggestive 
of coeliac sprue in childhood (53, 60, 159). We personally found anamnestic 
indications of childhood coeliac sprue in two-thirds of our patients. For the 
time being it remains a moot question whether the remainder of the adult 
patients have really acquired the disease later in life or have suffered from 
an asymptomatic or latent form o f the disease in childhood and ever since.
In view of the above considerations, the incidence o f coeliac sprue does 
not diminish after the first few years of life but remains constant or may 
even show a slight increase. The incidence of clinical symptoms does show 
two peaks, however (fig. 1.1): one during the first few years of life, and the
Fig. 1.1. The incidence of clinically manifest coeliac sprue. On the left the age distribution 
at the time of diagnosis in children is given (Hamilton et al., 1969; Young et al., 1971), 
while the age distribution of our 47 adult patients at the time o f diagnosis is drawn on 
the right. The unshaded area in the right figure represents the percentage of patients
without a history of childhood symptoms.
other during the fourth and fifth decades. Which of these two peaks is 
higher seems to vary regionally (14, 24, 569), and probably depends on the 
type of medical care available or on the knowledge of and interest in this 
syndrome.
It has been known for some time that coeliac sprue can occur in several 
members of a family. Extensive studies, focused on the familial occurrence
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of coeliac sprue, have confirmed the suspected higher incidence (126, 625, 
844). Most investigators found that some 10% o f the first-degree relatives of 
coeliac patients examined showed unmistakable mucosal changes consistent 
with coeliac sprue (537, 570, 709, 821). Some found a frequency of almost 
20% (31). However, in none of the above mentioned studies were biopsies 
done in all family members, and the percentages given may therefore be 
slightly exaggerated. Individuals with health complaints are probably more 
willing to undergo a jejunal biopsy than those who feel well. This suspicion 
seems to be confirmed by the fact that Rolles et al. (714) found a frequency 
of 5.5% in a study in which all family members were examined.
Familial occurrence of a disease can be based on environmental as well as 
on genetic factors. It seems unlikely, however, that the increased familial 
frequency of coeliac sprue is determined largely by environmental factors, 
because an increased probability in marital partners, school children or 
military recruits has never been established. The role of genetic factors in 
this context seems more important. This is also suggested by the frequent 
presence of certain hereditary leucocyte antigens in coeliac patients, e.g. 
HLA 8 and HLA-DW3 (258, 363, 475, 820). The mode of transmission of 
these hereditary factors is still obscure. It is suspected that transmission is 
determined by a number of different genes, each of which either increases 
or reduces the risk that coeliac sprue develops. The number of predisposing 
factors present in the individual determines, according to this conception, 
whether he or she may develop coeliac sprue (709). The actual development 
of the disease is in addition dependent on other factors, as is clearly illustra- 
ted by the fact that discordance for the disease is sometimes observed in 
monozygotic twins (406, 581, 885). The exact nature of the last mentioned 
factors is still obscure (571).
It looks as if coeliac sprue occurs in particular in Europe, N orth America 
and Australia, but the number of cases reported from other continents has 
increased in recent years (398, 599, 881), although it represents only a frac- 
tion of the incidence as for example in Europe. The incidence in Sweden is 
estimated to be 1:3000 births (247); British estimates range from 1:1850 
(571) to 1:1100 (582). The calculated frequency in Switzerland is as high as 
1:900 (785) and that in Ireland 1:300 (625). Data on the incidence in The 
Netherlands have not yet been published. On the basis of the annual number 
of hospitalised infants under the age of 1 with coeliac sprue reported to 
the Dutch Foundation for Medical Registration, an incidence of 1:6250 is 
obtained when dividing these registered coeliacs by the total number of 
infants (healthy or ill) in that age category (672). In view of the fact that only
10
15-35% of infants with coeliac sprue are identified as such during the first 
year of life (358, 581, 936), the true incidence of coeliac sprue is probably 
3-6 times as high, i.e. roughly 1:1500. Another possible way of estimating 
the incidence in The Netherlands is by dividing the national consumption 
of gluten-free flour, being approximately 14.000 kgs a year (670) by the 
average consumption per patiënt estimated at 65 kgs a year for an adult. 
This calculation yields a total number of merely 215 patients on a gluten- 
free diet, i.e. a incidence of 1 :60.000. The total membership of the Dutch 
Coeliac Society is even slightly greater (126 children, 251 adults; 671). It 
should be emphasized, however, that calculations on the incidence of coeliac 
sprue cannot be anything but very inaccurate.
The rate of detection of the disease is dependent on the familiarity of the 
attending physician with the many manifestations of coeliac sprue. We have 
the strong impression that the knowledge of the symptomatology of coeliac 
sprue is still very imperfect. In the Netherlands, some physicians are heard 
to state that they have never seen a case of coeliac sprue in the course of 
their career, whereas others detect a number o f new patients every year. The 
fact that in our adult patients the mean interval between onset of symptoms 
and diagnosis was some 13 years (!) indicates that the diagnosis is only too 
often being overlooked. The true incidence o f clinically manifest coeliac 
sprue, therefore, is probably much higher than the above mentioned calcu­
lations suggest; to say nothing about the hardly detectable cases of occult 
coeliac sprue. It is consequently difficult to escape the impression that the 
differences in the reported incidence of coeliac sprue are in part based on 
differences in medical care and diagnostic acumen. In Asian children living 
in England, for example, the disease is found as frequently as in English 
children (631), although coeliac sprue is reportedly rare in India (881).
There are several other possible explanations for the discrepancies in the 
reported incidence of coeliac sprue. For example, the frequency of HLA 8 -  
the leucocyte antigen present in 60-90% of coeliac patients (13, 258, 416, 820)
-  proves to differ widely in different parts of the world. HLA 8 is most fre­
quently present in Caucasians who seem to have also the highest probability 
of coeliac sprue. Histocompatibility testing has shown that the frequency of 
HLA 8 is low in the peoples of Asia or Central and South America (395), 
where coeliac sprue seems scarcely to occur, if a t all. Another possible deter­
minant of the differences in incidence is the mean amount of cereals (gluten) 
contained in the diet of certain population groups. Black (74) found a 
higher incidence of coeliac sprue in that socio-economic group of the pop­
ulation of Scotland which had a greater per-capita consumption of bread. 
However, the incidence of coeliac sprue in the various countries correlates
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There are, however, no objective data on the possible influence of the time 
of gluten introduction in the diet on the development of coeliac sprue in 
children. As with other possible determinants, this argument remains specu- 
lative.
only moderately with the mean per-capita consumption of wheat (582). 
This may be due to differences in methods of baking bread (679) or the use 
of other wheat strains. Many publications indicate differences in baby- 
feeding habits as a cause of the variable incidence of coeliac sprue (581).
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CHAPTER 2
PATHOGENESIS OF COELIAC SPRUE
2.1 INTRODUCTION
Although the coeliac sprue syndrome was accurately described almost 100 
years ago (305), little is known with certainty about its aetiology and 
pathogenesis at the present time. On the other hand it cannot be denied that -  
particularly in the past 25 years -  unmistakable advances have been made in 
this respect. An important event in this context was the discovery that the 
presence in the diet of a protein fraction from certain cereals caused the 
symptoms of coeliac sprue (208, 209). On the other hand, the detection of 
villous abnormalities and inflammatory changes in the mucosa of the small 
intestine (663) and the introduction of a simple and elegant method of ob- 
taining biopsy specimens from the intestinal mucosa (185, 779) facilitated as 
well as stimulated research into the nature of this disease and its pathogenesis. 
Another important advance was made with the recent introduction of facil- 
ities for culturing mucosal biopsies, on the basis of which research into the 
pathogenesis of the disease is possible in vitro (109,446, 859).
The causative factor and a few theories on the pathogenesis of coeliac 
sprue will be discussed in the following sections.
2.2 CAUSATIVE FACTOR
Research into the causative factor in coeliac sprue did not really begin in 
earnest until after the discovery of the noxious influence of gluten by Dicke 
(208, 209). On the basis of clinical experiments this investigator was able to 
demonstrate that the factor noxious to coeliacs was contained in the protein 
fraction of wheat and rye flour. In addition he noted that this factor con- 
tinued to be present after treatment of this protein with a diluted salt solu- 
tion and that, according to the definition of Osborne (652), it had therefore 
to be gluten.
On the basis of its solubility in ethanol, gluten can be separated into a 
soluble gliadin fraction and an insoluble glutenin fraction. At further
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chemical analysis, both fractions prove to consist of different subfractions 
(459). For many years, several investigators have concerned themselves 
with attempts at further fractionation and determination of these sub­
fractions. It was found that the method of electrophoretic separation could 
be regularly improved, as a result of which subfractions initially regarded as 
pure were later found to consist of several components (254). Moreover, 
differences were found according to the origin and purity of the wheat 
strains involved. As a result of these circumstances investigators have long 
been disagreeing about the number of fractions, their nature and their 
nomenclature (254).
On the basis of several observations it seems likely, for the time being, 
that a-gliadin -  one of about 40 different gliadin components (459) -  is the 
fragment which determines the noxious influence of gluten (260, 374, 459). 
This a-gliadin probably has a coiled, fibril-like structure and a molecular 
weight of some 30,000. lts amino acid composition is nów partly known. In 
particular it contains many consecutive molecules of glutamine and glu- 
tamic acid beside a relatively large number of proline molecules (459). 
Further breakdown of a-gliadin with the aid of trypsin yields a fraction with 
a molecular weight of 18,000, which is believed to carry the toxic properties 
of a-gliadin (375).
According to Phelan et al. (679), the noxious effect of gliadin is not local- 
ized in a particular peptide fragment but determined by the presence of 
carbohydrates bound to this gliadin. According to their observations, the 
toxic properties of gliadin disappear after decomposition of these compounds 
with the aid of carbohydrases.
It is to be noted, meanwhile, that flour made of cereals other than wheat 
and rye can sometimes also be harmful for coeliac patients (section 9.2.1). 
The protein fractions from these other cereals differ from gliadin not only in 
name but also in structure (39). This may stimulate further research into the 
causative factor, as does the fact that there are also nutrients with glutamine- 
bearing peptides (e.g. meat, eggs, rice and corn), which cause no changes or 
complaints (454).
It is evident that, despite extensive research by many investigators, there 
is as yet no certainty about the precise nature of the factor in the gluten 
fraction of wheat and rye flour or in the protein fraction of other cereals, 
which causes the lesions of the small intestine and the clinical symptoms in 
patients with coeliac sprue.
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2.3  PATHOGENESIS
2.3.1 Peptidase deficiency theory
The first investigator to suggest that coeliac sprue might be caused by an 
enzyme deficiency was Frazer (288, 290). His hypothesis was based on the 
observation that gliadin, after incubation with fresh intestinal mucosa of 
hogs, lost its toxicity. This theory has been tested by several other investi­
gators (89,231, 854).
It postulates that a coeliac patiënt is suffering from a primary deficiency of 
one or several intestinal peptidases which normally ensure complete decom- 
position of gliadin. This deficiency is believed to result in accumulation of a 
given toxic peptide in or near enterocytes, which peptide damages the cell 
by disrupting the lysosomes (705).
Several observations have seemed to confirm this theory, for deficiency of 
dipeptidases in the mucosa of untreated coeliacs has been demonstrated by 
several authors (150, 224, 231, 516). In addition it was found that, when in- 
cubated with a half-digested gluten solution, jejunal mucosa specimens 
from untreated patients released fewer amino acids such as proline and 
glutamine than did normal jejunal biopsy specimens (168, 230).
According to this theory the favourable effect of gluten withdrawal is 
quite understandable, and the influence of corticosteroids can be explained 
by their stabilizing effect on the lysosomal membrane (89).
During treatment with a gluten-free diet, however, the jejunal mucosa ré­
sumés normal peptidase activity (231, 285), and this phenomenon is one of 
the principal arguments advanced by opponents to reject this theory: the 
diminished peptidase activity is apparently not a primary but a secondary 
phenomenon. A similar phenomenon is the decrease in lactase activity in the 
jejunal mucosa of untreated coeliacs. This lack of activity also disappears 
during treatment with a gluten-free diet (191, 231, 285). The only possibility 
to uphold this theory is to assume the existence of a primary deficiency 
of an enzyme not so far identified. However, suggestions in this direction 
(150,454, 489) have not yet been confirmed or proven to be unlikely (926).
2.3.2 Immunological theory
At this time, the theory which aims to explain the abnormalities in coeliac 
sprue in immunological terms, has more advocates than the peptidase defi­
ciency theory. The principal arguments advanced in support of an immuno­
logical pathogenesis a re : the altered proportions of immunologically com-
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petent cells in the lamina propria of the intestinal mucosa (alterations which 
differ according to various investigators; 172, 232, 738, 810); changes in the 
serum immunoglobulin levels, e.g. increased IgA and decreased IgM (28, 76, 
396, 810); and the presence of antibodies against gliadin (12, 267, 465, 472) 
and against reticulin (17, 107, 252, 501, 544, 766) in the serum of coeliac 
patients. Other arguments are the regular finding of an atrophied reticulo- 
histiocytic system (561, 568), and the fact that administration of glucocor- 
ticosteroids has proved to be an effective aid in combating the disease symp­
toms. Moreover, identical mucosal lesions have been found in some patients 
with acquired immunodeficiency (108, 166, 246) and in test animals which 
were rendered immunodeficient (269).
The immunological theory postulates that coeliac sprue patients have an 
intolerance to gliadin which may be based on inability to develop normal 
tolerance to gliadin antigen, normally acquired by production of local anti­
bodies (268). As a result, the presence of gliadin in the jejunal lumen gives 
rise to a local hypersensitivity reaction. For the time being, however, both 
the nature of this local reaction and its mechanism of action remain obscure 
(29,222, 397,781).
There are several conceivable ways in which this immunological reaction 
might be produced. It may be that gliadin binds itself to enterocytes and 
then attracts anti-gliadin antibodies. The enterocytes would consequently be 
destroyed, either directly (antibody mediated cytotoxicity) or via a cellular 
immune response (cel) mediated toxicity). On the other hand, gliadin could 
prompt the production of certain local antibodies in the jejunal mucosa, fol- 
lowed by local formation of an antigen/antibody complex which causes 
damage to the enterocytes. Finally, it is not inconceivable that, in coeliac 
patients, abnormal lymphocytes circulate which bind the gliadin penetrating 
the intestinal epithelium and so give rise to tissue damage (29, 270, 826).
Apart from the above mentioned arguments, observations made by Shiner 
and Shmerling (781, 782) also corroborate the immunological theory. These 
investigators found that, after gluten provocation in treated coeliacs, first the 
endothelial cells of the capillaries in the lamina propria begin to swell, and 
that subsequently the basement membrane becomes thicker and the number 
of plasma cells in the lamina propria increases. This increase in plasma cells 
is accompanied by increased local synthesis of immunoglobulins against 
gliadin peptides (259, 260, 520). The serum complement level also falls 
(223, 725); this is caused by precipitation of complement in the basement 
membrane of the mucosa (223, 781). Finally, it is a striking phenomenon 
that the intestinal epithelial layer in coeliac sprue patients shows a marked 
increase in interepithelial lymphocytes (266,297,412,782).
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2.3.3 Other theories
On the basis of purely theoretical considerations (77) and of experience 
gained with experimental animal models (616, 708), other theories on the 
pathogenesis of coeliac sprue have been evolved. In this context it does not 
seem useful to discuss these theories and hypotheses in detail. An exception 
may be made for the lectin theory recently advanced by Weiser et al. (904). 
These investigators postulated that enterocytes in coeliac sprue patients 
function abnormally and are prematurely destroyed because of the fact 
that gliadin, or a fraction o f it, attachés itself to the cell membrane o f the 
enterocytes, thereby acting as a lectin, which reaction initiates cell toxicity. 
This attachment is believed to be effected as a result of the presence of ab- 
normal glycoproteins in the cell membrane, or as a result of deficient hydro- 
lysis of gliadin (904).
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CHAPTER 3
MORPHOLOGY OF THE SMALL INTESTINE UND ER 
NORMAL CONDITIONS AND IN  COELIAC SPRUE
3.1 GENERAL INTRODUCTION
In the small intestine as in nearly every other organ, form and function are 
related. And in this case, too, interaction is bidirectional. On the one hand, 
the function of the small intestine is determined by its structure, and on the 
other hand the structure of the small intestine seems to be subservient to the 
function which this organ is expected to fulfil. This interdependence prevails 
in normal circumstances as well as in diseases. For a better understanding of 
the function of the small intestine, we believe it is useful first to present a few 
remarks on the architecture and structure of the small intestine, and on the 
changes to which they are subject in patients with coeliac sprue. It is not our 
intention to give a detailed description of the morphology of the small in­
testine. More detailed data can be found in textbooks on anatomy or in 
other publications (775, 783, 857).
3.2 THE NORMAL SMALL INTESTINE
3.2.1 Macroscopic anatomy
Reports on the length of the small intestine range from 3.5 m to 7 m (860). 
One of the factors which influence its length is the muscle tonus, by which 
the length during operation and post-mortem examination exceeds that 
found at radiological examination for example. At post-mortem examina­
tion, the length of the small intestine varies, from hardly 2.5 m to some 8 m 
(843), while during intubation a length of 2.16-3.37 m has been found (75). 
This fairly long bowel lies coiled up in the abdominal cavity, which is made 
possible by a rather summary fixation to the posterior abdominal wall. 
Only the duodenum, of which the proximal part is localized retroperitone- 
ally, and the terminal loop of ileum are more or less fixed. The jejunum and 
ileum ly in a double-layered, loosely draped mesenterial membrane, and can 
move freely. In between the layers of the mesentery are localized the arterial
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and venous vessels, the lymphatic vessels and the autonomie nerve fibres.
The small intestine is divided into duodenum, jejunum and ileum. The 
duodenum is 12 inches long and its junction with the jejunum is character- 
ized by a bend (the duodenojejunal flexure) at the level of the ligament of 
Treitz. On the distal side the end of the jejunum is not sharply defined, and 
no real demarcation indicates its transition to the ileum. The boundary 
between jejunum and ileum is arbitrarily taken to  be localized at two-thirds 
of the total length of the small intestine (860). The jejunum differs from the 
ileum in that it has a larger diameter and a thicker wall.
The wall of the small intestine consists of the following layers, from the 
outside to the inside: serosa, lamina muscularis propria (of which the outer 
part contains muscle fibres with a longitudinal, and the inner part with a 
circular course), submucosa and mucosa. The mucosa is characterized by 
marked plication, especially in the proximal jejunum ; more distally the 
number of plicae slightly diminishes. These folds, the so-called plicae cir- 
culares (valvulae conniventes or Kerckring folds) are reduplications of the 
mucosa which are kept together by the submucosa. Their course is usually 
not quite circular but they extend to halfway o r two-thirds of the circum- 
ference. They remain present also as the bowel distends (775). In addition 
there are irregular folds, created by the peristaltic contractions.
The mucosa of the small intestine is covered with finger or tongue shaped 
projections, which are called villi. These are present throughout the small 
intestine, and only just visible with the naked eye. They give the mucosa a 
velvet-like appearance. For better evaluation of the length and shape of the 
villi, a magnifying-glass or dissecting microscope has to be used.
3.2.2 Stereomicroscopic aspect o f  the mucosa
Our current knowledge of the structure of the villi of the small intestine 
dates back to the time when it became possible to take biopsy specimens 
from the small intestine perorally (185, 779). The mucosa of the small in­
testine has since been examined in many situations, and one of the findings 
was that the shape of intestinal villi can vary rather widely (fig. 3.3). The 
normal villi are cylindrical, finger-like structures with a length of 0.5-1 mm. 
They are usually described as finger-shaped. However, their shape varies as 
widely as their length, and differs locally within the intestine, per individual, 
and probably also per geographic region (42). Especially in the duodenum, 
the villi are often of a different shape, i.e. they are less slender, more broad- 
ened, and thus more reminiscent of leaves or tongues than of fingers. Distal 
to the duodenojejunal flexure, these leaf-shaped villi are observed only
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sporadically. The villi in the ileum are usually somewhat shorter and also 
more widely interspaced. Nevertheless, the villi are as a rule lying so closely 
together that the crypt openings are not readily recognizable.
3.2.3 Microscopie morphology o f the mucosa
The histological section of a peroral biopsy specimen from the small in­
testine as a rule shows not much more than the mucosa. In some cases, also 
part of the submucosa can be observed beneath the lamina muscularis 
mucosae. The mucosa consists of an epithelial layer of cylindrical cells 
called enterocytes, which covers the lamina propria on the side of the in­
testinal lumen (fig. 3.1). The lamina propria constitutes the interior mass of
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Fig. 3.1. Diagram of the anatomical organization of the small intestinal mucosa. The 
kinetic cell compartments are given on the left, while the main histological elements are 
summarized on the right.
the villi of the small intestine. It is within this lamina propria that the small 
blood vessels, lymphatics and nerves extend. In addition the lamina propria 
contains smooth muscle fibres, reticulin fibres, elastin filaments and various 
cells, chiefly lymphocytes, plasma cells, macrophages and eosinophilic 
cells. The presence of these cells is indicative of the important role which the 
lamina propria plays in the defence of the intestinal wall against micro- 
organisms and toxic substances from the lumen.
Villi and crypts are readily recognizable in a well-cut histological section.
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The villi vaguely resemble coniferae, owing to the corrugated course of the 
epithelial layer which probably results from fixation of the tissue or from 
contraction of the smooth muscle tissue. The cylindrical enterocytes show 
no signs of degeneration at the tip of the villus, where they are ultimately ex- 
truded, at the so-called extrusion zones. Interspersed with the enterocytes 
one observes occasional goblet cells, and in addition lymphocytes or even 
granulocytes are sometimes found in the epithelial layer (297, 757). The villi 
are lined with functionally mature enterocytes. Maturation and production 
of these cells take place in the Lieberkühn crypts. These crypts, which ex- 
tend within the lamina propria as far as the muscularis mucosae, are actually 
short tubules which supply the enterocytes for the lining of the intestinal 
villi (fig. 3.1). In the histological sections the crypt epithelium is often ob- 
served to continue in the epithelial layer of the intestinal villi, but some 
crypts show no continuity (fig. 3.3.b). In the past, these features have been 
ascribed to tangential cutting of the jejunal biopsy specimen, but analytical 
studies by Cocco et al. (146) have shown that these apparently separate 
tubules may communicate with each other as well as with the villi. Particul- 
arly in the jejunum, the crypts may consist of several tubules, whereas in the 
ileum one usually finds only one crypt tubule per villus (146).
The crypts contain at the bottom the so-called undifferentiated cells which, 
through mitosis and differentiation, supply both the enterocytes and the 
goblet cells. In addition one finds endocrine cells and Paneth cells. The func­
tion of the latter has so far remained obscure. Apart from their role in cell 
production, the crypts of the small intestine are possibly also important in 
some secretory processes of the mucosa of the small intestine, e.g. the secre­
tion of mucus, intestinal hormones and probably also of fluids and electro- 
lytes (378).
The crypts can be divided into a proliferative compartment, where cell 
production takes place, and a maturation compartment which consists of 
cells that gradually differentiate to fully developed, mature enterocytes 
(fig. 3.1). These enterocytes are pushed up and line the intestinal villi. The 
enterocytes of the intestinal villi as a whole are called functional com­
partment (894) (fig. 3.1).
3.2.4 Ultrastructure o f the enterocyte
The cylindrical, functionally mature enterocytes carry their nucleus in the 
basal part, while the other cell organelles are contained in the apical half 
(fig. 3.2). These organelles include the mitochondria, the Golgi apparatus, 
the smooth and the rough endoplasmic reticulum, the ribosomes and the
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Fig. 3.2. Diagram of a normal enterocyte, showing the arrangement of the various intra- 
cellular structures (Redrawn from Trier et al., Gastroenterology 49: 575, 1965; with 
permission of the author and publishers).
lysosomes (860). On the side of the lumen the cell membrane forms the so- 
called brush border -  a collection of finger-shaped cell extensions called 
microvilli. These microvilli contain some central supporting fibres which 
arise from a firm network beneath the brush border: the terminal web. It is 
probably from these fibrous structures that the enterocytes derive the firm- 
ness of their apical wall. The terminal webs of adjacent cells connect 
through the so-called tight junctions. On the side of the intestinal lumen 
these junctions seal the intercellular spaces almost hermetically while still 
permitting them to distend fairly freely. The microvilli enlarge the surface 
area of the interface between enterocytes and intestinal lumen by about 
factor 30 (860). On top of the brush border lies the so-called fuzzy coat, a 
layer which, because of the amount of glycoproteins contained in it, is 
sometimes called glycocalyx. The glycocalyx is formed by the enterocytes 
themselves and, by virtue of the enzymes which it contains, is believed to 
play an important role in membrane digestion (860, 866).
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3.3 THE SMALL INTESTINE IN COELIAC SPRUE
3.3.1 Macroscopic anatomy
In coeliac sprue, lesions of the mucosa of the small intestine develop in 
response to the presence of gluten in the diet. The pathological changes are 
usually confined to the mucosa, while the remainder of the intestinal wall is 
normal. At laparotomy a distension of the loops of the small intestine and a 
dough-like consistency of the intestinal wall are occasionally found. The not 
uncommon presence of enlarged mesenteric lymph nodes will be discussed 
elsewhere (section 6.5.4).
3.3.2 Stereomicroscopic aspect o f the mucosa
When examining the mucosa of the small intestine from untreated coeliac 
patients with the aid of a magnifying-glass or dissecting microscope, no 
normal villi are observed. The shape of the villi depends on the severity of 
the mucosal damage. In the most severe form, a flat mucosa is seen in which 
no villi or villous remnants are visible. In such a mucosa only the crypt 
openings can be distinguished (fig. 3.3.g). One is regularly struck by the 
presence of polygonal local elevations in this otherwise flat surface, which 
have been compared with cobble-stones or mosaic pieces (86). Less severe 
mucosal damage produces a pattern of convolutions: gyrate structures in 
which individual villous remnants have merged (fig. 3.3.e). Finally, there are 
also unilaterally broadened, tongue-shaped villi, which are sometimes so 
broad as to resemble a ridge rather than a tongue (fig. 3.3.c).
The mucosal features in coeliac sprue patients generally vary with the 
site from which the biopsy specimen is taken. The changes in the proximal 
segment are usually more marked than those at more distal levels; this is 
probably related to the gluten concentration in the intestinal lumen (734).
Examination of biopsy specimens with the aid of a magnifying-glass or 
dissecting microscope has the advantage that an impression of the severity 
and extent of the mucosal lesion can be instantly gained (86, 733). Observed 
local abnormalities can be taken into account moreover when cutting the 
histological sections.
The terminology and classification of the various villous appearances in 
the literature vary. Personally we have always, after painstaking examination 
of biopsy specimens and registration of the villous types observed, classified 
specimens according to the predominant type in four categories: normal 
villi, slightly abnormal villi (tongues and ridges), a convoluted type, or a flat 
mucosa (fig. 3.3).
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Fig. 3.3. The various appearances o f the jejunal mucosa, as seen under the dissecting 
microscope (on the left) or at histological examination (on the right). The illustrations 
show normal finger-shaped villi (a, b), leaf-shaped villi (c, d), convolutions (e, ƒ), and 
a flat mucosa (g, d).
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For a sophisticated form of stereomicroscopic examination it is now 
possible to make use of the scanning electron microscope (562). More details 
of the mucosal surface can be observed in this way. Apart from reproduc- 
tions of excellent quality, however, this sophisticated technique of examina­
tion has so far failed to add important supplementary data.
3.3.3 Microscopie morphology o f  the mucosa
Doniach and Shiner (228) were the first to publish a classification of the 
various mucosal changes observed at microscopie examination of biopsy 
specimens from the small intestine in coeliac sprue patients. They described 
the shortening or disappearance of intestinal villi respectively as partial and 
subtotal villous atrophy. Efforts have since been made to stop the use of 
the term atrophy, which most investigators consider to be inappropriate.
In the histological section the mucosa, which shows no villi on stereo- 
microscopy, is bounded by a horizontal to slightly sloping surface epithe- 
lium which consists of cubical to flat enterocytes (fig. 3.3.h). Their nuclei are 
pyknotic and vary in shape, size and localization (859). In such biopsy 
specimens the crypts have markedly increased in  length, and sometimes also 
in width. They often show several ramifications which may have been cut 
tangentially. The cells in the crypt basis show numerous mitoses. The base­
ment membrane is often more readily visible than  is normally the case, and 
may contain some collagen interspersed with the connective tissue fibres in 
and beneath this membrane (755). A pronounced increase in cellular infiltra- 
tion is always observed in the lamina propria. In particular the number of 
plasma cells producing immunoglobulin IgA and IgM is increased (232). 
Lymphocytes and eosinophilic granulocytes are also increased in number, if 
less markedly so. Moreover many lymphocytes are found in the surface 
epithelium, in between the enterocytes (266). In  the smooth muscle cells of 
the muscularis mucosae and muscularis propria, finally, a brown pigment is 
sometimes visible around the nucleus, which consists of accumulated ceroid 
(847).
3.3.4 Ultrastructure o f the enterocyte
Electron microscopie examination of the mucosa of the small intestine in 
coeliac sprue patients invariably reveals marked abnormalities of the micro­
villi : not only are there fewer microvilli, but those present are shorter and 
of irregular shape, as well as chaotically rather than neatly arranged. Changes 
of the brush border are usually the first to appear in the case of enterocyte
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damage (783). The brush border can ultimately disappear almost completely.
Histochemical examination shows that the brush border also contains 
fewer enzymes. This is demonstrable by enzyme staining of histological sec- 
tions (655) as well as by quantitative determination in cell homogenates
Most intracellular structures present a swollen appearance, e.g. Golgi 
apparatus, mitochondria and lysosomes. The amount of endoplasmic reti- 
culum seems to be diminished. In addition large fat globules and vacuoles 
are often observed in the enterocytes (655, 783, 859).
The above described changes are observed only in the enterocytes on the 
villous remnants or on the mucosal surface. The enterocytes in the crypts 
nearly always remain normal (655, 859).
The epithelium of the intestinal mucosa consists of rapidly dividing cells 
which have a short life-span. The life-span is varyingly estimated, ranging 
from 2-4 days (178) to 4-6 days (536). The worn-out enterocytes (which are 
not identifiable as such either morphologically or histochemically) are ex- 
truded at the villous tips, at the so-called extrusion zones. The production of 
enterocytes takes place in the crypts. The enterocytes therefore migrate from
Fig. 3.4. Diagram of the comparative surface areas (stippled squares) of functional entero­
cytes covering various villous shapes. (Reproduced from Creamer, in Postgraduate Gas- 
troenterology: 18, Baillière, Tindall and Cassell, 1966; with permission of the author and 
publishers).
(191).
3.4 MORPHOGENESIS OF THE COELIAC MUCOSA
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the crypt basis to the villous tip and this distance comprises their life-span 
(859). The exfoliation of enterocytes is believed to be a primary process, 
for it continues even when mitosis is experimentally inhibited (775).
The existing dynamic balance between cell production and exfoliation 
determines the number of enterocytes available for lining the mucosal sur­
face. The size of this surface seems to determine the degree of evagination of 
the mucosa or, in other words, the number and shape of the villi (fig. 3.4). 
One of the determinants of this dynamic balance is the rate of production. 
A decreased production o f enterocytes in the intestinal crypts is observed 
after irradiation of the small intestine or administration of cytotoxic drugs, as 
well as in the presence of malignantprocesses (52,706,710). In refractory sprue, 
too, the mitotic activity in the crypts is certainly decreased (section 11.3).
In coeliac sprue, the life-span of the enterocytes is greatly reduced. Ex- 
periments involving perfusion of intestinal loops have demonstrated 
markedly increased cell exfoliation, up to 4-6 times the normal (178, 184). 
In response to this, the intestinal crypts attempt to compensate the enterocyte 
loss by increased mitotic activity, via a feed-back system not yet understood 
(300, 301). In fact the number of mitoses in the crypts is found to be greatly 
increased (655, 894). In addition one observes hyperplasia of the crypts, 
which become longer as well as wider, and show increased ramification 
(587, 894). The rate of migration of enterocytes from crypt to surface also 
increases (859). As a result, the enterocytes may lack sufficiënt time to 
mature to differentiated absorptive cells, and consequently the mucosal 
surface in coeliac patients may be lined with functionally immature cells
Fig. 3.5. Diagrammatic representation of the sequential changes in the villous appearances 
from normal villi to a flat mucosa, or vice versa. (Reproduced from Loehry et al., Gut 10: 
11,1969; with permission of the authors and publishers).
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(655, 707). Due to the decreased number of surface cells in coeliac sprue, it 
is hardly possible to provide sufficiënt covering for normal villus formation 
(fig. 3.4). In addition, the inflammatory reaction with oedema and cellular 
infiltration in the lamina propria probably also plays a role in the morphoge- 
nesis (757). Experiments with gluten instillation have shown that a subepi- 
thelial inflammatory reaction actually comes first and that as a result the 
aspect of the villi changes characteristically within a few hours (734, 782). 
The morphology of the intestinal mucosa depends on the severity of this 
inflammatory reaction and the degree of cell exfoliation. This is why stereo- 
microscopic examination of biopsy specimens from the small intestine can 
reveal a variety of features. In the case of minor mucosal damage rather 
short, leaf-shaped villi or ridges will be visible. A convoluted mucosa indi- 
cates rather serious damage. The most severe lesions are associated with an 
entirely flat mucosa (fig. 3.5).
3.5 MORPHOMETRY OF THE MUCOSA
There is an increasingly urgent need for quantification of the morphological 
characteristics of the intestinal mucosa. This is based on the need for methods 
to differentiate between normal and abnormal on objective grounds, which 
at the same time make it possible to detect minor changes. Without quanti- 
tative data, one must rely too heavily on subjective impressions, and be too 
dependent on the shortcomings of such impressions so far as minimal 
changes are concerned.
Several phenomena can be quantified. The height as well as the width of 
the villi can be measured, and the same applies to the depth of the crypts 
and the thickness of the mucosa (543). The accuracy of these determina- 
tions, however, is influenced by shrinking associated with fixation, and 
distortion while cutting histological sections (894). It is also possible to 
measure the height of enterocytes (733, 817), but in coeliac patients this is 
often not properly feasible due to the marked destruction of the cells of the 
surface epithelium (894).
In addition, one can count the mitoses in the crypts and relate their 
number to the total number of epithelial cells: the so-called mitotic index 
(655). Several investigators count the lymphocytes in-between the entero­
cytes of the surface epithelium (266), in the supposition that this number 
correlates well with the severity of the mucosal damage caused by gluten 
(297). It is also possible to determine the number of inflammatory cells in 
the lamina propria (412).
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Finally, many methods have been devised to measure the surface area of 
the intestinal mucosa (123, 134, 239, 543, 733). Despite various, very inge- 
nious techniques it has not been possible to include the third dimension in 
these determinations, which are all carried out in two-dimensional, histolo- 
gical sections.
Although all the above mentioned techniques have their drawbacks, they 
also have the advantage of objectivity and of the possibility to demonstrate 
minimal changes. Apart from the research done to demonstrate the validity 
of these various methods, however, they have so far scarcely been applied.
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CHAPTER 4
PHYSIOLOGY OF THE SMALL INTESTINE
4.1 GENERAL INTRODUCTION
Food, once ingested, becomes fragmented by chewing and mixed with saliva 
to facilitate swallowing. Saliva contains the enzyme a-amylase, which de- 
grades the starch in the food. After passing through the oesophagus the 
food bolus enters the stomach, where it is further kneaded by vigorous 
contractions of the gastric wall and mixed with gastric juice, which contains 
pepsinogens and hydrochloric acid. The secretion of gastric juice is regulat- 
ed by nervous and hormonal factors, especially by gastrin. The stomach 
serves as a temporary store for the food ingested. By periodic relaxation of 
the pyloric muscle, small amounts of the chyme are passed into the duode­
num. The mode of evacuation of the stomach is dependent on the volume of 
stomach contents, the osmotic pressure and fat content of the meal, and the 
acid concentration (192). In addition to nervous reflexes, intestinal hormones 
probably also play an important role in the evacuation of the stomach.
In the duodenum, the chyme comes into contact with pancreatic juice and 
bile. The pancreatic juice contains many proteolytic enzymes and lipases 
in addition to amylases. The optimal pH for intestinal digestion is much 
higher than the pH which prevails in the stomach; hence the importance of 
secretion of bicarbonate by the pancreas. The pancreatic secretion is regul- 
ated mainly by the intestinal hormones secretin and cholecystokinin (pan- 
creozymin). The former induces in particular the water and bicarbonate 
secretion, while the latter effects the release of digestive enzymes. In addi­
tion, nervous factors play a part in the regulation of pancreatic secretion. 
One of the functions of bile is to emulsify the fatty substances in the chyme 
in order to facilitate hydrolysis by lipases, and to form micelles. Release of 
bile by the gall-bladder is effected by nervous and humoral stimuli, particul- 
arly by cholecystokinin. During the passage of the chyme through duodenum 
and jejunum, further degradation of carbohydrates, protein and fats takes 
place. The digestive juices degrade not only food constituents but also 
physiological substances released in the small intestine. These so-called endo- 
genous substances include protein-rich fluid leaking from the intestinal wall,
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mucus, exfoliated enterocytes and the digestive juices themselves. The in­
testinal wall is protected from the influence of these proteolytic enzymes by 
the layer of mucus secreted by the goblet cells. Digestion is usually suffi- 
ciently advanced in the proximal jejunum to facilitate absorption.
The complex process of absorption of digested food constituents takes 
place during the slow transport of the chyme through the small intestine. 
The motility of the small intestine, which serves not only the propulsion of 
the chyme but also the mixing with digestive juices and the homogenization 
o f the mass, is a process controlled by the autonomie nervous system. Ab­
sorption of most food constituents is completed in the proximal jejunum. 
Bile acids and vitamin B12 are absorbed in the ileum only. The absorbed 
substances are transported further via the blood stream, while lipids mainly 
pass via intestinal lymphatics.
The undigested, unabsorbed chyme residue ends up in the colon, where 
bacterial degradation of fibrous food constituents takes place, along with 
some absorption of water and electrolytes. The ultimate residue is elimin- 
ated from the body by defaecation.
4.2 MOTILITY
The small intestine is in constant motion. This process, which in actual fact 
involves several phenomena, is called motility. Its function is to mix the 
chyme properly with digestive juices, homogenize it, bring it into contact 
with the absorptive surface, and finally to evacuate the ultimate residue.
The movements of the small intestine are executed by the smooth muscle 
fibres contained in the intestinal wall. The muscular coat of the small in­
testine consists of an outer layer of longitudinal smooth muscle fibres, and 
an inner layer of circular fibres. At some sites bundles of fibres probably 
pass from the one layer to the other. The mucosa is separated from the sub- 
mucosa by a thin layer of smooth muscle fibres, the so-called lamina mus- 
cularis mucosae, which likewise consists of a longitudinal and a circular 
layer. From this muscularis mucosae bundles of muscle cells extend into the 
valvulae conniventes (Kerckring’s folds) and the individual villi as well 
(138).
So far, little has been established with certainty concerning the motility of 
the small intestine. One of the reasons is that investigation is hardly practi- 
cable without drastically changing normal physiological conditions.
Motility actually consists of a collection o f muscular contractions of 
separate intestinal segments, which seem to be induced by electrical im-
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pulses from a more proximal level; these impulses are also known as basic 
electrical rhythm, pacesetter potential, electrical control activity, or slow 
waves (748). It is suspected that the pacemaker of these electrical impulses 
is localized in the duodenum, immediately below the outlet of the common 
bile duet. It is also possible, however, that this electrical impulse is an 
illusory phenomenon consisting of the depolarization waves of muscle cell 
groups in consecutive intestinal segments. These depolarizations probably 
occur in the outer longitudinal muscular layer, according to an intrinsic 
rhythm. Due to the influence on the time of depolarization in the adjacent 
intestinal segment the depolarization seems to propagate itself. Only this 
second hypothesis can explain why, after transection of the small intestine, 
depolarization waves continue to occur in the distal fragment (138). The 
intrinsic rhythm of the depolarizations in the various parts of the small in­
testine varies slightly: the frequency is 10-12 per minute in the proximal 
part, and 8 per minute in the distal small bowel (840).
Intestinal peristalsis in the proper sense of the word consists of segmental 
muscular contractions which occur very locally over a distance of 1-2 cm, at 
intervals of 4-8 cm. These contractions are also known as fast activity, spike 
bursts, or electrical response activity (748). They do not move but disappear 
after a few seconds, to be replaced by contractions at other sites, usually 
exactly between the preceding localizations (fig. 4.1). The segmental mus-
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Fig. 4.1. Diagram of the segmental contractions of the small intestine. The sequence of 
rhythmic segmentations is indicated by lines 1-3. The arrows show from where the chyme 
of the new segments originates, the dotted lines the regions of division. (Redrawn from 
Hightower, in Handbook of Physiology section 6 IV : 2001, American Physiological Society, 
1968; with permission of the author and publishers).
cular contractions can occur only during the depolarization phase of the 
basic electrical rhythm. This rhythm, therefore, does not itself produce seg­
mental contractions but only dictates the moments at which these are 
possible.
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The segmental contractions push the chyme away in several directions, 
cranially as well as caudally (fig. 4.1). The fact that the chyme ultimately 
does move caudally therefore remains a mystery. Perhaps the explanation 
is that the frequency of the segmental contractions is higher at proximal 
than at distal levels (840).
Apart from the above mentioned segmental contractions, some other 
types of movement of the small intestine have been registered, such as cir- 
cular contractions which propagate themselves over a small distance. The 
origin and purpose of these contractions have so far remained obscure. In 
addition, some motor activity can appear or disappear due to irritation of 
the mucosa or to stimulation of the afferent nerves, as in the reflexes of 
Bayliss and Starling and the intestino-intestinal inhibitory reflex (138).
The activity of intestinal motility is influenced by many factors, and in 
particular by neurogenic impulses. Stimulation of the parasympathetic 
receptors gives rise to contractions. Activation of the sympathetic nerve 
causes the contractions to diminish. In addition, some intestinal hormones 
perhaps also exert an influence on motility. The basic electrical rhythm of 
duodenum and jejunum is believed to be stimulated by cholecystokinin/ 
pancreozymin and inhibited by secretin (345). Peristalsis is believed to be 
promoted by 5-hydroxytryptamine, which is produced by the APUD cells in 
the mucosa of the small intestine (240). The type of nutrition and the bac- 
terial flora may also influence motility.
On a smaller scale, too, movements occur in the small intestine. The 
intestinal mucosa shows ever-changing plications due to contractions of the 
lamina muscularis. The intestinal villi are also in constant motion: they 
make pendular and pumping movements. These movements are stimulated 
by mechanical stimuli; the candidate hormone villikinin may also play a 
role in this respect. It is suspected that these micro-movements of the villi 
of the small intestine are of importance in reducing the unstirred layer (sec­
tion 5.1.5) and in propelling the absorbed substances from the villous core 
to the submucosa (771).
4.3 INNERVATION
The innervation of the small intestine can roughly be described as an in- 
trinsic local nervous system, localized in the wall of the intestinal tract and 
operating relatively independently, with in addition a number of extrinsic 
nerves which transmit the impulses from the central, the sympathetic and 
the parasympathetic nervous system.
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The intrinsic part of the innervation consists of an enormous number of 
neurons and nerve fibres, localized in the intestinal wall in certain layers 
which are called plexuses. The most prominent of these are the myenteric 
plexus (Auerbach’s plexus) and the submucosal plexus (Meissner’s plexus); 
the former is localized between the longitudinal and the circular muscular 
layer of the intestinal wall, and the latter between the circular muscular 
layer and the lamina muscularis mucosae (532). Further examination 
probably reveals several other distinguishable plexuses (138). Both above 
mentioned plexuses consist of a dense network of neurons and unmyelin- 
ated nerve fibres, which can be efferent, afferent or associative (fig. 4.2). 
The efferent part comprises the neurons which innervate above all the 
musculature of the intestinal wall, and in addition also the muscle cells of 
the blood vessels in the intestinal wall. The efferent sympathetic and para- 
sympathetic fibres which partly synapse with these neurons, are likewise re- 
garded as belonging to this efferent part. The afferent part consists of neu­
rons which receive sensory impulses from the (sub)mucosa. Their fibres 
synapse, either locally with efferent neurons or centrally in the sympathetic 
or parasympathetic ganglia near the spinal cord. The associative neurons 
govern the extensive connections between the neurons in the same plexus 
or between those of both plexuses (138, 532). It is not impossible that several 
other types of nerve elements are localized in the plexus (138).
The efferent and afferent fibres of the sympathetic and parasympathetic 
nervous system extend between the intestinal wall and the spinal cord. They 
synapse in the two plexuses with the motor and sensory neurons of the in­
testinal wall proper.
The nerves of the gastrointestinal tract play an important role in the diges-
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Fig. 4.2. Diagram of the au­
tonomie nervous control o f  plexus
the small intestine. In additi­
on to the local intrinsic reflex 
arc, the pathways of the ex- 
trinsic nerves are indicated 
(Design adapted from Lund- 
gren, 1972). afferent efferent
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tion and absorption of food in that they influence motility, blood supply and 
secretory processes. In actual fact this regulation is achieved in interaction 
with intestinal hormones. These interactions are so closely interlocked that 
it is impossible to assess the role of every separate nervous or hormonal 
factor (548).
The neural regulation of motility, blood supply and secretion probably 
takes place largely on a local level. Afferent stimuli from the intestinal 
lumen or the intestinal wall can produce effects via a direct reflex arc. The 
extrinsic (i.e. sympathetic or parasympathetic) efferent nerve fibres can 
produce effect, if necessary, by facilitation or inhibition of the reflex or by 
direct stimulation of the effector cell (fig. 4.2). Similar effects can be produ- 
ced by the release of intestinal and other hormones.
The motility of the small intestine is extrinsically influenced by both the 
parasympathetic and the sympathetic nerves. The parasympathetic fibres can 
directly stimulate the smooth muscle cells of the intestinal wall (fig. 4.3.a) but
PARASYMPATHETIC CONTROL
Fig. 4.3 Diagram of the ex­
trinsic parasympathetic con- 
trol on the intestinal wall 
musculature and the local in­
trinsic reflex arc (Reproduced 
from Lundgren, in Pathophy- 
siology: 617, Lippincott, 
1972; with permission of the 
author and publishers).
they can also exert an indirect excitatory influence on local excitatory and 
inhibitory reflexes (fig. 4.3.b and c). The sympathetic fibres, on the other 
hand, inhibit spontaneous intrinsic motility and abolish the effect of the 
parasympathetic (fig. 4.4.a and c). Motility, on the other hand, can also 
diminish due to an increase in the catecholamine concentration (fig. 4.4.b) 
(532).
The stimulation of motility concerns in particular the segmental contrac­
tions, which become both more frequent and more vigorous. Perhaps the 
pacesetter potential is also influenced by nervous factors (548).
The blood supply to the wall of the small intestine (the muscular layer as 
well as the submucosa) is subject to the extrinsic influence via the sympa-
plexus
local excitatory local inhibitory 
reflex reflex
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thetic nerves. The efferent sympathetic fibres cause vasoconstriction by stimu­
lation of the smooth muscle fibres in the arterial wall. There are no indications
SYMPATHETIC CONTROL
Fig. 4.4. Diagram of the ex- 
trinsic sympathetic control 
on the intestinal wall muscu- 
lature and the local intrinsic 
reflex arc (Reproduced from 
Lundgren, in Pathophysio- 
logy: 618, Lippincott, 1972; 
withpermission of theauthor 
and publishers).
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so far that the parasympathetic exerts any influence on the blood supply 
(532).
Secretion in the stomach is extrinsically stimulated by the parasympathe­
tic, partly by direct stimulation of the cells of the gastric wall, but also via 
its influence on the gastrin production. There are vague indications that 
secretion in the pancreas is likewise stimulated by the parasympathetic
system (548).
4.4 CIRCULATION
The blood supply to the small intestine is covered almost entirely by the 
superior mesenteric artery. This artery communicates, however, with the 
coeliac artery via the pancreaticoduodenal arteries. The superior mesenteric 
artery produces a total of 10-16 branches, which in turn divide or combine to 
form a sort of network between the membranes of the mesentery. At the 
interface between mesentery and small intestine, the vasa recta arise which 
extend on either side around the intestine. These semicircular blood vessels 
produce smaller branches which penetrate all layers of the intestinal wall. 
They also anastomose abundantly and form plexuses at various levels in the 
intestinal wall. The arterioles which supply blood to the intestinal villi arise 
from such a vascular network in the submucosa (fig. 4.5). The stroma of 
each intestinal villus contains a small central arteriole which rises perpen- 
dicularly to the apex, where it divides into a number of capillaries that ex-
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tend down on the outside of the villous stroma and, on their way, ramify in 
such a manner that an extensive capillary network is formed immediately
Fig. 4.5. Diagram of the vas- 
cularisation of the intestinal 
villus. Depicted are the sub- 
mucosal artery (a) and vein 
(6), the submucosal venous 
plexus (c), main villous ar- 
teriole (rf)and venule (e), and 
capillary network (ƒ). (Re- 
produeed from Sessions et 
al., in Progress in Gastroen- 
terologyl: 252, Grune and 
Stratton, 1968; with permis- 
sion of the authors and pu- 
blishers).
beneath the epithelial layer of the villus. These capillaries connect with 
small venules which open up into veins that largely follow the pattern o f the 
arterial vascularization. At the base of the villi there are probably direct 
anastomoses between arterioles and venules so that, when intestinal activity 
is low, the circulation in the villi can be short-circuited (533, 771, 775).
The arterial blood supply to the small intestine serves the function of 
providing it with the nutrients and the oxygen which it needs to fulfil its 
functions, such as absorption, secretion and motility. The venous system 
takes care of the removal of the substances absorbed.
During the process of digestion and absorption, the blood flow through 
the small intestine is increased by 100-200%. This is made possible by vaso- 
dilatation which occurs as a reflex action in response to mechanical stimula- 
tion o f the mucosa of the small intestine by food (66). Moreover, the blood 
flow can be stimulated by the intestinal hormones secretin and cholecysto- 
kinin, which are released in response to chemical stimulation of the mucosa
(262). Finally, metabolites of the intestinal motility process may also play a 
role in vasodilatation (649). The extrinsic autonomie nerves play no signi­
ficant role in dilatation of the intestinal blood vessels. It seems likely that
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only sympathetic nerve fibres innervate the intestinal vasculature, giving rise 
to only brief and transient vasoconstriction (532). However, within some 
minutes a so-called autoregulatory escape mechanism is activated by the re­
lease of local vasodilatators or by reduced sensitivity of the sympathetic 
receptors (772). This mechanism ensures that the intestinal villi are supplied 
with a sufficiënt amount of blood at all times.
The circulation in the mucosa of the small intestine plays an important 
role in intestinal absorption. N ot only because it ensures rapid removal of 
the absorbed nutrients, but also in supplying substances required for the 
metabolism of the absorbing enterocytes. Consequently there seems to be a 
correlation between the amount of blood supplied and the intestinal absorp­
tion (527). The importance of the circulation for the absorptive process is 
also emphasized by the fact that about three-quarters of the total blood 
supply to the small intestine goes to the mucosa and submucosa, whereas 
the musculature of the intestinal wall receives only one-quarter (532).
It seems plausible that absorption is influenced by the arrangement of the 
blood vessels in the villi (fig. 4.5). The fact that the blood in the central 
arteriole and that in the subepithelial capillary network flow in opposite 
directions makes it hypothetically possible that marked differences in con- 
centration of solutes are built up along these vascular loops. This is ex- 
plained on the basis of the so-called counterflow principle, analogous to the 
situation in the kidney in the loop 6f Henle (120). Exchange of water be­
tween arteriole and venule at the base of the villus could give rise to marked 
hyperosmolarity in the villous tip, both in the arteriole and in the surroun-
Fig. 4.6. Diagram of the func- 
tional implications of the 
postulated countercurrent 
exchange in the intestinal 
villus. The curved arrows re- 
present the flux of water from 
the main villous arteriole (a ) 
to the capillaries (b and c), 
producing a gradual build- 
up of the ion concentration 
towards the villous tip. The 
straight broad arrows indi- 
cate the flux of water and 
solutes from the intestinal 
lumen, resulting from local 
osmolar differences.
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ding tissue (fig. 4.6). Water from the intestinal lumen may be attracted, and 
with it solutes via the so-calied solvent drag (section 5.1.6). With the result 
that substances can be absorbed against a concentration gradiënt. Another 
result of the possible cross diffusion of water at the villous base is haemocon- 
centration in the upper half of the villus. Due to a decreased flow rate, the 
time for exchange between epithelial layer and the villous capillaries may be 
prolonged. Experimental observations seem to support this counterflow 
hypothesis (120, 533).
4.5 LYMPHATIC SYSTEM
The lymphatic system of the small intestine consists of an extensive network 
of lymphatics with delicate extensions in each villus. These extensions -  
variously known as central, terminal or initial lacteals -  are in fact the 
‘blind’ starting-points of the lymphatic system. Apart from extracellular 
tissue fluid they also transport chylomicrons, so that the term ‘lacteals’ is 
more appropriate than ‘lymphatics’. The wall of the lacteals consists of a 
thin layer of endothelial cells. At several sites this wall shows valve-like cell 
junctions which are usually firmly closed but can open to accommodate the 
passage of lymph. This endothelial layer is probably covered by a fragment- 
ary basement membrane and besides surrounded by a network of reticulin 
fibres (450).
The initial lacteals connect with the larger lymphatics in the submucosa, 
which at some sites communicate with lymph follicles or aggregates of 
lymphoid tissue in the intestinal wall like the so-called Peyer plaques in the 
ileum. The lymphatics form an extensive system of ramifying and anastom- 
osing vessels, merging into larger collecting vessels, which extend circularly 
as well as longitudinally in the muscular layers of the intestine. As the 
diameter of the lymphatics increases, their wall becomes firmer due to the 
presence of fibres and muscle cells. Except in the most minute lymphatics, 
valves are found at regular intervals in the lumen. In the mesentery, the 
lymphatic vessels roughly follow the pattern of the mesenteric blood vessels. 
At several sites along this route one finds lymph nodes, which are arranged 
in groups at the origin of the superior mesenteric artery. The large lymphatic 
vessels which arise here combine to form the gastrointestinal trunk, ending 
in the cisterna chyli. From this cisterna arises the thoracic duet, which 
empties into the left subclavian vein (450).
Via the lymphatic system, fluid and substances are transported which 
originate partly from the tissues and partly from the intestinal lumen. Ex-
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tracellular tissue fluid results from the flux of water and other plasma con­
stituents on the arterial side of the capillaries. Most of this tissue fluid is 
usually taken up again by the veins. However, macromolecular substances 
such as immunoglobulins, proteins, chylomicrons produced by the entero­
cytes, as well as the immunocytes from the lymph follicles cannot be readily 
taken up through the venous wall. The lymphatic system transports these 
macromolecular substances and the immunocytes. In addition, the lympha- 
tics can assist in transporting smaller molecules, should the blood circulation 
insufficiently cope with these (286).
It is assumed that chylomicrons and macromolecular substances are 
taken up via the valve-like inlets in the wall of the initial lacteals. Passage 
through these valves is made possible by an increase of pressure in the 
villous stroma around the lacteal as a result of accumulation of fluid and 
plasma constituents effused from the blood stream, and of substances ab­
sorbed from the intestinal lumen (fig. 4.7.a). After taking up fluid, (macro)-
Fig. 4.7. Diagram of the uptake and transport of chylus by the initial lacteal. Arrows show 
the postulated movement of chylous particles from the interstitial tissue into the lacteal (a 
and b) and their subsequent ejection when the villus contracts (c). (Reproduced from 
Sessions et al., in Progress in Gastroenterology I: 254, Grune and Stratton, 1968; with 
permission of the authors and publishers).
molecules and particles, the lacteal will become dilated. In consequence 
the pressure within the lymphatic vessels exceeds that outside the vessel, 
with the result that the valves close. As a result of the tension generated in
a b c
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the circular fibres around the basement membrane, the dilated lacteal will 
attempt to expel the amount of chylus and lymph taken up (286).
An important contribution to the transport of lymph from the lacteal to 
the submucosa is probably made by the muscle fibres in the villous stroma, 
which can cause both transverse and longitudinal contraction of the villus, 
thus milking the lacteal empty, so to speak (fig. 4.7.c). Perhaps this milking 
is done in coordination with contractions of the muscularis mucosae and 
the musculature of the intestinal wall (771). The somewhat larger lymphatics 
have themselves a small number of muscle fibres in their walls, giving them 
the possibility to contract independently. It cannot be excluded, however, 
that the drainage of lymph is further assisted by arterial pulsations, changes 
of pressure in the abdominal cavity or movements of the mesentery. The 
direction in which the lymph flows is otherwise determined by the presence 
of valves in the medium-sized and large lymphatic vessels (286).
4.6 DIGESTIVE SECRETIONS
4.6.1 Introduction
The degradation of food in the intestine is ensured by enzymatic and 
chemical processes. The enzymes and other substances required for this 
purpose are supplied by the digestive juices secreted in the gastrointestinal 
tract. These include saliva, gastric juice and pancreatic juice. For the emulsi- 
fication of lipids and micelle formation, bile is secreted. The digestive juices 
play an important role in the absorption of food constituents in that they 
change these constituents to a form which permits rapid and efficient ab­
sorption.
4.6.2 Gastric secretion
Gastric juice consists of several constituents, each originating from certain 
cell types in different parts of the stomach (192). The most important area of 
gastric juice production is the corpus ventriculi which, like the fundus, con- 
tains glands which produce hydrochloric acid (HC1), pepsinogens and in­
trinsic factor. The production takes place in the parietal (or oxyntic) cells, 
which secrete intrinsic factor as well as hydrochloric acid (400), while the 
chief (or zymogenic) cells produce pepsinogens. At the junction between the 
glandular ductules and mucosal surface are localized the so-called mucous 
neck cells, probably precursors of the chief cells, which secrete mucus and
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perhaps also pepsinogens (746). Mucous cells are otherwise found every- 
where between the parietal cells and the chief cells in the glands.
The tubular glands in the antrum produce mucus, with some pepsinogens, 
but no HC1. In addition the antral glands also contain gastrin-producing 
cells (577). The glands of the cardia produce only mucus. The whole surface 
of the gastric mucosa is lined with epithelial cells which produce mucus.
Stimulation of gastric acid production can take place in three ways 
(phases) (888). In the cephalic phase this comes about extrinsically via the 
vagus nerve, which is stimulated when food is seen, smelled or tasted. During 
the gastric phase the local receptors in the wall of the stomach are stimul­
ated, while in the intestinal phase acid production is caused by stimuli which 
originate from the duodenum or jejunum. Throughout all these phases, 
gastric acid secretion is provoked by acetylcholine or gastrin, often in com- 
bination with each other (888).
Gastric acid production is probably inhibited in as many different ways, 
such as by acidification of antrum or duodenum, and by inhibiting the 
release of gastrin. In response to the entrance of fats, acids or hypertonic 
solutions in the duodenum, cholecystokinin and secretin are released. These 
hormones are suspected of inhibiting the gastric acid production, but this is 
by no means certain (888). The pepsinogens, of which seven types are known 
so far (746), are secreted as inactive zymogens. Pepsinogen is turned into 
active pepsin by detachment of some peptide groups, caused by gastric acid 
and already activated pepsin. These pepsins are important proteolytic 
enzymes, maximally effective between pH 1 and pH 3. The secretion of 
pepsinogens is stimulated in the same way as that of gastric acid, apart from 
the fact that secretin, believed to stimulate pepsin production, probably in- 
hibits acid production (888).
4.6.3 Pancreatic secretion
The pancreas produces several digestive enzymes such as a-amylase, lipases, 
cholesterol esterase and phospholipase, pro-carboxypeptidase A and B, pro- 
elastase, chymotrypsinogen and trypsinogen, along with some less well- 
known enzymes. The proteolytic enzymes are secreted as inactive zymogens. 
Trypsinogen is activated in the duodenum by enterokinase, which requires 
the presence of calcium ions. Activated trypsin activates other enzymes such 
as chymotrypsinogen, pro-elastase and phospholipase, while all activated 
enzymes autocatalytically activate their precursors. The enzyme a-amylase is 
secreted in an active form, just like the lipases. In addition, the pancreas 
secretes a fluid which contains large amounts of bicarbonate, sodium and
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potassium ions in concentrations more or less equal to those in plasma, and 
small quantities of chloride, calcium and magnesium (238).
Pancreatic secretion is stimulated by the presence of food in the stomach 
or duodenum. The secretion is regulated by hormonal as well as nervous 
factors. Of the intestinal hormones, secretin in particular stimulates the 
pancreas to secrete water and bicarbonate. The release of digestive enzymes 
is incited particularly by cholecystokinin and, in lesser degree, by secretin. 
Enzyme secretion is believed to be stimulated also by the parasympathetic 
nerves (101).
Like gastric juice, pancreatic juice is released in several ways or phases. In 
addition to the cephalic phase there is a gastric phase, in which the pancreas 
is stimulated in response to mechanical irritation of the stomach through 
local reflex arcs. There exists also an intestinal phase in which local intestinal 
hormones are released and perhaps the parasympathetic system is stimulated 
as well (101).
The synthesis of enzymes by the pancreas can be influenced by the com- 
position of the diet. There seems to be some sort of adaptation, in that 
enzyme synthesis is adjusted to the requirements (206).
4.6.4 Bile secretion
Bile is produced by hepatocytes and in part also by epithelial cells in the bile 
ducts. The hepatocytes mostly secrete bilirubin and bile acids, along with 
cholesterol and phospholipids; the bile duet cells secrete in particular sodium 
and bicarbonate. Water and solutes go passively along with the active secre­
tion of the above mentioned organic and inorganic ions. Secretion by the 
bile duet cells is believed to be controlled by some intestinal hormones such 
as secretin and cholecystokinin (9).
The bile is collected and concentrated in the gall-bladder which, if necess- 
ary, can release a large amount of bile all at once. Concentration is eflected 
by absorption of water, together with sodium, chloride and bicarbonate.
Efflux of bile to the duodenum is normally prevented by the sphincter of 
Oddi. This sphincter relaxes in response to cholecystokinin which also 
causes the gall-bladder to contract vigorously. This hormone is released 
when lipid substances enter the duodenum.
The bile acids are synthesized in the hepatocytes from cholesterol. By 
alterations in the steroid skeleton, cholic acid and chenodesoxycholic acid 
are produced. They are conjugated to glycine or taurine and so secreted in 
the bile. This conjugation is absolutely necessary for their function, which is 
to form micelles (210). Having served as vehicles for lipid substances in the
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lumen of the small intestine, the bile acids are reabsorbed in the terminal 
ileum. This is effected by an active transport process which accounts for the 
reabsorption of almost 95% (235), while the remainder is degraded by bac- 
teria in the colon to deoxycholic acid and lithocholic acid, which are in 
part eliminated with the faeces. Relatively much of the deoxycholic acid, 
but only a small fraction of the lithocholic acid is reabsorbed. The reabsor­
bed bile acids are returned, degraded or not by bacteria, to the liver via the 
portal circulation and recovered by the hepatocytes. The bile acids are again 
secreted in bile, after renewed conjugation to glycine or taurine, if necessary. 
In actual fact, synthesis of bile acids has only to compensate for their loss via 
the faeces. This loss is estimated to be 0.2-0.5 g per day, but can be many 
times as large in the case of disease or resection of the terminal ileum (9).
4.7 INTESTINAL HORMONES
Hormones of different types are produced in the digestive tract. Several 
organs of this tract contain endocrine cells in such amounts that, all in all, 
the gastrointestinal tract is one of the largest endocrine organs (666). In the 
past, these endocrine cells were known as clear cells (‘helle Zeilen’) (273), 
but also as enterochromaffin, argentaffin or argyrophilic cells because 
they are able to precipitate silver salts and are thus to be identified in histo­
logical specimens. The name currently preferred is APUD cells, which 
denotes the various properties of these cells, e.g. the presence of yf mines and 
their capability of amine Precursor £/ptake and öecarboxylation. They are 
localized mainly in the crypts of the small intestine. These cells contain hor- 
mone granules in their basal part. Using electron microscopie and especially 
immunofluorescence techniques, several types of endocrine cell have been 
identified. According to the hormone produced by them, these cells are 
called A-cell (glucagon), G-cell (gastrin) and S-cell (secretin). In addition, 
several other cells have been identified of which the significance has so far 
remained obscure. In the small intestine, only a few of these endocrine cell 
types are present (666). All APUD cells secrete in addition to  a particular 
hormone or hormone-like polypeptide one or several amines, like 5-hydroxy- 
tryptamine or serotonin. The function of this 5-hydroxytryptamine is still 
unexplained. Perhaps it promotes motility or even circulation in the small 
intestine (240).
The intestinal hormones influence the function of stomach, bowels, pan­
creas and gall-bladder, and perhaps in addition also processes outside the 
digestive tract. Purified or even synthetic preparations of these hormones
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have become available only a few years ago, making it possible to study their 
influence on processes in the gastrointestinal tract. The possibility of de- 
monstrating physiological (i.e. usually minute) quantities of hormone in 
body fluids by means of radio-immunoassay has also been of great importan- 
ce for further research into the presence and activities of intestinal hormones. 
Effects of these hormones on absorption and secretion in the small intestine, 
on fluid and enzyme secretion in stomach and pancreas, and on motility 
and tissue growth of the digestive tract, have been described by several in­
vestigators (341). N ot infrequently, however, these effects could be produced 
only with extremely large, so-called pharmacological doses of hormones 
which, moreover, often were not pure or obtained from a different animal 
species. Another disadvantage in studying the effect of a given hormone is 
that other hormones are sometimes secondarily released or that its effects 
are masked by simultaneous action of other hormones (341).
It has been established with certainty that at least three hormones are 
formed and operating in the small intestine: secretin, cholecystokinin 
(CCK-PZ) and gastrin. In addition, several ‘candidate hormones’ have 
been described, i.e. polypeptides of which it is not yet certain that they exert 
any influence on the gastrointestinal tract, or that their effect is not produced 
secondarily via other hormones. This group encompasses such substances as 
enteroglucagon, gastric inhibitory polypeptide (GIP), vasoactive intestinal 
polypeptide (VIP), motilin, pancreatic polypeptide and somatostatin (342, 
699).
Gastrin is known to be present in several components (889). It is formed 
in the G-cells, which are mainly localized in the antrum of the stomach and 
in the duodenum (637). Gastrin is released via stimulation of the vagus ner- 
ves or in response to the presence of food in the stomach (485). This stimul­
ation is inhibited by the presence of acid in the stomach (889). In physiolog­
ical concentrations, gastrin can probably only stimulate gastric acid secre­
tion, activating the pepsinogens as a secondary effect (440).
Secretin, too, occurs in a number of variants, which usually have a higher 
molecule weight than secretin proper (80). Secretin is produced by the S-cells 
which are found in great numbers in the duodenum (591). The hormone is 
released after reduction of the pH in the duodenum due to the entrance of 
gastric juice and, in lesser degree, of food (699). Stimulation of the vagus 
nerve causes no release of secretin (828). The principal and under physiol­
ogical conditions probably only effect of secretin is stimulation of water and 
bicarbonate secretion by the pancreas (426). Perhaps other hormones such 
as CCK-PZ or VIP contribute to this effect (342). The increased secretion of 
pancreatic enzymes observed after administration of secretin, is probably
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based on a so-called wash-out effect (814). The blood flow to the small in­
testine through the superior mesenteric artery probably increases (262). The 
motility of the small intestine and the intestinal absorption of water and 
sodium, however, are believed to be inhibited by secretin (441).
The hormone cholecystokinin, also known as pancreozymin in view of its 
influence on the pancreas, is produced by certain not yet identified cells in 
the mucosa of the small intestine. The concentration of CCK-PZ attains its 
maximum in the jejunum, but substantial concentrations are present also in 
the duodenum and ileum (79). CCK-PZ is released in response to the pre- 
sence of food (more specifically amino acids and fatty acids) and in lesser 
degree to the presence of hydrochloric acid in the duodenum and jejunum 
(251, 314). Cholecystokinin stimulates the gall-bladder to contract and 
probably also promotes bile production (445). In addition, this hormone is 
believed to stimulate the pancreas to secrete enzymes (815), bicarbonate 
(623) and insulin (868). The intestinal motility is probably also promoted by 
CCK-PZ (370), as well as the blood flow via the superior mesenteric artery 
(97, 262). Finally, absorption of sodium chloride and potassium in the 
jejunum is believed to be inhibited by CCK-PZ (441).
As pointed out, it is not certain whether the ‘candidate hormones’ exert 
any influence on the digestive tract, or produce an effect only via the stimula- 
tion of other hormones. Some of these ‘candidate hormones’ are polypep- 
tides which are isolated from the mucosa of the small intestine, while the 
presence of other ‘candidate hormones’ is assumed merely in order to explain 
certain physiological phenomena (343). In view of the uncertainty about 
their existence and activities, these ‘candidate hormones’ will not be further 
discussed in this context.
The effect of hormones on their target cells (e.g. the parietal cell of the 
stomach or the pancreatic acinar cell) occurs through stimulation of recep- 
tors in the cellular wall. The nature or afiinity of the receptor determines 
whether a hormone can produce any effect and, if so, which effect occurs 
(341). The target cells probably have several types of receptor, both for the 
various hormones and for the neurotransmitters.
The effect of a hormone on a target cell is produced -  at least in some 
cases -  via a mediator: cyclic AMP. If  so, the hormone is the first messenger, 
which informs the target cell of the desirability of a certain effect, and cyclic 
AMP is the second messenger (829). Alteration of the amount of cyclic 
AMP in the cell, caused by a given hormone, is believed to produce the de- 
sired effect in the target cell. This change in the AM P concentration results 
on the one hand from enzymatic conversion of ATP in the cytoplasm by the 
enzyme adenylcyclase, bound to the cell membrane and localized close to the
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hormonal receptor site (829). On the other hand, the intracellular concentra- 
tion of cyclic AMP is also determined by the rate at which AMP is degraded 
by enzymes, which are also localized near the cell membrane and influenced 
by hormones (513).
4.8 INTESTINAL MUCUS
Like most of the epithelium lining the digestive tract, the mucosa of the 
small intestine contains mucus producing cells: the so-called goblet cells. 
These differ from the other cells of the intestinal epithelium in that they are 
specialized in the production and secretion of mucus. Goblet cells evolve 
from undiiferentiated cells in the crypts of the intestinal mucosa. The mucus 
is produced in or near the Golgi apparatus. Continuous synthesis and 
polymerization of mucus takes place throughout the life-span of these goblet 
cells, which is estimated to be 4-6 days. It takes an  average to two hours for 
mucus to be synthesized from its basic elements and to become visible in 
the apical part of the goblet cell. Subsequently, secretion into the intestinal 
lumen takes place within a few hours via apertures in the apical cell mem­
brane (518). The secretion of mucus is promoted by stimulation of the 
sympathetic nerve fibres, resulting from the contact between the food and 
the mucosa of the small intestine (192). The intestinal hormones probably 
play no role in the secretion of intestinal mucus.
Mucus has a number of special physical properties. Since it can form a 
gel, its viscosity is high. It also has a marked adhesive power, and the ability 
to form film-like layers. The basic elements which make up mucus consist of 
glycoproteins (mucoproteins), i.e. proteins with carbohydrates on the side 
chains. The composition differs slightly from one individual to another. So 
little as these basic elements are influenced by chemical or physical changes, 
so unstable is the three-dimensional structure of intestinal mucus (762). As a 
gel, mucus is made up of a large number of basic elements which, through the 
electrical forces of the charged side chains and terminal groups, can form 
large spatial structures (16). When these electrical forces are lost, due to a 
decrease in pH or the attachment of certain ions, the structure of the mucus 
changes. The gel becomes fragmented and begins to liquefy before dissolv- 
ing in the intestinal lumen (762). Usually there is continuous degradation of 
mucus by gastric juice, enzymes and bacteria. Under normal conditions 
production of mucus can keep pace with its destruction so that a dynamic 
equilibrium exists.
The function of intestinal mucus is partly determined by its physical pro-
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perties (762). The mucus secreted by the goblet cells forms a continuous 
layer covering the epithelial cells of the gastrointestinal tract, which pro­
bably protects the intestinal wall from the influence of proteolytic enzymes, 
bacteria, etc. Perhaps bacteria are even killed in this layer of mucus (664). 
It is not inconceivable that this covering of the enterocytes can also influence 
absorption from the intestinal lumen, either because the mucous gel acts 
as a kind of filter, or as a result of the fact that certain ions become bound to 
the mucus during the absorptive process (762).
This protective coating of mucus secreted by the goblet cells should not be 
confused with the so-called glycocalyx on the brush border of the entero­
cytes, which likewise partly consists of glycoproteins. This layer is probably 
secreted by the underlying enterocytes, and forms an integral part of their 
outer wall. The glycocalyx contains many enzymes and may therefore play 
a role in the digestion of food (511).
4.9 EXFOLIATION OF ENTEROCYTES
The mucosa of the small intestine is covered by an epithelial sheet consisting 
of cells which have only a limited life-span. There is constant production of 
epithelial cells in the crypts of the intestinal mucosa. The cells produced are 
moved up and meanwhile continue to differentiate. Later, as functional, 
mature enterocytes, they make up the lining of the intestinal villi. Once 
moved up to the apex of the villus, the enterocytes are extruded at the so- 
called extrusion zones (fig. 3.1). Exfoliation is believed to be necessary be­
cause the enterocytes are exhausted or worn out (section 3.2.3). This means 
that the epithelial lining of the intestinal villi is in a process of constant rege- 
neration. Each epithelial cell is extruded a few days after its production. The 
life-span of the enterocyte is varyingly estimated, ranging from 2-4 days
(178) to 4-6 days (537). It follows that one-sixth to one-half of the total 
number of enterocytes is shed each day. The exfoliated cells are estimated to 
amount to 250 g per day (186, 507). Under normal conditions the exfoliated 
cells are rapidly degraded in the intestinal lumen. The cell constituents are 
probably for the greater part reabsorbed. Under normal conditions, there­
fore, little material is lost to the body (179).
4.10 ENTERIC PLASMA PROTEIN LOSS 
The occurrence of protein leakage from the tissues into the lumen of the
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digestive tract was first observed in 1957. The discovery was made in a 
patiënt suffering from hypoproteinaemia, caused by protein loss via the 
gastric wall as a result of hypertrophic gastritis (140). In subsequent years, 
more or less serious protein loss in the gastrointestinal tract was demon- 
strated in a wide variety of conditions (431, 850, 879). The possibility of 
measuring the protein leakage in so many situations was created by marked 
simplification of the measuring procedure. The method currently regarded 
as the simplest and most accurate is that of labelling plasma proteins with 
51Cr (848). The widely used designation plasma protein leakage resulted 
from the observation that this process entails a loss of all plasma proteins, 
which from the blood stream enter the intestinal lumen via the intercellular 
fluid. This protein loss often gives rise to a decreased plasma protein con­
centration. It was established with the aid of the above mentioned method 
that some protein loss in the gastrointestinal tract also occurs in healthy 
subjects, although in a much lesser degree than the loss found in patients 
with gastrointestinal disorders (437). The phenomenon per se is not ab- 
normal, therefore, but only its degree. It seems useful to point out that, 
through leakage of tissue fluid, several constituents of this fluid other than 
proteins also enter the intestinal lumen. This has been demonstrated by, 
among other things, analysis of fluid recovered after intestinal perfusion
(179).
Little has so far been established concerning the underlying mechanism of 
this enteric protein leakage in normal subjects. The epithelial layer which 
lines the wall of the gastrointestinal tract is usually a tight, continuous layer. 
Leakage of tissue fluid might take place at the apex of the villus, at the 
so-called extrusion zone, where the worn-out enterocytes are shed so that a 
temporary breach occurs in the continuous row of epithelial cells. It is con- 
ceivable that, during this exfoliation of enterocytes, a minute quantity of 
tissue fluid from the villous stroma enters the intestinal lumen. Some in­
vestigators suggest that the protein loss occurs via the intercellular spaces in 
the epithelium (437, 879). Using autoradiography after administration of 
labelled albumin, Brooks et al. (105) were in fact able to demonstrate that 
albumin accumulated in these intercellular spaces particularly in those parts 
of the epithelial layer localized at the villous tip or resting over capillaries. 
The albumin did not seem to enter the intestinal lumen from these spaces, 
however, perhaps as a result of the tight junctions which firmly connect the 
enterocytes at their apical side. Perhaps the albumin also partly enters the 
enterocytes proper (e.g. by pinocytosis) and finds itself in the intestinal 
lumen only after their exfoliation (105).
Protein which leaks into the intestinal lumen is bound to be largely de-
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graded and reabsorbed. One of the factors which determine the degree of 
degradation and reabsorption is the site where the leakage occurs. Protein 
leaked into the distal part of the small intestine is probably subject to a less 
marked degree of degradation and reabsorption than protein which enters 
the proximal jejunum. The enteric leakage of protein, therefore, does not 
always have to be associated with an equally large loss of protein or protein 
degradation products in faeces or urine.
4.11 INTESTINAL FLORA
Even under normal conditions, the human intestine harbours a world of 
micro-organisms. These in principle exogenous micro-organisms enter the 
body with the food, and it is from this constant supply that the human in­
testinal flora is selected (73). Only very specific bacteria are able to maintain 
themselves in the gastrointestinal tract; the majority of micro-organisms are 
destroyed or excreted. Determinants of the ability of bacteria to maintain 
themselves in the human intestine are the requirements of these micro- 
organisms as well as the characteristics of the environment which accommo- 
dates them. This natural selection determines the particular nature of the 
bacterial flora in the intestinal tract, which is usually fairly stable and self- 
regulating. Only in the upper part of the digestive tract can a variable bac­
terial flora be present as a result of the ever-repeated ingestion of common as 
well as less common micro-organisms (237). The faeces, too, contains a 
variable population of micro-organisms, including the bacteria which failed 
to ‘take’. In the small and large intestine, however, a fairly stable bacterial 
flora prevails which usually resists any change. The micro-organisms conven- 
tionally found in the intestine have become accustomed to the particular con­
ditions in the intestine. New micro-organisms still have to develop these 
properties but often are not given the chance or the time to adjust. An im­
portant factor for maintenance in the intestine is that the micro-organisms 
develop the ability to propagate by slow instead of by rapid division (311).
The nature of the bacterial flora prevalent in the intestine is largely deter­
mined by the interactions between the various types of micro-organisms. 
These include competition with regard to available nutrients or enzyme pro- 
teins, the influence on pH or oxygen pressure, the production of growth- 
inhibiting or growth-promoting substances, and the possible transfer of 
resistance to antibiotics (226). In addition, the composition of the bacterial 
flora in the small intestine is determined also by some factors unrelated to 
these interactions. Im portant factors in this respect are the peristalsis, which
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ensures constant removal of micro-organisms, and the presence of gastric 
juice and bile acids (237). Many investigators suspect that as yet unidentified 
inhibitors of bacterial growth are also present in gastric juice, pancreatic 
secretion, bile or intestinal fluid (226). The intestinal wall itself functions as 
an effective barrier against invasion of micro-organisms from the intestinal 
lumen. The mucosa is probably enabled so to function by its coating of 
mucus and by local synthesis of antibodies (copro-antibodies). All the 
above mentioned factors keep the growth of intestinal bacteria under con- 
trol in normal circumstances. I t has been calculated that, in the absence 
of any inhibition of growth, the micro-organisms in the digestive tract 
would be so numerous within 24 hours, that the total amount of necessary 
nutrients would exceed the body mass of an average human individual (311).
The small intestine normally contains few bacteria in its proximal part: 
as a rule less than 104/ml. Some of these are micro-organisms from the food 
or the oral cavity, which are en route. The autochthonous flora of the 
proximal small intestine largely consists of Gram-positive aerobic or facultat- 
ive anaerobic micro-organisms such as streptococci and lactobacilli. Small 
numbers o f enterobacteria or strictly anaerobic bacteroides can also be 
present (322). In the distal part of the small intestine the population of 
micro-organisms is much larger, usually some 105-107/ml. The bacterial 
flora at this level is also more varied and stable, and in addition to strepto­
cocci and lactobacilli comprises about equally large numbers of enterobac­
teria and bacteroides (237, 322). A faecal flora usually prevails in the lower 
ileum. It comprises bacteroides, bifidobacteria and non-spore-forming 
anaerobes, along with many other micro-organisms. As many as 37 species of 
micro-organism have been isolated from faeces, which probably contains 
still many more bacterial species (605).
The bacterial flora in the small intestine largely determines the intemal 
environment via its influence on many processes in the intestinal lumen such 
as digestion, absorption and degradation of food constituents, vitamins, 
enzymes, medicinal agents, etc. Some micro-organisms are even able to 
synthesize certain vitamins. It has been stated that, in terms of metabolic 
activity, the bacterial flora of the digestive tract in its totality is equivalent to 
the liver (918). However, since under normal conditions the bacterial flora in 
the small intestine comprises only a limited assortment and small numbers of 
micro-organisms, it probably plays only a minor role in the absorption and 
degradation of food constituents (226, 237). A different situation prevails in 
the colon, where the cellulose-rich vegetable food constituents are partly 
degraded by bacteria (419). The question, however, is to which extent these 
degradation products are still absorbed. The same applies to the vitamins
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synthesized in the colon (923). Some pharmacological agents, e.g. salazosul- 
phapyridine, depend on bacterial conversion for release of their active me- 
tabolites (918). The presence of an intestinal flora is also of great importance 
in preventing truly pathogenic micro-organisms from settling down. This is 
achieved via the creation of a particular environment in which no suitable 
conditions prevail for these pathogenic micro-organisms (237). Due to the 
presence of micro-organisms in the intestine the human organism is con- 
stantly immunized against the bacteria commonly found in food.
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CHAPTER 5
INTESTINAL DIGESTION AND ABSORPTION
5.1 GENERAL INTRODUCTION
5.1.1 Surface
The interaction between the contents of the lumen and the mucosa of the 
small intestine takes place at and via the membrane which separates one 
from the other. Their interface is greatly enlarged by the presence of mucosal 
folds (valvulae conniventes of Kerckring), intestinal villi, and microvilli. 
This surface enlargement is quite pronounced, particularly in the proximal 
segment of the small intestine (921). The total area of the interface between 
the enterocytes and the intestinal lumen has been estimated to equal that of a 
lawn-tennis court (180, 808). It is not quite clear why this surface area should 
be so large. An obvious suggestion would seem to be that it is required for 
optimal absorption. However, experience gained with patients after resec- 
tion of a large portion of the small intestine contradicts this. The available 
surface area is evidently substantially larger than  would be strictly neces- 
sary; there is, it seems, a considerable functional reserve. This is also appa- 
rent from the large amounts of food which the human organism is able to 
absorb. This has been demonstrated for several food constituents such as 
fat, the absorption of which is still normal at a daily intake of some 600 g 
(460), and for protein, of which amounts up to  600 g/day can likewise be 
absorbed (701). Perhaps the large surface area o f the small intestine should 
be viewed as a vestige of man’s remote past, when meals were less regular 
and food was taken when the hunt was successful, often after a fast of several 
days.
5.1.2 Mucosal contact time
The absorption of each substance increases as the increase in duration of 
exposure to the absorbing surface. The propulsion of the food bolus in the 
small intestine, therefore, should not be too rapid if adequate absorption is
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to be ensured. The average speed of intestinal contents is estimated to be 
1.5-2 cm/minute while fasting, and is believed scarcely to increase after 
ingestion of a modest meal. After food consumption, the intestine distends 
if necessary in order to pass more food without accelerating its transit. This 
adaptation of the diameter of the intestinal lumen to the amount of ingested 
food, together with the above mentioned functional reserve of absorbing 
surface, is an important aid in coping with a sudden supply of large amounts 
of food (808).
5.1.3 Digestion
The ingested food is largely digested before it is absorbed in the small in­
testine. Degradation is required to obtain fragments sufficiently small to be 
absorbed. Dietary proteins are thereby sufficiently altered to lose their 
antigenic properties. Experience shows, however, that very large molecules 
such as haem and polyglutamate, can be adequately absorbed without 
degradation (44, 157). It has also been found that some protein molecules 
are able to pass the intestinal wall without any preceding degradation, thus 
retaining their antigenic properties (891). Another explanation of the use of 
intraluminal digestion is perhaps that fragments can be more quickly ab­
sorbed because they pass through the cell membrane more easily (121). 
Absorption, however, does not always prove to be faster as the fragments 
become smaller. Oligopeptides, for example, are absorbed at least as quickly 
as amino acids (173, 791).
It has long been assumed that food constituents are completely degraded 
in the intestinal lumen before they are absorbed. It has gradually come to be 
established, however, that digestion of proteins, fats and carbohydrates in 
the intestinal lumen is usually incomplete (567). It is probable that digestion 
also takes place to an important extent in the brush border of the enterocytes 
(866), and even intracellularly (673). The brush border therefore has a func­
tion beyond merely that of enlarging the absorbing surface. It contains 
many enzymes for food digestion and also carriers for the transport of 
degradation products, as well as ATPase to obtain the energy from ATP 
required for active transport (807). The notion has developed that the side- 
by-side presence of digestive enzymes, carriers and energy suppliers in the 
brush border ensures rapid and efficient absorption of food constituents (414).
5.1.4 Translocation 
It is difficult to imagine how the digested nutrients pass through the intestinal
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wall during the translocation process, because the cell membrane of the 
enterocyte consists largely of lipids. Only the passage of fat-like substances 
poses no problems because they can -  more or less -  diffuse through this 
membrane. For all other ions and for water, translocation would theoretic- 
ally seem to be almost impossible. In actual practice, however, these sub­
stances prove to pass through the cell membrane without difficulty. There 
are only two conceivable ways in which this can take place.
One possible way is via water-filled pores in the enterocyte membrane, 
otherwise known as aqueous channels. Perfusion studies with solutions of 
molecules of different size would seem to warrant the conclusion that, in 
the jejunum, most of these pores have a diameter of 0.8 nm, versus about 
0.3 nm in the ileum. In addition, a small number of wider pores are believed 
to be present through which larger molecules can pass (282). It is conceivable 
that these pores are not only found in the enterocyte membrane but also at the 
tight junctions between the enterocytes (284).
Another possibility is that non-lipid substances pass through the cell 
membrane by means of so-called transport carriers which are believed 
capable of carrying these substances through the cell membrane. These 
carriers have been conceived of as a kind of rotating ticket-window or turn- 
stile, taking up substances on the luminal side of the cell membrane, and 
releasing them intracellularly (175). The exact nature of these carriers is un- 
known, for they have never been isolated or visualized. Yet their existence is 
plausible, for phenomena such as active transport, facilitated diffusion and 
congenital disorders in intestinal amino acid transport could hardly be ex- 
plained without this carrier concept.
5.1.5 Unstirred layer
The absorption of substances from the intestinal lumen is expected to be 
influenced by the phenomenon of the so-called unstirred layer (213). This 
term refers to the fact that there exists no direct contact between the lipid 
enterocyte membrane and the aqueous solution in the intestinal lumen. There 
is a kind of liquid intermediate layer present, called unstirred layer, which 
differs in composition from the remainder of the intestinal contents. lts 
thickness should range from 10 to 1000 jxm, dependent on the nature of the 
lipid membrane and the flow of intestinal contents. A t the villous tips this 
layer is much thinner than near the crypts. The unstirred layer impedes the 
absorption of various substances, particularly of hydrophobic molecules. It 
prevents a direct contact between luminal contents and intestinal wall. 
Changes in the intestinal contents are not demonstrable in the unstirred
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layer until after some time, and often in a lesser degree. The rate at which 
nutrients are absorbed, therefore, can be largely determined by the quality 
of the unstirred layer (213).
5.1.6 Absorption
The fundamental process which underlies absorption in its totality is based 
on the characteristic property of all epithelial cells, including enterocytes, to 
maintain a certain intracellular sodium concentration (659). The cells of the 
intestinal wall maintain a sodium concentration, which is comparatively 
low. The sodium is pumped out of the enterocytes, into the intercellular 
space via the lateral cell membrane. This transport usually takes place against 
an electrochemical gradiënt, and therefore requires energy. For this purpose 
the lateral cell membrane contains Na+-K+-activated ATPase (797), which 
can convert the ATP synthesized by the enterocytes to energy (fig. 5.1.a;
intestinal
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Fig. 5.1. Diagram of the various components of the intestinal absorption process of fluid 
and electrolytes.
a. the sodiumpump at the lateral cell membrane
b. the solvent drag into the intercellular space
c. the emptying of the intercellular space
d. the transepithelial carrier transport mechanism (coupled translocation of sodium and 
amino acids or hexoses)
e. the solvent drag into the enterocyte
659). In this way, hyperosmolarity is created in the intercellular space, and 
water is attracted. It has not been established whether this water is attracted 
from the enterocytes via their lateral cell membrane and/or from the in-
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testinal lumen via the tight junctions. This water flux takes along solutes by 
means of convection, a process known as solvent drag (fig. 5.1.b). In this 
way, certain ions can even be transported against a concentration gradiënt.
There is an additional absorptive mechanism operating in the brush border 
membrane. The translocation of various substances by means of carriers is 
believed to take place here. These carriers, which in some respect are specific 
for the substance to be absorbed (567), seem to be able to function only if 
sodium can be translocated along with the molecule or ion in question. In 
fact the sodium translocation is probably the primary process. Since the 
intracellular sodium concentration is low, as sodium is continuously being 
pumped to the intercellular space (fig. 5.1.a), the sodium from the intestinal 
lumen can enter the enterocyte with the concentration gradiënt, in a tran­
sport process which requires no energy. On the ‘pillion-seat’ of the carrier, 
the sodium takes along other substances such as glucose or amino acids into 
the cell (fig. 5.1.d; 175, 763). Just as sodium stimulates the absorption of 
glucose and amino acids, the latter two substances stimulate the absorption 
of sodium (284). It follows from the above that translocation of sodium is of 
fundamental importance for all absorption processes in the small intestine.
The translocation of sodium and other substances over the brush 
border membrane also attracts water, which creates a solvent drag (fig. 5.1 .e).
In addition to active transport, passive transport can take place through 
the cell membrane. This passive transport, otherwise known as diffusion, is 
possible only with the concentration gradiënt or electrochemical gradiënt. If 
diffusion takes place with the aid of carriers, it is called facilitated diffusion.
All absorbed substances enter the intercellular spaces, be it as a result of 
diffusion, solvent drag, or active transport. The accumulation of absorption 
products causes dilatation of the initially narrow intercellular spaces (284). 
As a result of the high hydrostatic pressure thus produced, water and solutes 
are pressed through the basement membrane into the lamina propria, 
where they are taken up by the capillaries (fig. 5.1 .c).
5.1.7 Secretion
Apart from absorption, secretion of water and ions also takes place in the 
small intestine. Tn fact there are two opposite fluxes over the intestinal wall: 
one from the intestinal lumen to the blood stream, and the other from the 
blood stream to the intestinal lumen. The phenomenon of secretion was 
detected when, in perfusion studies of the small intestine, a larger amount of 
water or solutes was occasionally recovered from the perfusate than had
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been initially instilled. Moreover, intravenously administered isotopes also 
proved to be demonstrable in the perfusate after a while.
In some types of diarrhoea, particularly in cholera, this secretion is quite 
substantial (802). The extent of the intestinal secretion under normal condi- 
tions, however, has not yet been established with certainty. Some authors 
maintain that the amounts secreted cannot be considerable (284), whereas 
others (659, 680) suspect them to be very large.
The mechanism of secretion in the small intestine is likewise still largely 
unknown. In principle, secretion could take place via the same routes as ab­
sorption, albeit in opposite directions. A passive secretion of water and 
electrolytes would be readily possible in the jejunum if it had sufficiently 
large epithelial pores. Active secretion is possible moreover, as suggested by 
the presence of ATPase in the brush border (284). Some investigators sus­
pect that secretion is effected by the enterocytes in the crypts of the in­
testinal mucosa, whereas the enterocytes of the villi serve only the absorp­
tion (378). The intestinal hormones seem to exert no influence on the nature 
and extent of the secretion (284).
Finally, it is not clear either why secretion takes place in the small in­
testine at all. It could be the result from osmotic attracting forces from the 
intestinal lumen (284). This attraction of fluid and electrolytes, which pro­
bably takes place especially in the proximal part of the small intestine, might 
be required to render the hypotonic or hypertonic intestinal contents iso- 
tonic, thus facilitating their absorption (284, 659). Another possibility is 
that sodium is deliberately and constantly secreted into the intestinal 
lumen to ensure a sufficiënt intraluminal sodium concentration. For the 
presence of sodium in the intestinal lumen is required for the translocation 
of several important nutrients, and probably for that of all nutrients (fig. 
5.1.d; 175, 763).
Due to secretion, the small intestine actually absorbs more than it would 
seem to do at first sight. This is why a distinction is sometimes made be­
tween net absorption and total absorption. Net absorption is defined as the 
resultant of absorption and secretion, or the difference between oral intake 
and faecal loss. Total absorption encompasses this net absorption as well as 
the indiscernible absorption of water and electrolytes, which were released 
by secretion (659, 802).
5.2 WATER AND ELECTROLYTES
The human organism largely consists of water and electrolytes. Their 
amounts have to be kept within certain limits to ensure proper body func-
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tion. Continuous loss of fluid and electrolytes takes place via the skin, lungs, 
urine and faeces. The amount lost depends on  physical activity, environ- 
mental temperature and humidity, and on metabolic factors. The excretion 
of water and electrolytes via the skin, lungs and intestine is less dependent 
on the oral intake than the excretion by the kidneys. The kidneys can lar- 
gely regulate the amount excreted. They have to  excrete a minimum amount 
of fluid under all circumstances, however, in order to eliminate such sub­
stances as urea, etc. There are therefore certain water and electrolyte re- 
quirements which have to be met by oral intake. These requirements 
show interindividual differences as well as intraindividual variations. The 
human organism obtains its sodium and chloride partly from meat, fish and 
dairy products. By far the largest amount is added to the food as taste corri- 
gent. The daily food intake contains a total of 6-18 g sodium chloride (700), 
and this is usually more than sufficiënt. The potassium requirement is 
estimated to be about 2.5 g/day (700). Potassium is contained in virtually 
all foods, e.g. potatoes, milk, vegetables, meat and bread.
The amounts of water and electrolytes presented for absorption in the 
small intestine are many times larger as the oral intake. This is caused by 
the large amounts of endogenous water and electrolytes released, for examp- 
le, with the digestive juices and the secretion via the intestinal wall (section 
5.1.7). The extent of this intestinal secretion cannot be readily established 
(284). It is suspected that the total amount o f  water and electrolytes pre­
sented for absorption per 24 hours (i.e. the sum of oral intake, digestive 
juices and secretion via the intestinal wall) amounts to about 10 litres of 
water, containing 1000 mmole sodium chloride (799). The maximum capa- 
city of the small intestine is probably at least twice as large (526).
The role which the stomach plays in the absorption of water and electro­
lytes is merely to serve as storage space for food. The stomach is virtually 
impermeable to water and sodium (147), and consequently the gastric con­
tents can long remain non-isotonic in relation to the blood (281). In the 
duodenum, whose wall is freely permeable to water and sodium, the food 
bolus is quickly rendered isotonic. This is effected by attraction of water via 
an osmotic gradiënt, while sodium chloride moves into the lumen via a con­
centration gradiënt (281) (fig. 5.2). As a result of the events in the duode­
num, the food bolus is isotonic -  so far as the aqueous phase is concerned -  
at the moment it reaches the jejunum (281). In  the duodenum itself, pro­
bably no significant absorption of water and electrolytes occurs; but imme- 
diately after, absorption becomes maximal. Water and sodium absorption 
largely take place in the proximal jejunum (91). Perfusion studies have 
shown that efficient absorption of water and sodium requires the presence
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of other substances such as glucose (798), galactose (283), maltose (579) and 
some amino acids (4). It is assumed that these substances are effective in 
that they stimulate the translocation of sodium over the cell membrane 
(section 5.1.6).
Solvent drag
♦
Fig. 5.2. Diagram of the localization and mechanisms o f electrolyte absorption in the 
small intestine.
The chloride ion probably always accompanies the sodium ion, for as 
much chloride as sodium is absorbed. In addition, some chloride is perhaps 
secreted in the jejunum (680).
In the jejunum, bicarbonate is probably absorbed against a concentration 
gradiënt. An alternative possibility is that the bicarbonate, together with the 
hydrogen ions secreted into the lumen, forms water and carbon dioxide; 
for secretion of hydrogen ions is believed to occur in exchange for absorp­
tion of sodium ions. By trapping the hydrogen ions, the bicarbonate sti- 
mulates the secretion of hydrogen and, secondarily, the absorption of 
sodium (283). Perhaps the bicarbonate secreted by the pancreas promotes 
by this mechanism the absorption of water and sodium (802).
Potassium passively disappears from the jejunum, either by diffusion to 
the plasma (680) or by solvent drag (864).
The absorption of water and electrolytes in the ileum is quite different 
from that in the jejunum. This is probably due to the fact that most of the 
substances which stimulate absorption of water and sodium, such as sugars, 
amino acids and bicarbonate, have already been absorbed in the proximal 
jejunum (91). Absorption in the ileum largely consists of an exchange be-
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tween different ions. For example, sodium is absorbed in exchange for 
hydrogen secretion, and chloride is absorbed in exchange for the secretion 
of bicarbonate (863). The hydrogen and bicarbonate ions secreted in the 
lumen of the ileum are osmotically inactive, probably because they form 
water and carbon dioxide. In the ileum, more chloride than sodium seems to 
be absorbed (207). It is not yet quite clear how potassium is absorbed in the 
ileum, but this is probably passive, by diffusion (864). Perhaps some secre­
tion of potassium also occurs in the ileum (243).
In the colon, too, an important amount of water and electrolytes is still 
absorbed, as shown by the marked quantitative and qualitative changes to 
which the contents of the terminal ileum are subject before leaving the body 
as faeces (681). The processes of absorption and secretion in the colon are 
roughly the same as those in the ileum (207), but there are also some im­
portant differences. For example, bacterial degradation of food roughage 
produces large amounts of organic anions, so that some chloride can still be 
absorbed (731). Another difference is that passage through the colon takes 
about ten times as long as the transit time through the ileum, so that there is 
more time for the various processes of absorption and exchange. An im­
portant feature of the colon in this respect is its relatively low permeability, 
which enables marked concentration gradients to be built up (68).
The absorption of water and electrolytes is influenced by several hor­
mones. Absorption in the proximal jejunum, for example, is inhibited by 
secretin and CCK-PZ, perhaps in order to keep intestinal contents liquid for 
a longer time in order to facilitate digestive processes (609). Calcitonin 
causes increased secretion of water and electrolytes (336). Aldosterone, 
finally, increases the absorption of water and sodium in the colon, and 
also the secretion of potassium in the colon (514).
5.3 CARBOHYDRATE
Carbohydrates are important for the human organism as a source of 
energy. About 50% of the caloric requirements are covered by carbohy­
drates, of which about 300-400 g are ingested per day. The carbohydrates 
ingested largely consist of starch (60%, of which one-fifth is amylose and 
four-fifths is amylopectin), and sucrose (30%). Only 10% is in the form of 
lactose, while trehalose and various monosaccharides are consumed in only 
very small quantities (335).
The digestion of starch is catalysed by the enzyme a-amylase, from saliva 
and especially pancreatic juice. Due to the fact that almost 10 times as much
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a-amylase as is thought necessary is probably available (335, 633), conver- 
sion to maltose, maltotriose and a-dextrin is fairly well completed in the 
duodenum (189) (fig. 5.3).
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The second phase of carbohydrate digestion, the degradation of dis- 
accharides, takes place at the brush border of the enterocytes. The brush 
border membrane contains several disaccharidases such as five types of 
maltase, but also enzymes which split lactose (two lactases), sucrose (su­
crase) and trehalose (trehalase) (596). It may be that these disaccharidases 
are not localized in the brush border but just on the outside, in the gly- 
cocalyx (439). The amounts of the different disaccharidases present in or 
near the brush border vary substantially. Normally, the ratio between the 
amounts of maltase, isomaltase, sucrase and lactase is 8:2:2:1. This ratio is 
constant throughout the whole length of the small intestine. The absolute 
amounts of the various disaccharidases, however, vary. Enzyme activity, 
while low in the duodenum, is maximal the proximal jejunum and decreases 
in the distal jejunum and the proximal ileum (632). The maltases convert 
maltose and maltotriose into glucose, to which also the dextrins are de- 
graded. The lactases split lactose into galactose and glucose, and sucrase 
converts sucrose into glucose and fructose (fig. 5.3).
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Whereas abundant data are available on carbohydrate digestion little is 
known with certainty about absorption of carbohydrates. They are probably 
absorbed only in the monosaccharide form. Since the monosaccharides are 
absorbed more quickly than a simple diffusion process could explain, tran­
sport carriers are likely to be involved in their absorption. Transport of 
monosaccharides over the cell membrane is linked to the translocation of 
sodium (section 5.1.6). It has not yet been established whether there are 
separate types of carrier for glucose and galactose, or whether these two 
make use of the same carriers. Fructose is probably absorbed, not by active 
transport but passively, by means of carriers (the so-called facilitated diffu­
sion) (327). The carriers and disaccharidases are probably localized close 
together so that, after the splitting of the disaccharides, the fragments can 
be passed on to the carriers (414). This explains why the absorption of 
disaccharides is about as rapid as that of monosaccharides (205, 333).
The degradation and absorption of carbohydrates is effected quickly and 
efficiently. The absorption is usually already completed in the jejunum (91). 
The rate at which carbohydrates are absorbed by the enterocytes is dependent 
on the speed of the carrier transport. The rate of lactose absorption, how­
ever, is determined by the rate of degradation, i.e. by the amount of lact­
ase available.
5.4 FAT
5.4.1 Introduction
The fat in the human diet, usually 60-100 g/day, covers about one-third of 
the energy requirement. In addition, fat serves as a vehicle for the fat- 
soluble vitamins. Some 95% of the nutritional fat consists of triglycerides. 
In addition to triglycerides, the human diet contains 0.5-1 g cholesterol and 
an even smaller amount of phospholipids (754).
The triglycerides consist of a glycerol skeleton to which three fatty acids 
are coupled. These fatty acids have a carbon chain which can differ in 
length. According to the length of their chain, a distinction is made between 
long-chain triglycerides (LCT, with chains of 12-20 carbon atoms), medium- 
chain triglycerides (MCT, with chains of 6-10 carbon atoms), and short- 
chain triglycerides (SCT, with chains of 2 or 4 carbon atoms). The triglyce­
rides in the diet comprise about 90% LCT and 10% MCT (335). Fatty acids 
are not essential for the human organism, with the exception of linoleic 
acid. Deficiency of this essential linoleic acid causes severe skin lesions (151, 
361,851).
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The Cardinal point in the absorption of fats lies in the solubilization, so 
that they are finely dispersed in the aqueous intestinal contents. Only in that 
way is efficient absorption by the enterocytes possible. Three processes 
actually play a role in this respect: emulsification, lipolysis and solubiliza­
tion (micelle formation) (335, 754).
5.4.2 Triglycerides
The emulsification of triglycerides is in fact started by the mastication of 
food in the mouth and by the kneading in the stomach. Apart from these 
mechanical processes, emulsification is mostly effected chemically, by various 
emulsifiers such as lecithin from bile, and monoglycerides. M ost of these 
emulsifiers are only available in or beyond the duodenum. In its emulsified 
form, fat consists of particles with a diameter of 0.3-1 (im (754).
Lipolysis, or hydrolysis of triglycerides is effectuated by various lipases. 
Gastric juice, for example, contains a lipase which hydrolyses especially the 
MCT-triglycerides (149). In the duodenum, several lipases (glycerol ester 
hydrolases) are released which have been produced in large amounts by the 
pancreas. These lipases detach the two outer (1-, 3-) fatty acids from the 
triglyceride molecules so that free fatty acids and (2-) monoglycerides remain 
(fig. 5.4). Most of the monoglycerides is not further hydrolysed but ab­
sorbed as such (467).
To be adequately absorbed, the triglyceride degradation products have to 
be dispersed in a particular way. This is effected with the aid of bile acids 
which form globular aggregates called micelles. An important factor for the 
formation of these aggregates is the molecular structure of the bile acids, 
with on the one side a highly polar end (which is hydrophilic), and on the 
other side a non-polar hydrocarbon group (which is hydrophobic). Only 
above a certain concentration (the so-called critical micellar concentration) 
do these bile acids form micelles. The orientation of these globular bile acid 
aggregates is such that the hydrophilic poles are on the outside, while the 
lipophilic poles are at the centre.
In the interior of this micelle, highly hydrophobic products such as 
cholesterol and fat-soluble vitamins can be carried. More on the outside of 
the aggregate, between the polar ends of the bile acids, more hydrophilic 
products such as monoglycerides, fatty acids and phospholipids are carried 
(fig. 5.4). The micelles ensure that the fat degradation products, cholesterol 
and fat-soluble vitamins are solubilized and finely dispersed so that ample 
contact with the brush border of the enterocytes is possible. At the transition 
from emulsion to micellar form, the diameter of the iat particles is reduced
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by factor 100-200, and consequently the interface between fat particles and 
intestinal fluid increases by factor 10,000-40,000 (525).
During their passage through the small intestine, the lipid food con­
stituents are gradually emulsified and degraded. The degradation products 
are in turn good emulsifiers, and on the other hand degradation occurs more 
readily if the lipids are already well emulsified. The degradation products are 
taken up by the available unoccupied micelles, or wait until they become 
available. The combined process of emulsification, hydrolysis and solubiliza- 
tion is an integrated interaction which ensures efficient absorption of lipids 
(408). Fatty acids are still efficiently absorbed in the absence of bile, while 
the absorption of fat-soluble vitamins or cholesterol is negligible under these 
conditions (690).
It has long been thought that absorption of triglycerides by the enterocyte 
was effected by pinocytosis at the brush border. Electron-microscopic fin- 
dings, however, have never confirmed this (219). Probably, therefore, ab­
sorption takes place by diffusion of monoglycerides, fatty acids and cholest­
erol (735). Transport through the cell membrane of the enterocyte should 
pose no problems for fatty substances because the membrane itself largely 
consists of lipids creating the possibility of a simple diffusion process (192). 
In the apex of the enterocyte, the absorbed fatty acids and monoglycerides 
are re-esterified to triglycerides and phospholipids. This re-esterification is 
immediately followed by chylomicron formation (fig. 5.4). Both processes 
probably take place in the smooth endoplasmic reticulum of the enterocyte. 
For this purpose, certain proteins are formed in the reticulum, notably (3- 
lipoprotein (754). The chylomicrons are probably formed in that the lipopro- 
tein complexes take up increasing amounts of re-synthesized triglycerides, 
thereby increasing in size (865). Ultimately fat droplets are created, which 
are surrounded by a thin layer consisting of phospholipids, (3-lipoprotein 
and cholesterol. The size of these chylomicrons is 0.1-3.5 nm. The chylo­
microns leave the enterocyte via the lateral cell membrane, probably by re- 
versed pinocytosis. They enter the intercellular space and, via apertures in the 
basement membrane, enter the subepithelial tissue (865). The chylomicrons 
are finally taken up in the initial lacteals. A small number of chylomicrons 
directly reach the portal circulation, possibly by shunting. Endogenous lipid, 
however, is transported in the very low density (pre-(3) lipoproteins (754).
The medium-chain triglycerides (MCT) are more rapidly degraded in the 
intestinal lumen by lipase than LCT. Moreover, their absorption requires 
no preceding hydrolysis, because degradation can also take place in the 
enterocytes. Most medium-chain fatty acids are transported via the portal 
circulation without preceding re-esterification.
66
5.4.3 Cholesterol
The human diet as a rule contains but little cholesterol: about 0.5-1 g/day, 
mostly consumed as eggs, meat and dairy products (754). However, the 
human organism itself synthesizes large amounts of cholesterol from ace- 
tates, particularly in the liver and in the epithelial cells of the digestive tract 
(212). Cholesterol found in the intestinal lumen therefore originates from 
several sources, such as foocl, exfoliated cells (estimated to amount to 
0.25-0.40 g/day) and bile (1-2 g/day) (192). Cholesterol is required for the 
synthesis of steroid hormones, vitamin D and bile acids. In addition it 
probably has other, not yet identified functions as indicated by its high con­
centration in several organs such as the brain.
So far as it is present in esterified form, cholesterol is hydrolysed by 
cholesterol esterase, an enzyme secreted by the pancreas but found also in the 
brush border of the enterocytes (855). The pancreatic cholesterol esterase is 
activated by bile acids. Due to its poor solubility in water, cholesterol can 
virtually only be dissolved by incorporation in micelles. In the absence of 
bile, therefore, virtually no cholesterol is absorbed (690). Cholesterol ab­
sorption probably takes place by diffusion (793), followed by re-esterifica- 
tion in the enterocyte (192). Cholesterol enters the lymph pathways with the 
chylomicrons, and so reaches the blood stream. Under normal conditions, 
only 20-40% of the ingested cholesterol is absorbed (93), mainly in the 
proximal jejunum (92). It is believed that 1-3 g cholesterol, from food, bile 
and exfoliated intestinal epithelial cells on the one hand, and from the 
cholesterol pool in the intestinal epithelial cells on the other, is transported 
daily via the lymph pathways (192).
Since the cholesterol level is usually more or less constant, it is evident that 
the synthesis, degradation and elimination of cholesterol are adjusted to 
each other by a control mechanism. When cholesterol absorption diminishes, 
its synthesis in the liver increases. Cholesterol synthesis in the epithelial 
cells of the digestive tract is partly determined by absorption of bile acids. 
Absence of bile acids from the intestinal lumen causes a substantial increase 
in cholesterol synthesis (212). The height of the serum cholesterol level is 
otherwise influenced by various hormonal, genetic and age-linked factors 
(196).
5.4.4 Phospholipids
In addition to triglycerides and cholesterol, food also contains a small 
amount of phospholipids, which are found in m eat and eggs. Otherwise the 
phospholipid requirement is largely fulfilled by their de-novo synthesis in
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the liver, small intestine, muscles and brain. The human organism needs 
these phospholipids for a normal functioning of cell membranes, mito- 
chondria and neurons. Phospholipids in food facilitate the emulsification of 
triglycerides and the incorporation of cholesterol and fat-soluble vitamins in 
the micelles.
Hydrolysis of phospholipids is effectuated by phospholipase A, an enzyme 
secreted by the pancreas and activated by bile acids. The hydrolysis products 
become soluble by incorporation in micelles. After absorption by the mucosa, 
the phospholipids, too, are re-synthesized and incorporated in the chylo­
microns (754).
5.4.5 Fat-soluble vitamins
5.4.5.1 Introduction
Absorption of the fat-soluble vitamins A, D, E and K takes place in 
roughly the same way as cholesterol absorption. Like cholesterol, these 
vitamins consist of relatively large molecules which, like all non-polar lipids, 
have a very poor solubility in water. For their absorption, therefore, micelle 
formation is essential. The vitamin-ester complex is abolished by hydroly­
sis, exactly as in the case of cholesterol. The enzymes required for this 
purpose originate from the pancreas and possibly also from the brush border 
of the enterocytes (302). Absorption takes place in the proximal part of the 
small intestine (88). After absorption, vitamins A and D are mostly re-esteri- 
iied within the enterocyte. After incorporation in chylomicrons fat-soluble 
vitamins are transported with the lymph. A small amount directly enters the 
portal circulation (842).
5.4.5.2 Vitamin A
Vitamin A (retinol) is contained in many foods such as milk, eggs, meat 
and fish. lts precursors, the carotene pigments, are found especially in green 
vegetables, carrots and yellow-red fruits such as apricots and peaches. 
Vitamin A is synthesized from this carotene in the human and animal in­
testinal wall. Since the liver has very large vitamin A reserves, deficiency 
does not become manifest until after months or years. The symptoms of 
vitamin A deficiency are: night-blindness, xerophthalmia, keratomalacia 
and keratosis follicularis. A low vitamin A level is found not only in the case 
of a deficient diet or malabsorption but also in some patients with infectious 
diseases, anaemia, hepatitis or cirrhosis of the liver. lts occurrence in these 
cases has so far not been elucidated (448).
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5.4.5.3 Vitamin D
The human organism can partly fulfil its vitamin D requirement by 
synthesizing a pro-vitamin which is converted to vitamin D 3 (cholecalci- 
ferol) by solar light on the skin. This vitamin D 3 can also be acquired via 
food. In less sunny climates, and as result of the wearing of clothes, this 
supply with the food is very important. Fish liver in particular contains 
large amounts of vitamin D 3. In'much smaller amounts, it is also present in 
liver, eggs and dairy products (700). After absorption in the intestine, vitamin 
D 3is first hydroxylated to 25-OH-D3 in the liver, and then to l,25-OH-D3and 
24,25-OH-D3 in the kidneys. The question remains whether the various 
vitamin D metabolites have their own particular functions. By far the most 
effective metabolite seems to be l,25-OH-D3, which induces the synthesis of a 
protein for calcium transport in the enterocytes (250). In addition to a 
stimulating effect on calcium absorption in the small intestine, vitamin D 
also enhances the degradation of bone tissue. Moreover, it inhibits renal 
excretion of calcium and phosphate, possibly by means of parathormone 
(691).
Vitamin D deficiency causes disorders of mineralization in bone tissue 
(rickets or osteomalacia). It is not only associated with a deficient diet and 
malabsorption but can also occur as a result of renal diseases or vitamin D 
resistance.
5.4.5.4 Vitamin E
Vitamin E (tocopherol) actually consists of a group of vitamins of which 
a-tocopherol is the most active. Vitamin E is found in virtually all foods, 
particularly in cereals, vegetable oils, green vegetables, eggs, butter and 
meat (especially liver). Nevertheless, vitamin E deficiency due to a wrong 
choice of food seems„to be possible (805). Vitamin E deficiency can also 
develop as a result of malabsorption (69). The consequences of vitamin E 
deficiency are unknown. Vitamin E is believed to inhibit oxidation of lipids 
in the cell membrane, and it is consequently regarded as important for the 
proper functioning of cell membranes. In infants haemolysis has been de­
scribed, and changes in the muscles and in the reproductive function have 
been observed in test animals (196). The presence of ceroid pigment in the 
muscle tissues of various organs has been ascribed to vitamin E deficiency 
(69, 847).
5.4.5.5 Vitamin K
Vitamin K is a term applied to several vitamins, of which only vitamin K x 
(phytomenadione) is of clinical significance. This vitamin is found in
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particular in green vegetables. In addition, it is endogenously synthesized by 
bacteria in the colon, mainly by Escherichia coli (328). Vitamin K  defi- 
ciency due to a deficient diet has been observed only in association with 
simultaneous use of antibiotics (292). The body’s vitamin K reserves seem 
to be small, and are exhausted after 3-4 weeks. The function of vitamin K 
concerns blood coagulation, as indicated by its designation (‘K ’ stands for 
‘Koagulation’).
Vitamin K  stimulates the production of the clotting factors II, VII, IX 
and X in the liver. The presence of this vitamin can be determined only 
indirectly, by measuring the concentration of the above mentioned coagula­
tion factors. This is usually done with the aid of the prothrombin time 
(PTT), thrombotest or normotest. Since these coagulation factors are 
synthesized in the liver, disorders of liver function can exert a nëgative in­
fluence on these determinations too.
5.5 PROTEIN
The human organism is continuously degrading its protein store. The 
mechanism and the site of this degradation are only partly understood (730). 
If  a positive nitrogen balance is nevertheless to be maintained, then this 
loss has to be replenished via the food. The amount of protein normally 
required for this repletion is estimated to be about 45 g/day (700). The usual 
daily diet contains about twice this amount, mainly in meat, fish, eggs and 
dairy products. Cereals and legumes also contain substantial amounts of 
protein. The human organism can digest and absorb large amounts of pro­
tein. In experimental situations, daily amounts up to 600 g were found to be 
adequately absorbed (701).
The digestion of dietary protein begins in the stomach, which secretes 
several types of pepsinogen, i.e. enzyme precursors which the gastric juice 
converts into active pepsins (911). The principal role of the stomach, apart 
from its function as storage space, is so to denature dietary protein with the 
aid of gastric juice and pepsins as to facilitate, and therefore accelerate, its 
degradation in the small intestine. This role is not such a very important 
one, as demonstrated by the fact that malabsorption of protein usually does 
not occur in treated pernicious anaemia.
The lion’s share in protein digestion is taken by the proteolytic enzymes 
secreted by the pancreas. Pancreatic secretion of these enzymes is stimulated 
by the intestinal hormone CCK-PZ, which is synthesized by cells in the 
mucosa of the duodenum and the proximal jejunum, and released after
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stimulation of these cells by e.g. food rich in fa t or proteins (section 4.7). 
There are several types of proteolytic pancreatic enzyme, each with a 
specific effect which is determined by their access to the link between certain 
amino acids. A distinction is thus made between the endopeptidases tryp- 
sinogen, chymo trypsinógen and pro-elastase, and the exopeptidases such as 
carboxypeptidase A and B (334). The former break certain peptide links 
within the protein molecule, while the latter break only the terminal peptide 
link at the carboxyl side of the molecule (fig. 5.5).
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Most pancreatic proteolytic enzymes are secreted as inactive precursors. 
An imDortant factor for activation of these precursors is enterokinase, an 
enzyme likewise synthesized by the duodenal mucosa (642). This entero­
kinase converts trypsinógen into trypsin, while trypsin in turn activates the 
precursors of the other enzymes. In addition, each activated enzyme catal- 
yses its own inactive precursor. Under normal conditions the amount of
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enzymes secreted by the pancreas is quite excessive in relation to the amount 
of protein contained in the food (334).
It is generally assumed that protein is not completely degraded to amino 
acids in the intestinal lumen, as it was believed to be in the past (567). An 
important part of the protein digestion takes place at the brush border of the 
enterocytes or in the enterocytes themselves (fig. 5.5). The brush border con­
tains a large amount and wide variety of peptidases, each of which is rela- 
tively specific (377). In addition the brush border is believed to carry a con- 
siderable amount of pancreatic enzymes which, as it were, become glued to 
the mucosa (316). The brush border of the enterocytes consequently has a 
great protein-splitting capacity. The degradation at this site is sometimes 
referred to as ‘membrane digestion’. Ugolev (866), who introduced this 
term, holds the rather extreme view that virtually the entire degradation of 
protein takes place at the brush border of the enterocytes.
The absorption by the enterocyte of all these amino acids, dipeptides or 
oligopeptides, takes place by active transport. This transport is dependent 
on the translocation of sodium over the cell membrane (section 5.1.6). The 
reverse also seems to be tru e : absorption of sodium and water is stimulated 
when amino acids or dipeptides can be absorbed simultaneously (4, 376). 
This active transport probably takes place by means of transport proteins or 
carriers. There would seem to be several carrier systems for the various 
amino acids, the neutral, basic and acid amino acids, as well as carriers for 
proline, hydroxyproline and glycine (334, 567). There are probably also 
separate transport carriers for certain dipeptides (6, 7) (fig. 5.5). The 
existence of so many different carriers for individual or grouped amino 
acids and dipeptides, is suggested by the occurrence of various hereditary 
disorders of amino acid transport which are evidently based on the lack of a 
given transport system (598). It seems likely that a substantial amount of 
protein is absorbed as dipeptide or even as oligopeptide (5, 638). This 
would imply that further degradation takes place within the enterocytes 
(fig. 5.5), because in the portal blood virtually only amino acids are found 
(634, 673). According to Peters (673), peptidase activity is for the most part 
localized within the enterocyte rather than outside. When absorbed as 
oligopeptide, more amino acids enter the circulation per unit of time than 
would be the case if the same amino acids were offered in a completely 
hydrolysed form (173, 790). This finding suggests that the rate of absorption 
is determined largely by the total number of transport carriers available.
Absorption of minute quantities of undigested protein also takes place. 
These proteins are found unchanged in lymph and portal blood (882, 891).
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This phenomenon, still unexplained, plays no essential role in protein ab­
sorption in its totality.
Absorption of dietary protein is believed usually to be completed in the 
proximal part of the small intestine (91, 638). However, this is not corrobor- 
ated by observations reported by other investigators who, in perfusion 
studies, were able to recover substantial quantities of protein and protein 
degradation products from the perfused intestinal loops, sometimes many 
hours after instillation (5). Protein from food is usually efficiently and al- 
most completely absorbed by the small intestine, however. The faeces as a 
rule contains no more than 2 g nitrogen (192, 291, 701), half of which origin- 
ates from endogenous and metabolic losses (700). This demonstrates that the 
total faecal loss of unabsorbed protein is less than 10% of the amount of 
dietary protein available for absorption.
In addition to protein from food, a substantial amount of endogenous 
protein released in the small intestine has to be absorbed. The exact amount 
o f endogenous protein involved cannot be estimated with any certainty, and 
estimates have so far been very disparate (181, 621). The endogenous pro­
tein fraction consists of digestive ferments and mucus, with probably about 
8 g protein per meal (638), exfoliated cells of the intestinal wall up to about 
10 g/day (188), and plasma protein leakage through the intestinal wall, 
which accounts for about 1 g/day. It has been maintained that, as a result of 
this supply of endogenous protein, the amino acid concentrations in portal 
blood only partly reflect the intermittent supply o f dietary protein (312, 627), 
so that, through the day, the supply of amino acids to the liver would be 
relatively constant -  a fact of importance for an efficient and optimal 
synthesis of protein. Hardly any data in support of this hypothesis have so 
far been presented, however (377).
5.6 CALCIUM
The human organism contains a substantial am ount of calcium, estimated to 
be 20-25 g/kg fatless tissue. About 99% of all calcium is found in the skeleton. 
The remaining 1% plays an important role in cell membrane function, the 
muscle cells and nerve synapses, in blood coagulation and in a variety of 
enzyme reactions. For the purpose of all these functions the calcium con­
centration in the various body compartments must be kept within certain, 
rather narrow limits (691). There is always some loss of calcium in urine and 
faeces. Under special circumstances calcium is lost also in other ways, e.g. 
during pregnancy and lactation. To replenish this loss, some calcium has
73
to be absorbed from the food. The amount of calcium in the daily diet of 
Europeans and Americans is estimated to be about 1000 mg, which is 
usually ample to cover requirements. Some 50% of this calcium is ingested 
as milk or dairy products (except butter) (641), and the diet of persons who 
take no dairy products is therefore sometimes relatively poor in calcium. 
Other dietary calcium sources are green vegetables, potatoes, meat and 
bread (196,422).
The presence of free hydrochloric acid is required to solubilize several 
calcium salts from food (427). In addition, certain food constituents preci- 
pitate free calcium ions or form less soluble complexes with them, such as 
the phytates (920), oxalates, carbonates and phosphates (468) or saturated 
LCT fatty acids (11). Other substances form readily soluble complexes with 
calcium ions and thus enhance calcium solubility; these substances include 
sugars, amino acids (411) and bile acids (898). In brief: several intraluminal 
factors influence the amount of calcium available for absorption.
The absolute amount of calcium absorbed from food varies less than the 
amount of soluble calcium contained in it. Relatively more calcium is ab­
sorbed at a low intake, up to twice the amount absorbed at a high calcium 
intake (812). Hence it can be maintained that the composition of the diet 
and the form in which calcium is supplied generally do not influence the 
amount of calcium absorbed (607). The same applies to the influence of 
gastric acid production or the release of bile and pancreatic juice.
Apart from the ingested calcium, an amount of so-called endogenous cal­
cium (i.e. calcium released in the intestine) is available for absorption. This 
calcium enters the intestinal lumen via the bile and pancreatic juice, or as a 
result of secretion from the enterocytes and of exfoliated cells. The amount of 
this endogenous calcium has not so far been accurately calculated, but is 
estimated to be 200 mg (641) or 400-1000 mg per day (691).
Absorption of calcium by the intestinal wall takes place by active tran­
sport; besides some passive transport by diffusion probably occurs (691). 
Active transport probably takes place by means of a transport carrier 
(887). Im portant factors for active transport are the presence of a calcium- 
binding protein (892) as well as of ATP and ATPase to supply the energy 
required (202).
The capacity of the small intestine to absorb calcium is maximal in the 
duodenum (71, 906). This does not necessarily imply, however, that most of 
the calcium is actually absorbed there. The time available for absorption is 
probably equally important, for calcium absorption takes a relatively slow 
course (411). Hence the distal part of the small intestine normally absorbs a 
probably important amount of calcium (174, 556).
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Calcium absorption is influenced by numerous factors, of which vitamin 
D is by far the most important. The presence of this vitamin is essential for 
a normal calcium absorption, as clearly demonstrated by the negative cal­
cium balance due to extremely large faecal losses in rickets (364). Vitamin D 
repletion improves calcium absorption in these cases, but only after several 
hours or days. This interval can be explained by the time required to con- 
vert the vitamin D administered to a metabolically active form (section 
5.4.5.3), and on the other hand by the time which elapses before the elfect 
of the 1,25-OH-D3 on the enterocyte becomes manifest. This effect is believed 
to consist of stimulation of the synthesis of calcium-binding protein (892) 
and/or the formation of ATPase for active transport (202). Other factors 
also influence calcium absorption, such as parathormone (606). Parathor- 
mone is effective only in the presence of vitamin D, perhaps because it stimu- 
lates synthesis of active vitamin D metabolites (303). Growth hormone, too, 
is believed to stimulate calcium absorption (789). The effect of corticoste- 
roids is not quite clear, but they probably reduce calcium absorption (640). 
The same applies to thyroid hormone (158). Although the above mentioned 
hormones can virtually influence calcium absorption it remains question- 
able -  apart from vitamin D -  to which extent this normally occurs.
The amount of calcium absorbed in the small intestine is adapted to indi- 
vidual requirements (71). The regulating mechanisms have so far not been 
identified. Perhaps they involve an influence on the conversion of vitamin D 
into 1,25 dihydrocholecalciferol in the kidney (203) or on the capacity of 
the active transport system (411). Under normal conditions active transport 
takes place only in the proximal part of the small intestine (751), but if the 
calcium intake is low it also occurs more distally (71). Regulation of calcium 
absorption is required in view of the fact that intestinal absorption plays an 
important role in calcium homeostasis. Other regulators of this homeost- 
asis are bone turnover and renal excretion; together they ensure that the 
amount of calcium in the human organism is kept within certain limits.
5.7 MAGNESIUM
So far, relatively little is known about magnesium absorption. This is pro­
bably due to the fact that the significance of magnesium for the human 
organism has long been uncertain. It has been established quite recently that 
magnesium deficiency can give rise to behaviour disorders, convulsions, ata- 
xia, vertigo, tremors, muscular weakness (359) and tetany (869). It is ob- 
vious, therefore, that magnesium plays an important role in the normal
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functioning of the neuromuscular system. It seems essential moreover for 
the activation of certain enzymes (505, 877). The function of magnesium 
resembles that of calcium in many ways. The same applies, to some degree, 
to the absorption of the two minerals.
There is usually some loss of magnesium with urine and faeces. To com- 
pensate this loss, some magnesium has to be absorbed from food. It is be­
lieved that, to maintain a positive magnesium balance, the daily intake 
should be about 4 mg/kg body weight (443). The normal diet usually con­
tains sufficiënt magnesium. Rich sources are bread, potatoes and green vege- 
tables (196). The absolute amount of magnesium absorbed from food varies 
-  like that of calcium -  less than the amount of magnesium in the diet, for 
relatively less is absorbed from a high-magnesium diet than from a low- 
magnesium diet (330). This is one of the control mechanisms by which the 
amount of magnesium in the organism is kept constant. Another, likewise 
important role is played by the kidneys, which normally excrete about one- 
third of the oral intake but release only minimal quantities into the urine in 
the case of a magnesium-deficient diet (47). Marked variations in the mag­
nesium concentrations in serum and body cells are otherwise prevented by 
the large magnesium stores in the skeletal system, in which about half the 
total amount of 21-28 g magnesium is contained (877). As a result of these 
reserves and the marked re-absorption in the kidneys, manifest magnesium 
deficiency due exclusively to a low-magnesium diet has never been observed 
(877).
The amount of magnesium absorbed is partly dependent on the degree of 
solubilization of the magnesium ions, which determines their availability for 
absorption. In this respect, the form in which magnesium is present in food, 
and the composition of the diet in general, are important (877). The same 
probably applies to the presence of gastric juice.
Apart from the dietary magnesium, endogenous magnesium is also re­
leased in the intestine, in amounts estimated to be 25 mg/day. This mag­
nesium originates from digestive juices and exfoliated enterocytes (192).
The absorption process of magnesium takes a very slow course, as de- 
monstrated in experiments with labelled magnesium. Radioactivity is 
demonstrable in the circulation only after an interval of one hour, while 
maximum radioactivity is measured after 2-8 hours. This suggests that ab­
sorption probably takes place throughout the length of the small intestine 
(330). The mechanism of absorption is largely unknown, but it is probably 
active, with the aid of a transport carrier. This would explain why absorp­
tion relatively diminishes as the amount of magnesium in the food in- 
creases (330). Some investigators postulate that the magnesium carrier is the
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same as the one involved in calcium transport, because administration of 
large amounts of calcium has a negative effect on magnesium absorption 
(15). Unlike the situation with calcium, magnesium is not more avidly ab­
sorbed when a deficiency prevails in the organism (192). Magnesium ab­
sorption is probably influenced by several hormones. So far, data are avail­
able only on the influence of parathormone and aldosterone, both of which 
are reported to inhibit magnesium absorption. Vitamin D probably enhances 
the absorption (877).
5.8 HAEMATOPOIETIC FACTORS
5.8.1 Iron
The human organism contains about 4-5 g iron, of which 2-3 g is contained 
in haemoglobin, while 1 g is stored in the iron stores (liver, spleen and bone 
marrow). The remainder is contained in the myoglobin of the muscle cells 
(400-900 mg), and the enzyme systems of all body cells (100 mg). Only 4 mg 
iron is bound to transferrin and is present in the circulation as serum iron 
(604). Particularly with a view to the role which iron plays in cellular meta- 
bolism (oxygen transfer), it is of importance that the amount of iron is kept 
within certain, fairly narrow limits. This implies that the small loss of iron 
with the faeces, urine, via the skin or during menstruation, has to be com- 
pensated by absorption from food, which on the other hand should not 
exceed the iron loss. The normal diet contains about 10-15 mg iron per day 
(110), mostly in meat, cereals, potatoes, vegetables or fruit (196, 422). These 
food constituents contain iron both in inorganic and in organic form.
When discussing iron absorption it is best to distinguish between the 
‘intraluminal’ phase, meant to change dietary iron to a form suitable for 
absorption, and the ‘mucosal’ phase, which refers to absorption in the strict 
sense. The intraluminal phase comprises all processes which, after ingestion 
of iron, take place in the stomach, duodenum and other parts of the small 
intestine. These are in fact a series of chemical reactions which differ in 
accordance with the type of food and the form in which the iron is contained 
in it. A number of reactions play a fundamental role in this intraluminal 
phase. First, there exists always an equilibrium between the divalent ferrous 
and the trivalent ferric ions; their concentrations depend on the nature of 
the iron salts as well as on the presence of reducing or oxidizing substances 
and on the pH of the luminal contents. A second point is that iron is also 
capable of forming co-ordination bonds, which virtually cannot be broken 
if organic substances are involved and if the pH is basic (110).
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In addition to these fundamental reactions, various other factors play a 
role in the solubility (i.e. availability for absorption) of iron. O f importance 
in this respect is the presence of substances, such as ascorbic acid, which 
reduce iron, and of substances which form stable, readily soluble com- 
pounds with iron, such as citrate, gluconate, lactate, succinic acid, mannitol, 
sorbitol, fructose and some amino acids. All these substances stimulate 
iron absorption. On the other hand, there can be factors with a negative 
influence on absorption because they form insoluble compounds with iron. 
Examples are the phytates, oxalates, carbonates, phosphates and certain 
pharmaceutical compounds such as EDTA, magnesium trisilicate and 
cholestyramine (110).
It looks as if the influence of the stomach and pancreas on iron absorption 
is essentially determined by their ability to alter the pH  and, therefore, to 
alter the solubility of iron (110). The question is whether the stomach also 
exerts other influences on iron absorption, e.g. by forming a stimulating 
factor known as intrinsic factor (482) or an inhibitory factor known as 
gastroferrin (197). On this point, the findings reported by different authors 
are controversial (110). At any rate it has been established in patients with 
achylia that absorption of inorganic iron (if dissolved in an acid milieu) and 
of haemoglobin iron is always normal in the absence of gastric juice (264, 
373). Nor are there sufficiënt clues to warrant the hypothesis that pancreatic 
juice or bile should contain factors which influence iron absorption (110).
The above mentioned factors seem to be of no importance for the solub­
ility of organic iron (429). Both haemoglobin and myoglobin are stripped 
of their protein fraction by proteolytic enzymes in the small intestine. Sub- 
sequently the haem is absorbed intact, without further conversion or degra­
dation (157).
An average of only 5-10% of dietary iron is absorbed, significantly less 
than the percentage of an oral dose of iron which fasting test subjects absorb 
(428). Absorption varies widely with the type of food that contains the iron. 
Moreover, the other constituents of the meal can also influence iron absorp­
tion. Eggs, for example, prevent the absorption of iron from food other than 
meat (122), and iron from vegetables is more readily absorbed if ingested 
together with veal (564). Due to the enormous diversity of possible interac- 
tions, iron absorption from a meal cannot be accurately predicted (110).
Normally, iron absorption takes place largely in the duodenum and 
proximal jejunum (645). The remainder of the small intestine is as such also 
able to absorb iron, but less efficiently than the proximal part. In the case of 
iron deficiency, the absorption in the distal part of the small intestine is 
quantitatively considerable (909). The absorption process actually comprises
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three phases: absorption of iron on the luminal side of the enterocyte, 
transport and storage in the enterocyte, and exchange of iron on the serosal 
side. The uptake on the luminal side is based on an active process (550), 
probably involving transport carriers (313). The chemical form in which 
iron is taken up is unknown. Perhaps it is bound to a suitable chelating agent 
such as an amino acid or sugar (428). Intracellular transport in the entero­
cyte probably also takes place after combination with a carbohydrate (136), 
amino acid (551), protein (927) or carrier (428), since it is unlikely that the 
active iron ion is present as such in the enterocyte (428). Part of the iron 
absorbed is bound within the enterocyte to the protein apoferritin, thus 
producing ferritin. From this ferritin, only a minute quantity of iron is 
later released into the circulation. The bulk remains in the enterocyte as 
ferritin. After exfoliation, it enters the intestinal lumen with the enterocyte 
and is excreted with the faeces or re-absorbed after cell degradation (155, 
276,428).
Haem is as such absorbed by the enterocyte (157), and degraded intracel- 
lularly (903). The iron ion released then follows the same metabolic path- 
ways as the other ionized iron (428).
The transfer of iron from the enterocyte to the blood stream is probably 
also effected by active transport (550), involving a specific transport carrier 
(684).
Iron absorption actually takes a biphasic course. Isotope studies have 
shown that there is a rapid phase, during which 40-60% of the total ab- 
sorbable iron fraction appears in the circulation within two hours. In 
addition there is a slow phase which lasts about 24 hours, during which a 
small proportion of the iron primarily stored in the enterocytes, is released 
into the blood stream (263). Normally, about half the iron absorbed (35- 
70%) remains sequestered in the enterocytes as ferritin (81). After exfoliation 
of these enterocytes, some of this ferritin iron can again be absorbed after 
digestion of the cell and degradation of the compound. This also explains 
why the faecal elimination of labelled iron given by mouth, continues for a 
few weeks after its administration (155,276).
Apart from the factors which influence iron solubility in the intestinal 
lumen, the requirement of the organism is an important determinant of the 
absorption of iron from food. The degree of iron absorption is inversely 
proportional to the size of the iron reserves in the organism (369). Iron ab­
sorption exceeds the normal in the case of iron depletion or increased 
erythropoiesis for example (902). On the other hand, iron absorption is 
evidently less when the iron reserves are repleted. This regulation, however, 
is not entirely adequate, for after protracted oral administration of large
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doses of iron, the organism can retain too much iron ultimately (111). Both 
the nature of the control mechanism and the manner in which it is informed 
about the individual’s iron status, have so far remained obscure (110).
5.8.2 Vitamin B12
Vitamin B12 has an essential function in various elementary metabolic pro- 
cesses, such as the nucleic acid synthesis and folie acid metabolism. The 
name vitamin B12 actually covers a group of biologically active cobalamins, 
all of which probably serve a similar function as coenzyme constituent. The 
qualitatively and quantitatively most important vitamin B12 analogue is 
deoxyadenosyl cobalamin (=  coenzyme vitamin B12). Virtually all cobala- 
min, both in the human organism and in the food, is synthesized by bacteria. 
In man vitamin B12 synthesis largely takes place in the colon. Hardly any 
of this endogenous vitamin B12 is absorbed. One must therefore rely on the 
vitamin B12 contained in the normal diet, which supplies an average of 16 |j.g 
(range 1.2-75.6 ij.g) per day (139). This is usually more than the recommen- 
ded dietary allowance, which is estimated to be 3-4 jjtg (196). Rich vitamin 
B12 sources are food of animal origin such as meat, fish, eggs, milk and 
cheese (422). The human organism has relatively substantial vitamin B12 
reserves (about 2 mg) in the liver; this is sufficiënt to meet daily require- 
ments for a few years (490).
In the food, vitamin B12 is usually bound to proteins, from which it is 
detached by cooking or through the action of pepsin in the stomach (133); 
this is usually done so thoroughly that all vitamin B12 from the food be- 
comes available for absorption (388). After release from its protein link, 
vitamin B12 is bound to intrinsic factor from the stomach.
Intrinsic factor (IF) is a glycoprotein synthesized by the parietal cells of 
the gastric mucosa. lts release is stimulated by gastrin, histamine and in- 
sulin. A  considerable excess of IF  is normally formed, of which only a very 
small fraction is probably required for vitamin B12 absorption (133).
Vitamin B12 and IF  are both substances of relatively low stability, which 
are readily degraded by enzymes or bacteria in the gastrointestinal tract (3, 
651). By complex forming they produce a fairly stable compound, which is 
probably less readily consumed by bacteria (761). Once formed in the 
stomach or in the most proximal part of the small intestine, these vitamin 
B12-IF complexes are carried with the food to the ileum, where they are 
absorbed (84).
The exact manner in which absorption takes place in the ileum is still 
uncertain. The enterocytes in the ileum probably have specific receptors on
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their microvilli for the vitamin B12-IF complex (225). It is thought that these 
receptors are especially susceptible to IF, because free IF  also attachés itself 
quite readily to them (2). The amount of vitamin B12 to be absorbed is 
probably determined by the number of unoccupied receptor sites in the 
ileum. This could explain why, of varying amounts of vitamin B12, no more 
than 2 jxg per meal is ever absorbed (133). Although the receptors in the 
ileum have a high affinity for the vitamin B12-IF complex, they bind it only 
at a particular pH  and in the presence of calcium or magnesium ions (125). 
Although coupling to the receptors is probably a rapid process (852), it 
nevertheless takes at least three hours for any vitamin B12 to appear in the 
circulation. The maximum concentration of vitamin B12 in the blood is not 
attained until after 8-12 hours (83). During this interval, the receptors in the 
ileum are blocked for further uptake of the vitamin B12-IF complex (1). It 
is probably during this interval that vitamin B12 is detached from its com- 
plexes by enzymes from the brush border (539). The free IF  remains at- 
tached to the receptor for some hours (394), and cannot be found in the 
faeces until some time later (931).
Vitamin B12 is found, after its absorption, in several organelles of the 
enterocyte, specifically in the mitochondria (674). Here, some cobalamins 
are incorporated if necessary in coenzyme-vitamin B12 complexes (675).
Transport of vitamin B12 from the enterocyte to the liver takes place ex- 
clusively by means of a carrier protein called transcobalamin II. lts absence 
leads to severe megaloblastic anaemia (351).
In addition to absorption, also some secretion of vitamin B12 takes place 
in the small intestine. The amount secreted is uncertain. Vitamin B12 is 
believed to enter the intestinal lumen with gastric juice, intestinal juice and 
bile (332, 650). Most of it is normally re-absorbed and thus proceeds in the 
enterohepatic circulation (165).
5.8.3 Folates
Folates are the compounds derived from folie acid. Food contains mainly 
folates (pteroylpolyglutamates), and only small quantities of folie acid 
(pteroylmonoglutamic acid). To cover its folate requirements, the human 
organism must rely on dietary folates. The requirements are estimated to 
amount to about 50 (ig/day (383). The normal diet as a rule provides more 
than enough folates: an average of 600-700 [i.g/day, mainly in the form of 
green vegetables, fruit and liver (131). Yet some synthesis takes place in the 
organism. Certain bacteria in the colon synthesize endogenous folate, but 
this is scarcely absorbed (404). Without a dietary supply of folates, the
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organism’s reserves of about 10 mg are exhausted within a few months 
(382). Folates are needed as coenzyme constituent in many enzymatic pro­
cesses, such as the nucleic acid synthesis and amino acid metabolism.
Polyglutamates from food are probably deconjugated to monoglutamates 
before being absorbed (63, 718). The enzyme needed for this purpose, folate 
conjugase ory-glutamyl carboxypeptidase is found in high concentrations in 
the lysosomes and mitochondria (401, 718). This suggests that polyglutamate 
deconjugation takes place intracellularly. It seems more rational, however, 
to assume that deconjugation precedes absorption and therefore takes place 
at the brush border (720) or in the intestinal lumen (718). The enzymes 
could be taken there by intracellular transport or they could be liberated by 
intraluminal degradation of exfoliated enterocytes (718). It is highly pro- 
bable that this polyglutamate deconjugation is not effected by a single en­
zyme but by a whole series of enzymes, each of which governs one step 
(719). In the blood stream, only the end-product monoglutamate is encount- 
ered (63).
Some foods make less folate available for absorption than might be ex- 
pected in view of their folate contents (702). This can be explained by both 
the presence of less readily absorbable polyglutamates (121) or by the for­
mation of complexes with substances such as cellulose (534). It is also possib­
le that food contains substances which interfere with the activity of folate 
conjugase (403).
Folate is preferably absorbed in the proximal part of the small intestine. 
This is also suggested by the fact that folate deficiency often follows diseases 
or resection of this part of the small intestine, whereas a deficiency is rarely 
observed in association with diseases of the ileum (170). Perfusion studies, 
too, have shown that monoglutamate absorption is maximal in the jejunum 
and negligibly small in the ileum (380). Absorption probably involves an 
active transport process by means of carriers (380, 381). The relevant data, 
however, are not entirely convincing (308,718 ).
After its absorption, further conversion of monoglutamate into 5-methyl- 
tetrahydrofolate takes place in the enterocytes (669). The intracellular 
transport of all possible types of folate, like their transport from the enter­
ocyte to the blood stream, probably takes place in the same way and with 
the aid of the same type of transport carrier (503, 747). The capacity of this 
carrier transport would seem to determine the rate at which polyglutamate as 
well as monoglutamate can be absorbed (878).
The entire process of deconjugation of polyglutamate and absorption 
with further conversion of monoglutamate is so quickly completed that an 
increase in serum folate concentration is observed within 15 minutes of its
82
oral administration (380, 718). O f an oral dose of monoglutamate, 60-80% 
is usually absorbed even when large doses (up to 15 mg) are given (380). Of 
polyglutamate, a similar fraction is absorbed only of physiological doses, 
while less is absorbed of larger doses o f polyglutamate (121, 824).
Some endogenous folate is released in the small intestine, moreover, from 
bile (60-90 jxg/day) and exfoliated enterocytes. Normally, however, a large 
part of this endogenous folate is re-absorbed, and the loss is therefore 
limited (40).
5.9 WATER-SOLUBLE VITAMINS
5.9.1 Vitamin C
Vitamin C (ascorbic acid) has an important function in the growth process 
and cell metabolism. lts  presence is required for formation of the ground 
substance of connective tissue and the matrix of bone tissue. In addition, 
it is probably of importance for the synthesis of some hormones and the 
absorption of such substances as iron (196). The vitamin C requirement is 
estimated to be 30 mg/day (700). Important sources are fruit, potatoes and 
green vegetables (196, 422). Vitamin C deficiency manifests itself by exten­
sive capillary haemorrhages in gingiva and skin, or in muscles and joints. 
This syndrome is known as scurvy.
Vitamin C is absorbed in the proximal small intestine (635, 816) by 
diffusion and possibly also by active transport. The absorption process is 
undoubtedly very complicated, because vitamin C given by mouth appears 
in the circulation only much later (816). The capacity to absorb vitamin C is 
high (635). Any surplus of vitamin C is stored, but when these stores are 
replete, the excess of vitamin C is excreted by the kidneys.
5.9.2 Thiamine
Thiamine (vitamin Bj) plays a particular role in carbohydrate metabolism. 
The thiamine requirement depends on the caloric intake, and should be 
0.5 mg per 1000 kilocalories (700). Sources rich in thiamine are bread, vege­
tables, potatoes, fruit, meat and milk (196, 422). A chronic thiamine de­
ficiency can lead to peripheral neuropathies or to cardiac failure, a condi­
tion known as beriberi. An alternative possibility is the occurrence of an 
encephalopathy, which is named after Wemicke.
Thiamine is probably absorbed in the proximal part of the small in­
testine, for diseases of the stomach or terminal ileum do not influence its
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absorption (845). Thiamine is absorbed unchanged, probably by active 
transport (613). The organism has no thiamine reserves, any surplus of this 
vitamin being excreted by the kidneys (196).
5.9.3 Riboflavin
Riboflavin (vitamin B2) is a constituent of the flavoprotein enzymes which 
are involved in various oxidation reactions in the human organism. The 
requirement for this vitamin is supposed to be 0.6 mg per 1000 kilocalories 
(700), which is obtained from dairy products, meat, eggs, green vegetables, 
fruit, potatoes and bread (196, 422). Symptoms of riboflavin deficiency are: 
angular stomatitis, cheilosis, glossitis (magenta tongue), seborrhoeic der­
matitis, lacrimation and photophobia (196).
Riboflavin is absorbed mainly in the proximal part of the small intestine, 
probably by diffusion (613).
5.9.4 Niacin
Niacin (vitamin B3), which refers to nicotinic acid as well as to nicotinamide, 
has a function as a constituent of certain coenzymes which are of great im­
portance in cell respiration, glycolysis and fat synthesis. The niacin require­
ment is estimated to be 6.6 mg per 1000 kilocalories (700). Dietary sources 
are meat, vegetables, fruit, potatoes and bread (196, 422). Niacin can also be 
derived from tryptophan in food. Niacin deficiency causes pellagra, a condi- 
tion characterized by dermatitis, diarrhoea and dementia (196).
Niacin is largely absorbed by diffusion in the proximal part of the small 
intestine (813).
5.9.5 Vitamin Be
Vitamin B6 (also called pyridoxine, but actually a collection o f three pyri- 
dines) has a function in the degradation and synthesis of amino acids. The 
vitamin B6 requirement is estimated to be 2 mg per day (700). Sources rich 
in vitamin B6 are meat, vegetables, potatoes, rice and bread (196). Vitamin 
B6 deficiency can give rise to neuropathies, dermatitis, stomatitis, glossitis, 
cheilosis or sideroblastic anaemia (196).
Vitamin B6 is absorbed in the proximal part of the small intestine. Even 
after very extensive resections, leaving intact only about 1 metre of the 
proximal jejunum, vitamin B6 absorption was found to be normal (99). 
Absorption probably takes place by diffusion. Virtually all vitamin B6 
in food is absorbed. Any surplus is largely excreted by the kidneys (99).
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5.9.6 Pantothenic acid
Pantothenic acid is a constituent of coenzyme A, which is involved in 
various metabolic processes, including the citric acid cycle. It is difficult to 
estimate the daily requirement of pantothenic acid, which is supplied by 
meat, eggs, potatoes, vegetables and bread (196, 422). An intake of 5-10 mg 
per day is regarded as sufficiënt (700). There is no certainty about the ques- 
tion whether pantothenic acid deficiency produces any symptoms, although 
myospasms, general malaise and burning feet have been ascribed to such a 
deficiency (196).
Pantothenic acid is probably absorbed by diffusion (813).
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CHAPTER 6
PATHOPHYSIOLOGY OF COELIAC SPRUE
6.0 INTRODUCTION
It is widely known that coeliac sprue is nearly always accompanied by 
malabsorption, and there are abundant relevant data on this subject. Far 
less attention has so far been paid to possible changes of the physiological 
processes in the small intestine in patients with coeliac sprue. There are 
indeed some indications that these processes take an abnormal course. This 
is quite conceivable, because the inflammatory lesions in the intestinal wall 
do involve mucosal and submucosal elements other than the enterocytes, 
such as the hormone or mucus producing cells, the nerve fibres and the blood 
vessels or lymphatics.
The following sections deal with various aspects of the pathophysiology of 
coeliac sprue. A survey of relevant observations so far published will be 
presented, with the addition of some personal observations. Before discussing 
the results of these observations, it would seem useful to give some informa- 
tion on the group of patients studied. For the methods of investigation the 
reader is referred to chapter 12.
6.1 COMPOSITION OF THE GROUP OF PATIENTS STUDIED
Coeliac sprue was diagnosed in 47 patients on the basis of three criteria 
(section 1.3). The first criterion to be fulfilled was the presence of characte- 
ristic villous abnormalities (section 3.3.2) in the first jejunal loop, 5-20 cm 
beyond the ligament of Treitz. A biopsy specimen was obtained from the 
small intestine before gluten withdrawal in each of the 47 patients with the 
exception of 3. In these 3 patients a biopsy specimen was not obtained until 
after gluten withdrawal, and in each of these cases revealed unmistakable 
abnormalities consistent with coeliac sprue. In view of the aim of our study -  
the severity of malabsorption and the effect of a gluten-free diet in coeliac 
sprue -  the second criterion was that clinically manifest malabsorption had 
to be present. Coeliacs without symptoms of malabsorption, who are regul-
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arly encountered in particular among patients with dermatitis herpetiformis 
(section 10.2), were not included in this group. All patients, moreover, had 
to fulfil a third criterion, e.g. a characteristic history, or a favourable re­
sponse to gluten withdrawal in clinical, biochemical or morphological respect 
(section 1.3).
Fig. 6.1. The composition of
our series o f coeliac sprue 
patients with its subdivision 
into different categories.
39 pa tien ts 4  patients
on g lu ten -fre e  diet on normal food
The total number of patients who fulfilled these criteria was 47 (fig. 6.1). 
Of these, 7 had already been on a gluten-free diet before being referred to us. 
Of the 40 remaining, untreated patients, a few showed coeliac sprue as well 
as some other disease, such as ulcerative colitis, diverticulosis of the small 
intestine, or carcinoma of the pancreas. In addition, one patiënt had multiple 
stenoses on the basis of non-granulomatous duodenojejunitis (section 11.2). 
There remained 36 patients, therefore, who were suffering from untreated 
coeliac sprue without any indication of other diseases which might account 
for symptoms or malabsorption. Observations on clinical symptoms or 
biochemical abnormalities in untreated coeliac sprue were made in this 
group of 36 patients. The effect of gluten withdrawal could be studied in 
only 32 patients, because 4 patients had been on the diet only briefly, i.e. 
less than 6 months, or not at all. The biochemical assays during gluten deple- 
tion were made in these 32 patients. The ultimate effect of the gluten-free 
diet could be evaluated in a total of 39 patients, including the 7 who had 
been on this diet before being referred to us.
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Table 6.1. Predominant symptom at presentation of 36 patients with untreated coeliac 
sprue.
DIARRHOEA 17  PATIENTS
ABDOMINAL PAIN 6  PATIENTS
ANAEMIA 7  PATIENTS
STOMATITIS APHTHOSA 2  PATIENTS
PETECHIAE 1 PATIËNT
ANKLE OEDEMA 1 PATIËNT
TETANY 1 PATIËNT
NON-HEALING FRACTURE 1 PATIËNT
Number of pa tients -
14 -
12 -
10  -
8 -
6 -
4 -
2 -
Fig. 6.2. The age distribu- “ j j
tion in our series of 47 pa- -----Ü— U—---- — ---------- ----- )__ J___,
tients with coeliac sprue at 20 4 0  6 0  8 0  100
the time of diagnosis. Age in years
The total group of 47 patients included 30 women and 17 men. The age 
distribution at the time of diagnosis is presented in fig. 6.2. In an effort to 
give an impression of the severity of the clinical symptoms in these patients, 
table 6.1 lists the motivations for the referral of the 36 untreated patients to 
us. The vast majority were suffering from diarrhoea or anaemia, which in 12 
patients was so severe as to necessitate immediate hospitalization. The other 
symptoms varied from abdominal pain or stomatitis to tetany or delayed 
fracture healing due to hypocalcaemia (cf chapter 8).
88
6.2 MOTILITY
Little research has so far been devoted to the motility o f the small intestine 
in coeliac sprue such as studies on the intraluminal pressure or electrical 
activity of the musculature of the intestinal wall. There are indications that 
the frequency of the basic electrical rhythm is diminished in coeliac sprue 
(137). Segmental contractions, moreover, are believed to diminish both in 
frequency and in vigour (293).
Several authors observed an abnormal passage of contrast medium in 
coeliac patients during fluoroscopy. The intestinal loops often impress as 
flaccid, atonic and collapsed, showing no reaction to filling with contrast 
medium, which at the same time does not provoke any peristalsis. In most 
cases peristalsis is slow and rather ineffective, causing an abnormally long 
transit time of the contrast medium (434, 563, 619, 775). In a proportion of 
patients, however, the small intestine is very contractile, so that passage
Fig. 6.3. Plain abdominal X 
ray in upright position, 
showing an ileus pattern 
with air-fluid levels in the 
small intestine. The film was 
obtained on a 62 -  year -  old 
untreated coeliac patiënt 
(patiënt no. 5, section 9.3.4) 
with a history of crampy ab­
dominal pain, vomiting and 
abdominal distension. At the 
subsequent surgical explora- 
tion no mechanical obstruc- 
tions were found.
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of the contrast medium through the small intestine takes only a few minutes 
(619). It is to be borne in mind, however, that peristalsis and transit time 
can also vary widely in normal individuals and that, apart from the amount 
and composition of the contrast medium (775), psychological factors can 
also be of influence in this respect (118).
In some patients with coeliac sprue this atony leads to paralytic ileus (113). 
Features of ileus (fig. 6.3) were observed in two of our patients (no. 5 and no. 
34; cf sections 9.3.4 and 9.4.3) leading to an exploratory laparotomy before 
coeliac sprue was diagnosed. The question arises of the aetiology of paralytic 
ileus in these patients. Generally speaking, paralysis can result from the in­
fluence of neurogenic, humoral or metabolic factors. A well known metabolic 
cause is hypopotassaemia. In retrospect, however, there was no indication of 
a decreased serum potassium concentration in our two patients. In one of 
them, who succumbed to myocardial disease shortly after, we did find an 
extensive accumulation of ceroid pigment in the muscular layer of the 
intestinal wall (fig. 6.4). In the other patiënt, a marked deposition of ceroid
.0
. '
0
Fig. 6.4. Deposition of ceroid pigment in the muscular layer of the jejunum. This post- 
mortem specimen was obtained from a coeliac patiënt (patiënt no. 34, section 9.4) who 
presented with a paralytic ileus some months earlier.
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was observed in the smooth muscle cells in a rectal biopsy specimen. The 
biopsy specimens from the small intestine in these patients showed a mus­
cularis mucosae without ceroid deposition. This means that the mucosal 
muscle cells are not always representative of the situation in the muscular 
layer of the intestine. I t therefore seems plausible that ceroid accumulation, 
resulting from vitamin E deficiency (section 7.4.6), plays a role in the aetiol- 
ogy of intestinal paralysis in coeliac sprue.
Another important factor may be the presence of an abnormal bacterial 
flora, due to which toxins and irritant degradation products (like volatile 
fatty acids and deconjugated bile acids) can be formed. An abnormal bac­
terial flora causes acceleration o f transit time in most cases, but it can also 
give rise to ileus-like features, which disappear after medication with anti- 
biotics (237). According to DiMagno et al. (214), the abnormal motility in 
coeliac sprue can be the result of a dysregulation o f intestinal hormones.
Due to absence or an abnormal shape of the villi, micro-movements of the 
intestinal villi in the proximal small intestine are not possible in coeliac 
patients (771).
The sometimes pronounced disorders of motility can exert a negative in­
fluence on absorption in patients with coeliac sprue. In the event of acceler- 
ated passage, the mucosal contact time is markedly reduced. On the other 
hand, in cases with very slow peristalsis and dilatation of the intestinal loops, 
the exchange between absorbing surface and intestinal contents can be im- 
paired as a result of the formation of a thick unstirred layer (sections 5.1.2 
and 5.1.5).
6.3. INNERVATION
Regulation and coordination of intestinal motility, blood supply and secre­
tion of digestive juices is ensured by the autonomie nervous system -  pro­
bably in interaction with intestinal hormones. As already discussed in the 
preceding section, the motility of the small intestine is abnormal in some 
coeliac patients. In addition there are indications that the secretion of 
digestive juices, too, is not always optimal in these patients (section 6.6). It is 
therefore not impossible that the function of the autonomie nervous system 
is disturbed in these patients. In any case, abnormalities of the peripheral 
nerves are not uncommon in coeliac sprue (163, 611, 656). These latter are 
usually lesions of a degenerative nature, which are ascribed to deficiency in 
vitamins of the B group. Whether deficiencies in other vitamins or in certain 
amino acids also play a role in this context, has so far remained obscure 
(656). A deficiency in these nutrients could cause degenerative lesions, not
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only of the peripheral and the central but also of the autonomie nervous 
system. It is not inconceivable, moreover, that the small nerve fibers in the 
intestinal wall could also be damaged by the inflammatory process in the 
mucosa or by toxins and degradation products of an abnormal intestinal flora.
The syndrome of idiopathic intestinal pseudo-obstruction, characterized 
by a distended abdomen with dilatation of intestinal loops, abdominal pain, 
vomiting, varying diarrhoea and malabsorption, is associated with neuro- 
muscular dysfunction of thé small intestine (549) and histological changes 
in the myenteric plexus (804). At first sight, this syndrome has certain 
similarities to coeliac sprue. However, it does not respond to gluten with­
drawal but shows a response (if only transient) to broad-spectrum antibio- 
tics (804). This suggests that an abnormal intestinal flora gives rise to the 
above mentioned pattern of symptoms (549). On the basis of the response to 
a gluten-free diet, differentiation between the two conditions is possible. By 
analogy to this syndrome it is not inconceivable that some abdominal symp­
toms such as abnormal motility could be the result of an abnormal function 
or structure of the autonomie nervous system. So far as we know, there are 
no published observations on the structure of the intestinal nervous tissue 
in untreated coeliac patients. Notions concerning abnormalities of the 
autonomie nervous system in coeliac sprue are therefore still speculative.
6.4 CIRCULATION
Hardly anything is known about the changes in the blood supply to the 
small intestine which can occur in coeliac sprue. Changes in vascular struc­
ture can be expected in the smaller vessels of the mucosa, specifically in that 
part of the small intestine in which the villi are absent or abnormal. The 
vascular convolutions which should be present in these villi will be either 
absent or deformed. An exchange between the blood vessels within the 
intestinal villus according to the so-called countercurrent principle, cannot 
take place under these circumstances.
The blood flow can be either activated or, on the contrary, impeded by 
the inflammatory changes in the intestinal wall, which give rise to oedema of 
the interstitial tissue. Distension of the wall of the small intestine due to 
stasis or gas formation can impair the blood supply. Also, the inflammatory 
process can usurp a large amount of the oxygen and nutrients supplied. It 
seems likely therefore that the proportion of the blood supply which is 
normally allocated to the absorption process, is smaller in coeliac patients. 
This factor can contribute to the existing malabsorption in coeliac sprue.
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6.5 LYMPHATIC SYSTEM
6.5.1 Introduction
In animals subjected to experimental ligation of the efferent lymphatics from 
the small intestine, diarrhoea with disturbed fat absorption and increased 
enteric protein leakage is sometimes observed after a short time. The mor- 
phology of the intestinal mucosa in these animals can also show distinct 
changes, such as broadened and sometimes markedly shortened villi (275, 
574, 600, 917). In human pathology, too, villous abnormalities are some­
times observed in the presence of an impaired intestinal lymph drainage, as 
in primary intestinal lymphangiectasia, Whipple’s disease and cardiac 
failure (546,678,913).
These experimental data raise the question of the role of intestinal lymph 
congestion in the pathophysiology of some types of malabsorption, such as 
in coeliac sprue. It seems useful therefore to present some relevant obser- 
vations.
6.5.2 Protein leakage and lymphocyte count
Leakage of lymph into the intestinal lumen is not infrequently associated 
with lymphocytopenia (431). In 8 untreated coeliac patients with a markedly 
increased enteric leakage, exceeding 200 ml plasma per day, the lymphocytes 
in the peripheral blood were counted. None o f these 8 patients showed 
lymphocytopenia, i.e. less than 20% lymphocytes in the differential leucocyte 
count (242). In 4 of these patients protein leakage was again measured 
during a gluten-free regime. In spite of a substantial decrease of enteric 
leakage in all cases, the lymphocyte count increased in only one patiënt.
6.5.3 Influence o f  restriction o fL C T  fa t  on protein leakage
Absorption of long-chain triglycerides (LCT) is associated with an in­
creased lymph flow. Restriction of these triglycerides in the diet reduces the 
intestinal lymph flow (340). If in coeliac sprue patients lymph congestion 
and leakage play a role in the aetiology of protein leakage through the in­
testinal wall, it should diminish during an LCT-free regime. In 3 patients 
who showed only a moderate resDonse to a gluten-free diet, the protein 
leakage was measured both with and without supplementary LCT restric­
tion. Two patients showed a spectacular improvement, as indicated in 
table 6.2. The case histories of these patients are presented in section 9.3.1 
and section 11.2.2. In the third patiënt, fat restriction had no effect on the
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Table 6.2. Influence o f restriction of dietary long-chain triglycerides on enteric plasma 
protein leakage.
PATIËNT ENTERIC PLASMA PROTEIN LEAKAGE (ml/24 hrs)
On gluten-free On gluten-free diet and
diet LCT-fat restriction
#  17 430 55
# 2 0 260 385
#  46 2 0 0 85
extent of protein leakage. It is to be noted that in the 2 patients with an 
improved leakage, the peripheral lymphocyte count did not increase.
6.5.4 Abnormalities o f  the mesenteric lymph nodes
O f the 47 coeliac patients in our series, 24 underwent a laparotomy, usually 
in view of a suspected appendicitis. In 5 patients the laparotomy revealed 
greatly enlarged mesenteric lymph nodes. Since the presence of abdominal 
nodes was probably not always explicitly checked, the real number of 
patients with enlarged mesenteric lymph nodes may have been somewhat 
larger. Three patients who died from causes other than coeliac sprue (sections
9.4.3 and 9.4.4) were submitted to post-mortem examination, which in all 
cases disclosed enlarged lymph nodes in the mesentery. Pathological exam­
ination of these nodes revealed non-specific changes in all cases, such as 
follicular atrophy or hyperplasia, sinus histiocytosis, fibrosis or cavitation 
with fat necrosis.
6.5.5 Comment
It seems plausible that in some patients with coeliac sprue the intestinal 
lymph flow is indeed impaired. Due to the absence of normal initial lacteals 
in the damaged mucosa of the small intestine, lymph uptake can be primarily 
disturbed, while the ‘milking’ of the lacteals is also impeded (fig. 4.7). More- 
over, the efferent flow of lymph can be hindered by compression of the 
lymphatics as a result of some oedema of the wall of the small intestine. 
More cranially, swollen and congested lymph nodes in the mesentery can 
obstruct a free lymph drainage. Laparotomy or post-mortem examination 
disclosed enlarged mesenteric lymph nodes in several of our coeliac patients. 
Histological examination of these nodes never revealed any characteristic 
pathology, but only non-specific changes. For that matter, many other in­
vestigators have reported enlarged lymph nodes in patients with coeliac 
sprue (466, 663, 912; cf chapter 11).
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The impaired drainage of intestinal lymph will be the more significant be- 
cause lymph production is probably increased in the damaged intestine of 
coeliac patients. Apart from an increased permeability of the blood capill- 
aries, a decreased colloid osmotic pressure due to hypoalbuminaemia can 
also play a role in this respect.
In the case of an obstructed lymph drainage caused by abnormal mesen- 
teric lymph nodes, only limited bypassing via collaterals is possible. The 
distance over which lymph can be bypassed is small, however (504, 646), and 
can hardly be very helpful when the drainage of a large segment of the small 
intestine is obstructed. In the case of severe congestion, the swollen subserous 
lymphatics may rupture, resulting in chylous ascites, which has in fact been 
described in coeliac sprue (466). On the other hand, lymph from ruptured 
mucosal lymphatics may also enter the intestinal lumen, as has been ob- 
served in abdominal tuberculosis (770) or primary intestinal lymphan- 
giectasia (431, 819, 879). This entails a loss, not only of fat-like substances 
but also of proteins (286).
The fact that the enteric protein leakage in two of our patients with 
coeliac sprue showed a marked improvement after restriction of LCT fat in 
the diet, suggests that leakage of lymph occurs from the intestinal wall into 
the lumen (table 6.2). Restriction of the fat consumption reduces lymph 
production in the small intestine, because transport of chyle via the lymph- 
atic system is scarcely required in that case (340). Reduced chyle production 
is bound to cause reduction of the congestion in the lymphatic system, and 
consequently less leakage occurs. In addition to chyle and tissue fluid, the 
intestinal lymphatics also transport lymphocytes from the lymph follicles 
and Peyer plaques. In the case of marked lymph leakage in the intestinal 
lumen, as in primary intestinal lymphangiectasia, peripheral lymphocyto- 
penia is usually present (431, 879). In our patients with marked protein 
leakage, however, lymphocytopenia was never observed. W hether this may 
be related to a perhaps increased lymphocyte production in the intestinal 
wall in coeliac sprue, remains a moot question.
6 .6  DIGESTIVE SECRETIONS
6.6.1 Introduction
Although patients with treated pernicious anaemia are usually in good con- 
dition and without signs of malabsorption, the view that the stomach, and 
specifically gastric juice, plays an essential role in digestion is still widely
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accepted. In patients with coeliac sprue, several investigators have observed 
an achlorhydria (104, 163). It therefore seemed useful to investigate the 
occurrence of achlorhydria in our patients. The function of the pancreas 
was studied in some untreated coeliac patients moreover, as some investiga­
tors have maintained that association of coeliac sprue with pancreatic in- 
sufficiency is not uncommon (60,163,489, 682, 937).
6.6.2 Gastric secretion
Gastric juice was collected from a total of 22 patients. In only one patiënt 
achlorhydria was found. In this patiënt a high acid output had been estab- 
lished 20 years earlier, and he was treated three times for ulcer disease. The 
achlorhydria now observed was associated with the presence of antibodies 
against parietal cells and an increased gastrin concentration of 280 pg/ml 
(normal value 66 ±  18 pg/ml; 496).
Tests for the presence of antibodies against parietal cells of the stomach 
were carried out in 16 patients, and were -  apart from the above discussed 
patiënt -  always negative.
6.6.3 Pancreatic secretion
A secretin test was carried out in 4 untreated patients with coeliac sprue. In 
all cases the amount of pancreatic juice secreted in half hourly collections 
increased by at least factor 2 after secretin stimulation. In 3 patients, more­
over, the bicarbonate concentration was markedly increased, attaining 
values of 95-135 mmole/1 (31 mmole/1 in the 4th patiënt).
6.6.4 Comment
In our group of 22 untreated coeliacs only one case of achlorhydria was 
found. The association between coeliac sprue and atrophic gastritis has never 
been explicitly mentioned, but a relation to other types of autoimmune 
disease has been observed (56, 764). Other authors have likewise reported 
coeliac patients with achlorhydria (104). Cooke (163) even observed this 
phenomenon in some 15% of his patients. Our own data show, however, that 
achlorhydria is not a common finding in coeliac sprue. In view of the mass of 
experimental and clinical data it is further highly unlikely that this achlorhy­
dria could be a factor of significance in coeliac malabsorption (cf chapter 7).
No evidence of pancreatic insufficiency was found in at least 3 of the 4 pa­
tients examined in this respect. Others, however, have reported an abnor-
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mally low response of the pancreas to parenteral administration of secretin 
as well as of cholecystokinin/pancreozymin, or to a test meal (60, 163, 199,
214, 489, 937). I f  present, this insufficiency is probably a secondary phenom- 
enon, for after gluten withdrawal pancreatic function can show a distinct 
improvement (272, 899). The mechanism by which coeliac sprue causes 
pancreatic insufficiency, is unknown. There are some hypotheses, including 
one that ascribes the pancreatic abnormalities to malabsorption of proteins 
(384, 834). The pancreas requires a minimum of amino acids for an adequate 
enzyme synthesis. Without this minimal supply atrophy of the exocrine 
pancreatic tissue develops, which is usually reversible (45, 870). Histological 
abnormalities of the pancreas have indeed been found in patients with 
severe and even refractory sprue (682). The possibility of concomitant pan­
creatic insufficiency is therefore to be taken into account, particularly in 
coeliac patients with a high nitrogen or low (chymo)trypsin excretion with 
faeces, and as well in those who show a poor response to a gluten free diet 
(489,682).
Although at least 3 of our 4 untreated patients showed a normal secretin 
test, it is not certain that their pancreas was actually functioning normally. It 
is conceivable that, due to reduced endogenous production of secretin 
and cholecystokinin in the enterocytes, a pancreatic insufficiency did ex- 
ist but failed to become manifest at vigorous exogenous stimulation. Di- 
Magno et al. (214) have suggested that relative insensitivity of the pancreas to 
hormonal stimuli could also play a role in the existing pancreatic insufficiency.
It should be mentioned, finally, that the concentration of bile acids in 
the intestinal lumen is perhaps also decreased in coeliac sprue. Of the total 
pool of bile acids, which as such seems extra large (529), an abnormally 
small amount is released into the small intestine by gall-bladder contraction 
(214, 528). Together with a marked dilution of the intestinal contents due to 
secretion of water in the duodenum and proximal jejunum (section 7.2), 
this gives rise to a decreased luminal concentration of bile acids. It is believed 
that this concentration is sometimes lower than the critical micellar con­
centration (214, 578), although this is not believed to be a common phenom- 
enon (594). The sensitivity of the gall-bladder to endogenous stimulation by 
cholecystokinin is probably reduced in coeliac sprue (98, 530).
6.7 INTESTINAL HORMONES
The epithelium of the stomach, duodenum and jejunum contains cells which 
synthesize the so-called intestinal hormones, such as gastrin, secretin and
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cholecystokinin as well as other hormone-like substances (666). Precisely as 
the proximal segment of the small intestine is most severely affected in coeliac 
sprue, these hormone-producing cells should also be subject to changes. 
One might primarily assume that the production of intestinal hormones 
should be reduced in coeliacs as a result of the mucosal lesions (214). The 
hormone-producing cells are localized mainly, however, in the crypts of the 
small intestine, which are largely spared from the damaging effect of gluten; 
they actually show a marked growth in response to the increased exfoliation 
of cells (587). It therefore seems probable that an increased production of 
intestinal hormones is to be expected in coeliac sprue.
Histological examination of biopsy specimens from the small intestine in 
untreated patients indicates that the number of enterochromaffin cells in the 
duodenum is signiücantly increased, and diminishes during a gluten-free 
regimen. The enterochromaffin cells also stain more intensively, which sug- 
gests an increased hormone production (130). Other investigators have re- 
ported an increase in the number of secretin-producing cells (687).
In view of these observations the production of intestinal hormones can 
be expected to be increased in coeliac sprue. LoW-Beer et al. (530) did in 
fact find extremely high serum cholecystokinin levels in fasting coeliacs. 
These high levels can be caused by diminished hormone degradation as well 
as by increased synthesis and secretion. Moreover, the assay may have in- 
cluded other cholecystokinin-like substances (530). The production of 
amines by the APUD cells also seems to be increased in untreated patients, 
for the urinary excretion of 5-hydroxytryptamine (serotonin) metabolites 
is markedly increased, and diminishes after the institution of a diet (129, 
486). DiMagno et al. (214) published observations, however, which are 
suggestive of a delayed and sometimes even reduced release of cholecysto­
kinin after instillation of food or amino acids in the duodenum. A similar 
phenomenon was observed with regard to gastrin release after administra- 
tion of a test meal to untreated coeliac patients (25). It is to be noted, how­
ever, that the above mentioned data can be interpreted in various ways (214,
215, 530, 531).
An explanation of these high serum hormone levels in coeliac sprue might 
be sought in reduced sensitivity of the target organs to hormonal stimuli. 
The less vigorous gall-bladder contraction seen in untreated patients (528) 
even after administration of exogenous cholecystokinin (98) would seem to 
suggest this. In the hands of some investigators, administration of exogenous 
cholecystokinin or secretin has also caused reduced secretion of enzymes, 
water and bicarbonate by the pancreas in coeliac sprue (384, 644, 937).
The above mentioned abnormalities in the production and release of
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intestinal hormones or in the sensitivity of the target organs to hormonal 
stimuli can result in dysregulation of gastric evacuation, intestinal peristalsis 
and secretion of bile and pancreatic juice in coeliac patients. This probably 
affords a partial explanation of the existing abnormal motility and maldiges- 
tion.
6 .8  INTESTINAL MUCUS
Intestinal mucus probably protects the intestinal wall against digestive juices 
and bacteria which degrade and transform the ingested food. lts protective 
function is clearly demonstrated by the marked secretory activity of the 
goblet cells in the intestinal mucosa in the presence of noxious or irritant 
substances. The number of goblet cells also seems to increase under such 
conditions, to a degree which has been described as colonic metaplasia 
(664). In  addition to the amount, the nature of mucus is one of the important 
determinants of its function. The composition o f  intestinal mucus depends 
on the subject’s age and nutritional state, and perhaps also on genetic factors 
(518).
The properties of intestinal mucus may be abnormal in diseases of the 
small intestine (518). It is uncertain whether an abnormally large amount of 
mucus is formed in the small intestine in coeliac sprue. Mucus formation 
might be expected to be increased due to the presence of an abnormal in­
testinal flora and of gluten, which is toxic to coeliacs. In most cases, however, 
biopsy specimens from the small intestine in coeliac sprue show no increased 
number of goblet cells. Absence of an increase in mucus formation can be the 
result of a deficiency of certain necessary substances (204). The mucus pro­
duction can have diminished again also, after initial hypersecretion, as if its 
sources were exhausted (192). If  the quality of the intestinal mucus were also 
changed in coeliac sprue, the result would be that the mucus could no 
longer adequately perform its normal function. This could mean an in­
sufficiënt protection of the mucosa from the influence of bacteria or proteo­
lytic enzymes. So far, however, no factual data on the production and com­
position of mucus in coeliac sprue have been published.
6.9 EXFOLIATION OF ENTEROCYTES
The turnover of the small intestinal epithelium is markedly increased in 
patients with coeliac sprue. The number of cells exfoliated and released in 
the intestinal lumen is substantially increased. This increase can be readily
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measured by determining the DNA content of the recovered fluid from per- 
fused intestinal segments, for 80-95% of the cells in this fluid are exfoliated 
enterocytes (683). Exfoliation in coeliac sprue is 4-6 times that in normal 
subjects (178, 184). This corresponds with a 5-6 times larger cell production 
observed in the mucosal crypts (929). These calculations are based on data 
obtained in studies of the proximal small intestine. A less markedly incre­
ased turnover of intestinal epithelium can be expected in more distal parts of 
the small intestine.
Under normal conditions the amount of enterocytes exfoliated in the 
lumen is estimated to be 250 g/day (186, 507). These cells are degraded in 
the intestinal lumen, and the degradation products are largely reabsorbed. 
It is conceivable that the pathological mucosa of the small intestine cannot 
adequately reabsorb the much larger supply of degraded exfoliated cells.
This phenomenon has been described as exfoliative enteropathy by Crea- 
mer and co-workers, analogous to the concept of exudative enteropathy 
(179, 184). Exfoliative enteropathy is defined as the occurrence of deficien- 
cies in nutrients resulting from an increased enteric loss of cell products of 
exfoliated enterocytes. These deficiencies are believed to become manifest in 
weight loss (184) as well as in faecal loss of iron (897), vitamin B12 (523), 
protein (188) and lipids (169).
It is not impossible that an insufficiënt reabsorption of degradation pro­
ducts of the increased amount of exfoliated enterocytes can contribute to 
the symptoms in coeliac sprue.
6.10 ENTERIC PLASMA PROTEIN LOSS
6.10.1 Introduction
Leakage of extracellular fluid from the wall of the small intestine into the 
lumen is markedly increased in various conditions (431, 879). Increased 
protein leakage proved to occur also in some patients with coeliac sprue 
(432, 658, 685, 726). In an effort to gain an impression of the incidence and 
severity of this phenomenon in coeliac sprue, the enteric protein leakage 
was measured in the majority of our patients (cf chapter 12).
6.10.2 Determination o f enteric protein loss
The enteric protein leakage was measured in a total of 30 untreated patients 
with coeliac sprue, of whom 28 showed an increased leakage (fig. 6.5). An
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Fig. 6.5. Enteric plasma protein loss in untreated 
coeliac sprue. The measured amounts of enteric 
leakage are drawn separately for patients with a 
flat and with a convoluted mucosa. Statistical 
analysis (Mann-Whitney test) revealed no signi­
ficant difference between both groups. The shaded 
area represents the range of normal values (cf. 
chapter 12).
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Fig. 6.6. Enteric plasma pro­
tein loss and gluten-free diet. 
The measured amounts of 
enteric leakage in corre- 
sponding patients before as 
well as during diet therapy 
are given. The shaded area 
represents the range of nor­
mal values (cf. chapter 12).
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extremely high protein leakage was observed in a few cases, particularly in 
patients with a flat jejunal mucosa, although it was also found in the pre­
sence of apparently less severe mucosal lesions (i.e. in a biopsy specimen 
showing convolutions). In only 2 untreated coeliacs was the protein leakage 
not increased (fig. 6.5). After introduction of a gluten-free diet the majority 
of cases showed diminished enteric leakage (fig. 6.6). It was found to have 
normalized in 4 out of 8 patients. In some cases this improvement occurred 
within a few months (fig. 6.6), but in other patients the leakage was still high 
after several years on a gluten-free diet (section 9.3).
6.10.3 Comment
The above observations clearly show that an increased protein leakage via 
the intestinal wall existed in virtually all untreated patients with coeliac 
sprue.
This increased leakage is probably due to the inflammatory process in 
the intestinal mucosa. Protein loss can also result, however, from leakage of 
lymph into the intestinal lumen. This leakage of lymph might result from 
congestion in the intestinal lymph circulation due to an obstructed drainage 
(section 6.5).
The exact mechanism of protein leakage from the inflamed intestinal wall 
is still unknown, but some processes which could explain the leakage can be 
mentioned. As in any other inflammatory process there is an augmented 
exudation due to increased permeability of the capillary wall (27). Moreover, 
exfoliation of enterocytes is increased (section 6.9), and the defects in the 
epithelial layer are consequently much more extensive. Interstitial fluid can 
enter the intestinal lumen via these defects. It is also possible that the in­
creased amount of interstitial fluid causes an elevated pressure in the sub- 
epithelial tissue so that the enterocytes are less closely arranged than usual. 
In dogs with experimentally provoked gastritis, leakage of tissue fluid via 
the so-called tight junctions was in fact observed (620). These junctions, 
which normally seal the interceliular spaces hermetically from the intestinal 
lumen, are apparently less tight under pathological conditions, and readily 
pass large molecules such as proteins. Factors which might affect the firm- 
ness of the tight junctions are abnormally shaped or damaged enterocytes, 
increased pressure in the interstitial tissue, or the release of toxic substances 
such as histamine (620). There is some evidence that leakage occurs at the 
villous tips, and is absent in the crypts (331).
Protein leaked into the intestinal lumen is for the most part degraded and 
reabsorbed, unless it enters the distal part of the ileum. In some coeliacs,
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however, it is quite possible that a considerable part of protein and protein 
degradation products gets lost with the faeces or urine. This may be due to 
the amount of protein or the site at which it is released into the small intes­
tine, and on the other hand to decreased absorptive capacities (section 7.5).
In addition to an increased leakage of protein, coeliac patients also show 
an extra loss of other substances contained in the interstitial fluid. Although 
most of these substances are normally reabsorbed, this phenomenon may 
play some role in the increased faecal loss of electrolytes, iron, vitamin B12 
or folates (179).
The structure of the intestinal mucosa shows an important degree of nor- 
malization after the institution of a gluten-free diet. The interstitial oedema in 
the wall of the small intestine diminishes and the integrity of the epithelial 
layer increases. This explains why protein leakage via the intestinal wall 
diminishes or returns to normal after gluten withdrawal in coeliac sprue 
(fig. 6.6).
6.11 INTESTINAL FLORA
6.11.1 Introduction
There are sound reasons for the assumption that the bacterial flora of the 
small intestine is abnormal in coeliac sprue, for there are many factors which 
interfere with a normal balance of micro-organisms in the small intestine. 
The mucosa of the small intestine is inflamed and shows lesions, and conse- 
quently the local milieu in and near the intestinal wall is changed. Another 
important factor is the abnormal peristalsis. Finally, due to malabsorption 
many food constituents are not absorbed, or only at a distal level, from which 
situation the micro-organisms can benefit. In view of these reasons it seemed 
useful to submit our patients with coeliac sprue to tests for the presence of an 
abnormal bacterial flora. These tests consisted of a culture o f intestinal fluid, 
a ‘breath’ test with 14C-glycocholic acid, and determination of urinary in- 
dican excretion (cf chapter 12).
6.11.2 Culture o f  intestinal fluid
In 9 untreated patients, some fluid was obtained from the jejunum by aspira- 
tion and cultured under aerobic as well as strictly anaerobic conditions. The 
culture results are listed in table 6.3. In 5 of the 9 cases an increased bacterial 
count was obtained, i.e. more than 10® micro-organisms per ml jejunal fluid 
were cultured.
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Table 6.3. Results of some tests used for the demonstration of an abnormal intestinal
flora in untreated coeliac patients (cf. chapter 12).
PATIËNT JEJUNAL JUICE 
CULTURE
u C-GLYCO- 
CHOLIC ACID 
DECONJUGATION
INDICAN 
EXCRETION 
IN  URINE
#  1 104 N.D. 142
#  5 104 N.D. 191
#  13 105 N.D. 142
#  20 5 x 105 N.D. 229
#  26 102 7-8 164
#  27 <  102 3-9 22
#  28 103 0-5 144
#  29 no growth 0-7 76
#  30 N.D. 0-4 216
#  32 107 0-7 57
CONTROLS <  103m.o./ml <  1,5 x lO -5 
of dose/mmole CO,
45-120 mg/24 hrs
6.11.3 ‘Breath’ test with u C-glycocholic acid
The so-called ‘breath’ test can be used to demonstrate the presence of an 
abnormal intestinal flora. This is possible as the degree o f 14C 0 2 expiration 
reflects the bacterial deconjugation and degradation of 14C-labelled glyco- 
cholic acid in the small or large intestine (295). The test was carried out in 6 
untreated patients (table 6.3), of whom 2 showed markedly increased 
deconjugation of glycocholic acid. There was little correlation, however, 
between the results of this test and the number of micro-organisms cultured 
or the indicanuria (table 6.3).
6.11.4 Urinary indican excretion
The urinary indican excretion was determined in 22 untreated patients, of 
whom 10 showed increased indicanuria. Indican excretion was as a rule 
normal in patients with less severe mucosal lesions in the proximal jejunum 
(fig. 6.7). The results obtained proved to show a fair degree of correlation 
with the number of micro-organisms cultured from the jejunal fluid, but the 
correlation with the ‘breath’ test results was less evident (table 6.3).
6.11.5 Effect o f  the gluten-free diet
In 5 patients jejunal fluid was cultured during treatment by a gluten-free 
diet, mostly because the clinical and biochemical effects of this treatment
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Fig. 6.7. Urinary indican excretion in untreated 
_ 4o coeliac sprue. The amounts excreted in urine are 
drawn separately for patients with a flat and with 
a convoluted jejunal mucosa. Statistical analysis 
(Mann-Whitney test) revealed no significant 
difference between both groups. The shaded area 
represents the range of normal values (cf. chapter 
12).
U rinary indican excretion 
(^ jm o le /2 4 h rs ) (m g /2 4 h rs )
Fig. 6.8. Urinary indican excretion and gluten- 
free diet. The amounts excreted by corresponding 
patients before as well as during diet therapy are 
given. Statistical analysis (Wilcoxon signed-rank 
test) revealed no significant improvement on diet 
therapy. The shaded area represents the range of 
normal values (cf. chapter 12).
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Table 6.4. Results of some tests on an abnormal small intestinal flora in diet-treated coeliac patients (cf. chapter 12).
PATIËNT JEJUNAL 14c -g l y c o - INDICAN 57C o - v it  B , 2 D-XYLOSE ADDITIONAL
JUICE CHOLIC ACID EXCRETION EXCRETION EXCRETION TREATMENT
CULTURE DECONJUGATION IN URINE IN  URINE IN  URINE
#  2 5 X 105 N.D. 160 0.6 1.8
#  5 108 2.3 182 N.D. 3.1
N.D. 0.35 79 N.D. 3.8 2 g tetracycline
during 4 wks
#  7 N.D. 2 .6 130 4.4 N.D.
N.D. 3.5 N.D. 6 .8 5.7 1 g tetracycline
during 4 wks
#  21 N.D. 12.3 203 1.7 1.7
2 x l 0 5 2.95 126 11.2 N.D. 1 gmiconazole
during 2 wks
N.D. 16.6 N.D. N.D. 2.2
N.D. 0.5 45 N.D. 4.8 2 g tetracycline
during 12 wks
#  22 103 0.5 56 N.D. 7.5
#  40 4 x  105 1.85 390 4.8 4.0
#  45 N.D. 16.6 28 N.D. 2.0
N.D. 0.9 31 N.D. 4.9 1 g tetracycline
during 4 wks
CONTROLS <  103 <  1.5 x l O - 5 45-120 15-35% 5.0-9.3
m.o./ml of dos e/ mmole C 0 2 mg/24 hrs of dose/48 hrs g/5 hrs
were disappointing. In 4 of the 5 cases culturing yielded more than 105 
micro-organisms per ml jejunal fluid (table 6.4).
The deconjugation of 14C-labelled glycocholic acid was studied in 6 
patients on a gluten-free diet and found to be abnormally high in all but one 
patiënt. The indicanuria was also increased in these 6 patients (table 6.4).
In the majority of patients, however, the indicanuria normalized after 
gluten withdrawal (fig. 6.8).
In 3 coeliacs with persistent symptoms or biochemical changes despite 
several years on a gluten-free diet, tetracyclin or an oral fungistatic drug 
(Miconazole) were prescribed in addition to the dietary measures. In some 
cases the ‘breath’ test or the indicanuria thereupon showed improvement, 
as table 6.4 indicates.
6.11.6 Comment
The above observations show that the bacterial flora of the small intestine 
is abnormal in many patients with coeliac sprue. It was also demonstrated 
quite clearly that this does not apply only to untreated patients but also to 
some patients on a gluten-free diet.
It is somewhat difficult to establish the presence of an abnormal bacterial 
flora in the small intestine. Each of the various procedures commonly used 
for this purpose has its disadvantages and inaccuracies. For example, fluid 
from the small intestine is usually aspirated only from the proximal jejunum, 
and this is not necessarily representative of the situation elsewhere in the 
small intestine. One always measures the concentration of micro-organisms 
per ml moreover, but this is not conclusive o f the total number of micro- 
organisms in the intestinal fluid as a whole. The technique of anaerobic 
culturing is very exacting, and the results are therefore often unreliable and 
disappointing (237).
With regard to the ‘breath’ test it is to be borne in mind that deconjugation 
of bile acids in coeliac sprue does not necessarily indicate an abnormal in­
testinal flora, but can also be increased for other reasons, such as structural 
changes in the terminal ileum or an extremely rapid passage through the 
small intestine. On the other hand. false-negative ‘breath’ test results are also 
possible, resulting from a delayed stomach evacuation or the presence of 
non-deconjugating micro-organisms (295,777).
The urinary indican excretion, flnally, can be increased as a result of the 
fact that unabsorbed protein (and with it tryptophan) enters the colon, e.g. 
due to malabsorption (280). In some cases an abnormal bacterial flora is not 
associated with an increased indicanuria because the micro-organisms in- 
volved are apparently unable to produce indole from tryptophan (356).
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Indole production can also be decreased when the luminal pH is low, due to 
fermentation processes (628).
It is probably due to these factors that the correlation between the various 
procedures used to demonstrate the presence of an abnormal intestinal flora 
is no more than fair (tables 6.3 and 6.4; 356).
Considering the separate procedures, we find that the culture results in- 
dicated an increased number of micro-organisms in 5 out of 9 untreated 
patients. This observation is in agreement with findings reported by Delli- 
piani (201) and Hamilton et al. (356). Brooks et al. (104), Draser et al. 
(236), and Neale et al. (628) never found an increased number of micro- 
organisms in the intestinal fluid in their patients. Modigliani et al. (601), on 
the other hand, found an abnormally large number of micro-organisms in 
nearly all untreated coeliacs.
The deconjugation of 14C-labelled glycocholic acid was markedly in­
creased in 2 of our 6 untreated patients. In a comparable number of coeliac 
patients Fromm et al. (295) invariably obtained a normal ‘breath’ test, as did 
Sherr et al. (777).
Indicanuria proved to be increased in about 50% of our patients, which is 
in agreement with the experiences reported by others (356, 525).
As a result of the presence of an abnormal bacterial flora, several meta- 
bolic disorders can develop. The great influence of the intestinal bacteria on 
human metabolism has been demonstrated in studies of patients with a so- 
called blind loop syndrome, whose symptoms are chiefly due to an abnormal 
intestinal flora (319, 328, 356, 630, 832). These metabolic disturbances can 
be roughly divided into the consumption of food constituents, the distur- 
bance of their digestion and absorption, or the formation of (sometimes toxic) 
degradation products. The consumption of nutrients can amount to a few 
grams per hour (319), which may result in deficiencies (442, 629, 932). The 
increased deconjugation of bile acids can interfere with the micelle forma­
tion of lipids (831), so that steatorrhoea becomes manifest (19). The ab­
sorption of monosaccharides and D-xylose (318, 326, 471), amino acids 
(310), and vitamin B12 (309) can also be decreased due to the presence of an 
abnormal intestinal flora. Disturbances in the absorption of the above men­
tioned nutrients are interpreted by some investigators as a consequence of 
the consumption or degradation of these substances (201, 318), but they can 
equally well be the result of structural alterations of the absorptive in­
testinal cells (319). The deconjugated bile acids have been held responsible 
for these lesions (19, 328). The increased enteric leakage via the intestinal 
wall in the presence of an abnormal intestinal flora is perhaps also a result of 
this epithelial damage (435, 648).
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The above considerations indicate that abnormal bacterial growth may 
lead to pronounced and sometimes multiple deficiencies. The question is to 
which extent the existing deficiencies in patients with coeliac sprue are due to 
the often abnormal intestinal flora in these cases. The influence of abnormal 
bacterial growth on malabsorption of fat, vitamin B12 and D-xylose in 
coeliac sprue has been convincingly demonstrated by the improvement of 
intestinal absorption after adminstration of antibiotics (table 6.4; 356, 716).
It is not quite clear why the intestinal flora is so often abnormal in coeliac 
sprue, but the reduced intestinal motility, malabsorption and mucosal 
lesions are important factors in this respect. Diminution of local immu- 
nological defence mechanisms of the small intestine is probably an additional 
factor. It is remarkable, however, that this abnormal intestinal flora can 
persist so long even after the institution of a gluten-free diet, and despite the 
improvement in the morphology and function of the mucosa of the small 
intestine. Symptoms of malabsorption in treated coeliac patients may be 
due to a persistent abnormal intestinal flora. It is of importance to bear this 
in mind because of the fact that these symptoms may be misinterpreted as 
indicative of the patient’s carelessness in observing the prescribed dietary 
rules.
6.11.7 Conclusions
1. In untreated as well as in treated patients with coeliac sprue, the bacterial 
flora of the small intestine is often abnormal.
2. The presence of an abnormal intestinal flora is not always readily de- 
monstrable as the procedures used for this purpose have their various 
disadvantages and inaccuracies.
3. Factors which permit the development of an abnormal bacterial flora in 
the small intestine are the reduced motility and the presence of unab- 
sorbed food constituents in the intestinal lumen. Additional factors of 
importance are probably the presence of mucosal lesions and an abnor­
mal local immunological defence.
4. The malabsorption in coeliac sprue can be due in part to the abnormal 
bacterial growth, either through the degradation and consumption of 
nutrients or through its damaging influence on the mucosa.
5. In patients with persistent malabsorption in spite of gluten withdrawal, 
the possibility of an abnormal flora in the small intestine has to be taken 
into account.
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CHAPTER 7
MALABSORPTION IN  COELIAC SPRUE
7.1 INTRODU CTION
The occurrence of malabsorption in coeliac sprue is well-known for a long 
time. The first observations in patients with a sprue syndrome made already 
reference to distinct clinical symptoms of malabsorption (305, 385). The 
fact that this malabsorption can induce deficiencies of various nutrients, has 
been demonstrated by clinical surveys in the last 10-20 years. In most of 
these studies malabsorption was only broadly investigated, and but a few 
publications go into more detail.
It seemed useful therefore to publish the results of a retrospective, clinical 
investigation in still another group of coeliac patients. On the one hand 
biochemical examinations in our group of coeliac patients have been fairly 
extensive, with the result that the incidence of various deficiencies in the 
same group of patients could be reported. On the other hand insight could 
sometimes be gained into the mechanisms by which these deficiencies are 
brought about, based on our own results and data from literature. The 
composition of the group of patients studied has already been reported 
(section 6.1). For the methods of investigation the reader is referred to 
chapter 12.
7.2 WATER AND ELECTROLYTES
Diarrhoea is a frequent symptom in patients with coeliac sprue (table 8.1). 
In some cases the daily production of faeces exceeds 1000 g, but as a rule the 
amount of faeces is much smaller (fig. 7.1). This increase in faecal weight 
might be indicative of a disturbed absorption of water and electrolytes.
By means of perfusion studies, several investigators have indeed de­
monstrated that absorption of water and electrolytes in the proximal 
jejunum is abnormal in coeliacs. As a rule, more sodium, potassium, 
chloride, bicarbonate and water was recovered after perfusion than had 
been instilled into the intestinal segment involved (78, 282, 410, 741, 759). 
In the majority of untreated coeliacs, therefore, there is a net secretion
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Fig. 7.1. Diagram of the daily 
production of faeces in 33 
patients with untreated coeliac 
sprue. The daily faecal weight 
was calculated from 5 day fat 
balance studies. The dotted 
line represents the upper limit of 
daily faeces production in Con­
trols.
of water and electrolytes in the proximal small intestine. By perfusion 
with labelled water, sodium or potassium, it has been demonstrated that 
absorption of sodium and potassium in the proximal small intestine is 
subnormal, whereas absorption of water is probably normal (759). Perhaps 
the diminished absorption results from a defect in the active transport 
mechanism, as is indicated by the fact that glucose is no longer able to 
stimulate the absorption of water and sodium chloride (282, 759). Moreover, 
the size of the absorptive surface has decreased due to the disappearance of 
villi and microvilli.
The increased secretion found in coeliac sprue patients has not yet been 
adequately explained. The increased permeability of the mucosa due to 
enlargement of the pores in the cell membrane o f the enterocytes (282) can 
scarcely explain the increased secretion. The theory that the secretion is 
based on loss of extracellular fluid via the intestinal wall, which is increased 
due to the enhanced capillary permeability resulting from the inflammatory 
reaction, also seems scarcely plausible (741). A  third possibility is primary 
stimulation of the secretory mechanism of the enterocyte. This can be effec- 
ted, for example, by an increase in the cyclic AMP concentration in the 
enterocyte as a result of stimulation of the adenylcyclase in this cell (section
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4.7). Such a phenomenon is held responsible also for the water and electro- 
lyte secretion in other disease states, such as cholera (800). All the above 
mentioned hypothetical secretory mechanisms in coeliac sprue can be trig- 
gered by the effect of certain substances on the intestinal mucosa. This role 
has been ascribed to deconjugated bile acids (741), secretion products from 
undifferentiated intestinal crypt cells (378) or toxins which originate from 
incomplete gluten degradation, from an abnormal intestinal flora or from 
the inflammatory reaction in the intestinal mucosa.
In spite of a considerable secretion of water and electrolytes in the prox- 
imal jejunum, only few coeliacs suffer from severe diarrhoea (fig. 7.1). This 
is due to the fact that absorption of water and electrolytes in the ileum has 
increased (752), so that a proximal loss can still be compensated in the 
distal part of the small intestine (792).
It should be mentioned also that several other mechanisms can exert an 
influence on absorption of water and electrolytes in coeliac sprue. Malab- 
sorption of carbohydrates and proteins, for example, can imply a reduced 
stimulant for sodium absorption (802). Unabsorbed nutrients, moreover, 
can retain an amount of water in the lumen by osmotic attraction. The 
aqueous diarrhoea which can occur in lactose intolerance, is thought to be 
partly due to this retention. Since lactase deficiency is regularly found in 
untreated patients with coeliac sprue (section 7.3), the malabsorption of 
water can perhaps be partly ascribed to osmotic retention. An abnormal 
bacterial flora in the small intestine can cause a reduction of intestinal 
transit time due to deconjugation of bile acids and to release of certain other 
degradation products (section 6.2). Some unabsorbed fatty acids, too, can 
cause accelerated peristalsis of the colon (20, 21). A decreased intestinal 
transit time reduces the time available for absorption (section 5.1.2). Several 
of the above mentioned (bacterial) degradation products cause increased se­
cretion of water and electrolytes by the intestine as well (20, 21, 588, 742).
A remarkable finding in perfusion studies was that, despite a gluten-free 
diet over a period of 2-10 months, secretion in the proximal small intestine 
hardly diminished (78, 741, 759). Clinical experience shows, however, that 
the diarrhoea improves fairly soon after gluten withdrawal. This might in- 
dicate that the above described additional factors in coeliac diarrhoea im- 
prove more quickly than the primary abnormal secretion or diminished ab­
sorption of water and electrolytes.
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7.3 CARBOHYDRATE
7.3.1 Introduction
A frequent symptom in patients with coeliac sprue is a distended, meteoristic 
abdomen, giving rise to complaints about dyspepsia, abdominal pain, bor- 
borygmi and flatulence (cf. chapter 8). The underlying increased develop- 
ment of gas in the small and the large intestine mainly results from carbohy- 
drate fermentation. It can therefore be expected that digestion and absorp­
tion of carbohydrates are often disturbed in coeliac sprue. The results of 
pertinent studies are discussed in the following subsections.
7.3.2 Microscopie examination offaeces fo r  starch
Faeces from 9 untreated coeliac patients were, after staining with Lugol 
solution, microscopically examined for the presence of starch granules. No 
starch was found in the faeces in 5 patients. In the remaining cases, an occa- 
sional small starch granule was found. The results, therefore, were never 
pathological, although all patients showed a pronounced malabsorption 
syndrome.
7.3.3. Glucose tolerance test
In 6 of a total of 14 untreated patients, a very slight increment of blood 
sugar (defined as less than 1.1 mmole/1; 639) was observed after oral ad- 
ministration of 100 g glucose. A  low profile glucose curve was found in 
patients with a flat mucosa as well as in those with less severe mucosal lesions 
(fig. 7.2).
7.3.4 Lactose tolerance test
A lactose tolerance test was carried out in 16 untreated coeliac patients. In 
only 2 cases was administration of 50 g lactose followed by a normal incre­
ment of blood sugar (i.e. more than 1.2 mmole/1). In patients with a con­
voluted mucosa in the jejunal biopsy specimen, too, the increment was al- 
ways reduced (fig. 7.3). Only 5 of the 14 patients with a low profile blood 
sugar curve developed symptoms as a result o f the lactose administration, 
e.g. meteorism, abdominal cramps or diarrhoea. There was no demonstrable 
correlation between the development of symptoms and the increment of 
blood sugar.
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Fig. 7.2. Glucose tolerance test 
in untreated coeliac sprue. The 
increments of blood sugar are 
drawn separately for patients 
with a flat and with a convoluted 
jejunal mucosa. The results in 22 
Controls are presented for com- 
parison. The range of normal 
values was not defined as a low 
profile curve may occur in many 
healthy individuals (cf. chapter 
12).
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Fig. 7:3. Lactose tolerance test in untreated 
coeliac sprue. The increments of blood sugar are 
drawn separately for patients with a flat and with 
a convoluted jejunal mucosa. Statistical analysis 
(Mann-Whitney test) revealed no significant 
difference between both groups. Hollow dots re- 
present patients without symptoms of intolerance, 
solid dots represent symptomatic cases. The 
shaded area represents the range of normal values 
(cf. chapter 12).
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The lactase content of the biopsy specimen o f the first jejunal loop was 
determined in 5 untreated coeliacs, including patients with an abnormal as 
well as with a normal bleod sugar increment after lactose administration. In 
none of the cases was any lactase activity demonstrable in the biopsy 
specimen.
7.3.6 Tolerance tests with other disaccharides
In 3 coeliac patients with a low profile blood sugar curve after lactose ad­
ministration, a tolerance test with 50 g sucrose was carried out also. In 2 of 
the 3 cases a normal increment of blood sugar (3.2 and 1.5 mmole/1), was 
found. A tolerance test with 50 g maltose in 2 patients likewise gave normal 
results (blood sugar increment 1.5 and 1.25 mmole/1, respectively).
7.3.7 D-xylose test
A decreased urinary D-xylose excretion was found after oral administration 
of 25 g D-xylose in 88% of 33 untreated patients (fig. 7.4). Abnormal fin-
7.3.5 Lactase activity o f  the jejunal mucosa
U rin a ry  D-xylose excretion 
(m m ole/1 ) ( g /5 h r s )
■f lat 
mucosa
Fig. 7.4. D-xylose test in untreated coeliac sprue. 
The results o f urinary D-xylose excretion are 
drawn separately for patients with a flat and with 
a convoluted jejunal mucosa. Statistical analysis 
(Mann-Whitney test) revealed no significant 
difference between both groups. The shaded area 
represents the range of normal values (cf. chapter 
12).
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dings were obtained both in patients with only slight mucosal lesions and 
in those with an avillous mucosa in the jejunal biopsy specimen. There was 
no demonstrable correlation between the degree of disturbance o f the 
D-xylose test and the severity of the mucosal damage in the biopsy specimen.
7.3.8 Effect o f  the gluten-free diet
An improved and normalized increment of blood sugar after lactose ad­
ministration was observed in 3 out of 8 cases after gluten withdrawal (fig.
7.5). Of the patients with a low profile blood sugar curve, only one showed 
clinical symptoms of lactose intolerance.
Fig. 7.5. Lactose tolerance test and gluten-free 
diet. The increments of blood sugar in correspond- 
ing patients before as well as during diet therapy 
are given. Hollow dots represent patients without 
symptoms of intolerance, solid dots represent 
symptomatic cases. Statistical analysis (Wilcoxon 
signed-rank test) revealed a significant improve- 
ment on diet therapy (2% <  p <  5%). The shaded 
area represents the range of normal values (cf. 
chapter 12).
The D-xylose excretion improved after gluten withdrawal in all except 2 
patients (fig. 7.6). In some cases the improvement occurred within 2-7 
months, but in others it took longer for the result to become normal. In 18 
out of 28 cases, D-xylose excretion became normal during a gluten-free diet.
7.3.9 Comment
On the basis of the results of microscopie examination of the faeces, it could
Maximum incremerrt. blood sugar 
(m m o le /l)  ( m g l . )
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U rina ry  D -xy lose  excre tion  
(m m o le /1 ) (g /5 h rs )
r14
w ith o u t w ith  
g lu te n -fre e  d ie t
Fig. 7.6. D-xylose test and gluten-free diet. The 
results of urinary D-xylose excretion in corre- 
sponding patients before as well as during diet 
therapy are given. Statistical analysis (Wilcoxon 
signed-rank test) revealed a significant improve- 
ment on diet therapy (p <  1%). The shaded area 
represents the range of normal values (cf. chapter 
12).
be stated that digestion and absorption of starch are usually normal in 
coeliac patients. However, the value of microscopie examination of faeces 
for starch is controversial (116). Our personal experience with microscopie 
examination of faeces to determine digestion has been negative so far as 
starch is concerned. In patients with severe malabsorption we usually 
found no starch in the faeces; but starch was found in patients with acceler- 
ated intestinal passage (e.g. due to abuse of laxatives) (145).
Theoretically, digestion and absorption of carbohydrates can be disturbed 
at several different levels. In patients with coeliac sprue, deficiency of the 
enzyme oc-amylase due to decreased secretion of this enzyme by the pancreas 
seems unlikely in view o f the enormous functional reserve o f this organ 
under normal conditions.
Disturbances based on abnormalities of the intestinal mucosa are more 
likely. For the so-called epithelial phase of carbohydrate digestion, the 
presence of a normal brush border is required in which, beside various 
disaccharidases, the transport carriers are also contained. In coeliac sprue the 
first morphological changes of the epithelial layer occur in the brush border. 
Moreover, the damage to the brush border is usually severe and fairly ex- 
tensive (655, 782, 859). A decrease in the concentration of disaccharidases is 
bound to result.
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Although virtually all disaccharidases are decreased in amount as a result 
of the above mentioned factors (553, 668), this is manifested almost exclusiv- 
ely in the form of lactose intolerance. This is due to the fact that, unlike the 
other disaccharidases, lactase activity in the intestinal mucosa is not abun­
dant, but rather marginal under normal conditions. In coeliac patients, 
lactase activity can become deficient even with a relatively small decrease in 
the amount of lactase resulting from mucosal damage.
Lactase activity shows usually the first as well as the most marked de­
crease when the intestinal mucosa is damaged. Several investigators have in 
fact observed a correlation between lactase activity and the severity of 
mucosal damage (668, 686, 907). It is therefore not surprising that we were 
unable to demonstrate lactase activity in biopsy specimens from the proximal 
jejunum of untreated coeliacs. Lactase activity is bound to be decreased in 
every morphologically abnormal jejunal specimen, and should -  in our 
opinion -  not be quantified unless for scientific purposes.
The large majority of patients showed only a slight increment of blood 
sugar on lactose ingestion, but only a few showed symptoms of lactose intol­
erance (fig. 7.3). If no symptoms of intolerance occur, a flat blood sugar 
curve after lactose administration can be due to delayed gastric emptying or 
rapid insulin secretion. I f  the patiënt does show symptoms, on the other 
hand, it should be realized that lactose intolerance can also be a primary 
phenomenon. This may explain, for example, the lactose intolerance in
Table 7.1. Incidence of a low profile (flat) glucose tolerance curve in untreated coeliac 
sprue.
AUTHORS CR1TERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE 
W IT H  LOW  
PROFILE 
CURVE
Cooke et al. gluc. concentration 31 0
(1963) <  100 mg%
Shiner gluc. increment 7 100
(1963) <  40mg%
Stewart et al. gluc. increment 58 84
(1967) <  40mg%
Mann et al. not stated 13 38
(1970)
Thys et al. gluc. concentration
(1971) <  130 mg% 6 100
< 110m g% 6 67
Modigliani et al. gluc. increment
(1975) <  30mg% 32 63
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treated coeliacs who no longer show any other evidence of malabsorption 
(fig. 7.5).
In the proximal part of the small intestine absorption of monosaccharides 
is usually decreased in coeliac sprue. In perfusion studies virtually all 
untreated coeliac sprue patients are found to have a diminished absorption 
of glucose as well as of fructose in the proximal jejunum (62, 78, 244, 410, 
752). The diminished absorption can be explained, not only by a decreased 
absorptive surface but also by a disturbed transport of monosaccharides 
through the intestinal wall. Glucose absorption does improve after gluten 
withdrawal, sometimes after a considerable time. In some cases glucose ab­
sorption is still abnormal while D-xylose excretion has already returned to 
normal (78, 410). The abnormalities of absorption found in the proximal 
part o f the small intestine do not by any means preclude the possibility of 
normal glucose and fructose absorption in the distal part of the small in-
Table 7.2. Incidence of a decreased urinary D-xylose excretion in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE
WITH
DECREASAD
EXCRETION
Sleisenger <  5 g/5 hrs 9 100
(1961) 
Cooke et al. <  4.2 g/5 hrs 24 83
(1963)
Shiner <  5 g/5 hrs 11 1 0 0
(1963) 
Benson et al. <  5 g/5 hrs 12 1 0 0
(1964) 
Brooks et al. <  5 g/5 hrs 10 1 0 0
(1966) 
Fahrlaender et al. notstated 14 71
(1966) 
Stewart et al. <  5 g/5 hrs 57 97
(1967) 
Mortimer et al. < 5  g/5 hrs 5 80
(1968) 
Jarnum et al. <  5 g/24 hrs 10 90
(1970) 
Mann et al. < 4 . 5  g/5 hrs 21 95
(1970) 
Thys et al. <  3.75 g/5 hrs 8 88
(1971) 
Modigliani et al. <  4 g/5 hrs 28 96
(1975) 
Own series < 5  g/5 hrs 33 88
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testine. All in all, therefore, there need not necessarily be carbohydrate 
malabsorption. The flat blood sugar curve often observed after oral glucose 
administration (table 7.1; fig. 7.2) does suggest that glucose absorption as a 
whole is decreased in untreated coeliac sprue. However, it is ill-advised to 
diagnose glucose malabsorption on the basis of a flat blood sugar curve or 
to screen for malabsorption by means of a glucose tolerance test, as is ob- 
viously frequently done (table 7.1). A low profile blood sugar curve, it 
should be borne in mind, may be observed in many normal individuals; ac- 
cording to Nolan et al. (639) even in 1 out of 4 people. In such cases the 
small increment of blood sugar is explained by delayed evacuation of gastric 
contents or abnormally rapid insulin secretion.
Although the pentose D-xylose is essentially a carbohydrate, it seems very 
questionable whether its absorption is a good parameter of carbohydrate 
absorption from food, which contains mainly hexoses. D-xylose, moreover, 
is an unphysiological substance, which under normal conditions is not 
present in food or in the human organism. In patients with untreated coeliac 
sprue, the absorption of this pentose is very often found to be disturbed. 
Our personal experience in this respect (fig. 7.4) conforms with that reported 
by others (table 7.2). The adequate discriminating function of the D-xylose 
test in coeliac sprue is probably based on the fact that this pentose is mainly 
absorbed in the jejunum (18). After gluten withdrawal, therefore, D-xylose 
absorption nearly always increases (fig. 7.6; table 7.3). The only disad- 
vantage of this otherwise excellent test is that false low results can be ob-
Table 7.3. Incidence of a decreased urinary D-xylose excretion in treated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE
W ITH
DECREASED
EXCRETION
Cooke et al. < 4 .2  g/5 hrs 8 38
(1963)
Shiner <  5 g/5 hrs 15 ,0
(1963) 
Benson et al. <  5 g/5 hrs 22 41
(1964) 
Cerf et al. <  5 g/5 hrs 7 86
(1975)
Modigliani et al. <  4 g/5 hrs 26 42
(1975) 
Own series <  5 g/5 hrs 27 37
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tained. This may be a result of delayed evacuation of gastric contents and 
decreased renal function, or -  which is of particular importance in coeliac 
sprue -  due to  the presence of an abnormal bacterial flora (section 6.11) or 
greatly accelerated intestinal passage (801).
7.3.10 Conclusions
1. The clinical symptoms in coeliac sprue suggest that digestion and absorp­
tion of carbohydrates are often disturbed.
2. Microscopie examination of faeces for starch granules seems to be of no 
value in demonstrating disturbances in carbohydrate digestion.
3. Reduced hydrolysis of lactose is demonstrable in most coeliac sprue 
patients, in whom other disaccharides may be properly degraded.
4. If  a patiënt continues to complain of dyspepsia or diarrhoea in spite of a 
gluten-free diet, the possibility of associated primary lactose intolerance 
should be considered.
5. Determination of the lactase content of the jejunal mucosa is useless in 
untreated coeliac sprue.
6. A flat blood sugar curve after oral glucose administration must not be 
used as an aid in diagnosing malabsorption.
7. D-xylose excretion is a good parameter for demonstration of malabsorp­
tion in the proximal part of the small intestine. This test is also very useful 
in studying the effect o f a gluten-free diet in coeliac sprue.
7.4 FAT
7.4.1 Introduction
Steatorrhoea was among the first abnormalities described in patients with 
coeliac sprue (305). The term idiopathic steatorrhoea commonly used before 
gluten intolerance was discovered, also indicates the importance attached to 
this symptom. It was once even maintained that a decreased fat absorption 
was imperative to make the diagnosis (159, 289), but subsequent studies 
showed that not all coeliacs have steatorrhoea (table 7.4). We considered it 
worthwhile to study the incidence of steatorrhoea in our group of untreated 
coeliacs. In addition we studied the question whether there were also ab­
normalities in the absorption of fat-soluble vitamins or of cholesterol, on
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Table 7.4. Incidence of steatorrhoea in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTJGATED
PERCENTAGE 
W ITH  STEA­
TORRHOEA
Buchan et al. > 7 g/24 hrs 36 92
(1962) 
Cooke et al. > 5 g/24 hrs 49 98
(1963)
Shiner > 5 g/24 hrs 17 100
(1963) 
Benson et al. > 5 g/24 hrs 7 100
(1964) 
Brooks et al. > 6 g/24 hrs 10 20
(1966) 
Fahrlaender et al. not stated 10 90
(1966) 
Stewart et al. > 6 g/24 hrs 58 81
(1967) 
Gent et al. > 7 g/24 hrs 56 75
(1968) 
Jarnum et al. > 21 meq/24 hrs 10 100
(1970) 
Mann et al. > 5 g/24 hrs 20 65
(1970)
Thysetal. > 8 g/24 hrs 6 83
(1971) 
Krondl et al. > 2 g/24 hrs 9 100
(1971) 
Modigliani et al. > 6 g/24 hrs 46 70
(1975) 
Own series <  95% absorption 32 88
the basis of the serum concentrations of these substances. Finally, we evalu- 
ated the effect of the gluten-free diet on fat absorption and on the serum 
concentrations of fat-soluble vitamins and cholesterol.
7.4.2 Fat absorption coëfficiënt
The fat absorption coëfficiënt, determined during a 5-day balance study, was 
found to be decreased in 91% of the 32 untreated patients with coeliac sprue. 
Fat absorption was disturbed in patients with severe as well as in those with 
less severe villous abnormalities in the proximal part of the small intestine. 
However, the steatorrhoea was significantly worse in the presence of a flat 
mucosa (fig. 7.7).
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Fat absorption
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fla t convoluted 
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Fig. 7.7. Fat absorption in untreated coeliac 
sprue. The absorption coefficients are drawn separ- 
ately for patients with a flat and with a convoluted 
mucosa. Statistical analysis (Mann-Whitney test) 
revealed a significant difference between both 
groups (p =  1%). The shaded area represents the 
range of normal values (cf. chapter 12).
Serum cholesterol 
(m m o le /1 ) (mg 7.)
■flat
mucosa
convoluted
mucosa
Fig. 7.8. Serum cholesterol in untreated coeliac 
sprue. The serum levels are drawn separately for 
patients with a flat and with a convoluted jejunal 
mucosa. Statistical analysis (Mann-Whitney test) 
revealed no significant difference between both 
groups. The shaded area represents the range of 
normal values (cf. chapter 12).
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7.4.3 Serum cholesterol concentration
A decreased serum cholesterol concentration was found in 59% of the 32 
untreated coeliacs. The severity of the villous abnormalities in the biopsy 
specimen did not seem to be a determinant of the frequency or the extent of 
the decreases in serum cholesterol (fig. 7.8). A rather poor correlation was 
found between the degree of hypocholesterolaemia and the degree of fat 
malabsorption (fig. 7.9).
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Fig. 7.9. Serum cholesterol and fat absorption. The serum cholesterol levels of untreated 
coeliac patients are plotted against the corresponding absorption coefficients of simultan- 
eously conducted fat balance studies. The dotted horizontal line represents the lower limit 
of normal serum cholesterol, and the dotted vertical line the lower limit o f normal fat 
absorption. The straight diagonal line is the calculated regression line (y =  3.58 +  0.005x; 
r =  0.08; p >  10%).
7.4.4 Serum vitamin A concentration
The serum vitamin A concentration was determined in a total of 28 untreated 
coeliacs. Since the range of serum vitamin A levels in normal healthy Con­
trols was found to be very wide, it was impossible to determine the lower 
limit of normal. Interpretation of the values found in coeliac sprue is 
therefore difficult. The results obtained are therefore presented as such, with 
the values found in Controls for comparison (fig. 7.10).
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Fig. 7.10. Serum Vitamin A in untreated coeliac sprue. The serum levels are drawn 
separately for patients with a flat and with a convoluted jejunal mucosa. The results in 54 
Controls are presented for comparison.
7.4.5 Vitamin A tolerance test
A vitamin A tolerance test was carried out in a total of 26 untreated patients. 
This test also proved to show a wide range o f  normal values (fig. 7.11). 
Unlike the serum vitamin A concentration, the vitamin A tolerance test was 
found to show a fair correlation with the fat absorption coëfficiënt (fig. 7.12).
7.4.6 Serum vitamin E  concentration
The serum vitamin E concentration was decreased in 95% of 19 patients. The 
decrease was as marked in patients with a flat or with a convoluted mucosa 
(fig. 7.13). No correlation was observed between the height of the serum 
vitamin E level and the quality of fat absorption (fig. 7.14).
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Fig. 7.11. Vitamin A tolerance test in untreated 
coeliac sprue. The increments of serum vitamin A  
are drawn separately for patients with a flat and 
with a convoluted jejunal mucosa. Statistical 
analysis (Mann-Whitney test) revealed no signi­
ficant difierence between both groups. The shaded 
area represents the range of normal values (cf. 
chapter 12).
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7.4.7 Thrombotest
The thrombotest, with which deficiencies in vitamin K-dependent coagula- 
tion factors can be demonstrated, was decreased in 6 of the total of 20 pa­
tients. These 6 patients all showed a flat jejunal mucosa. In patients with less 
marked abnormalities in the jejunal biopsy specimen, the thrombotest was 
always normal (fig. 7.15). There was a fair correlation between the throm­
botest value and the degree of steatorrhoea (fig. 7.16).
7.4.8 Effect o f  the gluten-free diet
M ost coeliac sprue patients show improved fat absorption after gluten with- 
drawal. In 8 out of 9 patients with a decreased fat absorption coëfficiënt 
before treatment, faecal fat excretion was less after gluten withdrawal. In 5 of 
these 8 coeliacs the fat absorption returned to normal (fig. 7.17). i
The hypocholesterolaemia disappeared in all but one patiënt on the gluten- 
free diet. In some cases the serum cholesterol level rose within a few weeks
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Maximum increment serum vitamin A 
((jm o le /l)
Fig. 7.12. Vitamin A tolerance test and fat absorption. The vitamin A increments of un­
treated coeliac patients are plotted against the corresponding absorption coefficients of 
simultaneously conducted fat balance studies. The dotted horizontal line represents the 
lower limit of normal vitamin A increment, and the dotted vertical line the lower limit of 
normal fat absorption. The straight diagonal line is the calculated regression line (y =  
-3 .4 4  +  7.43x; r =  0.47; 0.5% < p <  1%).
(fig. 7.18). A remarkable phenomenon was that a slight decrease in serum 
cholesterol often followed on a substantial initial increase. This finding 
might indicate that the gluten-free regimen was less strictly observed after a 
while. Another possibility is that cholesterol synthesis, after initial maximal 
stimulation, gradually diminishes again after a while.
The serum vitamin A concentration showed no significant change after 
gluten withdrawal. It was sometimes still very low after many years.
Some effect of the diet on the vitamin A tolerance test was discernible. 
After gluten withdrawal the maximal increment of serum vitamin A was 
slightly higher in 5 out of 8 cases (fig. 7.19).
The vitamin E concentration, however, increased in response to the diet 
in all patients except one, although a normal vitamin E level was reached in 
only 3 cases (fig. 7.20).
The thrombotest (if decreased) also returned to normal on the gluten-free 
diet, often within a few weeks (fig. 7.21).
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Serum vitam in E 
(^ jm o le / l)
Fig. 7.13. Serum Vitamin E in 
untreated coeliac sprue. The 
serum levels are drawn separ- 
ately for patients with a flat and 
with a convoluted jejunal mu­
cosa. Statistical analysis (Mann- 
Whitney test) revealed no signi­
ficant difference between both 
groups. The shaded area re- 
presents the range of normal 
values (cf. chapter 12).
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Fig. 7.14. Serum vitamin E and 
fat absorption. The serum vita­
min E levels of untreated coeliac 
patients are plotted against the 
corresponding absorption coeffi- 
cients o f simultaneously conduc- 
ted fat balance studies. The 
dotted horizontal line represents 
the lower limit of normal serum 
vitamin E, and the dotted 
vertical line the lower limit of 
normal fat absorption. The 
straight diagonal line is the cal- 
culated regression line (y =  
7.60 +  0.036 x ;  r =  0.11; 
P >  10%).
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Fig. 7.15. Thrombotest in un­
treated coeliac sprue. The results 
are drawn separately for patients 
with a flat and with a convoluted 
jejunal mucosa. Statistical anal­
ysis (Mann-Whitney test) re­
vealed no significant difference 
between both groups. The shad­
ed area represents the range of 
normal values (cf. chapter 12).
Throm botest
Fat absorption (•/<.)
Fig. 7.16. Thrombotest and fat 
absorption. The results o f the 
thrombotest o f untreated coeliac 
patients are plotted against the 
corresponding absorption coeffi- 
cients of simultanteously con- 
ductedfat balance studies. The 
dotted horizontal line represents 
the lower limit of normal throm­
botest results, and the dotted 
vertical line the lower limit of 
normal fat absorption. The 
straight diagonal line is the cal- 
culated regressionline(y =  —36 
+  1.35x ;r =  0.79; p <  0.0005).
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Fig. 7.17. Fat absorption and gluten-free diet. The 
absorption coefficients in corresponding patients 
before as well as during diet therapy are given. 
Statistical analysis (Wilcoxon signed-rank test) 
showed a significant improvement on diet therapy 
(p ^  1%)- The shaded area represents the range of 
normal values (cf. chapter 12).
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Fig. 7.18. Serum cholesterol and gluten-free diet. Both the extent and the rate of normali- 
zation of serum cholesterol levels on diet therapy iri all 16 followed-up patients with hypo- 
cholesterolaemia (fig. 7.8) are recorded.
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Fig. 7.19. Vitamin A tolerance test and gluten- 
free diet. The increments of serum vitamin A in 
corresponding patients before as well as during 
diet therapy are given. Statistical analysis (Wil- 
coxon signed-rank test) showed a significant im- 
provement on diet therapy (2% ^  p ^  5%). The 
shaded area represents the range of normal values 
(cf. chapter 12).
Fig. 7.20. Vitamin E and gluten-free diet. The 
serum levels in corresponding patients before as 
well as during diet therapy are given. Statistical 
analysis (Wilcoxon signed-rank test) showed a 
significant improvement on diet therapy (p <  
1%). The shaded area represents the range of 
normal values (cf. chapter 12).
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Fig. 7.21. Thrombotest and gluten-free diet. The 
results in corresponding patients before as well as 
during diet therapy are given. Statistical analysis 
(Wilcoxon signed-rank test) showed a significant 
improvement on diet therapy (2% <  p <  5%). The 
shaded area represents the range of normal values 
(cf. chapter 12).
7.4.9 Comment
The results described above show clearly that uptake of fat and fat-like sub­
stances is usually disturbed, and relatively often markedly disturbed, in 
untreated patients with coeliac sprue. In many cases the serum concentra- 
tions of cholesterol and fat-soluble vitamins are likewise decreased.
The normal chain of events in fat digestion and absorption can be distur­
bed at many levels. The solubilization of fats can be insufficiënt; their ab­
sorption by the enterocytes can be diminished; and the transport of fat via the 
lymphatics can be decreased.
Itisnotinconceivable that such processes as emulsification and solubiliza­
tion are less. than optimal in coeliac patients due to deficiency of phos- 
pholipids, bile acids and lipases. According to Miettinen et al. (594), 
coeliacs produce less bile than normal subjects, while bile secretion, too, 
can be diminished as a result of decreased endogenous stimulation of gall- 
bladder contraction (214). Moreover, the loss of bile acids can also be in­
creased as a result of their diminished reabsorption due to lesions in the distal 
ileum (594), or because they are rendered useless by bacterial deconjugation 
(718). Due to the above mentioned factors the concentration of bile acids in 
the intestinal lumen can decrease to below the critical micellar concentration 
(578). DiMagno et al. (214) did in fact find a correlation between the micellar
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concentration in the intestinal fluid and the severity of steatorrhoea in 
coeliac patients.
According to some authors, the exocrine function of the pancreas is 
decreased in patients with coeliac sprue (section 6.6.3). As a rule, however, 
the pancreas secretes enzymes in such large amounts that a deficiency of 
lipases in the intestinal lumen will only occur if the pancreatic function is 
reduced to 10% of its original capacity (91). In coeliac patients, improvement 
of fat absorption was observed after administration of additional pancreatic 
enzymes by Cooke (163), which is in fact indicative of disturbed lipolysis. 
In one of our untreated coeliac patients, however, we observed no effect 
of high doses of pancreatic enzymes on the amount of faecal fat. Others, 
too, have reported negative experiences in this respect (180, 682).
Disturbance of fat absorption due to damage of the epithelium of the 
small intestine seems to be more important in coeliac sprue. This is also in- 
dicated by the fact that absorption of fatty acids, which require no solubiliza- 
tion and hydrolysis, is as markedly disturbed as absorption of triglycerides 
(119). The epithelial damage can involve, beside reduction of the absorptive 
surface, abnormal functioning of the remaining enterocytes (102). This 
may result in a disturbed re-esterification of absorbed monoglycerides, enab- 
ling the intracellular fatty acids to diffuse back into the intestinal lumen 
(880). Chylomicron formation can also be disturbed, on the one hand as a 
result of the already mentioned reduced re-esterification to triglycerides, 
and on the other hand as a result of disturbed synthesis of apolipoproteins. 
Such a form of secondary hypo-(3-lipoproteinaemia has been described, for 
example, in congenital intestinal lymphangiectasia (220).
The uptake of chylomicrons in the initial lacteals may be impeded in 
coeliac patients, as these lymphatics are often deformed. Normal lymph 
drainage can be impossible due to congestion in the lymphatics (section
6.5).
It is finally to be noted that, apart from malabsorption, increased faecal 
loss of endogenous fat can be partly responsible for deficiency of fat and 
fat-like substances. These endogenous lipids originate partly from bile and 
from the enteric plasma loss, but most of them enter the intestinal lumen via 
the increased exfoliation of enterocytes (169).
Disturbances in fat absorption are likely to entail malabsorption of 
cholesterol and fat-soluble vitamins. In coeliac patients, the absorption of 
vitamin A (449), vitamin D (841), vitamin E (542) and vitamin K (774) is 
indeed often decreased. Consequently one might expect the serum concen- 
trations of these vitamins to be decreased in coeliac sprue. The serum vitamin 
concsntrations in our untreated coeliacs, however, were more often normal
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than could be expected on the basis of the fat absorption coëfficiënt (figs. 
7.12 and 7.16). Most other investigators, listed by Kasper et al. (461), also 
had unsatisfactory experiences with vitamin A as parameter of fat absorption. 
The serum carotene concentration is reportedly a more reliable parameter, 
perhaps because the human organism has no significant reserves of carotene, 
at it has of vitamin A (525). But on the use of carotene determination, too, 
opinions differ (461). The same applies to views on the value of vitamin A 
and carotene tolerance tests (449, 462). Our own experience with the vitamin 
A tolerance test was not so disappointing. In many patients the increment of 
vitamin A concentration was less marked then in Controls (fig. 7.11), while a 
fair degree of correlation with the degree of fat malabsorption was also 
found (fig. 7.12).
The correlation between serum vitamin E concentration and fat absorp­
tion was not evident (fig. 7.14). Several other investigators reported more 
favourably on this correlation (469, 542). The consequences of a decreased 
vitamin E concentration are still questionable, moreover. In some cases 
vitamin E deficiency can manifest itself in ceroid accumulation in the smooth 
müscle cells of the intestinal wall. Because the brown colour of ceroid may be 
faintly visible through the serosa, this situation has been named ‘brown 
bowel syndrome’ (69, 847). Perhaps this ceroid acccumulation is related also 
to disturbances in the motility of the small intestine in coeliac sprue (section 
6.2). A peroral biopsy of the intestinal mucosa does not seem appropriate 
for demonstration of ceroid. In none of our patients was ceroid demonstrable 
in the muscularis mucosae (not even with the aid of fluorescence), although 
the muscular layer of the intestine was sometimes packed with ceroid gra- 
nules (fig. 6.4). A deep rectal biopsy may give more information in this re­
spect (69).
Table 7.5. Incidence of a prolonged prothrombin time in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE
W ITH
PROLONGED
P .T .T .
Benson et al. >  2 secs. above control 30 47
(1964)
Jarnum et al. < 85% 10 80
(1970)
Mann et al. < 50% 14 28
(1970)
Thys et al. <60% 8 25
(1971)
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The amount of circulating vitamin K  can be measured only indirectly, by 
means of coagulation tests such as prothrombin time (PTT) and thrombotest. 
Neither the thrombotest (fig. 7.15) nor the prothrombin time (table 7.5) are 
often ‘spontaneously’ abnormal. This is not very surprising, for vitamin K 
absorption has to be markedly decreased before this becomes manifest in a 
prolonged PTT (773).
After gluten withdrawal usually a marked improvement or even nor- 
malization of fat absorption is seen (fig. 7.17; table 7.6). This improvement
Table 7.6. Incidence of steatorrhoea in treated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE 
W ITH STEA­
TORRHOEA
Buchan et al. >  7 g/24 hrs 19 16
(1962) 
Cooke et al. >  5 g/24 hrs 10 50
(1963)
Shiner >  5 g/24 hrs 17 53
(1963) 
Benson et al. >  5 g/24 hrs 11 36
(1964) 
Bolt et al. >  7 g/24 hrs 12 42
(1964) 
Brooks et al. >  6 g/24 hrs 7 0
(1966) 
Cerf et al. >  5 g/24 hrs 17 71
(1975) 
Modigliani et al. >  6 g/24 hrs 28 43
(1975) 
Own series <  95% absorption 10 40
was also apparent in the serum concentrations of cholesterol (fig. 7.18) and 
the fat-soluble vitamin E and K (fig. 7.20, fig. 7.21). The vitamin A absorp­
tion test showed only sometimes a small improvement (fig. 7.19). This 
indicates that the absorption of vitamin A probably differs from that of 
triglycerides or cholesterol and is influenced by other factors still to be 
identified.
7.4.10 Conclusions
1. The fat absorption coëfficiënt was abnormal in the large majority of un­
treated coeliac patients. The extent of steatorrhoea seemed to depend on 
the severity of the mucosal lesions.
2. The serum concentration of fat-soluble vitamin A proved to be a poor
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parameter of fat absorption. In this respect the serum vitamin E concen- 
tration was superior.
3. The serum cholesterol concentration -  although a poor parameter of fat 
absorption -  was found to be decreased in 59% of the untreated patients.
4. The serum vitamin E and cholesterol concentrations were found to be 
suitable parameters in evaluating the effect of the gluten-free diet.
5. Possible explanations of the fat malabsorption in coeliac sprue are to be 
found in particular in reduction of the mucosal surface area and in ab­
normal functioning of the remaining enterocytes.
6. Additional factors may be relative pancreatic insufficiency, deficiency of 
conjugated bile acids and impaired lymph transport.
7. Apart from malabsorption of exogenous fat, an increased loss of endo- 
genous fat can contribute to the severity of steatorrhoea.
7.5 PROTEIN
7.5.1 Introduction
Many affections of the digestive tract are associated with a decreased serum 
albumin concentration. Hypoalbuminaemia is a common finding in coeliac 
sprue (table 7.7). Some coeliac patients in fact seek medical advice because
Table 7.7. Incidence of hypoalbuminaemia in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE 
W ITH  HYPO­
ALBUMINAEMIA
Buchan et al. < 35 g/1 37 59
(1962) 
Cooke et al. < 41 g/1 47 57
(1963) 
Benson et al. < 38 g/1 30 73
(1964) 
Ross et al. < 35 g/1 42 55
(1966a) 
Jarnum et al. < 37 .7  g/1 10 70
(1970) 
Mann et al. < 38 g/1 19 84
(1970) 
Thys et al. < 30 g/1 8 63
(1971) 
Modigliani et al. < 30 g/1 46 39
(1975) 
Own series < 4 5 .8  g/1 36 86
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of hypoproteinaemic oedema. For these reasons we considered it useful to 
study the incidence of hypoalbuminaemia in our series of coeliac patients, 
and to establish which mechanisms can be held responsible for this decrease 
in serum albumin concentration.
7.5.2 Serum albumin concentration
We determined the serum albumin concentration in each of our 36 un­
treated patients with coeliac sprue. Hypoalbuminaemia was found in 86% 
(fig. 7.22). In patients with less severe lesions in the jejunal biopsy specimen, 
the incidence of hypoalbuminaemia was as high as in those with a flat 
mucosa. Peripheral oedema was observed in all patients with a serum al­
bumin concentration of less than 30 g/1.
Serum  albumin 
( g / l )
■flat convoluted 
mucosa mucosa
Fig. 7.22. Serum albumin in untreated coeliac 
sprue. The serum levels are drawn separately for 
patients with a flat and with a convoluted jejunal 
mucosa. Statistical analysis (Mann-Whitney test) 
revealed no significant difference between both 
groups. Hollow dots represent patients with 
peripheral oedema, and solid dots those without 
oedema. The shaded area represents the range of 
normal values (cf. chapter 12).
7.5.3 Enteric protein loss
The data obtained on the enteric protein loss were presented in section 6.10. 
In a summary of these data, it can be stated that increased protein loss was 
evident in nearly all 30 untreated patients, i.e. in 93%. Comparison o f the
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serum albumin concentration with the extent of enteric protein loss reveals a 
negative correlation between these two variables (fig. 7.23). The range is 
somewhat wide, however; at a protein loss of, for instance, 100 ml plasma 
per day, it was found that the serum albumin concentration could vary from 
25 to 44 g/1.
Serum albumin 
(g /l)
Enteric plasma protein loss (m l/24hrs)
Fig. 7.23. Serum albumin and enteric plasma protein loss. The serum albumin levels of 
untreated coeliac patients are plotted against the corresponding amounts of protein leakage 
calculated from simultaneously conducted enteric protein loss studies. The dotted hori­
zontal line represents the lower limit of normal serum albumin, and the dotted vertical 
line the upper limit of normal enteric protein loss. The straight diagonal line is the calcu­
lated regression line (y =  45.2 — 0.046 x ; r =  —0.72; p <  0.0005).
7.5.4 Albumin synthesis
The rate of albumin synthesis was measured with the aid of 14C-labelled 
carbonate, according to McFarlane (575). This was done by our colleagues 
Yap and Hafkenscheid, as part of their extensive studies in this field (932, 
933,934).
Synthesis was found to be normal in 5 of the 6 untreated coeliacs. De­
creased albumin synthesis was observed in 1 patiënt (table 7.8), in whom the 
serum concentration of the essential amino acid tryptophan was markedly
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reduced. In addition, the serum concentrations of threonine, valine, leucine, 
and phenylalanine were moderately decreased. In 2 patients with normal 
albumin synthesis, however, slightly reduced serum concentrations of some 
essential amino acids were likewise found. The liver function tests were 
slightly abnormal in only 2 patients, including the one with the decreased 
albumin synthesis.
7.5.5 Effect o f  the gluten-free diet
In all patients the serum albumin concentration increased after gluten with­
drawal. In about 50% of the cases the albumin concentration returned to 
normal within 5 months, but in some it took much longer for the hypoalbu- 
minaemia to disappear (fig. 7.24).
Enteric protein loss diminished as a rule rapidly after gluten withdrawal, 
and became normal in 4 out of 8 cases (section 6.10).
Weeks o f diet th e ra p y
Fig. 7.24. Serum albumin and gluten-free diet. Both the extent and the rate of normaliza- 
tion of serum albumin levels on diet therapy in all 28 followed-up patients with hypo- 
albuminaemia (fig. 7.22) are recorded.
7.5.6 Comment
In view of the high incidence of hypoalbuminaemia it seems likely that diges­
tion and absorption of dietary protein are abnormal in many cases of coeliac
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Table 7.8. Serum albumin, enteric protein loss, albumin synthesis rate and serum concentration of e:
PATIËNT SERUM ENTERIC ALBUMIN FRAC- THREO- VALII
ALBUMIN PROTEIN SYNTHESIS TIONAL NINE
(g/D LOSS RATE SYNTHESIS f  t t m o l e / l ) (fimc
(ml plasma/ (g/175 cm/ RATE
24 hrs) 24 hrs) (%/24 hrs)
#  1 33.0 215 20.4 16.6 167 266
#  5 34.0 110 7.0 6.7 75 145
#  20 25.4 360 26.8 45.4 165 172
#  26 44.2 82 29.2 20.2 262 274
#  27 17.7 400 20.7 34.6 28 127
#  30 26.8 330 22.8 28.0 N.D. N.D.
Controls 45.8-55.1 <  30 22.3 ±6.8 16.2±4.2 103-172 189-3
(M ±S.D .) (M ±S.D .)
sprue. This is also indicated by the fact that faecal nitrogen excretion is in­
creased in some coeliac patients, although this increase can of course also 
be due to increased loss of endogenous protein. The faecal nitrogen excre­
tion is less than 2 g per day under normal conditions (291, 701), but in 
coeliac patients can be as high as 4-7 g per day (601). In extreme cases it may 
even exceed the amount of nitrogen in the food (436). Several mechanisms 
can cause this increase of faecal nitrogen and by that a decreased serum 
albumin concentration.
It is conceivable that, owing to decreased endogenous stimulation, the 
pancreas does not always function optimally in coeliac patients. This stimu­
lation is effected via the hormones cholecystokinin and secretin, which are 
both synthesized in the mucosa of the duodenum and the proximal jejunum. 
It is precisely in this region that mucosal lesions are most pronounced in 
coeliac sprue and, theoretically, the production of these hormones can there- 
fore be decreased. In view of the diminished response to exogenous secretin 
observed by some investigators (section 6.6.3), the pancreas itself can also be 
abnormal. Another possibility is that pancreatic trypsinogen, released in the 
intestinal lumen, is insufficiently activated due to deficiency in enterokinase. 
One might presume that enterokinase deficiency develops in coeliac sprue, 
as this catalyser is synthesized in the duodenal mucosa, but this is not, in 
fact, so (506, 925). In any case it should be borne in mind that the pancreas 
normally secretes an enormous surplus of proteolytic enzymes (334), so 
that it is questionable whether decreased endogenous stimulation of pan­
creatic enzyme production would really have repercussions in protein diges- 
tion.
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cids in 6 untreated coeliac patients (cf. chapter 12).
1 ISO-
LEUCINE
s/l) ((xmole/l)
LEUCINE
(fj.mole/1)
PHENYL-
ALANINE
(fxmole/1)
LYSINE
(u.mole/1)
TRYPTO­
PHAN
(umole/l)
SGOT
(u/1)
SGPT
(u/1)
101 168 84 288 40 10 21
58 99 49 173 9 21 10
53 88 38 200 28 12 3
75 147 91 206 64 7 11
60 96 60 99 79 6 11
N.D. N.D. N.D. N.D. N.D. 12 15
49-118 110-213 53-103 150-268 34-68 <  15 <  15
The absorption of entirely or partly digested protein can also be decreased 
in coeliac patients. With the disappearance of villi and brush border, the size 
of the absorptive surface area diminishes. The importance of a sufficiently 
large surface area for protein absorption is demonstrated by the occurrence 
of an increase in faecal nitrogen excretion after extensive intestinal resections 
(85). The remaining enterocytes in coeliac patients have only a low enzyme 
activity, including peptidase activity (224, 231), so that the normal mem- 
brane digestion by peptidases may be disturbed (743). There may be also 
insufficiënt or defective transport carriers present in the brush border mem- 
brane.
Although decreased protein absorption might be theoretically expected in 
all cases of coeliac sprue, the various relevant observations are not unequi- 
vocal. For example, the in-vitro uptake of radioactive amino acids by duo- 
denal biopsy specimens from coeliac patients proved to be less effective than 
that in normal test subjects (102). Perfusion studies of the proximal jejunum 
revealed decreased absorption of methionine (753) and glycine (6, 173) in 
untreated coeliacs. Silk et al. (790), however, observed that glycine absorp­
tion was normal in about 50% of the cases, perhaps (as the investigators 
themselves pointed out) because their patients were suffering from less 
severe forms of coeliac sprue. Absorption of dipeptides such as glycylglycine, 
glycylleucine and glycylalanine, too, was usually not markedly disturbed (6) 
or even normal (790). In view of these data it can therefore be maintained 
that absorption of amino acids and dipeptides is normal in a substantial 
number of coeliac patients. The same seems to apply to some proteins, for 
after consumption of caseiri (704) or albumin (230), a normal or even exag-
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gerated increase of the corresponding serum amino acid levels is by no 
means unusual.
In addition to exogenous dietary protein, the small intestine also has to 
cope with an amount of endogenous protein. Normally, this endogenous 
supply (which consists of a small amount of extracellular protein leaked into 
the intestinal lumen, digestive enzymes and exfoliated enterocytes) is 
probably not much larger than half the amount of protein in the food (377). 
In patients with coeliac sprue, the amount of endogenous protein released in 
the intestinal lumen is usually much larger. On one hand, enteric protein 
loss has significantly increased (section 6.10), and on the other hand the 
number of exfoliated enterocytes is markedly increased in coeliac sprue 
(section 6.9). In view of the fact that faecal nitrogen excretion is frequently 
increased, the total amount of exogenous as well as endogenous protein to 
be digested and absorbed in the small intestine can exceed the capacity of 
this diseased bowel in coeliac patients.
Protein not absorbed in the small intestine can be degraded by bacteria in 
the large intestine and, partly, excreted in the faeces in the form of nitrogen 
containing degradation products. In patients with an abnormal bacterial 
flora in the small intestine, bacterial degradation of protein or amino acids 
can occur in this part of the intestine as well. A large proportion of these 
bacterial degradation products is absorbed in the small intestine (648). A 
well-known bacterial protein degradation product is indole, which is derived 
from tryptophan. After conversion in the liver, this substance is excreted in 
the urine as indican. Beside indican many other bacterial protein degrada­
tion products occur in the urine (371, 595). It is to be borne in mind, how­
ever, that increased indican excretion is not necessarily due to an abnormal 
bacterial flora but can also result from an excessive supply of protein to the 
large intestine (e.g. in the case of massive gastrointestinal haemorrhage), 
and perhaps also develops in association with severely disturbed protein 
absorption as may occur in coeliac sprue. About 50% of our untreated 
coeliacs showed increased urinary indican excretion as well as other sym­
ptoms of an abnormal bacterial flora in the small intestine (section 6.11). 
This abnormal flora can consume or degrade some of the protein in the 
intestinal lumen, thus precluding its absorption and further utilization.
As a result of malabsorption and increased bacterial degradation of 
amino acids and oligopeptides, an insufficiënt amount of amino acids may 
end up in the portal circulation. In several of our coeliac patients the serum 
concentrations of some essential amino acids were indeed decreased. 
Although this need not reflect the amino acid levels in the portal blood, it is 
possible that in these patients the liver was insufficiently supplied with
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amino acids, and that this affected protein synthesis. In one of our patients, 
albumin synthesis was markedly decreased (table 7.8), and in this patiënt 
the serum concentrations of several essential amino acids, specifically tryp- 
tophan, were decreased. In none of the other patients was so low a tryp- 
tophan concentration found. It therefore seems plausible that a deficiency in 
tryptophan -  which is known to stimulate albumin synthesis (728, 934) -  
influenced the rate of synthesis in this case. Albumin synthesis was found to 
be normal in the other fïve coeliac patients. In view of their hypoalbumin- 
aemia, however, a substantially increased synthesis would have been expected 
in these patients. For the liver as a rule adjusts albumin synthesis to its loss, 
which can be compensated as long as the maximal rate of synthesis, which is 
about twice the normal synthesis, isfnot exceeded (730). Perhaps the ab­
sence of a compensatory increase in albumin synthesis by the liver in the 
remaining patients does indicate a relative deficiency in the amino acids. 
This probably constitutes an important mechanism responsible for hypoal- 
buminaemia in coeliac sprue.
According to some authors, the supply of amino acids to the liver for 
protein synthesis is reduced chiefly as a result of the reduced intake of 
dietary protein due to anorexia (689, 790). This hypothesis does not seem 
very plausible, because the regularly increased faecal nitrogen excretion 
seems to indicate that more protein is supplied for absorption than the 
small intestine can cope with.
7.5.7 Conclusions
1. A decreased serum albumin concentration is found in the majority of 
untreated patients with coeliac sprue.
2. In absolute sense, the rate of albumin synthesis is normal in most pa­
tients, and decreased only in exceptional cases. An increase in albumin 
synthesis, however, expected in view of the hypoalbuminaemia, is seldom 
found.
3. This may be explained by a relative deficiency in necessary amino acids, 
as a result of malabsorption and bacterial degradation of protein in the 
small intestine.
4. The protein malabsorption frequently -  but by no means always -  ob­
served in coeliac sprue, is probably not a result of reduced proteolysis by 
digestive enzymes, but more likely of a decreased absorptive surface 
area and enterocyte abnormalities.
5. The demands made on the absorptive capacity of the small intestine are
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greater in coeliac patients as a result of the marked increase in released 
endogenous protein. This endogenous protein largely originates from 
enteric protein loss and increased exfoliation of enterocytes.
6. Some of the protein in the small intestine may be degraded by an ab­
normal bacterial flora and converted to products which often cannot be 
further utilized.
7. After gluten withdrawal the serum albumin concentration increased in 
all patients, and in some 50% even reached a normal level within 5 
months. The serum albumin concentration therefore seems to be a 
simple and reliable parameter in studying the effect of diet therapy.
7.6 CALCIUM
7.6.1 Introduction
It is a well-known empirical fact that the plasma calcium concentration is 
decreased in many coeliac patients (table 7.9). Clinical symptoms also 
suggest calcium deficiency; tetany and bone pain are regularly observed 
(table 8.1; 60, 87, 113, 553, 723). The incidence of disorders of calcium
Table 7.9. Incidence of hypocalcaemia in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE 
W ITH HYPO­
CALCAEMIA
Buchan et al. < 4 .5  meq/1 35 60
(1962) 
Cooke et al. <  9.2 mg% 44 64
(1963) 
Benson et al. <  9.0 mg% 30 67
(1964) 
Ross et al. <  9.0 mg% 35 57
(1966a) 
Brooks et al. not stated 11 63
(1966) 
Harrison et al. <  8.9 mg% 5 80
(1969) 
Mann et al. <  8.8 mg% 20 65
(1970) 
Melvin et al. <  4.5 meq/1 9 44
(1970) 
Thys et al. <  8 mg% 9 56
(1971) 
Modigliani et al. <  8.5 mg% 46 81
(1975)
Own series <  2.35 mmole/1 35 63
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raetabolism was investigated in our patients. In addition to the results 
of these investigations, the factors which influence calcium balance in 
coeliac sprue are discussed.
7.6.2 Plasma calcium concentration
The plasma calcium concentration was determined in 35 untreated coeliac 
patients. Since the majority also showed more or less marked hypoalbumin- 
aemia, the calcium values obtained were corrected for the existing plasma 
protein concentration (657). After this correction, 22 of the 35 patients 
(63%) proved to show a real decrease in plasma calcium concentration 
(fig. 7.25). Marked hypocalcaemia was observed only in patients with a
Plasma calcium
(m m o le / l)  (m g 7»)
mucosa mucosa normal values (c f. chapter 12).
flat mucosa in the jejunal biopsy specimen. Decreased calcium concentra- 
tions were also found, however, in patients with less severe mucosal lesions. 
No correlation could be established between the severity of hypocalcaemia 
and the degree of steatorrhoea or the volume of enteric protein leakage.
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Table 7.10. Relevant data on calcium and bone metabolism in 11 untreated coeliac patients.
PATIËNT #  1 #  2 #  5 #  10 #  13 #  20 #  27 # 2 8 #  29 #  30 #  34 CONTROLS
SERUM CALCIUM 
(C O R R .)
1.45 2.10 2.00 2.28 2.44 2.17 1.56 2.36 2.40 2.25 2.33 2.35-2.50
mmole/1
CALCIUM
ABSORPTION
AB-
NORM
AB-
NORM
AB-
NORM
BONE HISTOLOGY*
SERUM ALKALINE 
PHOSPHATASE
MAL
& O P
219
MAL
120
MAL
164
OST
FIBR
177
MAL
153
MAL
194
MAL
326
MAL
163
MAL
65
MAL 
&  OP
96 148 45-90 U /l
HYDROXYPROLINE
EXCRETION
T m /G F R * *
854
1.85
315
0.66
651
0.57 1.55
469 405 351 416 150-400
(imole
0.71-1.36
X-RAY STUDIES NORM AB-
NORM
NORM
AMINO-ACIDURIA NORM AB-
NORM
AB-
NORM
* Meaning of abbreviations: MAL stands for osteomalacia, OP for osteoporosis, and OST FIBR for osteitis fibrosa.
** Tm/GFR means: maximal tubular reabsorption of phosphate related to the glomerular filtration rate.
7.6.3 Calcium absorption
The absorption of a small dose (10 jxCi) of 47Ca was measured in 3 untreated 
patients (fig. 7.26), both by determination of plasma radioactivity during 4 
hours following administration of 47Ca and by determination of 47Ca reten- 
tion with the aid of a whole-body counter during 3 weeks. The latter method 
is thought to show a better correlation with the calcium balance (10, 715). 
Both determinations revealed low calcium absorption in each of the 3 
patients. For the other findings obtained in these 3 patients we refer to 
table 7.10.
Fig. 7.26. Calcium absorption in coeliac sprue. The absorption of 47Ca, measured by de­
termination o f both plasma radio-activity and by whole-body retention, in 3 untreated 
patients is given by hollow symbols. The solid symbols represent the absorption in cor- 
responding patients during treatment with a gluten-free diet and temporary vitamin D  
administration (cf. chapter 12).
7.6.4 Alkaline phosphatase activity
The serum alkaline phosphatase activity was determined in 33 untreated 
patients and found to be increased in 19 (58%); these 19 included patients 
with a flat mucosa as well as with a convoluted mucosa in the jejunal biopsy 
specimen (fig. 7.27). The liver function tests were normal in all patients but
2. In these 2 patients the serum LAP activity (which, like the alkaline phos­
phatase activity, is increased in cholestasis but normal in disorders of bone 
metabolism) was 23 and 40 U /l, respectively (normal value <  28 U /l) .
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Serum alkaline phosphatase
(U/l) (K-AU/I)
Fig. 7.27. Serum alkaline phosphatase in untre­
ated coeliac sprue. The serum levels are drawn 
separately for patients with a flat and with a con­
voluted jejunal mucosa. Statistical analysis 
(Mann-Whitney test) revealed no significant 
difference between both groups. The shaded area 
represents the range of normal values (cf. chapter 
12).
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Fig. 7.28. Urinary hydroxyproline excretion in 
untreated coeliac sprue. The amounts excreted in 
urine are drawn separately for patients with a 
flat and with a convoluted jejunal mucosa. The 
shaded area represents the range of normal values 
(cf. chapter 12).
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The urinary hydroxyproline excretion was determined in 10 untreated 
patients. Expressed as mean of excretions on 2 or 3 consecutive days, the 
excretion was increased in 5 (fig. 7.28).
7.6.6 Histological examination o f  bone tissue
In 11 untreated coeliacs a bone biopsy specimen was obtained for histolog­
ical examination. Five patients showed clinical symptoms suggestive of 
osteomalacia, such as pain in the bones, a waddling gait or a non-healing 
fracture. In all cases histological evidence of disturbed mineralization was 
found. Osteomalacia was diagnosed in 10 patients, and osteitis fibrosa in 
one. The biopsy specimens from 2 patients showed distinct signs of osteopo- 
rosis. For the other observations in these cases we refer to table 7.10.
7.6.7 Two-hour phosphate clearance
In 4 patients the tubular reabsorption of phosphate was determined during 
a two-hour phosphate clearance test, in an effort to exclude or demonstrate 
hyperparathyroidism. An abnormally low phosphate clearance was found in 
2 patients, one of whom also showed histological features of hyperparathy­
roidism in the bone biopsy specimen (table 7.10).
7.6.8 Radiographs o f the hand skeleton
In one patiënt with marked hypocalcaemia, radiographs of the hands revealed 
unmistakable subperiosteal erosions. In 2 other patients, o f whom only one 
had a slightly decreased plasma calcium concentration, no erosions were visi- 
ble (table 7.10).
7.6.9 Amino-aciduria study
An abnormally high urinary excretion of some amino acids was found in 2 
out of 3 patients; the amino acids in question were glycine and lysine in the 
one, and glycine, threonine, serine, alanine and tyrosine in the other. One of 
these patients also showed subperiosteal erosions in the hand skeleton 
(table 7.10).
7.6.10 Effect o f  the gluten-free diet 
After gluten withdrawal, the plasma calcium concentration rose to a normal
7.6.5 Hydroxyproline excretion
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level in all patients, usually within 6 months (fig. 7.29). In order to exclude 
the influence of persistent hypoproteinaemia, the calcium concentration 
was always corrected for the protein concentration (657). Administration or 
withholding of vitamin D caused no marked difference in the rate of nor- 
malization of the calcium concentration.
Weeks o1 diet the rap y
Fig. 7.29. Plasma calcium and gluten-free diet. Both the extent and the rate of normaliza- 
tion of plasma calcium levels on diet therapy in all 19 followed-up patients with hypo­
calcaemia (fig. 7.25) are recorded.
Calcium absorption and retention also improved after gluten withdrawal 
(fig. 7.26). In 2 patients, markedly increased calcium absorption was ob­
served 56 and 72 weeks after gluten withdrawal, respectively. In these 
patients vitamin D suppletion had been discontinued more than 6 months 
earlier.
The serum alkaline phosphatase activity decreased to a normal value in 
73% of the patients. The rate of normalization of alkaline phosphatase 
activity did not seem to depend on administration or withholding of vitamin 
D (fig. 7.30).
The urinary hydroxyproline excretion also decreased after gluten with­
drawal and became normal in 3 out of 4 cases (fig. 7.31).
In 9 patients the bone biopsy was repeated after 20-80 months (mean: 36 
months) on the gluten-free diet. Most of these patients had received vitamin 
D suppletion for a limited period. In all cases but one, histological examina­
tion of bone tissue revealed a markedly improved degree of mineralization.
150
Serum  alkaline phosphatase
( U / I )  ( K - A U / I )
w ith o u t w ith  
g lu te n - fre e  d ie t
3 5 0 -
3 0 0 -
2 5 0 -
2 0 0 -
15 0 -
1 0 0 -
50
0
Fig. 7.30. Serum alkaline phosphatase and gluten- 
free diet. The serum levels in corresponding 
patients before as well as during diet therapy are 
given. Statistical analysis (Wilcoxon signed-rank 
test) revealed a significant improvement on diet 
therapy (p <  1%). The solid dots represent pa­
tients who received additional vitamin D  therapy. 
The shaded area represents the range of normal 
values (cf. chapter 12).
M onths o f d iet the rap y
Fig. 7.31. Urinary hydroxy- 
proline excretion and gluten- 
free diet. The amounts ex­
creted by corresponding pa­
tients before as well as dur­
ing diet therapy are given. 
The solid dots represent 
patients who received addi­
tional vitamin D  therapy. 
The shaded area represents 
the range of normal values 
(cf. chapter 12).
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In a total of 5 patients the bone tissue had returned to complete normality, 
and in 4 other biopsy specimens a slight increase in osteoid was still discern- 
ible.
The amino-aciduria observed in 2 patients, disappeared 2-3 months after 
gluten withdrawal.
7.6.11 Comment
In nearly all untreated coeliac patients, the calcium balance proves to be 
negative. This is undoubtedly due to faecal calcium loss, for the urinary 
calcium excretion is extremely low, as can be expected in calcium deüciency 
(367, 589, 693).
In view of the increased faecal calcium loss, absorption of calcium from 
the food can be expected to be markedly disturbed in coeliac sprue. This 
could be a result especially of the structural abnormalities in the mucosa of 
the proximal small intestine, where calcium absorption is probably most 
important under normal conditions (906). Other phenomena can also explain 
calcium malabsorption, such as the binding of calcium ions to fatty acids 
(11) or a markedly accelerated passage through the small intestine (411). 
Another important factor can be the vitamin D deüciency observed in many 
cases (589, 841), as a result of which active transport of calcium by the in­
testinal mucosa is reduced.
In spite of the above mentioned disturbing factors, calcium absorption 
proves to be normal in some coeliacs, regardless of whether it is determined 
on the basis of plasma radioactivity or whole-body counting after a small 
(10) or a large dose of radioactive calcium (433). Several other investigators, 
however, regularly found diminished absorption of radioactive calcium, 
both from a single test dose (693), a meal (11), and from milk (71, 853). 
Wensel et al. (906) also found an abnormally low calcium absorption upon 
perfusion of the proximal jejunum. In our opinion it can be maintained that 
calcium absorption is reduced in coeliac sprue, as the ‘normal’ absorption 
found in some patients actually means a decreased absorption if one ac­
counts for the pronounced calcium deüciency in these patients. This theory 
is supported by the marked improvement in calcium absorption observed 
after gluten withdrawal (fig. 7.26; 411,433, 589).
As mentioned, the faecal calcium loss is considerable (367, 589, 693), and 
sometimes even exceeds the amount of calcium contained in the patient’s 
food (589). Particularly if we bear in mind that absorption of orally ad- 
ministered calcium is often quite fair, this means that a substantial part of 
this faecal calcium must involve endogenous loss. This also explains why the 
amount of faecal calcium shows no correlation with the oral calcium intake
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(589). Several investigators have measured this endogenous calcium loss by 
determination of radioactivity in the faeces after intravenous administration 
of calcium isotope. Endogenous calcium loss was usually markedly in­
creased, up to 2-3 times the normal amount (367, 589, 693). Since a consider- 
able part of the endogenous calcium is probably reabsorbed at a more distal 
level in the small intestine, the amount of calcium which primarily enters the 
intestinal lumen must be substantially higher. It is impossible to estimate 
even approximately the total amount of this primarily secreted, so-called 
digestive juice calcium (411). Moreover, it is not quite clear how and where 
the endogenous calcium is released. This can take place via pancreatic 
juice and bile (103), but also via leakage of tissue fluid from the intestinal 
wall into the lumen. Yet this is not sufficiënt to explain the enormous endo­
genous calcium loss found in coeliac patients. We must therefore assume that 
substantial secretion of calcium from the intestinal epithelium takes place 
(411, 589), although this has not been confirmed in perfusion studies (906).
Calcium absorption is known to adjust itself to human calcium require­
ments. Vitamin D is held responsible for this adjustment (section 5.6). This 
vitamin probably determines whether or not extra calcium is absorbed in 
the distal part of the small intestine, which in principle has the ability to do 
so. In spite of the calcium hunger due to the constantly negative balance, 
compensatory hyperabsorption of calcium in the distal small intestine does 
not seem to occur in coeliac patients. If  this compensatory absorption is 
indeed determined by vitamin D, then there is every reason for non-absorp- 
tion in the ileum, for the serum vitamin D concentration is usually decreased 
(589) as a result of vitamin D malabsorption (841). After parenteral ad­
ministration o f vitamin D, calcium absorption (11) and calcium balance 
(641) improve, and osteomalacia disappears (589, 693). In some cases, how­
ever, large doses of vitamin D are required to produce any effect, suggesting 
the existence of a partial vitamin D resistance in coeliac sprue (615). The 
latter may result from a decreased effect of vitamin D on the damaged 
intestinal mucosa (693).
As a result of the negative calcium balance, the serum calcium concentra­
tion tends to decrease. A decreased plasma calcium concentration is often 
found in untreated coeliac patients. We observed hypocalcaemia in 63% of 
our patients (fig. 7.25), which agrees with reports by other investigators 
(table 7.9). Secondary hyperparathyroidism can develop in response to this 
decreased plasma calcium concentration (117, 367, 589). In 4 patients we 
found evidence of hyperparathyroidism, such as osteitis fibrosa, sub- 
periosteal erosions, decreased tubular reabsorption of phosphate or para- 
thyreoid hyperplasia. Disorders of renal tubular function may develop as a
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result of this hyperparathyroidism (535, 617). We observed transient amino- 
aciduria in 2 coeliac patients, one of whom was suffering from proven 
hyperparathyroidism. Amino-aciduria in coeliac sprue has also been re­
ported by others (355,488).
Another consequence of the negative calcium balance is intensified mobil- 
ization of calcium from bone tissue, which in the long run leads to osteopor- 
osis. However, osteoporosis is not very often observed in coeliac sprue. We 
found histological features of osteoporosis in only 2 of 11 patients in whom a 
bone biopsy was performed. Ross et al. (723) and Melvin et al. (589) like- 
wise reported that osteoporosis was rare in their patients. On the basis of 
radiographs the incidence of osteoporosis is sometimes estimated higher 
(163), but proper differentiation between osteoporosis and osteomalacia is 
impossible on the basis of radiographs.
Osteomalacia as a result of vitamin D deficiency is a regular finding. We 
found signs of marked osteomalacia in virtually all biopsy specimens from 
untreated coeliacs; this is in agreement with findings reported by others 
(589). The presence of osteomalacia is usually indicated by increased serum 
alkaline phosphatase activity and raised urinary excretion of hydroxypro- 
lines (table 7.10). Increased serum alkaline phosphatase activity was found 
in 58% of our patients, which lies in between the percentages reported by 
others (table 7.11). However, for correct interpretation of increased al­
kaline phosphatase activity, liver abnormalities always have to be excluded. 
In several publications exclusion of liver pathology has not been mentioned 
explicitly.
The iso-enzyme originating from the intestine has been found unimpor- 
tant in contributing to an increase in serum alkaline phosphatase activity 
(366). A striking finding was that several patients with proven osteomalacia 
showed normal alkaline phosphatase activity (table 7.10), which was also 
noted by others (589). The question is whether determination of urinary 
hydroxyproline excretion does not supply a more sensitive parameter 
(table 7.10; 589).
Vitamin D absorption improves soon after gluten withdrawal (589, 841), 
resulting in an increased calcium absorption. The mucosal lesions in the 
proximal small intestine also ameliorate, as a result of which absorption in- 
creases on the one hand, and endogenous calcium loss diminishes on the 
other (589). In 2 patients on a gluten-free diet who were temporarily given 
vitamin D suppletion, we did observe increased absorption of calcium 
(fig. 7.26). According to other investigators (411, 433), this increase can also 
occur without vitamin D suppletion. The improved calcium absorption 
causes the calcium balance to become positive (589). As a consequence the
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Table 7.11. Incidence of an increased serum alkaline phosphatase level in untreated coeliac 
sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE 
WITH-INCREASED 
ALK. PHOSPH.
Cookeetal. >  12 KAU/1* 49 67
(1963)
Ross et al. >  4BU/1** 25 44
(1966b)
Mortimer et al. >  12 KAU/1 8 0
(1968)
Harris et al. >  13 KAU/1 111 62
(1969)
Harrison et al. >  50 U/l*** 5 100
(1969)
Jarnum et al. >  39 U/l 10 80
(1970)
Melvin et al. >  13 KAU/1 9 22
(1970)
Modigliani et al.. >  50 U /l 42 60
(1975)
Own series >  90 U/l 33 58
* KAU =  King Armstrong Units 
** BU =  Bodanski Units 
*** U  =  Bessey Units
plasma calcium concentration normalizes (fig. 7.29; 60, 104, 160), and the 
secondary hyperparathyroidism disappears. Newly formed bone tissue 
is normally mineralized again and the osteoporosis disappears once the 
calcium deficiency is corrected, which in some cases may take years (411). 
After an average of at least 2 years on a gluten-free diet, we no longer found 
significant abnormalities in bone biopsy specimens; this is in agreement 
with the findings of other investigators (589, 693). Parallel to this develop- 
ment, serum alkaline phosphatase activity as well as urinary hydroxy­
proline excretion decreased (fig. 7.30; fig. 7.31).
7.6.12 Conclusions
1. If the existing calcium deficiency is taken into account, the absorption of 
a single dose of calcium tracer is usually decreased in untreated coeliac 
patients.
2. Active transport of calcium in the jejunum and ileum will be diminished 
due to vitamin D deficiency.
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3. Nearly all untreated coeliac patients show a considerable faecal calcium 
loss, which is partly the result of an increased endogenous loss.
4. Due to a negative calcium balance, calcium from bone tissue will be 
mobilized, which leads to osteoporosis in the long run.
5. Secondary hyperparathyroidism with bone abnormalities and renal func- 
tional disorders can develop as a result of a decreased plasma calcium 
concentration.
6. The bone tissue, moreover, nearly always shows signs of insufficiënt 
mineralization as a result of the vitamin D deficiency. The true incidence 
of osteomalacia in coeliac sprue can only be determined by systematic 
bone biopsies.
7. Less complicated methods of tracing osteomalacia are determination of 
serum alkaline phosphatase activity and urinary hydroxyproline excre­
tion. False negative results, however, are not uncommon.
8. After gluten withdrawal, most abnormalities quickly disappear as a 
result of improved absorption of vitamin D, and consequently of calcium 
as well, in addition to decreased endogenous calcium loss. The deficien- 
cies and abnormalities of bone tissue, however, need more time to 
disappear completely.
7.7 MAGNESIUM
7.7.1 Introduction
Magnesium deficiency is thought to be regularly associated with calcium 
deficiency (525). Perhaps the reverse is also true. Hypocalcaemia is fre- 
quently observed in untreated coeliac patients (fig. 7.25, table 7.9), but hypo- 
magnesaemia has not been frequently described (43). However, few investi­
gators have systematically determined the serum magnesium concentration 
in their patients (601, 618, 693). We therefore considered it useful to study 
the incidence of hypomagnesaemia in our patients and to establish whether 
the plasma calcium concentration was indeed also decreased in them. The 
possible cause of magnesium deficiency will also be discussed in the follow- 
ing section.
7.7.2 Serum magnesium concentration
The serum magnesium concentration was determined in 16 untreated 
coeliacs, and found to be decreased in 4, all with a flat jejunal mucosa 
(fig. 7.32). All patients with hypomagnesaemia were in a poor clinical condi- 
tion. There was a fair correlation between serum magnesium concentra-
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Serum magnesium 
(m m ole/1)
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0.8  -
0.7
0.6  -
0 .5
0 .4
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Fig. 7.32. Serum magnesium in untreated coeliac 
sprue. The serum levels are drawn separately for 
0 8 patients with a flat and with a convoluted jejunal 
mucosa. The shaded area represents the range of 
normal values (cf. chapter 12).
tion and fat absorption (fig. 7.33). In 3 of the 4 patients with hypomagne- 
saemia, the plasma calcium concentration was decreased. However, the 
calcium concentration was decreased also in 9 of the 12 patients with a 
normal serum magnesium concentration. None of the patients with hypo- 
magnesaemia showed symptoms of tetany.
7.7.3 Effect o f  the gluten-free diet
The serum magnesium concentration always increased to a normal value 
after gluten withdrawal (fig. 7.34). In 2 patients with hypomagnesaemia the 
elfect of diet therapy on serum magnesium was evaluated only after 1 year or 
more. In the other 2 cases the hypomagnesaemia was normalized after 2 and 
9 weeks.
7.7.4 Comment
The serum magnesium concentration is decreased in a few patients with 
coeliac sprue (fig. 7.32; 601, 693). These are usually patients in poor condi- 
tion, as has been noted before in patients with idiopathic steatorrhoea, many
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Serum magnesium 
(mmole/l) (m eq/l)
Fat absorption (%)
Fig. 7.33. Serum magnesium and fat absorption. The serum magnesium levels o f un­
treated coeliac patients are plotted against the corresponding absorption coefficients of 
simultaneously conducted fat balance studies. The dotted horizontal line represents the 
lower limit of normal serum magnesium levels, and the dotted vertical line the lower limit 
of normal fat absorption. The straight diagonal line is the calculated regression line (y =  
0.61 +  0.0034x ;r =  0.48; 2.5% < p <  5%).
of whom must have suffered from coeliac sprue (87). We observed no clinical 
symptoms of magnesium deficience, such as tetany.
The hypomagnesaemia is probably partly caused by malabsorption of diet- 
ary magnesium. In this malabsorption, an important role may be played by 
unabsorbed fatty acids, which bind the magnesium ions to poorly soluble 
soaps. This probably explains the correlation between serum magnesium 
concentration and fat absorption (fig. 7.33). I t is further supported by the 
observation of Booth et al. (87) who noticed an improvement of the mag­
nesium balance in their patients with idiopathic steatorrhoea after intro- 
duction of a fat-restricted diet.
Magnesium absorption in the small intestine is supposedly very slow (330). 
It is therefore readily conceivable that a shortened intestinal transit time, 
present in many coeliac patients, exerts a negative influence on this absorp­
tion.
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Serum magnesium 
(m m o le /l) (m e q / l)
Fig. 7.34. Serum magnesium and gluten-free diet. 
The serum levels in corresponding patients before 
as well as during diet therapy are given. Statistical 
analysis (Wilcoxon signed-rank test) did not reveal 
a significant improvement on diet therapy. The 
shaded area represents the range of normal values 
(cf. chapter 12).
Moreover, there is probably an increased loss of magnesium which origin- 
ates from the digestive juices and the increased number of exfoliated cells. 
Due to this endogenous loss, the total amount of magnesium found in the 
faeces can be markedly increased, up to a few times the total amount o f the 
oral intake in some cases (317).
Too little is known about magnesium absorption under normal condi- 
tions, to explain the mechanisms underlying the abnormal absorption in 
coeliac sprue.
The faecal magnesium loss returns to normal within a few months of 
gluten withdrawal (317). The serum magnesium concentration, too, in- 
creases relatively rapidly in treated patients.
7.7.5 Conclusions
1. Although there is no clinical evidence of magnesium deficiency, some 
patients with coeliac sprue nevertheless show hypomagnesaemia.
2. The negative magnesium balance is caused by an abnormally large faecal 
magnesium loss.
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3. Beside poor absorption of dietary magnesium, increased loss of endogen­
ous magnesium contributes to the large faecal magnesium loss.
4. The degree of fat malabsorption seems to influence magnesium absorp­
tion, probably because unabsorbed fatty acids bind the magnesium ions 
to poorly soluble soaps.
7 .8  HAEMATOPOIETIC FACTORS 
7.8.1 Iron
7.8.1.1 Introduction 
Anaemia is acommonfinding in coeliac patients (table 7.12). Gee’sclassical 
description (305) already makes mention of ‘cachexia, a fault of sanguifica- 
tion, betokened by pallor and tendency to dropsy’ as a constant symptom. 
This anemia can be hypochromic or megaloblastic. In more than 50% of 
cases, the same blood smear shows evidence of iron deficiency as well as of 
folie acid deficiency -  a so-called dimorphous picture (405). We studied the
Table 7.12. Incidence of anaemia in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF '  PERCENTAGE
PATIENTS W ITH
INVESTIGATED ANAEMIA
39 64
50 40
31 55
not stated 43
9 44
10 60
9 33
75 88
47 90J 37 54
47 55
^36 75
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Buchan et al. < 12g%
(1962)
Cooke et al. <  11.5 g%
(1963)
Benson et al. < 14 g%
(1964)
Ross et al. < 12g%
(1966a)
Mortimer et al. < 12 g%
(1968)
Jarnum et al. < 11 g%
(1970)
Thys et al. < 12 g%
(1971)
Hofifbrand < 11.58% (?)
(1974) < 13.5 g% (<?)
Cerf et al. < 12 g% (9)
(1975) < 13 g% (<?)
Modigliani et al. < 12 g%
(1975)
Own series < 7.9 mmole/1 (?)
<  8.7 mmole/1 (cj)
incidence of anaemia in the untreated patients o f our series and attempted to 
analyse the nature of this anaemia as well as the cause of the deficiency in 
iron, folie acid or vitamin B12.
7.8.1.2 Haemoglobin concentration 
Anaemia was found in 78% of the total of 36 patients with untreated 
coeliac sprue, of whom 14 had recently received anti-anaemic therapy 
(fig. 7.35). Only two of these for anaemia treated patients had a normal 
haemoglobin concentration. A decreased haemoglobin concentration was as 
frequent in patients with severe as in those with less pronounced villous ab­
normalities in the jejunal biopsy specimen. A striking finding was the discrep- 
ancy between men and women; anaemia was present in virtually the men, 
but only in two-thirds of the women. In men, moreover, the degree of 
anaemia depended on the severity of the mucosal lesions.
Haemoglobin Haem oglobin
(m m o le /l)  (g%) (m m o le / l)  (g%>)
Females Males
f la t convoluted f la t  convoluted
mucosa mucosa mucosa mucosa
Fig. 7.35. Haemoglobin in untreated coeliac sprue. The haemoglobin concentrations are 
drawn separately for females and males, and for patients with a flat and with a convoluted 
jejunal mucosa. Statistical analysis (Mann-Whitney test) revealed no significant difference 
between both female groups, whereas in males a significant difference was found (p <  5%). 
The shaded area represents the range of normal values (cf. chapter 12).
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7.8.1.3 Bone marrow study
In 21 patients, a sternal puncture was performed. In 9 cases the bone 
marrow showed megaloblastic characteristics, which in 5 cases were accomp- 
anied by signs of iron deficiency. In 5 of these 9 patients the serum folate con­
centration was determined, and found decreased in all; the serum vitamin 
B12 concentration was decreased in 2 of the 3 patients in whom it was 
determined. In the remaining 12 sternal punctates, evidence of iron defi­
ciency was present in 3; 9 marrow smears were normal in all respects, al- 
though hypofolaemia was present in all patients and 2 out of 5 had a low 
serum vitamin B12.
7.8.1.4 Serum iron concentration
The serum iron concentration was determined in 27 patients who had not 
previously received iron suppletion. It was found to be decreased in 41%. 
In patients with severe jejunal mucosal abnormalities, the serum iron con­
centration was disturbed more frequently as well as more markedly (fig. 
7.36). In 2 out of 11 patients with a decreased serum iron concentration, the 
total iron-binding capacity was increased.
Serum iron
C/Jmole/I) (jug7o)
Fig. 7.36. Serum iron in untreated coeliac sprue. 
The serum levels are drawn separately for patients 
with a flat and with a convoluted jejunal mucosa. 
Statistical analysis (Mann-Whitney test) revealed 
no significant difference between both groups. 
The shaded area represents the range of normal 
values (cf. chapter 12).
■ 40
f la t convoluted 
mucosa mucosa
162
7.8.1.5 Iron absorption 
In 3 untreated coeliacs the iron absorption was measured with the aid of a 
whole-body counter after administration of a solution containing 58Fe- 
labelled ferrous salt. The absorption was markedly decreased in 2 patients 
with an iron deficiency, and normal in 1 case without iron deficiency (table 
7.13).
Table 7.13. Absorption of inorganic 59Fe-ferrous iron in 4 coeliac patients.
PATIËNT HAEMO­
GLOBIN
( m m o l e / 1 )
SERUM
IRON
( f m i o l e / 1 )
TOTAL 
IRON 
BINDING 
CAPACITY 
( ( j .m o le /1 )
WHOLE
BODY
RETENTION 
OF 6 ,Fe 
( %  o f  d o s e )
WEEKS
ON
GLUTEN-
FREE
DIET
#  9 4.9 1.4 78 N.D. 0
6.2 5.4 69 84.0 2
#  10 7.5 1.4 79 1.4 0
9.6 N.D. N.D. 64.8 24
#  29 8.3 20.8 66 36.5 0
#  32 7.3 7.4 100 29.0 0
7.0 N.D. N.D. 94.6 6
Controls (?) 7.9-9.8 
(<?) 8.7-10.9
8.9-24.7 50-85 >  50%
7.8.1.6 Effect of the gluten-free diet
The haemoglobin concentration increased in all patients after gluten 
withdrawal. Patients with severe anaemia generally also received iron, folie 
acid or vitamin B12 supplements, but even without suppletion the haemo­
globin level rose (fig. 7.37).
The serum iron concentration also increased in the majority of patients. 
In 4 of the only 7 patients with iron deficiency, who received no iron supple­
ments, a normal serum iron concentration was found after gluten with­
drawal. In the 3 remaining cases the serum iron concentration showed no 
or hardly any increase, which was probably due to other causes.
In 3 patients, iron absorption was again determined after gluten with­
drawal. It was found increased in all, including those whose absorption had 
previously impressed as being normal. As table 7.13 shows, iron absorption 
can sometimes improve very quickly.
7.8.1.7 Comment
Iron absorption in coeliac sprue has been studied by several investigators. 
The published data on this subject are rather variable, however. Badenoch
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Haemoglobin Haemoglobin
(m m ole /1 ) (g°/0) (m m ole/1 ) (g7o)
Females Males
Fig. 7.37. Haemoglobin and gluten-free diet. The haemoglobin concentrations in corre- 
sponding patients before as well as during diet therapy are given. Statistical analysis 
(Wilcoxon signed-rank test) revealed a significant improvement on diet therapy (p <  1%). 
The solid dots represent patients who received additional anti-anaemic therapy. The 
shaded area represents the range of normal values (cf. chapter 12).
et al. (34) found decreased 69Fe absorption in all untreated patients with 
idiopathic steatorrhoea examined, regardless of whether they were or were 
not suffering from iron deficiency. The severity of the steatorrhoea, so far as 
predictable on the basis of the degree of diarrhoea, did not seem to make any 
difference either. According to Webb et al. (897), however, iron absorption 
is remarkably often normal in untreated coeliacs. Cooke (163) also regularly 
found normal absorption. A difiiculty in the interpretation of these discre- 
pant findings is that the presence or absence of (latent) iron deficiency is 
seldom explicitly mentioned, which is indispensable for correct evaluation 
of iron absorption (372).
It is an obvious assumption that iron absorption is disturbed specifically 
as a result of pathological changes in the epithelium of the proximal in­
testinal mucosa. The intraluminal phase of absorption is probably normal,
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although undegraded and unabsorbed food can influence iron solubility. 
These epithelial changes imply that, on the one hand, the absorptive sur­
face is reduced (with the disappearance of villi and microvilli), while on the 
other hand the remaining enterocytes may be deficient in carriers for tran­
sport over the cell membrane. Intracellular iron transport as well as transfer 
to transferrin can be disturbed, moreover.
Coeliac patients are probably subject to an increased endogenous iron 
loss as well. This loss seems to be largely caused by increased exfoliation of 
enterocytes; a minor role can be played by increased enteric plasma leakage 
(179, 830).
As a result of reduced absorption and increased loss of iron, a deficiency 
develops. This is indicated by the decreased serum iron concentration in 
41% of our patients. Other investigators have also regularly found low 
serum iron concentrations in coeliac sprue (table 7.14).
Table 7.14. Incidence of a low serum iron concentration in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF 
PATIENTS 
INVESTIG ATED
PERCENTAGE 
W ITH  LOW  
SERUM IRON
Cookeetal. <  40 ng% 50 52
(1963)
Benson et al. <  70 (xg% 9 33
(1964)
Ross et al. <  70 |ig% 42 24
(1966a)
Thys et al. <  60 (J.g% 9 67
(1971)
Cerf et al. <  50 [ ig / 37 24
(1975)
Modigliani et al. <  80 u.g% 35 83
(1975)
Own series < 8 . 9  mmole/1 27 41
Iron absorption as a rule improves after gluten withdrawal, sometimes 
within a few weeks (table 7.13; 34, 163, 576). The rapid improvement of 
iron absorption is particularly impressive during corticosteroid medication 
(34).
As a result of improved iron absorption and decreased endogenous iron 
loss, the serum iron concentration increases (60) and the anaemia (if not 
due to other deficiencies) disappears (fig. 7.37).
7.8.1.8 Conclusions
1. The low serum iron level, present in many untreated coeliacs, is largely
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due to decreased iron absorption, which fails to adjust itself to the existing 
iron deficiency.
2. The decreased iron absorption is presumably the result of mucosal lesions 
in the small intestine, which above all reduce the absorptive surface.
3. Increased endogenous iron loss via exfoliation of enterocytes and enteric 
leakage of extracellular fiuid can aggravate the iron deficiency.
4. Iron absorption improves after gluten withdrawal and the endogenous 
iron loss normalizes. As a consequence the iron concentration in serum 
increases.
7.8.2 Vitamin B 12
7.8.2.1 Introduction 
Megaloblastic anaemia is not uncommon in untreated coeliacs. It seemed
of importance, therefore, to determine the serum vitamin B12 concentration.
In addition the Schilling test was performed, as vitamin B12 absorption is
reported to be often abnormal in coeliac sprue (table 7.15).
Table 7.15. Incidence of a decreased urinary *Co-vitamin B12 excretion in untreated 
coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVESTIGATED
PERCENTAGE
W ITH
DECREASED 
* C o -V IT  B i2 
EXCRETION
Cooke et al. not stated 50 12
(1963)
Benson et al. <  3.5%/48 hrs 7 43
(1964)
Stewart et al. <  10%/24hrs 11 82
(1967)
Mann et al. <  7%/24 hrs 9 78
(1970)
Thys et al. not stated 6 67
(1971)
Modigliani et al. <  8%/24hrs 45 47
(1975)
Own series <  15%/48 hrs 30 67
7.8.2.2 Serum vitamin B12 concentration 
The serum vitamin B12 concentration was determined in a total of 10 
coeliac patients who had not previously received vit B12 replacement. It was 
found to be decreased in 5 cases (fig. 7.38). Vitamin B12 absorption, how-
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Fig. 7.38. Serum vitamin Bls 
in untreated coeliac sprue. The 
serum levels are drawn separa­
tely for patients with a flat and 
with a convoluted jejunal mu­
cosa. The shaded area represents 
the range of normal values (cf. 
chapter 12).
U rinary 57C o-v it B 12 excretion 
(“/odose / 4 8  hrs)
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Fig. 7.39. Schilling test in untreated coeliac sprue. 
The results of urinary 8,Co-vitamin B12 excretion 
are drawn separately for patients with a flat and 
with a convoluted jejunal mucosa. Statistical 
analysis (Mann-Whitney test) revealed no signi­
ficant difference between both groups. The shaded 
area represents the range of normal values (cf. 
chapter 12).
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ever, was normal in 3 of these 5 patients, which makes it difficult to explain 
the decreased serum vitamin B12 concentration.
7.8.2.3 Vitamin B12 absorption
Vitamin B12 absorption was decreased in 57% of the total of 30 untreated 
coeliacs (fig. 7.39). The majority of the patients received no supplement of 
‘intrinsic factor’ because achlorhydria had been previously excluded.
No correlation was found between the severity of vitamin B12 malabsorp­
tion and the degree of steatorrhoea. However, increased indicanuria was 
more frequent in those with a disturbed Schilling test (fig. 7.40). In 2 
patients the Schilling test was repeated after 1 week of tetracyclin, giving 
results which were not significantly different. The same applied to ad­
ministration of pancreatic enzymes and bicarbonate, which likewise failed 
to improve vitamin B12 absorption in one patiënt.
7.8.2.4 Effect of the gluten-free diet
Vitamin B12 absorption nearly always improved after gluten withdrawal
Urinary 57Co excretion 
(% dose /4 8  hrs)
Urinary indican excretion (m g /24 hrs)
Fig. 7.40. Schilling test and indicanuria. The results of urinary 57Co-vitamin Bla excretion 
of untreated coeliac patients are plotted against the amounts of indican excreted in urine 
o f preceding or following days. The dotted horizontal line represents the lower limit of 
normal 57Co-vitamin B12 excretion, and the dotted vertical line the upper limit of normal 
indican excretion. The straight diagonal line is the calculated regression line (y =  19.75 — 
0.07 x ; r =  -0 .4 9 ; 1% < p <  2.5%).
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(fig. 7.41). The figure does not show that the improvement occurred 
usually within 2-6 months; in other cases it was much more gradual and still 
abnormal 2 years after the institution of the diet. Marked disturbance of 
the Schilling test (less than 10% excretion in 48 hours) persisted in 5 patients. 
It was established by questioning that these patients did not properly ob- 
serve the d iet; this was confirmed by the finding o f a flat mucosa in the jejunal 
biopsy specimen. In 61% of a total of 18 treated coeliacs a normal vitamin 
B12 absorption was observed (fig. 7.41).
U rina ry 5 7 C o -v it B 12 excretion 
(°/o dose /  4 8  hrs)
Fig. 7.41. Schilling test and gluten-free diet. The 
results of urinary 57Co-vitamin B 12 excretion in 
corresponding patients before as well as during 
diet therapy are given. Statistical analysis (Wil- 
coxon signed-rank test) revealed a significant im­
provement on diet therapy (p <  1%). The shaded 
area represents the range of normal values (cf. 
chapter 12).
7.8.2.5 Comment
Although vitamin B12 deficiency which leads to megaloblastic anaemia 
or combined degeneration of the cord is rare in coeliac sprue (405), malab­
sorption of this vitamin is very frequently observed. In two-thirds of our 
patients we found a disturbed Schilling test, and this is in fair agreement 
with reports by other investigators (table 7.15). At first sight it may seem 
rather surprising that vitamin B i 2 absorption, which takes place in the ileum, 
is so often disturbed in a condition which usually involves only the proximal 
small intestine. In fact it is not easy to explain vitamin B12 malabsorption in 
coeliac sprue.
w ith o u t w ith  
g lu te n -fre e  d ie t
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Gastric juice from coeliac patients contains an adequate amount of in­
trinsic factor (IF), as indicated also by the fact that vitamin B12 absorption 
does not improve after IF  suppletion (160). Dietary vitamin B12 is normally 
attached to IF  before it enters the small intestine. This complex formation 
with IF  is thought to give the vitamin some protection from consumption 
or degradation by intestinal bacteria. Certain bacteria can nevertheless con- 
sume or degrade this vitamin (309, 760). The bacterial flora in the small in­
testine is regularly abnormal in untreated coeliacs (section 6.11), and in 
these patients consumption and degradation of vitamin B12 by bacteria can 
be a real problem. The correlation found between the presence of an ab­
normal bacterial flora and malabsorption of vitamin B12 is thereby explained 
(fig. 7.40). Bacteria which produce indole are generally found capable of 
binding vitamin B12 as well (823). Rosenberg et al. (716) clearly demon- 
strated the significance of an abnormal intestinal flora by the marked im- 
provement in vitamin B12 absorption after administration of broad-spectrum 
antibiotics in an untreated coeliac patiënt.
There are several indications that the receptors for the vitamin B12-IF 
complex in the ileum are readily damaged, and that the process of conjuga- 
tion between receptor and complex occurs only under certain favourable 
circumstances. It is suspected that in various situations the receptors or the 
enterocytes in the ileum can be damaged so that normal vitamin B12 ab­
sorption is impossible (133, 457, 517, 662, 778, 852). In coeliac patients the 
enterocytes in the ileum may be damaged, for example, by unabsorbed food 
constituents, bacterial degradation products or the micro-organisms them­
selves. Moreover, there may be lesions in the ileal mucosa as a result of the 
coeliac sprue.
Stewart et al. (817) often found abnormally flat enterocytes in the distal 
and middle part of the ileum in coeliac patients. They found a significant 
correlation between the height of these cells and vitamin B12 absorption. 
Perhaps differences in enterocyte height are associated with abnormalities 
of the receptors or of the intracellular organelles.
Another possible explanation of vitamin B12 malabsorption lies in the 
hypothesis that the calcium and magnesium ions required for conjugation 
of the vitamin B12-IF complex to the receptor (125), are not present in a 
free form because they are bound to unabsorbed fatty acids.
Although vitamin B12 malabsorption occurs in the majority of coeliac 
patients and the serum vitamin B12 concentration is regularly decreased 
(fig. 7.38; 104), megaloblastic anaemia based on vitamin B12 deficiency or a 
combined degeneration of the cord is observed only very sporadically (405, 
656). This is explained by the fact that vitamin B12 absorption is usually less
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markedly disturbed and less protracted than in pernicious anaemia for 
example, so that vitamin B12 reserves remain adequate much longer (405, 
525).
An abnormally high 57Co-vitamin B12 absorption was found in none of 
our untreated coeliacs. This phenomenon has been observed by others, who 
attribute it to mucosal hyperplasia and enhanced absorption in the ileum 
(540).
7.8.2.6 Conclusions
1. The majority of untreated coeliac patients show moderate-to-marked 
vitamin B12 malabsorption.
2. Intrinsic factor (IF) deficiency cannot plausibly be held responsible for 
this finding.
3. Some of the vitamin B12-IF complexes may be consumed or degraded by 
certain micro-organisms, as an abnormal intestinal flora is often present 
in coeliac sprue.
4. Unabsorbed nutrients, bacterial degradation products or the micro- 
organisms themselves perhaps interfere with the conjugation of the 
vitamin B12-IF complex to the receptor in the ileum.
5. Although it is mainly in the proximal part of the small intestine that 
mucosal lesions occur in coeliac sprue, there may also be (usually slight) 
abnormalities of the enterocytes present in the distal ileum. These slight 
abnormalities may influence vitamin B12 absorption.
6. Although vitamin B12 malabsorption and a decreased serum vitamin B12 
concentration are frequently observed in coeliacs, clinical symptoms of 
vitamin B12 deficiency are rare.
7.8.3 Folates
7.8.3.1 Introduction
Megaloblastic anaemia regularly develops in patients with coeliac sprue. 
This anaemia is usually a result of folate deficiency, and rarely due to vitamin 
B12 deficiency (section 7.8.2). Folate deficiency therefore seems to be a 
relatively common phenomenon in coeliac sprue. This deficiency can be 
manifested, not only as anaemia but also as glossitis or stomatitis aphthosa. 
In an efïort to gain some insight into the incidence of folate deficiency, we 
measured the serum folate concentration in our group of untreated patients. 
In addition the effect of the gluten-free diet on the serum folate concentra­
tion was evaluated.
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7.8.3.2 Serum folate concentration 
The serum folate concentration was decreased in 91% of 22 untreated 
patients (fig. 7.42). In only two cases was a normal serum folate concentra-
Serum fo la te
( p m o le / l ) (n g /m l)
Fig. 7.42. Serum folate in untreated coeliac sprue. 
The serum levels are drawn separateiy for patients 
with a flat and with a convoluted jejunal mucosa. 
Statistical analysis (Mann-Whitney test) revealed 
no significant difference between both groups. The 
shaded area represents the range o f normal values 
(cf. chapter 12).
f la t  convoluted 
mucosa mucosa
tion found; both were patients with a convoluted mucosa in the jejunal 
biopsy specimen. The incidence or severity of hypofolaemia was not different 
in patients with a flat or with a convoluted jejunal mucosa. Anaemia existed 
in a total of 16 of the 20 patients with a decreased serum folate concentra­
tion.
7.8.3.3 Effect of the gluten-free diet
After gluten withdrawal the serum folate concentration increased in all 
patients, irrespective of folie acid replacement (fig. 7.43). The serum folate 
concentration became normal in 94% of the treated patients.
7.8.3.4 Comment
A decreased serum folate concentration was found in virtually all untreated 
coeliac patients (fig. 7.42). Other investigators also noticed a high incidence 
of hypofolaemia in coeliac sprue (table 7.16). This is not really surprising
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Serum  fo la te 
( j jm o le / l) (n g /m l)
Fig. 7.43. Serum folate and gluten-free diet. The 
serum levels in corresponding patients before as 
well as during diet therapy are given. Statistical 
analysis (Wilcoxon signed-rank test) revealed a 
significant improvement on diet therapy (p <  
1%). The solid dots represent patients who re­
ceived temporarily folie acid replacement therapy. 
The shaded area represents the range o f normal 
values (cf. chapter 12).
Table 7.16. Incidence of hypofolaemia in untreated coeliac sprue.
AUTHORS CRITERION NUMBER OF
PATIENTS
INVEST1GATED
PERCENTAGE 
W ITH  HYPO­
FOLAEMIA
Brooks et al. <  5 ng/ml 8 100
(1966)
Cooke not stated 51 96
(1968)
Mortimer et al. <  3 ng/ml 6 67
(1968)
Hoffbrand <  6 ng/ml 163 100
(1974) <  3 ng/ml 163 86
Modigliani et al. <  5 ng/ml 9 88
(1975)
Own series <  3 ng/ml 22 91
because folates can only be absorbed in the proximal part of the small 
intestine (380), where the mucosal lesions are most marked in coeliac sprue. 
The absorption of a dose of labelled or unlabelled folie acid (pteroylmono- 
glutamate) proves to be decreased in many coeliac patients (table 7.17).
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Table 7.17. Incidence of an impaired folate absorption in untreated coeliac sprue.
METHOD CRITERION NUMBER OF PERCENTAGE 
PATIENTS W ITH
INVESTIGATED IMPAIRED
ABSORPTION
Kinnear et al. 
(1973)
Urinary 
excretion of 
oral labelled
<  mean-1 SD 8 88
folie acid <  mean-2 SD 8 50
Cooke et al. 
(1963)
Urinary 
excretion of 
oral versus 
i.m. folie acid
<80% 33 97
Serum folate 
after oral 
folie acid
<  40 ng/ml 15 100
Baker et al. 
(1964)
Serum folate 
after oral 
folie acid
<  40 ng/ml 7 100
Stewart et al. 
(1967)
Serum folate 
after oral 
folie acid
<  40 ng/ml 43 86
Urinary 
excretion of 
oral labelled 
folie acid
<  30%/24 hrs 9 100
Modigliani et al. 
(1975)
Serum folate 
after oral 
folie acid
< 4 0  ng/ml 23 100
The cause of folate malabsorption in coeliac sprue is still obscure. Perhaps 
the degradation of dietary polyglutamates to monoglutamate is decreased. 
However, a deficiency of the required enzyme conjugase (y-glutamylcarboxy- 
peptidase) has never been demonstrated in jejunal biopsy specimens from 
coeliac patients. This is perhaps due to the fact that this enzyme is contained 
in the lysosomes and mitochondria, and not in the brush border of the entero- 
cytes (231, 402, 430). Nevertheless the observation of Hoff brand et al. (402), 
who found that polyglutamate absorption can be disturbed in patients with 
normal monoglutamate absorption, suggests that polyglutamate degrada­
tion is not always normal, and sometimes constitutes a limiting factor in 
folate absorption. Perhaps the enzyme is insufficiently effective due to 
interference with other substances in the intestinal lumen (63). Conjugase 
deficiency cannot be the only explanation, however, for monoglutamate ab­
sorption is also disturbed in the majority of patients (table 7.17).
The reduced absorptive surface area of the jejunum due to loss of micro- 
villi and disappearance of villi can also play a role in folate malabsorption.
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Some investigators observed a significant correlation between folate ab­
sorption and the severity of mucosal lesions (297, 480). This may be ex- 
plained by a decreased attachment of folates to the epithelial surface (510), 
or a deficiency of transport carriers and of energy for active transport over 
the epithelial membrane (381). Even the transport from the enterocytes to 
the systemic circulation may be impaired (878). Baker et al. (35) observed 
that absorption of both monoglutamate and polyglutamate in coeliac 
patients improved after administration of an autoclaved extract of calf 
jejunum. This observation suggests that coeliac patients indeed have a de­
ficiency of transport carriers or other, heat-resistant and therefore non- 
enzymatic substances.
The ability to convert monoglutamate in the enterocyte to a reduced and 
methylated form does not seem to be decreased in  coeliac patients (430).
Although an abnormal bacterial flora in the small intestine usually causes 
increased endogenous folate synthesis and increased serum folate levels, 
some bacteria can in fact need folate for their metabolism. In the presence of 
such bacteria in the proximal jejunum, dietary folate can be consumed in- 
stead of being produced (48, 160, 404). In such cases monoglutamate ab­
sorption can improve after antibiotic medication (48).
Some other factors can conceivably also contribute to folate deficiency in 
coeliac patients. For example, folate requirements can be markedly in­
creased, mainly due to an accelerated turnover of the intestinal epithelium 
(405). It is further not unthinkable that some coeliac patients use a diet 
deficient in folates because they think that raw vegetables and fruits are not 
readily digested by their diseased bowels.
Folate malabsorption improves after gluten withdrawal. This improve­
ment is sometimes seen within 2 weeks, and after 6 months absorption is 
normal in virtually all patients (308, 478). As a result of improved absorption 
and disappearance of possible additional factors such as an abnormal flora 
in the small intestine, a deficient diet and increased folate requirements, the 
serum folate concentration increases (fig. 7.43).
7.8.3.5 Conclusions
1. A decreased serum folate concentration is found in nearly all untreated 
coeliac patients.
2. Absorption of monoglutamate as well as polyglutamate is reduced in the 
majority of patients.
3. Structural abnormalities of the proximal jejunum, as a result of which the 
absorptive surface area is decreased, seem to be an important determinant 
of folate malabsorption.
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4. There may be a deficiency in transport carriers or energy suppliers for 
the active transport of folate.
5. There are no indications that conversion of monoglutamate to 5-methyl- 
tetrahydrofolate by the enterocytes is decreased.
6. Some dietary folate can be consumed by bacteria in the small intestine 
and therefore not be available for absorption.
7. The folate deficiency can be based in part on additional factors such as a 
deficient diet and increased requirements.
8. Folate absorption quickly improves after gluten withdrawal, and the 
serum folate concentration returns to normal within a few months.
9. Since the serum folate concentration is decreased in nearly all untreated 
coeliac patients, and practically always normalizes after gluten with­
drawal, it seems to be a suitable parameter to verify both the effect and 
the observance of the gluten-free diet.
7.9 WATER-SOLUBLE VITAMINS
7.9.0 Introduction
Generally speaking, water-soluble vitamins are absorbed in the proximal 
part of the small intestine, probably by diffusion. In the case of lesions in 
this part of the small intestine, as for example in coeliac sprue, absorption 
may occur in the ileum also. Perfusion studies have shown that the capacity 
of only a small portion of the small intestine is sufficiënt to cover vitamin C 
requirements for example (635). Whether this also applies to vitamins of the 
B group, remains uncertain. Apart from malabsorption, other factors may 
play a role in the aetiology of a vitamin deficiency, such as the composition 
of the diet and the requirements for certain vitamins, which may be increased 
e.g. due to the accelerated turnover of the intestinal epithelium. Besides, it 
is possible that part of the amount of vitamin ingested does not become 
available for absorption due to bacterial consumption and degradation.
7.9.1 Vitamin C
The absorption of vitamin C (ascorbic acid) is normal to slightly decreased 
in the majority of untreated coeliac patients (816, 817). However, vitamin C 
deficiency is not rare, as indicated by the frequent finding of low serum con­
centrations, a low concentration of vitamin C in the leucocytes, and in­
creased capillary fragility (919). In addition to low absorption, increased 
vitamin C requirements may play a role in this respect (919).
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7.9.2 Thiamine
All untreated coeliac patients show decreased absorption of labelled thia­
mine (vitamin B^. No correlation has been found between thiamine ab­
sorption and other absorption tests, or between thiamine absorption and 
the severity of villous abnormalities in the jejunal biopsy specimen (845). 
Beriberi has been observed in association with coeliac sprue (636). Thiamine 
absorption returns to normal after gluten withdrawal in all cases (845).
7.9.3 Riboflavin
There are no published data on the absorption of riboflavin (vitamin B2) in 
patients with coeliac sprue.
7.9.4 Niacin
There are also no data on the absorption of niacin (vitamin B3) in coeliac 
patients. Niacin deficiency has been described in patients with an abnormal 
bacterial flora in the small intestine, however (833), and is therefore not 
unthinkable in coeliac sprue.
7.9.5 Vitamin ö 6
Decreased absorption o f labelled vitamin B„ (pyridoxine) is observed in 
about 50% of untreated coeliac patients (99, 817). There is no distinct corre­
lation with other absorption tests or with the severity of villous abnormalities 
in the jejunal biopsy specimen (99). Most untreated coeliacs show a decre­
ased serum vitamin Be concentration, but this returns to normal after gluten 
withdrawal (22). Sideroblastic anaemia has been described in association 
with coeliac sprue (198,405).
7.9.6 Pantothenic acid
There are no data on pantothenic acid absorption in coeliac sprue. Panto­
thenic acid deficiency is not unthinkable in coeliac patients. According to 
M onro (603), some symptoms in untreated coeliac patients could be ascribed 
to pantothenic acid deficiency.
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CHAPTER 8
CLINICAL FEATURES
8.1 INTRODUCTION
The clinical features of coeliac sprue are hardly characteristic. Most symp­
toms result from the malabsorption caused by the diseased small intestine 
(861). The nature and severity of this malabsorption are largely determined 
by the extent of the intestinal lesions or, rather, by the capacity of the re- 
maining unaffected intestine (647, 732, 817). Nevertheless, differences exist 
among individuals so that, given an apparently identical pathological sub- 
strate, some patients show megaloblastic anaemia whereas others suffer from 
osteomalacia (182).
The symptoms observed in coeliac patients are variable, and this is partly 
determined by the way the disease manifests itself. There are generally 
speaking three different types of onset. To begin with, mention should be 
made of the more or less acute intestinal catarrh, which usually causes the 
patiënt to report relatively quickly to his family doctor with complaints of 
diarrhoea, weight loss and malaise. An entirely different situation is en- 
countered in the chronic form of the disease, in which symptoms of malab­
sorption are predominant. Owing to the insidious nature of the symptoms 
and the fact that some abnormalities are of long standing, the patiënt often 
tends to regard the symptoms as ‘part of his life’ or even as ‘normal’. N ot 
infrequently, the patiënt describes his pattern of defaecation and his stools 
as ‘ordinary’, although in fact they are far from normal. As a result, the 
patiënt sometimes postpones seeking medical advice until he is in very poor 
condition as a result of longstanding and marked malabsorption. In this 
form, the syndrome in adults differs widely from the clinical symptoms in 
children with coeliac sprue. It can also happen that the patiënt is troubled 
only by a single symptom -  e.g. stomatitis, spontaneous fracture, increased 
bleeding tendency or anaemia -  but at more detailed examination proves to 
suffer from several deficiencies. In the third category of patients attention is 
drawn to coeliac sprue more or less accidentally when they are examined 
because of dermatitis herpetiformis or in the context of a family study. In 
view of the above it is evident that the clinical picture and symptoms in 
patients with coeliac sprue can vary widely in nature and severity.
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8.2 INCIDENCE OF THE VARIOUS SYMPTOMS
Before the nature of the various symptoms is discussed, it may be useful to 
consider their incidence. In our group of 36 untreated coeliac patients, of 
whom about two-thirds presented with (sub)acute intestinal symptoms and 
the remainder with deüciency symptoms (table 6.1), the incidence of the 
symptoms to be subsequently discussed was determined. The relevant data 
are presented in table 8.1. Our findings are largely in agreement with those 
reported by other investigators (53, 60, 104, 113, 160, 553, 601, 722). They 
can therefore be regarded as representative of the clinical syndrome of 
coeliac sprue as observed in a group of ad uit patients.
8.3 GENERAL COMPLAINTS AND SYMPTOMS
Malabsorption of nutrients and increased endogenous losses in coeliac 
patients lead to weight loss and in the long run even to emaciation. About 
one-third of our patients had a very low body weight, i.e. an obesity index 
according to Quetelet (476a), which was below the 2.5% limit of the Dutch 
population (694). In some cases the small stature of the patiënt -  less than 
164 cm for males and less than 154 cm for females (i.e. the 3% limit of the 
normal population (915)) -  indicates that the malabsorption and losses 
must have existed already during the growth period. In patients under age 
20 a small stature can still be based on retarded development, which can 
also be apparent from the bone age and the absence of secondary sex 
characteristics (525, 722). It is a well known fact that many coeliac patients 
are of small stature; in fact the condition has been jocularly described as 
‘jockey’s disease’ (33). Beside malabsorption and endogenous losses, other 
factors can play a role in weight loss. Anorexia, for example, is not un- 
common (section 8.4), and bacterial degradation of food constituents in the 
small intestine can also be a factor. However, coeliac patients need not always 
be underweight. Some of them are in fact relatively obese (537, 553, 601). 
Several of our untreated patients had a Quetelet obesity index exceeding the 
75% limit of the normal population (694).
When weighing these patients, one should ascertain that they are not 
suffering from oedema (60, 553, 723, 846) or ascites (489, 601), which could 
cause a üattered body weight. Oedema nearly always results from a de­
creased serum albumin concentration due to, among other things, an in­
creased enteric protein loss (section 7.5). In rare cases they are an expression
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General complaints and symptoms Number of
patients
lassitude and malaise 29
weight loss 31
underweight* 9
overweight* 4
oedema 13
small stature* 4
(sub)febrile tempcraturc* 8
nycturia 10
hypotension 0
Table 8.1. Complaints and symptoms in 36 untreated patients with coeliac sprue.
Gastrointestinal tract
diarrhoea or frequent defaecation 27
(periodical) constipation 6
pale and pulpy stools 13
meteorism 11
borborygmi 18
flatulence 8
abdominal pain 16
anorexia 13
nausea or vomiting 8
hyperphagia 7
stomatitis aphthosa 7
glossitis 7
hepatomegaly 6
Haematopoiesis and coagulation
pallor 19
headache 10
dizziness 9
dyspnoea 11
haemorrhagic diathesis 5
Howell-Jolly bodies or target cells 8
Musculoskeletal system
skeletal deformities 9
(spontaneous) fractures 5
osseous pain 1
tetany 4
Skin, hair and nails
hyperpigmentation 13
dry and scaly skin 7
eczema 3
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Table 8.1 (continued)
Number of 
patients
4
5
1 
3
3
(out of 22 female patients)
4
(out of 22 female patients)
6
(out of 15 pregnant patients)
5
(out of 32 married patients)
dermatitis herpetiformis 
lossofhair 
psoriasis 
watchglass nails 
clubbing of fingertips
Reproductive functions 
delayed menarche
secondary amenorrhoea
abortion or miscarriage
infertility
Nervous system
gait disturbances 
loss o f reflexes 
sensoryloss 
paraesthesiae
* for definition see text.
of a high output failure of the heart due to anaemia or in exceptional cases 
even to a thiamine deficiency (636).
In some patients the systolic blood pressure is low (i.e. lower than 100 
mmHg) (60, 525, 861), for reasons which cannot be established with cer- 
tainty. Some authors ascribe this to adrenocortical insufficiency (861).
We noticed that a fair number of patients had a slightly increased body 
temperature (i.e. a morning temperature higher than 37°C). Cooke et al. 
(159) noticed the same in patients with idiopathic steatorrhoea. In these 
patients we often also found severe anaemia, in association with which 
slight pyrexia is not uncommon (922).
Coeliac patients regularly suffer from nycturia, which can be so pro- 
nounced that the day-night rhythm is almost reversed. In spite of extensive 
investigations, this phenomenon has so far remained unexplained (389, 
838, 839, 924).
8.4 GASTROINTESTINAL TRACT
As an affection of the small intestine, coeliac sprue of course causes mainly
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complaints about digestion. Stools are often abnormal, although some 
patients fail to notice this, probably because they have never passed normal 
stools. In the classical case, the stools are voluminous, loose, yellowish-grey, 
fatty and with a rancid odour. Due to the high fat content the stools do not 
readily wash away and have a pale colour, which is normalized after fat 
extraction (727). The fact that the stools float on water is largely due to the 
large amount of gas contained (515). This gas is partly produced by ferment- 
ation of undigested sugars (disaccharides). As a result, and especially be­
cause of the large amounts of unabsorbed nutrients and water, the stools can 
be very voluminous. Nevertheless we noticed that the total weight of the 
daily production of faeces was usually not much increased (fig. 7.1). In the 
majority of our cases, moreover, the faeces did not show a typically steatorr- 
hoeic aspect. In no case was macroscopic blood observed. All in all, a normal 
appearance of the faeces is apparently compatible with the condition.
Peristalsis, sometimes visible in emaciated patients, can be either acce- 
lerated or retarded (section 6.2). Together with an increased amount of 
waste, rapid peristalsis gives rise to frequent, voluminous defaecation which 
can occur mostly at night (724). This acceleration of peristalsis, which may 
cause an explosive urge to defaecate, probably results from fermentation and 
the release of irritant substances such as bacterial degradation products of 
fat and carbohydrates, in addition to unabsorbed bile acids. The increased 
gas production due to this fermentation also explains other phenomena 
such as borborygmi, meteorism and flatulence. However, by no means all 
patients have accelerated peristalsis. In fact fluoroscopy often reveals de- 
layed passage (619). Some coeliac patients have an entirely normal pattern 
of defaecation or may even suffer from (periodical) constipation (256). 
Symptoms of paralytic ileus may be present in sporadic cases (fig. 6.3).
One can imagine that distension of loops of small and large intestine 
causes cramp-like abdominal pain. The complaints about abdominal pain 
in about 50% of patients (216, 553), however, need not always be caused by 
coeliac sprue. In some of our patients the pain was found to be due to 
other causes such as endometriosis, cholelithiasis, malrotation or abdominal 
angina. Palpation of the abdomen usually discloses no abnormalities. In 
some cases, however, the liver can be enlarged; this is often based on steatosis 
(233, 851).
As pointed out, weight loss is observed in many coeliac patients and 
anorexia, or even vomiting may be an additional factor in this respect 
(53, 60, 306). Perhaps some patients eat little for fear of increased ab­
dominal pain or diarrhoea (338), or because they think that their bowels 
should be strained as little as possible. But eating can also be impeded by
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the presence of glossitis, stomatitis angularis (60) or stomatitis aphthosa 
216, 271), which may be an expression of a deficiency in iron, folie acid, 
vitamin B2 or vitamin B12 (53, 928). On the other hand, anorexia can be 
caused by an abnormal bacterial flora in the small intestine. Two of our 
coeliac patients with an abnormal intestinal flora continued to suffer from 
anorexia in spite of a gluten-free diet; the anorexia disappeared only after 
treatment with broad-spectrum antibiotics.
In some cases, on the other hand, patients show an excessive appetite 
(117, 745), although this is generally less extreme than the hyperphagia ob­
served in patients with pancreatic insufficiency (352).
8.5 HAEMATOPOIESIS AND BLOOD COAGULATION
Anaemia is one of the most common abnormalities in coeliac sprue. Par- 
ticularly clinics with a well-known interest in haematology report a high in­
cidence of anaemia (53). Anaemia was also observed in many of our patients; 
it was found to be about equally often due to folie acid deficiency as to iron 
deficiency. Vitamin B12 deficiency was rarely observed, although vitamin B12 
absorption was regularly disturbed (section 7.8.2). Symptoms of anaemia 
such as pallor, headache, dizziness or dyspnoea are quite common in coeliac 
sprue.
Due to malabsorption of the fat-soluble vitamin K, coagulation factors 
dependent on the presence of this vitamin may become deficient (e.g. 
factors II, VII, IX and X). In severe cases this may result in a haemorrhagic 
diathesis manifested by subcutaneous haemorrhages, epistaxis, haematuria 
and rectal or vaginal blood loss (265, 489, 724). A rare complication is the 
occurrence of retroperitoneal bleeding (33), or haemarthros (489). Purpura, 
which we observed on the lower legs of one of our female patients, may be a 
result of vitamin C deficiency. A characteristic feature in coeliac patients is a 
more or less marked atrophy of the spleen (405, 561). As a result of this 
atrophy, erythrocytes with nuclear remnants (Howell-Jolly bodies) or target 
cells circulate in the blood (265).
8 .6  MUSCULOSKELETAL SYSTEM
The osseous abnormalities found in coeliac patients mainly result from 
vitamin D malabsorption. The increased calcium secretion in the proximal 
small intestine may play an additional role. Vitamin D deficiency in children
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with coeliac sprue can give rise to the familiar features of rickets, e.g. frontal 
bossing, beading of the ribs and deformed extremities. Some adult patients 
still show residual symptoms. At a more advanced age, vitamin D deficiency 
causes osteomalacia. The patients sometimes complain of vague osseous 
pain low in the back or in the hips (60, 724), muscular weakness and dis­
turbances of gait (113). The two symptoms last mentioned can also be based 
on a myopathy, which is not uncommon in these patients (70, 353). Physical 
examination sometimes reveals skeletal deformities, visible also on radio­
graphs, along with pseudo-fractures (Looser-Milkman zones). The negative 
calcium balance (589) regularly leads to generalized osteoporosis which, 
together with osteomalacia, can give rise to compression fractures of the 
vertebrae or spontaneous fractures of the extremities (60). These complica- 
tions as a rule do not occur unless severe disorders of mineralization have 
long been present; they are therefore not often observed.
Symptoms of secondary hyperparathyroidism, as a reaction to hypocal- 
caemia due to calcium loss, are occasionally observed (117). Probably as a 
result of this secondary hyperparathyroidism the plasma calcium concen­
tration is less often decreased than might be expected, provided the calcium 
concentration measured is corrected for possible hypoproteinaemia (657). 
Nevertheless, symptoms of tetany (due either to hypocalcaemia or to a de­
creased serum magnesium concentration) are regularly observed in coeliac 
patients (60, 601, 723, 846).
8.7 SKIN, HAIR AND NAILS
Skin lesions are often observed in coeliac patients (60, 104). In such cases the 
skin is usually dry and rather scaly, sometimes to an extent which produces 
pellagra-like features. According to Wells (905) this is a false impression pro­
duced by a combination of increased desquamation and intensified pig- 
mentation of the skin. Nicotinic acid deficiency is usually not involved 
(905).
Another common cutaneous abnormality in coeliac sprue is hyperpig- 
mentation as a result of increased deposition of melanin in the skin. This 
hyperpigmentation can be either generalized (353, 601) or local; in the latter 
case the face may sometimes show the features of a so-called mask of preg- 
nancy (127). The cause of this hyperpigmentation is still obscure. Trier 
(861) ascribed it to adrenocortical insufficiency, but no other investigator has 
so far confirmed the presence of such insufficiency. Moreover, similar hyper- 
pigmentations are sometimes observed in cachectic or chronically under-
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nourished patients in whom adrenal function is normal (115, 787). In­
creased desquamation of the skin is also observed in some cases of malnutri- 
tion, and is ascribed to deficiency in calories, proteins and essential fatty 
acids (905). It seems plausible that such deficiencies should also be held re- 
sponsible for the skin lesions in patients with coeliac sprue (559).
Apart from eczema (294), many other skin diseases have been described 
in coeliac sprue, like acne rosacea (895) and psoriasis (163). The association 
is probably quite accidental. This does not apply, of course, to dermatitis 
herpetiformis which is generally known to be closely associated with coeliac 
sprue (section 10.2).
Complaints about loss of hair and brittle nails are not uncommon. The 
loss of hair can involve the scalp but also other areas such as the axillae, 
pubic region or extremities (745). In this respect, too, malnutrition is held 
responsible, while calcium deficiency cannot be excluded as apossibleaddi- 
tional factor (905). There is no explanation for symptoms such as watch- 
glass nails or clubbing of fingertips (60, 216), although the latter can in some 
cases be due to hyperparathyroidism (698). Spooning of nails is thought to 
be indicative of iron deficiency (53). David et al. (193, 194) observed that, 
like the mucosal villi, the epidermal lines of the fingertips in untreated 
coeliac patients show atrophy, which is thought to improve after gluten 
withdrawal. The significance of their findings has been strongly doubted by 
others, however (572, 624).
8 .8  REPRODUCTIVE FUNCTIONS
Women in poor general condition regularly show menstrual disorders. Com­
plaints about irregular menstruation are therefore not uncommon in female 
coeliac patients. There may be secondary amenorrhoea which -  as in the 
case of anorexia nervosa -  disappears as the patiënt gains weight again. 
Delayed menarche or even primary amenorrhoea may also occur in coeliac 
patients (307); this may indicate, not only a poor general condition, but also 
delay of puberty due to retarded physical development (525). In addition to 
menstrual disorders, female coeliacs may suffer from miscarriages or in- 
fertility (447, 610), but these seem to show no correlation with the severity 
of malabsorption (53). The cause of this infertility is unknown, but defi­
ciencies in vitamin Bx or folie acid, may play a role in this respect (610).
In male coeliac patients, fertility can be reduced not only as a result of 
impotence but also due to abnormalities of the semen (37). That these are 
due to coeliac sprue is apparent from the improvement of the semen after 
gluten withdrawal (37).
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8.9 NERVOUS SYSTEM
Several neurological abnormalities have been observed in coeliac patients 
(162, 611, 656). Most of these cases involve polyneuritis, but there are also 
reports on central system affections such as myelopathy and encephalomyelo- 
radiculopathy (162). The question, however, is whether the presence of 
these abnormalities is not often pure coincidence; particularly since the 
neuropathies sometimes do not develop or exacerbate until after gluten 
withdrawal (128, 162). As a rule the neurological lesions are ascribed to 
deüciency in vitamins of the B group. It is uncertain whether deüciencies in 
other vitamins or in certain amino acids also play a role in this respect (656). 
Development of a combined degeneration of the cord, however, is exceed- 
ingly rare in coeliac sprue (162, 656), although a low serum vitamin B12 
concentration is regularly observed. The neurological symptoms are, as a 
rule, conüned to slight reflex abnormalities and disorders of sensation. 
Besides, some patients complain of gait disturbances or paraesthesiae, which 
can in part be attributed to manifest calcium or magnesium deüciency (656). 
Complaints about night blindness are sometimes heard; this may result from 
vitamin A deüciency. Our own experience is that subjective complaints of 
night blindness could never be objectively confirmed.
8.10 PSYCHE
In descriptions of adult coeliac patients, notes on psychological peculiarities 
are regularly found (60, 104, 315). Some two-thirds of our own series of 
patients were described by the examining physician as excessively nervous, 
unstable, depressive or even hysterical. Some of them had in fact been 
treated by a psychiatrist before referral. The majority of these psychological 
disorders were probably a result of chronic fatigue, general malaise, ab- 
dominal symptoms or sterility problems. After disappearance of these symp­
toms as a result of gluten withdrawal, the majority of our patients proved 
to be quite sthenic and stable. There is a very real risk that, because a 
patiënt appears to be psychologically affected, his physical complaints are 
not taken seriously and interpreted as functional. In a retrospective study of 
all patients registered as suffering from functional abdominal disorders, 
Ross et al. (724) found coeliac sprue in 10% of cases!
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CHAPTER 9
CLINICAL COURSE AND RESPONSE TO TREATMENT
9.1 SPONTANEOUS COURSE
Before dealing with the treatment of coeliac sprue, it may be useful to 
discuss briefly the natural history of the disease. This seems to be particul- 
arly important with a view to a more accurate assessment of the effect of the 
gluten-free diet.
Earlier experience has shown that children treated by a gluten-free diet 
during a number of years, can often later return to an unrestricted diet 
without suffering a relapse of symptoms. The impression was that a number 
of these young patients had ‘outgrown’ the disease, so to speak. Only a few 
children with coeliac sprue showed a relapse of symptoms after discontinuing 
the gluten-free diet, and were therefore forced to return to it (425, 776, 875).
Many patients who develop symptoms of coeliac sprue rather abruptly 
in adult life, are found to have already had symptoms of it in childhood. By 
questioning, we found that two-thirds of our group of adult patients had a
severity  of 
symptoms
degree of
improvement
Fig. 9.1. Diagram of the variable spontaneous course of coeliac sprue, illustrating that 
periods with more or less severe symptoms alternate with symptom-free intervals.
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childhood history indicative of the disease. The majority reported that they 
had regularly had symptoms as a child on an unrestricted diet, mostly until 
puberty. A symptom-free interval had usually followed -  a phenomenon 
commonly known as ‘teen-age remission’ (53). This remission can persist 
throughout the teens. In female patients the symptoms can recur with pregn- 
ancy (776). It is also possible that coeliac sprue does not become manifest 
again until in late life, during the fifth or sixth decade.
It is a remarkable phenomenon that the majority of children with coeliac 
sprue can return to a normal diet after some time without developing symp­
toms. Some adult coeliacs also acquire a gluten tolerance. Several of our 
patients who interrupted the regimen for varying periods of time, experienced 
no subjective (and sometimes even no objective) untoward consequences. 
Untreated patients may show a very variable course of the disease, in 
which periods with more or less severe symptoms alternate with symptom- 
free intervals (fig. 9.1). This is clearly illustrated by the spontaneous im- 
provement seen in two of our patients before a biopsy of the small intestine 
had confirmed the diagnosis (table 9.1).
Table 9.1. Spontaneous improvement in coeliac sprue. Observations in 2 untreated 
coeliac patients.
PATIËNT PARAMETER AT FIRST JUST TIME
EXAMINATION BEFORE INTERVAL
DIET IN
TREATMENT WEEKS
#  31 Body weight (kg) 59.5 62.2 27
Bowel movements 4-6 1-2
(24 hrs)
Serum albumin (g/1)* 44.8 50.5
#  35 Body weight (kg) 53.6 59 14
Bowel movements 4-10 1-2
(24 hrs)
Serum albumin (g/1)* 37.8 47.1
Serum cholesterol 3.5 4.8
(mmole/1)**
* Controls: 45.8 - 55.1 g/1 
** Controls: 4.0 - 7.2 mmole/1
The spontaneous course of coeliac sprue can be retrospectively recon- 
structed on the basis of data from case histories. By way of illustration we 
have done this for two of our patients (figs. 9.2 and 9.3). Figure 9.2 clearly 
shows the characteristic teen-age remission, which is almost entirely absent in
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7pregnancies (6 abortions) ♦  ♦  ♦  ♦  ♦  ♦
pregnancies periods of stress
Fig. 9.2. Characteristic profile of coeliac sprue in a 41-year-old female patiënt with a 
history of diarrhoea and retardation of growth at the age of 26 months (reflected in her 
present height of 1.53m).The symptoms disappeared spontaneously at age 9, but severe 
diarrhoea returned when she was 34 years old, during the 8th pregnancy which led to an 
abortion. Of the 7 preceding pregnancies 6 had also resulted in an abortion. The next 
conception, after which she used a gluten-free diet, led to normal childbirth. Gluten with­
drawal, prescribed on the basis of a flat jejunal biopsy, led to a normal serum concentra­
tion of albumin (54.1 g/1, from 41.1 g/1), folate (5 ng/ml, from 1.3 ng/ml) and cholesterol 
(5.7 mmole/1, from 3.4 mmole/1) and an improved D-xylose test (3.1 g/5 hrs, from 1.0 g/ 
5 hrs). Although no longer observing dietary restrictions she is usually free of symptoms, 
apart from brief periods coinciding with seasonal stress in her job. She further shows 
normal biochemical parameters, apart from a decreased serum folate concentration (2.2 
ng/ml) and a low D-xylose excretion (3.8 g/5 hrs).
♦  ♦  ♦
extra feeding end of war stress
i 3.29.977 l
Fig. 9.3. Profile o f the spontaneous course of coeliac sprue in a 44-year-old female pa­
tiënt, prior to gluten withdrawal. Abdominal symptoms had developed at age 4, when she 
had received extra feeding in view of underweight. The symptoms disappeared after a few 
years, and returned shortly after World War II. After a few years of varying abdominal 
symptoms, injections of liver extract were given at age 18, whereupon her general condi- 
tion showed marked improvement and the menarche occurred. After a remission of about
5 years periodical diarrhoea recurred, but it was not until a few years later that this was 
interpreted as a symptom of coeliac sprue. Gluten withdrawal was prescribed on the basis 
of a flat mucosa in a jejunal biopsy specimen, whereupon the symptoms disappeared. The 
body weight increased by about 6 kg, and absorption of fat and D-xylose became normal.
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figure 9.3. In both figures the erratic course of the disease -  if untreated -  is 
evident. The course of coeliac sprue may be different, however, varying from 
entirely asymptomatic to one without the slightest remission. For some 
patients this meant that they were in very poor health until their condition 
was properly diagnosed or until the gluten-free diet became known as the 
proper way of treatment. In the past, the prognosis for children with coeliac 
sprue was somewhat poor, as demonstrated by a death rate which ranged 
from 10% (660) to 30% (362).
9.2 TREATMENT BY THE GLUTEN-FREE DIET
9.2.1 Nature o f  the diet
The various diets in use before 1950 had in common that they were rather 
one-sided due to marked restrictions in the number of food constituents 
permitted (261, 346, 423, 749, 776). A turning-point in the treatment of 
coeliac sprue was reached in 1950, when Dicke (208, 209) published his ob­
servations on the noxious effect of gluten. Clinical experiments showed 
that the syndrome responded favourably to withdrawal of wheat, rye and 
oats from the diet. A few years later it was demonstrated that barley is like- 
wise harmful (734). Potatoes, rice and maize are always tolerated well by 
coeliac patients (453), and the same applies to buckwheat and millet (586).
A gluten-free diet is therefore generally defined as a regimen without 
wheat, rye, oats and barley, with products of potatoes, rice, buckwheat, 
maize, soya, etc. as farinaceous foods (586). The question whether oats and 
barley are harmful to coeliac patients is still controversial, however (23, 
39, 217, 453, 454, 734). Differences of opinion in this respect are apparent 
in the varying dietary prescriptions used in different British clinics (39). As 
long as it has not been demonstrated with certainty that oats and barley are 
harmless, it seems wise to avoid these cereals in the gluten-free diet. In our 
clinic, a gluten-free diet is defined as a regimen without wheat, rye, barley 
and oats.
It is to be noted -  by the way -  that the designation ‘gluten-free’ is actually 
a misnomer. The noxious influence of wheat and rye is based on a fraction 
of gluten called a-gliadin (section 2.2). The harmful protein fraction in oats 
and barley has a slightly different composition and a different name, e.g. 
avenin (oats) or hordein (barley) (38, 39). However, it seems advisable to 
maintain the customary designation ‘gluten-free’ for the time being, as long 
as the causative factor is not exactly known.
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9.2.2 Adherence to the diet
Of the 47 coeliac patients who are under our care or have been treated by 
us, 43 were placed on a gluten-free diet (fig. 6.1). In a few of these patients 
the ultimate effect of this diet could not be evaluated, as 3 patients were 
simultaneously suffering from some other affection, such as ulcerative 
colitis, diverticulosis of the small intestine, or pancreatic carcinoma. The 
symptoms and lesions found in these 3 patients could not be properly inter- 
preted, therefore. One patiënt was suffering from non-granulomatous 
duodenojejunitis (section 11.2). There remained 39 patients, in whom the 
effect of diet treatment could be evaluated. Within this group of patients, a 
distinction was made between those who stated that they had strictly ad- 
hered to the prescribed diet, those who admitted some occasional negli- 
gence, and patients who consumed regularly some gluten. The three groups 
thus formed consisted o f :
22 patients thought to adhere strictly to the diet;
8 patients thought to adhere well to the diet;
9 patients thought to adhere poorly to the diet.
Comment
When dividing the patients into categories of strict, adequate or poor ob- 
servance of the diet, one is forced to rely largely on the patients’ statements. 
No reliable method has so far been developed to verify whether a patiënt 
adheres to the diet, or not. Methods recommended for this purpose, such as 
the D-xylose test (713), lactulose test (183), folie acid tolerance test (695) 
or screening for anti-gluten antibodies (837), are inadequate (36, 786). Yet 
the need for such verification is obvious to anyone who is evaluating the 
effect of treatment in coeliac sprue. It is only too often found that a patiënt 
who hardly responds to a ‘gluten-free’ diet at home, rapidly improves under 
clinical supervision. Some patients do not admit, moreover, to having partly 
or totally neglected dietary rules until after the occurrence of a severe re- 
lapse, a ‘good’ doctor-patient relationship notwithstanding. Finally there 
are some coeliacs who -  in good faith -  consume small amounts o f gluten 
because many processed foods contain gluten which cannot be identified 
from the list of ingredients printed on the wrappers. It is the experience of 
some investigators that it is useful to have a dietician in attendance at the 
out-patient clinic for coeliac patients or to let her do domiciliary visits (36, 
818). As long as it is uncertain which patients observe the diet strictly, and 
which do so only moderately well, it is impossible to evaluate the effect of
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gluten withdrawal on the clinical, biochemical and morphological abnor- 
malities properly.
9.2.3 Effect on clinical symptoms
The effect of the gluten-free diet on the clinical symptoms in coeliac sprue 
partly depends on the clinical syndrome shown by the patiënt before gluten 
withdrawal. Those who were suffering from more or less acute intestinal 
catarrh, usually showed rapid improvement: the diarrhoea, abdominal 
cramps, nausea, flatulence and meteorism as a rule disappeared within a 
few days, while the appetite improved and the body weight increased. Those 
who had a chronic malabsorption syndrome with osteomalacia, megalo- 
blastic anaemia or hypoproteinaemic oedema, usually showed gradual im­
provement, which became manifest after 1-4 months in the case of anaemia 
or oedema, but could take much longer in osteomalacia. Only glossitis or 
stomatitis aphthosa disappeared very quickly.
A difficulty in the evaluation of the effect of gluten withdrawal on the
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Fig. 9.4. Effect of the gluten-free diet on the body weight in coeliac sprue. The body 
weight is expressed by the Quetelet index (weight in hectograms, divided by height in 
metres; 176a, 177) as well as by the weight percentiles applying to the normal Dutch 
population (694). Each arrow represents one patiënt. A  weight gain is symbolized by an 
arrow turned upwards, a weight loss by an inverted arrow. Statistical analysis (Wilcoxon 
signed-rank test) revealed a significant improvement on diet therapy (p <  1%).
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clinical symptoms is that it is uncertain which criteria should be applied. 
For patients who previously presented with symptoms of an intestinal 
catarrh, normalization of the defaecation or an  increase in body weight, 
could be used as criterion. All our patients who had suffered from frequent 
defaecation or loose stools prior to gluten withdrawal, ultimately resumed a 
normal pattern of defaecation. Six patients actually developed a more or 
less marked form of constipation, which could usually be controlled by a 
cellulose-rich diet. One of these patients occasionally used a slice of ordinary 
bread by way of laxative. A weight gain was recorded in 35 of the 39 patients 
(fig. 9.4). In the majority of cases the weight gain was pronounced, and in 
fact 15 patients became obese. Two female patients discontinued the gluten- 
free diet for this reason, and 4 patients were placed on a weight-reducing 
diet.
The effect of gluten withdrawal was also very good and rapid in patients 
with symptoms resulting from anaemia, stomatitis or tetany. Many of the 
patients complaining of chronic fatigue or abdominal pain, however, con- 
tinued to do so. On the basis of the initial symptoms, the ultimate clinical 
result was subjectively disappointing for 13 of the 39 patients, even though 
the majority of these 13 showed unmistakable improvement in biochemical 
parameters. In terms of the impression of the attending physician, however, 
the clinical effect of the gluten-free diet can be different from the patients 
view (table 9.2). It was a striking finding that the effect on clinical symp­
toms was moderate in several patients who stated a strict adherence to the
Table 9.2. Effect of diet treatment on clinical symptoms, as assessed by the attending
physician.
MARKED
IMPROVE­
MENT
SOME
IMPROVE­
MENT
NO
IMPROVE­
MENT
STRICT DIET 16 patients 5 patients 1 patiënt
RATHER STRICT DIET 7 patients - 1 patiënt
NO STRICT DIET 4 patients 3 patients 2 patients
diet. There was actually little difference from the group of patients who 
occasionally ‘sinned’. The results were evidently less good in those who 
neglected the dietary dictates. Some of these latter patients accounted for 
their carelessness because no improvement of symptoms had been experien- 
ced.
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Comment
Evaluation of the clinical effect of the gluten-free diet is a subjective matter, 
both for the patiënt and for the physician. It is difficult to compare the results 
reported by the various investigators as a result of differences in their 
patients’ age, condition and degree of cooperation. A study of the literature 
revealed that the majority of investigators found clinical improvement in 
100% of their patients (60, 105, 113, 218, 803). We observed a favourable 
effect of gluten withdrawal in 92% of our patients which is in agreement with 
reports published by Cooke et al. (160), Ruffin (739), Modigliani et al. (601), 
and Cerf et al. (128). The only investigators to report much less favourable 
results were Shiner (780) and Pink et al. (682), who observed improvement in 
only 77% and 70% of their patients, respectively. The latter included, how­
ever, patients with associated pancreatic lesions, and refractory sprue, 
which explains their moderately succesful results.
9.2.4 Effect on biochemical parameters
It can be stated that in general biochemical abnormalities improve after 
gluten withdrawal. The effect of the gluten-free diet on the individual bio­
chemical parameters was discussed in chapter 7.
In an effort to gain an impression of the ultimate and over-all effect of 
the gluten-free diet, we determined in the various categories of patients 
whether certain biochemical parameters were normalized after gluten with­
drawal for a period of 6 months to 19 years (mean duration: 7 years). We 
focused on the parameters which in the same group of patients were most 
frequently disturbed prior to gluten withdrawal (fig. lO.l.c). Only the 
most recent biochemical findings were recorded, which in some cases differed 
markedly from the best results ever observed in them (fig. 9.5). A study of 
the data in this figure leads to the conclusion that patients who supposedly 
strictly observed the diet showed fewer abnormalities in vitamin B12 ab­
sorption, whereas all other biochemical parameters showed no differences 
between the 3 categories of patients on statistical analysis (Kruskal-Wall is 
test; 492a).
Comment
Comparison of own results with those of other investigators is not easier 
for the biochemical parameters than for the clinical symptoms. This is due, 
not to lack of suitable criteria but to the impossibility of obtaining informa-
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Fig. 9.5. Diagram of the effect of gluten withdrawal on biochemical parameters in coeliac 
sprue. As parameters were chosen the most frequently disturbed tests prior to gluten 
withdrawal (fig. 10.1.c). The most recent test results were recorded of patients who sup- 
posedly adhered strict (column S), well (column W) or poorly (column P) to the gluten- 
free diet.
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Table 9.3. Effect of diet treatment on biochemical parameters.
AUTHORS NORMAL NORMAL NORMAL NORMAL NORMAL NORMAL NORMAL NORMAL
SERUM 57C o -v i t SERUM HAEMO­ SERUM D-XYLOSE FAT SERUM
IRON B 12e x - CHOLES­ GLOBIN ALBUMIN EXCRE­ ABSORP­ FOLATE
(%) CRETION TEROL (%) (%) TION TION (%)
(%) (%) (%) (%)
Buchan et al. (1962) 100(16) 100 (36) 84 (19)
Cooke et al. (1963) 90 (20) 90 (20) 32 (19) 62(8) 50 (10) (33 12)
Shiner (1963) 40 (15) 47 (17)
Benson et al. (1964) 100 (2) 100 (2) 89 (26) 100 (25) 48 (23) 38 (24)
strict adherence 80 (10) 82 (11)
poor adherence 23 (13) 0(13)
Bolt et al. (1964) 58 (12)
Dissanayake et al. (1974) 67 (30) 95(37) 97 (29)
strict adherence 80 (15) 100(18) 100 (14)
good adherence 67(9) 92 (12) 100 (10)
poor adherence 33(6) 86(7) 80 (5)
Cerf et al. (1975) 56(9) 60 (20) 14(7) 29(17) 50(6)
Modigliani et al. (1975) 76 (21) 58 (26) 57 (28)
muc. morph. improved 80 (15) 65 (20) 72 (18)
muc. morph. unaltered 67(6) 33(6) 30 (10)
Own series 90 (29) 58 (24) 86 (36) 58 (38) 67 (39) 63 (35) 53 (15) 82 (34)
strict adherence 100(16) 67 (15) 80 (20) 57 (21) 73 (22) 71 (21) 75(8) 81 (21)
good adherence 63 (8) 67(3) 100 (7) 63 (8) 75(8) 67(6) 50(2) 100 (7)
poor adherence 100(5) 33(6) 89(9) 56(9) 44(9) 38(8) 20(5) 67(6)
n o t e : ,
The figures in brackets refer to the number of investigated patients. The various criteria for normal values are listed in tables 7.3, 7.6, 7.7, 7.12, 
7.14, 7.15 and 7.16.
tion on the composition of their groups of patients and the supervision of 
diet observance. It hardly needs to be pointed out that patients with a long- 
standing severe malabsorption syndrome show a less rapid normalization 
of biochemical parameters than those whose condition was diagnosed 
soon after the onset of. symptoms. Normalization o f blood chemistry is 
largely dependent on the suppletion of possible deficiencies. Virtually no 
author indicates how many patients in his series received supplements of 
vitamin B12, folie acid, vitamin D, calcium or iron, which interferes with a 
correct interpretation of the great variances in published results (table 9.3).
1-2 yrs
gluten-free diet
5 -lO y rs
gluten-free diet
>10 yrs
without
gluten-free diet
normal
mucosa
Fig. 9.6. Diagram of the effect of gluten withdrawal on the villous morphology in coeliac 
sprue. The stereomicroscopic aspect of mucosal biopsies from the proximal jejunum in 36 
corresponding patients before as well as during diet therapy is recorded. Besides the villous 
morphology of 3 patients without pre-treatment biopsies is given. The different columns 
refer to various periods of diet treatment.
9.2.5 Effect on mucosal morphology
In all our patients, a repeat biopsy was obtained from the proximal jejunum, 
in between 3 months and 15 years after gluten withdrawal. In the vast 
majority of cases (i.e. in 24 of the 39 patients) this was performed after more 
than 2 years on a gluten-free diet (fig. 9.6). In a number of patients only one 
single biopsy specimen was obtained, while during the past 7 years multiple 
repeat biopsies were taken, going beyond the proximal jejunal loop. In all 
cases, however, the effect of the diet was evaluated on the basis of the speci­
men from the first jejunal loop, 10-20 cm beyond the ligament of Treitz.
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As fig. 9.6 indicates, normal villi were rarely observed in the biopsy 
specimens, although in the majority of cases the diet had reportedly been 
strictly observed for over 2 years. In none of the patients who had been 
rebiopsied within 2 years had the mucosa resumed normal features. Another 
remarkable fact was that some of the patients who conceded small diet in- 
fringements showed a completely normal mucosa in the repeat biopsy 
specimen, whereas others showed a flat mucosa after supposedly strict ob- 
servance of the diet for over 10 years.
Comment
Lesions of the intestinal mucosa gradually ameliorate after gluten with­
drawal. This improvement is first apparent in the enterocytes. Within a few 
days, the enterocytes resume a normal intracellular structure and an intact 
brush border (655, 782). The recovery of the intestinal villi is much slower 
and can sometimes be demonstrated only by morphometric methods (135). 
The transition from a flat mucosa to a normal mucosa with finger-shaped 
villi takes place via intermediate stages, like convolutions, ridges and leaf- 
shaped villi (fig. 3.5). In some cases it may be years before all these stages are 
completed and the intestinal mucosa looks normal again (818).
Actually, it is rather incomprehensible why the complete restoration of 
the villous morphology takes so long. If the food no longer contained toxic 
agents, then it could be expected (in view of the rapid turnover of the in­
testinal epithelium) that the mucosa should return to normal within a few 
days to weeks. In-vitro culturing of flat jejunal biopsy specimens of untreated 
coeliac patients, showed incipient formation of villi within 48-72 hours 
(446, 862). According to Jos et al. (446), certain other noxious factors delay 
or prevent restoration of the mucosa in coeliac patients, such as incompletely 
degraded nutrients which as a result of the increased permeability of the 
epithelium enter the intestinal mucosa. It has also been suggested that local 
immunological factors impede rapid restoration of the mucosa (260).
It is customary to verify the effect of the gluten-free diet by taking a repeat 
biopsy specimen from the jejunal mucosa in all patients. As with the initial 
biopsy specimen on which the diagnosis was based, the secondary specimen 
is usually taken slightly distal to the ligament of Treitz. I t is quite possible, 
however, that this is not the most suitable site for a control biopsy, as the 
mucosal abnormalities at this level disappear last of all, long after more 
distal intestinal loops have already become normal (734, 817). Perhaps even 
more important is the fact that the initial lesion can have been so severe that 
no restitutio ad integrum is possible (737). More exact information can be
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obtained by performing multiple biopsies, preferably also from more distal 
intestinal loops. It can thus be established whether the lesions have become 
less extensive (218, 737). The effect of gluten withdrawal can also be deter- 
mined on the basis of a single biopsy specimen from the first jejunal loop, 
provided one pays special attention to the morphology of the individual 
enterocytes (818).
We personally observed an entirely normal villous pattern in only 6 out 
of 39 repeat biopsies. The majority of publications on the effect of the gluten- 
free diet on the mucosal morphology indicate unchanged, or still severe 
lesions of the proximal jejunal mucosa in a substantial number of patients 
(37, 60, 82,113,128,160). This may well be a result of poor observance of the 
diet, as Dissanayake et al. (218) observed a normal jejunal mucosa in 16 of 
a total of 18 patients on a strict gluten-free diet.
The question whether or not complete morphological restoration always 
occurs after gluten withdrawal probably remains controversial as long as it 
is impossible to ascertain strict observance of the prescribed diet. In prac- 
tice, however, it seems sufficiënt to require only improvement rather than 
normalization of the morphology for verification of the diagnosis ‘coeliac 
sprue’ (30).
9.3 ADDITIONAL MEASURES
9.3.1 Further dietary restrictions
Patients with coeliac sprue are regularly sufïering from lactose intolerance. 
In our own series, the lactose tolerance test revealed evidence of intolerance 
in 4 untreated patients. As such this is not surprising, because the mucosal 
damage may lead to lactase deficiency (section 7.3). It is advisable to per- 
mit little or no milk in the early phase of treatment as it may cause ab­
dominal symptoms in some patients; even long after the institution of the 
gluten-free diet lactose may not be tolerated (26, 152,160, 907).
Restriction of the use of other disaccharides such as sucrose or maltose 
has been recommended for juvenile coeliac patients (26, 148), but seems 
unnecessary for adults.
Cooke’s observation (163) that in exceptional cases the diarrhoea did not 
disappear until after abstinence from eggs, has not so far been corroborated 
by others.
Some investigators recommend restriction of the amount of fat in the diet, 
particularly for children (818). There are some theoretical arguments in 
favour of this. As the fat absorption is usually still disturbed in patients re-
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cently placed on a gluten-free diet, part of the non-absorbed dietary fat may 
enter the colon, where it is degraded by bacteria to, among other things, 
volatile fatty acids. These fatty acids can cause an increased frequency of 
defaecation. On the basis of practical experience, however, we do not believe 
that fat restriction is often indicated. In only one exceptional case were we 
forced to prescribe a low-fat diet, as the following case history shows.
Patiënt no. 17 (fig. 9.6) had complained o f  abdominal pain and lassitude through- 
out her childhood. A t age 40 she was referred for cachexia (body weight 46 kg, 
height 1.73 m ) and severe megaloblastic anaemia (haem oglobin 3.2 m m ole/1) as a 
result o f  folate deficiency. Coeliac sprue was diagnosed on clinical grounds and 
an obvious improvement was seen after gluten withdrawal and folie acid supple- 
tiön. The body weight increased by 20 kg, and the serum haem oglobin, albumin 
and fat absorption became normal. After 8 months the diet was discontinued at the 
patient’s request. A bout a year later her condition was found to have seriously 
deteriorated. She had lost 5 kg body weight, showed hypoalbuminaemia (28.7 g/1)
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Fig. 9.7. Diagram of the effect of additional prednisone medication and L.C.T.-fat restric­
tion in a coeliac patiënt on gluten-free diet (case history no. 17). As parameters are chosen 
the body weight, serum albumin concentration, enteric plasma protein loss and fat absorp­
tion coëfficiënt.
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and had a fat absorption coëfficiënt of 87 %. At the time the biopsy specimen from 
the small intestine showed a flat mucosa. After 8 months on a gluten-free diet the 
mucosa showed a marked improvement; body weight increased by 4 kg, fat absorp­
tion increased from 87 % to 94 %, and the protein loss decreased from 340 ml to 95 
ml plasma per day. About 2 years after reinstitution of the diet, deterioration oc- 
curred for no apparent reason. At the time, subepithelial collagen deposition was 
for the first time observed in the flat jejunal biopsy. She lost 16 kg body weight, 
and developed extensive hypoproteinaemic oedema. During clinical observation 
(in order to ensure strict observance of the diet), no improvement was observed. 
Administration of prednisone (initially 40 mg per day, but later gradually less) 
caused only a partial, transient improvement. Ultimately a low-fat diet was pre- 
scribed, with suppletion of calories in the form of MCT fat. This was followed by 
a spectacular improvement, which persisted even after discontinuation of predni­
sone. The mucosal abnormalities in the proximal jejunum also improved. The 
biopsy specimen ultimately showed somewhat plump but otherwise virtually normal 
villi without subepithelial collagen deposits. The patiënt still keeps a fat-restricted, 
gluten-free diet, and has so far remained free from symptoms. Apart from a slightly 
decreased serum folate concentration, she shows no biochemical abnormalities.
Comment
The above case history shows that there may be reasons present for fat re­
striction other than the wish to prevent formation of volatile fatty acids in 
the colon. Our presumption in this case was tha t the high enteric protein 
loss resulted from an obstructed intestinal lymph drainage, due to abnormal 
mesenteric lymph nodes. Dietary fat restriction reduces the amount of chyle 
in the intestinal wall which has to be transported, so that the demand on the 
draining capacity of the intestinal lymphatic system is reduced. A reduction 
of lymph congestion may result in a decreased enteric protein loss (section 
6.5).
9.3.2 Replacement therapy
Although absorption of food constituents improves and becomes normal 
soon after gluten withdrawal, it seems nevertheless sensible to prescribe 
temporary supplements of some lacked nutrients. Replacement therapy is 
probably not strictly necessary, but it does ensure a rapid disappearance of 
deficiencies developed in the course of time. O f our group of 39 coeliac 
patients, 20 received supplements o f iron, folie acid, vitamin B12, vitamin D 
or calcium in the initial phase of therapy. Vitamins A, E or K were occasion- 
ally also suppleted. When the patiënt is in a deplorable condition at the start 
of diet treatment, replacement therapy -  by preference parenterally -  is 
strongly recommended.
201
9.3.3 Parenteralfeeding
In patients with very severe diarrhoea it may be advisable to administer all 
food parenterally. We ourselves were never forced to resort to total parente­
ral feeding except in 2 cases of refractory sprue (section 11.4). Modigliani 
et al (601) observed in 5 coeliac patients a spectacular improvement after 
parenteral feeding, such as an immediate arrest of diarrhoea, rapid weight 
gain and improvement of the mucosal morphology.
9.3.4 Administration o f  glucocorticosteroids
Four coeliac patients who had been referred to us with unexplained symp­
toms of malabsorption, had for some time been using glucocorticosteroids 
in view of a concomitant disease, such as rheumatoid arthritis, Besnier- 
Boeck-Schaumann disease or a suspected systemic condition. In spite of 
relatively large doses of prednisone (15-25 mg) or dexamethasone (1.5 mg), 
they continued to have or even developed severe symptoms of diarrhoea 
and malabsorption.
Of the total group of 47 coeliacs, 8 patients were temporarily given pred­
nisone beside a strict gluten-free diet. Four patients had initially responded 
to gluten withdrawal but later showed no or hardly any response (patients 
no. 2, 5, 17 and 46), while the other 4 patients received corticosteroids in 
view of their poor general condition at the start of treatment. In the latter 
category of patients the effect of this medication was impressive, and the 
glucocorticosteroids could be gradually discontinued after 4-10 months 
without any untoward effect.
The following case history illustrates that no favourable response to 
gluten withdrawal can be forthcoming until glucocorticosteroids are given 
in addition.
Patiënt no. 5 was found to suffer from coeliac sprue at age 62. Diarrhoea had 
existed since early childhood, but had shown Progressive exacerbation in the last
5 years. During this period the body weight decreased by about 10 kg (to 53.2 kg  
while 1.72 m  tall), and the patiënt developed megaloblastic anaemia (haemoglobin  
concentration 6.5 mmole/1) and hypoalbuminaemia (34.4 g/1). A  few months be- 
fore he was referred to us, the patiënt had twice been hospitalized because o f para- 
lytic ileus (fig. 6.3). At that time, laparotomy had revealed no abnormalities o f  the 
abdominal organs. Since a systemic disease was suspected, the patiënt had received 
prednisone (20 mg per day) during the last 2 years. W e discontinued the predni­
sone medication when he was admitted and prescribed a gluten-free diet because a 
jejunal biopsy had revealed a flat jejunal mucosa. Despite strict observance o f  the 
diet and supplements o f  folie acid, vitamin B12 and all fat-soluble vitamins, the
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patiënt showed no improvement; 2 months later, the clinical condition seemed to 
have deteriorated rather than improved. The clinical course took a surprising turn 
when 40 mg prednisone per day was prescribed in addition to the gluten-free diet 
(table 9.4). The prednisone was discontinued after 7 months. Today, some 5 years 
later, the patiënt is in excellent condition on a gluten-free diet. The body weight is
69.2 kg, and there are no biochemical abnormalities other than a slightly decreased 
D-xylose excretion (3.9 g in 5 hours). The jejunal biopsy specimen shows a con­
voluted pattern.
Table 9.4. Effect of additional treatment with glucocorticosteroids in a coeliac patiënt 
not responding to a gluten-free diet (patiënt no. 5).
PARAMETER NO DIET
PREDNISONE 
(20 mg)
GLUTEN-FREE 
DIET (8  W k s)  
NO PREDNI­
SONE
GLUTEN-FREE 
DIET (1 6  W k s)  
PREDNISONE
(4 0  m g ,  8  w k s )
Body weight (kg) 53.2 4 8 .6 5 9 .6
Haemoglobin (mmole/l) 6.2 4.8 7.7
Serum albumin (g/1) 34.4 34.7 49.9
Serum cholesterol (mmole/l) 2.9 3.2 4 .9
Fat absorption (%) 5 9 N.D. N.D.
Comment
More or less at the same time as the first publications on the results of diet 
treatment, reports were published on the favourable effect of glucocorti­
costeroids and ACTH in patients with probable coeliac sprue (8, 509, 538). 
Later, partial improvement of the intestinal lesions and malabsorption in 
patients with biopsy-proven coeliac sprue was also demonstrated during 
administration of prednisone (40 mg/day) (886) or dexamethasone (1.5 
mg/day) (653). In-vitro organ culture studies of jejunal biopsy specimens 
from coeliac patients likewise proved that hydrocortisone can prevent the 
harmful effects of gluten (463). The mechanism of action of corticosteroids 
in this respect is still obscure, but various hypotheses have been advanced 
(463, 886).
The effect of glucocorticosteroids has been found to be decidedly inferior 
to that of a gluten-free diet. In 4 of our patients no effect on the intestinal 
symptoms or malabsorption was observed despite administration of a fair 
dose of prednisone (15-25 mg per day). Other investigators have also noticed 
that treatment with glucocorticosteroids often produced little effect in coeliac 
patients who subsequently responded quite well to a gluten-free diet (233).
203
A very evident indication for glucocorticosteroids exists in patients who 
show no or only an insufficiënt response to gluten withdrawal (128, 357,409). 
This is demonstrated clearly by the case history of patiënt no. 5. That this 
effect is not based on coincidence was demonstrated by in-vitro experiments 
described by Klaeveman et al. (479). They demonstrated that biopsy speci­
mens from a patiënt with ulcerative jejunoileitis showed no normalization 
during tissue culturing until glucocorticosteroids were prescribed in addi- 
tion to a gluten-free diet. No explanation of this effect has so far been found.
Another indication for glucocorticosteroids exists in patients whose con- 
dition is so poor that a rapid favourable turn in the clinical course is urgently 
required. We personally observed an impressive improvement in 4 patients 
who were in very poor condition.
Whenever glucocorticosteroids are contraindicated, azathioprine medica- 
tion can be tried instead (357).
9.4 COMPLICATIONS
9.4.1 Introduction
The preceding sections may have given the impression that the treatment of 
patients with coeliac sprue poses no problems. This will hold for the majority 
of cases. Once coeliac sprue is diagnosed, the average patiënt is likely to make 
a complete recovery within a few months of gluten withdrawal. Occasion- 
ally, however, the disease takes a different course. The absolute number of 
patients with a complicated course is probably small; yet we observed 
complications in a total of 8 out of 47 patients. (patients no. 2, 5, 17, 21, 27, 
34, 46, 47). This large number is probably due to the fact that our patients 
formed a selected group due to referral from other hospitals. Brief case 
histories of these patients are presented in the following sections (so far as 
they have not been presented elsewhere in this study).
9.4.2 Abnormal bacterialflora
Patiënt no. 21, a wom an in w hom  coeliac sprue was diagnosed at age 60, initially  
showed a good improvement after gluten withdrawal and a 3 weeks course o f  pred- 
nisone in view o f  her poor general condition. In the course o f 6 m onths, she gained
3.5 kg body weight but showed no improvement in biochemical parameters such 
as serum albumin concentration (35 g/1) and D -xylose excretion (1.7 g in 5 hours). 
A  severe relapse occurred after 6 months: the patiënt produced watery stools 10-20 
times daily, and showed a considerable weight loss. The intestinal m ucosa regressed
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from a convoluted pattern to  a flat mucosa. The patiënt fervently denied negligence 
in observing the diet. Antigluten antibodies were not demonstrable in the serum. 
Laboratory findings (‘breath’test for bile acid deconjugation and indican excretion) 
were suggestive o f  bacterial overgrowth, and the faeces contained numerous Can- 
dida fungi. Treatment w ith m iconazole (250 mg q.i.d. orally) was follow ed by 
disappearance o f  symptoms within 48 hours, while the ‘breath’test and indicanuria 
became almost normal. A  relapse which developed a few months later, was effec- 
tively controlled with tetracycline (table 6.4).
Comment
An abnormal intestinal flora is relatively common in coeliac patients (sec­
tion 6.11). In the majority of cases this abnormal bacterial flora probably 
causes few symptoms. The above case histories, however, demonstrate that 
serious effects may develop. Symptoms such as nausea, meteorism, ab­
dominal pain and diarrhoea can in some cases be ascribed to an abnormal 
intestinal flora, after exclusion of other possible causes. In some cases this 
abnormal flora gives rise to biochemical abnormalities, such as malabsorp­
tion of D-xylose or vitamin B12. It is of importance to account for this 
possibility in order to ensure effective therapy and, on the other hand, to 
avoid erroneous conclusions concerning diet observance or gluten insensi- 
tivity.
9.4.3 Other complications
A t age 60, patiënt no. 27 was placed on a gluten-free diet in view o f  severe diarrhoea 
which she had contracted 6 m onths earlier during a Mediterranean trip. She had 
had abdominal symptoms as a child, but these had disappeared at age 12. Before 
institution o f  a gluten-free diet a jejunal biopsy was taken, which showed a flat 
mucosa. In view o f  her poor condition, expressed by anaemia (haem oglobin con­
centration 5.8 mmole/1), marked hypoalbuminaemia (19 g/1), fat malabsorption 
(47% ) and hypomagnesaemia (0.63 mmole/1), glucocorticosteroids were given in 
addition. The patiënt initially showed improvement: the body weight increased 
by 11 kg (without oedema), the anaemia and hypoalbuminaemia disappeared, and 
the serum magnesium concentration also returned to normal. Scarcely 6 months 
later she had to be readmitted with a severe relapse o f  diarrhoea and marked 
electrolyte disturbances (plasma K+ 2.7 mmole/1; plasma H C O :, 15.8 mmole/1), 
fat malabsorption (64% ) and hypoalbuminaemia (17 g/1). Her situation was com- 
plicated by an arterial occlusion in the left lower leg, for which anticoagulants 
were prescribed. She admitted to  having taken normal bread for several months. 
After an increase o f  the prednisone dosage and re-institution o f  the diet, she made 
another surprising recovery within a few weeks. Three months later, however, she 
again discontinued the regimen and severe malabsorption developed once more. 
Anticoagulant medication had further caused recurrent epistaxis and severe blood  
loss in urine and faeces. Consequently there was marked anaemia (2.3 mmole/1),
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and severe electrolyte disturbances (plasma K + 2.2 mmole/1; plasma H C 0 3_ 12.4 
mmole/1). Renal function, which had previously been fair, was markedly reduced 
(creatinine clearance 17 ml/m in). In the course o f  a few m onths the renal function  
deteriorated further, and led eventually to  a fatal issue. At post-mortem examina- 
tion, both kidneys showed features o f extensive interstitial fibrosis and som e intra- 
tubulary located oxalate crystals. The glomeruli appeared completely normal.
Patiënt no. 34, whose defaecation pattern had been abnormal all his life, under- 
went a laparotomy for faecal vomiting at age 68. A t this operation, markedly 
distended intestinal loops were found, without any sign o f  organic obstruction. 
Additional findings were enlarged mesenteric lymph nodes, w hich showed no 
specific abnormalities at histological examination. After this laparotomy the pa­
tiënt was transferred to  our department, where studies revealed malabsorption o f  
fat (60% ), vitamin B12 (1.7%  67Co-vit B12 excretion in 48 hours), and D -xylose  
(1.6 g in 5 hours). Additional findings were an iron deficiency anaemia (H b 6.3 
mmole/1), and decreased serum concentrations o f albumin (30.7 g/1) and vitamin 
E (4.0 jj.mole/1). Since a jejunal biopsy specimen showed a flat m ucosa, a gluten- 
free diet was prescribed. Before the effect o f gluten withdrawal could be evaluated  
the patiënt died as a result o f  cardiac failure by recurrent arrhythmia. Post-mortem  
examination revealed no abnormalities o f  the abdominal organs other than a so- 
called brown bowel due to accumulation o f ceroid in the muscular layer (847). A  
conspicuous amount o f  ceroid pigment was likewise found in the myocardium. It 
is not inconceivable that the cardiac arrhythmia in this patiënt resulted from  myo- 
cardial degeneration caused by vitamin E deficiency, among others.
Comment
Renal failure, the direct cause of death in patiënt no. 27 has also been 
reported by other investigators (489, 724). In both publications the suspicion 
was expressed that this renal failure had to be ascribed to  a tubulopathy, 
which could have resulted from a disturbed electrolyte balance due to 
vomiting, diarrhoea and malabsorption. The real cause of renal failure in 
our patiënt is difficult to indicate. Transient tubular necrosis could have 
been provoked by hypotension and potassium deficiency. This does not ex- 
plain, however, her progressivély deteriorating renal function. It is more likely 
that the interstitial fibrosis was caused by the diuretic agent furosemide 
(534a), prescribed in view of hypoalbuminaemic oedema. Besides hyper- 
oxaluria, often present in coeliac sprue (574a), may have played an im­
portant role.
It need not be argued that many other complications are conceivable in 
the course of coeliac sprue. Some may be the result of the therapy given, 
such as a perforation of the stomach by glucocorticosteroid medication 
(patiënt no. 2) or sepsis caused by an in-dwelling intravascular catheter 
(patiënt A, section 11.4). Similar complications have been reported by other
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investigators (90, 601). The same applies to the causes of death (843) which, 
in view of their often accidental nature, will not be further discussed.
9.4.4 Malignant degeneration and malignancies
A t age 55, patiënt no. 2 was diagnosed as having coeliac sprue, which had given 
rise to  attacks o f  tetany over a period o f  15 years. T he biopsy specimens from his 
jejunum showed not only a flat mucosa but also a marked degree o f  subepithelial 
collagen deposition (fig. 11.3). The patiënt responded to gluten withdrawal by a 
weight gain o f  12 kg (from 57 kg to 69 kg, while 1.66 m tall) and normalization o f  
the haem oglobin concentration (from 7.1 to 8.7 mmole/1), serum calcium concen­
tration (from 2.1 to 2.39 mmole/1) and serum cholesterol concentration (from 3.9 
to  5.0 mmole/1). The serum albumin level rose from 40  to  44 g/1, D-xylose excretion 
from  1.3 to 3.2 g per 5 hours, and the fat absorption coëfficiënt from 40 to 85%. 
Four years after the institution o f  the diet the patiënt began to complain o f  epi- 
gastric pain, nausea and vomiting. A t that time jejunal biopsies showed the same 
flat mucosa as specimens obtained before gluten withdrawal. During clinical ob- 
servation no effect o f  the gluten-free diet was observed either. Extreme dietary fat 
restriction also failed to give any improvement. The frequency o f defaecation, 2-4 
times daily in previous months, increased to 10-15 tim es daily. There was Progres­
sive weight loss to 52 kg, which even had to be corrected for the presence o f  marked 
hypoproteinaemic oedema (albumin 30 g/1 with an enteric plasma loss o f  200 ml/ 
day). The fat absorption decreased again to 50%, associated with a decreased 
vitamin E concentration (7.4 mmole/1) and an abnormally low thrombotest (41 %). 
Treatment with 40 mg prednisone daily, first by m outh and later parenterally, 
caused no improvement. The amount o f  faeces did n ot decrease during administra­
tion o f  an elementary diet or total parenteral feeding, and was eventually 1600-3300 
g per day. After 2 months o f  treatment with large doses o f  prednisone, intestinal 
perforation symptoms suddenly occurred. Subsequent laparotomy disclosed per- 
foration o f  the duodenal bulb as well as an extensive adenocarcinoma o f  the gall- 
bladder with multiple metastases in the liver. The last finding was a surprise be­
cause liver function tests had not been disturbed (alkaline phosphatase activity 78 
U /l; BSP retention 1.8%). The patiënt died from com plications during the post- 
operative phase. Post-mortem examination revealed multiple superficial ulcers in 
duodenum and jejunum, and subepithelial collagen accumulation in the intestinal 
mucosa.
Patiënt no. 47 had suffered from intermittent diarrhoea and vomiting during som e 
years in childhood. H e had in addition been treated for rickets. Diarrhoea and 
weight loss recurred at age 42. Fatty and pale stools were produced 5 times daily. 
The patient’s weight was reduced by about 8 kg to 45.6 kg (height 1.68 m), and he 
was suffering from general malaise, anorexia and vague abdominal pain. Physical 
examination revealed no abnormality other than a poor nutritional condition. 
Biochem ical tests disclosed fat m alabsorption (48 %) as well as a markedly de­
creased absorption o f vitamin B la (3 % excretion in  48 hours) and D -xylose (1.0 g 
excretion in 5 hours). A  gluten-free diet was prescribed because a jejunal biopsy  
specimen showed a flat mucosa. This was follow ed by subjective improvement and
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a weight gain o f 2 kg. Four weeks after gluten withdrawal Progressive obstructive 
jaundice necessitated a laparotomy, however. This revealed an inoperable tumour 
in the head o f  the pancreas, and multiple metastases in the liver. The patiënt died
2 months later.
Comment
Although there had been several earlier publications on the association of 
steatorrhoea with malignant processes of the digestive tract and elsewhere in 
the organism (see 822 for a review), Gough et al. (324) were the first to 
suggest that neoplastic lesions could be a complication of coeliac sprue. 
Until that time it had often been thought that the malignancy was the 
primary condition, and steatorrhoea the consequence, resulting from 
malignant infiltration of the intestinal wall or lymph obstruction in the 
mesenteric lymph nodes. The coeliac patients described by Gough et al. 
(324) had for the most part suffered from steatorrhoea over many years 
before a malignant process became manifest. The jejunal mucosa in these 
patients, moreover, was consistent with coeliac sprue and, more specifi- 
cally, showed no tumour infiltration. After Gough et al. (324), many others 
have described malignant processes in coeliac patients (32, 60, 104, 128, 256, 
393,413, 473, 667, 817, 843). In our own series of 47 patients we found twice 
a malignancy, being an adenocarcinoma of the gall-bladder and of the 
pancreas.
Several investigators maintain that a malignant process outside the di­
gestive tract can as such cause mucosal abnormalities which are strongly 
reminiscent of those observed in coeliac sprue (176, 200, 241, 245, 508, 643, 
794). If this is true, the incidence of it must be very low (200, 521). One 
cannot exclude the possibility, moreover, that these exceptional patients 
were also suffering from (previously asymptomatic) coeliac sprue.
An important fact is that the risk of malignant lymphoma or malignancy 
in coeliac patients far exceeds the statistical expectation. Harris et al. (365) 
were the first to demonstrate this statistical significance. Their conclusions 
were later confirmed by Stokes et al. (822) and Whorwell et al. (914). In 
view o f this increased risk of malignancy, many ‘coeliac centres’ forcibly 
advise their patients to observe a gluten-free regime for life. The argument is 
usually that the harmful effect of dietary gluten on the jejunal mucosa would 
increase the risk of malignant degeneration. So far, however, there is no 
evidence to support the statement that gluten withdrawal reduces the risk of 
malignancies (365, 822, 914). It is strange, moreover, that most of the 
malignant processes observed are localized outside the jejunum (365), and 
that relatives of coeliacs also seem to run an increased risk (50, 822).
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On the basis of common experience the general opinion is that develop- 
ment or exacerbation of abdominal pain, fever, anorexia, weight loss or 
skin lesions should raise a suspicion of the presence of a malignant process 
(112). The fact that a patiënt who used to respond well to gluten withdrawal 
suddenly deteriorates and develops features of refractory coeliac sprue, is 
likewise suggestive of the presence of a malignant process (patiënt no. 2; 
112, 324).
9.5 CONCLUSIONS
1. The spontaneous course of coeliac sprue is somewhat variable, due to 
abrupt exacerbations and symptom-free intervals.
2. The evaluation of the effect of gluten withdrawal is seriously hindered by 
the impossibility of assessment of the adherence to the diet.
3. The effect of diet treatment on clinical symptoms depends on the clinical 
presentation before gluten withdrawal. Rapid improvement is seen in 
patients suffering from diarrhoea, glossitis or stomatitis. Symptoms 
resulting from chronic malabsorption take longer to ameliorate, while 
complaints o f Iassitude or abdominal pain often persist.
4. Biochemical abnormalities improve in general after gluten withdrawal. 
Patients who admit to adhere poorly to the diet show, apart from the 
Schilling test, no more abnormal biochemical tests than those who 
supposedly observe the prescribed diet more faithfully.
5. The effect of gluten withdrawal on the mucosal morphology of the 
proximal jejunum is often disappointing. A normal villous pattern was 
seldom found, and never observed within 2 years of diet therapy.
6. It is advisable to take additional measures in the early phase of treatment, 
such as restriction of milk (lactose) or fat, and replacement of lacked 
nutrients.
7. Patients in a poor general condition do benefit from additional glucocor- 
ticosteroid medication. In exceptional cases gluten withdrawal is in­
sufficiënt to cause any improvement until glucocorticosteroids are given 
temporarily in addition.
8. An abnormal intestinal flora may be partly responsible for the malab­
sorption syndrome in coeliac sprue, necessitating in some patients the 
prescription of antibiotics.
9. Malignancies are relatively often seen in coeliac patients. Exacerbation 
of symptoms and the occurrence of therapy-resistance should raise a 
suspicion on the presence of a malignant process.
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CHAPTER 10
ASSOCIATION WITH OTHER DISEASES
10.1 INTRODUCTION
Reports on the association of coeliac sprue with other diseases have re- 
gularly been published (56, 764). The fact that some coeliacs suffer from 
concomitant diseases is as such not strange. The incidence of some condi­
tions, however, exceeds that in the remainder of the population. A well- 
known example of this is the association of coeliac sprue with dermatitis 
herpetiformis (DH) (57, 106, 287, 296, 557, 560, 849). The association be­
tween coeliac sprue and other diseases is much less pronounced, but the 
possibility of a certain relation between these diseases and coeliac sprue is 
still open for the time being.
10.2 DERMATITIS HERPETIFORMIS
10.2.1 Personal observations
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Fig. 10.1.a. Diagram of various biochemical investigations in dermatitis herpetiformis 
patients with villous abnormalities.
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Fig. lO.l.c. Diagram of various biochemical investigations in untreated coeliac patients.
We examined a total of 34 patients with DH, which had been diagnosed on 
the basis o f the morphological aspect and localization of the lesions, and 
verified by histological examination of a skin biopsy specimen. Another 
necessary criterion was the favourable effect of dapsone on the skin lesions 
and symptoms.
On the basis of preferably multiple biopsy specimens from the proximal 
jejunum, abnormalities of the intestinal mucosa were determined in exactly
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Table 10.1. Abnormal biochemical results in dermatitis herpetiformis patients.
AUTHORS SERUM
IRON
SERUM 
VIT B12
57C o -v it  
B12 e x ­
c r e t i o n
SERUM
CHOLES­
TEROL
HAEMO­
GLOBIN
SERUM
ALBUMIN
D-XYLOSE
EXCRE­
TION
FAT
ABSORP­
TION
SERUM
FOLATE
Fraser et al. 2/12 0/12 4/11 5/11
(1967)
Fryetal. 4/13 1/13 0/13 5/13 7/13 11/13
(1967)
Marks et al. 14/27 3/17 1/28 15/28 7/25 18/27
(1968)
Shuster et al. 4/16 0/10 3/13 3/13 6/18
(1968)
Brow et al. 0/14 0/10 0/5 18/22 2/21 2/21 16/18
(1971)
Sönnichsen et al. 3/5 2/7 2/7
(1971)
Ruppin et al. 6/15
(1975)
Own series 2/23 4/7 2/23 12/25 10/28 8/20 4/6 5/18
50% of these 34 DH  patients. The biopsy specimen showed an entirely flat 
mucosa in 6, a so-called convoluted pattern in 7, and only minor changes 
such as ridges or leaf-shaped villi in 4 of these patients. Of the 17 patients 
with mucosal abnormalities, 4 showed a clinically and biochemically manifest 
malabsorption syndrome, so that they were considered as coeliac patients.
As mentioned, 50% of our D H patients showed no abnormalities of the 
intestinal villi. Since in 14 cases only a single biopsy specimen had been ob- 
tained from the jejunal mucosa, all patients were invited for secondary 
multiple biopsies. In 5 cases no repeat biopsy was obtained owing to inter- 
current death (1), very advanced age (2) or refusal to cooperate (2). Se­
condary multiple biopsies never necessitated revision of the previous classi- 
fication. The multiple biopsy specimens, usually 6 per patiënt, revealed 
mucosal abnormalities in none of these cases.
Biochemical tests were carried out both in the DH  patients with villous 
abnormalities (including the above mentioned 4 coeliacs) and in those with a 
normal villous pattern. The results are presented in fig. 10.1 (a and b). For 
comparison, the results of our group of 36 coeliac patients are also listed 
(fig. lO.l.c). Statistical analysis (Wilcoxon signed-rank test) of the bioche­
mical test results revealed a significantly higher concentration of haemoglo- 
bin, folate and cholesterol in blood or serum of D H  patients without mucosal 
lesions, compared to those with an abnormal jejunal mucosa. The D-xylose 
test differed also significantly.
Analysis of the biochemical results shows that decreased serum iron or 
cholesterol concentrations were rarely found in our DH  patients. M alab­
sorption of D-xylose and vitamin B12, however, was relatively common, 
and the same applies to a decreased serum folate level, hypoalbuminaemia 
and steatorrhoea. A striking feature was that a decreased serum albumin 
level was found as often in DH  patients with as in those without villous 
abnormalities. However, the former showed a significantly higher incidence 
of anaemia and D-xylose malabsorption.
10.2.2 Comment
The association between DH and coeliac sprue was quite evident in our 
observations. Four patients with coeliac sprue were suffering also from DH. 
The biochemical findings showed that a subclinical form of malabsorption 
was present in many more DH patients. This was quite evident in the group 
of DH patients with an abnormal villous pattern : biochemical abnormalities 
were found in 14-67% of the cases. Malabsorption seemed to be less common
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in the group of patients with a normal jejunal mucosa, but it was still present 
in a substantial number of patients.
Similar absorption studies in patients with DH have been published 
(table 10.1). Comparison reveals a number of discrepancies. Some authors 
found a high incidence of an abnormal haemoglobin concentration (106), 
serum iron (296), folate (106), vitamin B12 (560), or albumin concentration 
(740). Absorption studies also yielded different results; some reports listed a 
high incidence of malabsorption of vitamin B12 (811), fat (296) or D-xylose 
(560). Our own observations also differ in some respects from those reported 
by others as regards serum folate and albumin levels (table 10.1). Differences 
in the composition of the various investigated groups are most likely to 
account for this. Only some of the biochemical abnormalities, such as 
anaemia or abnormal D-xylose test, were found to depend on the presence 
or absence of morphological mucosal lesions (fig. lO.l.a and b). Others have 
confirmed this with regard to  anaemia, steatorrhoea or decreased D-xylose 
excretion (296, 560).
We found an abnormal villous morphology in exactly 50% of our DH 
patients. Most other investigators found a decidedly higher incidence (table 
10.2). Since mucosal lesions may be patchy in D H  patients (106), multiple 
biopsies are advised. In all DH patients with a normal mucosa in a single 
specimen, however, the multiple secondary biopsies also failed to reveal 
villous abnormalities.
Some investigators hold that all DH patients have an abnormal intestinal 
mucosa, even if  it looks apparently normal. Fry et al. (298), for example, 
found an increased number of lymphocytes among the enterocytes in the 
jejunal biopsy specimen in virtually all their cases. In perfusion studies, 
Kumar et al. (494, 495) demonstrated that absorption in the jejunum of DH 
patients was usually abnormal, even when the mucosal morphology appe- 
ared normal. The high incidence of hypoalbuminaemia in our DH patients 
without villous abnormalities, supports this observation. An important 
argument in this context can be found in the observations of Weinstein et al. 
(901). These investigators found that the morphologically normal jejunal 
mucosa in 2 D H  patients became pathological within a few months on a high- 
gluten diet. This phenomenon was not observed in two healthy volunteers 
tiven the same high-gluten diet. Taken together, these observations indicate 
that the jejunal mucosa is essentially abnormal in every DH patiënt, and 
sensitive to gluten if sometimes only in large doses.
The association between DH  and coeliac sprue has not so far been fully 
explained. Several observations, often not more than fragments of the 
aetiological puzzle, indicate an immunological pathogenesis (299). It has
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Table 10.2. Villous morphology in dermatitis herpetiformis patients.
AUTHORS NUMBER OF FLAT CON­ SLIGHTLY NORMAL
PATIENTS MUCOSA VOLUTED AB­ MUCOSA
INVESTI- MUCOSA NORMAL
GATED MUCOSA
Fraseretal. 12 3 4 2 3
(1967)
Bendl et al. 10 3 — 2 — 5
(1968)
Marks et al. 26 5 13 8
(1968)
Marks et al. 28 10 8 10 —
(1970)
Brow et al. 22 15 6 — 1
(1971)
Graber et al. 9 3 3 3 —
(1971)
Gebhard et al. 28 — 15 — 4 9
(1973)
White et al. 31 — 23 — 8
(1973)
Fryetal. 42 9 8 6 19
(1974a)
Ruppin et al. 16 16
(1975)
Own series 34 6 7 4 17
been established, for example, that immune complexes circulate in the blood 
of all DH patients (602). IgG and IgM antibodies against nuclear substance 
or reticulin are also regularly present in the blood (765). Several observa- 
tions indicate moreover, that IgA deposits are to be found in the skin of DH 
patients, both at the sites of lesions and in apparently unaffected parts of 
the skin (167, 585, 767). Apart from IgA, complement is also found in the 
lesions (768). A combination of the above mentioned findings would seem 
to suggest that the skin lesions in DH patients result from deposition of 
circulating immune complexes, involving IgA and complement (299).
For the moment this hypothesis raises more questions than it answers. 
The circulating immune complexes prove to be of a varying nature and are 
as frequent in DH patients with as in those without a gluten-free diet. Such 
complexes are also often found in the circulation of coeliac patients without 
DH (602). It is further not readily understandable why DH patients should 
often have an abnormal intestinal mucosa, whereas only a few patients with 
coeliac sprue develop DH. Until these questions can be answered, dermatitis 
herpetiformis has to be regarded as a separate, if associated, entity rather 
than as a complication of coeliac sprue.
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10.3 CONCOMITANT DISEASES
10.3.1 Personal observations
Several patients in our series had a concomitant disease or stated they had 
been suffering from other diseases as well. Table 10.3 lists these diseases and 
the number of cases observed.
Table 10.3. Concomitant diseases in coeliac sprue.
-  Observations in 47 patients. -  verg. Table 10.4
NUMBER OF PATIENTS
Diabetes
Hyperthyroidism
Idiopathic thrombopenia
Achlorhydria
Rheumatoid arthritis
Chronic bronchitis
Fibrosing alveolitis
Idiopathic pulmonary haemosiderosis
Sarcoidosis
Peptic ulcer
Intestinal diverticulosis
Ulcerative colitis
Renal tubular disease
Endometriosis
Stein Leventhal’s syndrome
XO-XY mosaicism
Anorexia nervosa
Vascular occlusive disease
4*
* Diagnosed and treated before referral.
10.3.2 Comment
The list of concomitant diseases in our patients shows that coeliac sprue can 
be associated with a wide variety of other diseases. Several publications have 
drawn attention to possible disease relationships (table 10.4). In view of 
personal observations as well as data from the literature, it seems question- 
able whether the incidence of these diseases in coeliac patients is higher than 
that in non-coeliacs. It would therefore seem rather premature to call these 
diseases associative, let alone to philosophise about possible explanations 
of this relationship (764).
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Table 10.4. Concomitant diseases in patients with proven or possible coeliac sprue.
-  cases collected from literature -
DISEASE NUMBER OF 
PATIENTS
REFERENCES
Diabetes 30 57, 72, 128, 163, 338, 358, 393,417, 
418, 484, 489, 499, 553, 601, 846, 
871, 873
Thyroid disease 17 163, 338, 493, 496, 499, 541, 601, 
796, 875
Addison’s disease 2 142, 323
Haemolytic anaemia 1 337
Achlorhydria 7 104,160,405
Acromegaly 1 601
Rheumatoid arthritis 3 104,256,337
Lupus erythcmatodes 2 795
Sjögren’s disease 3 498,685
Vasculitis-arteritis 8 221,372,601,795, 843
Polymyositis 4 372
Epilepsy 4 601,611
Neurological disorders 24 128,162,601
Chronic bronchitis 12 163,187,256,601
Fibrosing alveolitis 10 415,497,711,750
Idiopathic puim. haemosiderosis 1 502
Birdfancier’s lung 5 64
Hay fever 5 399
Sarcoidosis 2 393,458
Atopic eczema 4 399
Chronic hepatitis 13 46,142,163,256,338,476,499, 744
a 1-antitrypsin deficiency — 884
Cystic fibrosis 6 320,464,836
Pancreatic insufficiency 11 59, 60, 272, 489, 601, 682, 899
Eosinophilic gastroenteritis 1 59
Ulcerative colitis 4 160,257,744
Renal disease 2 489,724
Cystinuria 2 355,358
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CHAPTER 11
SPECIAL FORMS OF SPRUE
11.1 INTRODUCTION
Patients with coeliac sprue show per definition both a distinct clinical and 
biochemical improvement after gluten withdrawal. In addition the lesions of 
the small intestine in these patients should improve. In the characteristic 
case this improvement -  particularly that in clinical symptoms -  ensues 
rapidly and ultimately becomes a complete remission. Rubin et al. (736) 
maintain that complete remission occurs per definition in every coeliac 
patiënt on a strict gluten-free diet.
One is regularly confronted nevertheless with patients who show a slow 
and incomplete improvement upon gluten withdrawal, and who sometimes 
require other measures in addition, such as administration of glucocorti- 
costeroids (section 9.3). One generally tends to regard these patients as 
coeliacs (90), although some authors do not agree (736). This point of view 
is difficult to hold in the rare cases of patients who, like many other coeliacs, 
present with a malabsorption syndrome and a flat jejunal mucosa but, 
despite strict observance of a gluten-free diet and a variety of other measures, 
show progressive deterioration and ultimately die as a direct or indirect 
result of their malabsorption. Adequate classification of these cases is not 
yet possible. Terms such as ‘unclassified sprue’, ‘intestinal atrophy’ or ‘fatal 
malabsorption syndrome’ are used in this situation. Some investigators 
suspect a relation to coeliac sprue, and express this in terms such as ‘malig- 
nant coeliac syndrome’ or ‘unresponsive coeliac disease’. Their suspicion is 
usually based on the fact that the patiënt had previously shown a complete 
or incomplete remission in response to gluten withdrawal.
In some patients with such an unresponsive malabsorption syndrome, 
ulcerations of the small intestine are found (56). We consider it useful to 
discuss this group of patients in a separate section. The same applies to 
patients in whom increased deposition of collagen is found in the jejunal 
mucosa. In the final section personal observations on 2 patients with re- 
fractory sprue will be presented.
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11.2 ULCERATIVE DUODENOJEJUNOILEITIS
11.2.1 Introduction
Although the first reports on the presence of ulcers of the small intestine in 
patients with malabsorption date back at least 50 years (721), Bayless et al. 
(55) were the first to point out the more than accidental nature of this com- 
plication in patients with coeliac sprue. From the literature and from per­
sonal Communications up to 1974, they collected some 30 cases of ulcers in 
coeliac patients (56). A small number of cases can be added to this series, 
e.g. those reported by Krondl et al. (492), Haex (348), Marche et al. (555) 
and Connon et al. (154), as well as some of our own patients.
11.2.2 Personal observations
We encountered once a case of ulcerative duodenojejunitis, while in another 
patiënt a complication was seen, which may have been a result of a jejunal 
ulcer. Their case histories will be presented. In  addition we saw a female 
patiënt (no. 17, section 9.3), whose jejunal biopsy specimens showed exten- 
sive erosions, with marked infiltration of the mucosa by micro-organisms 
and granulocytes. The post-mortem on patiënt no. 2 (section 9.4) moreover, 
who died of a metastatised adenocarcinoma o f the gall-bladder, revealed 
multiple superficial ulcers in duodenum, jejunum and ileum which consisted 
of granulation tissue.
Patiënt no. 46 had suffered from rickets in childhood but reportedly had never had 
abdominal symptoms. At age 33 she had been treated for tuberculous cervical 
lymphadenitis. She was further under medical care in view of chronic bronchitis. 
At age 51 she was referred to our department with complaints of nausea, post- 
prandial vomiting, borborygmi and frequent passage of pulpy stools, symptoms 
which had been present over the past 7 years. An exploratory laparotomy had been 
performed prior to her referral, as a gastric carcinoma was suspected. No lesions 
of the stomach and other abdominal organs had been found on that occasion. In 
the course of these 7 years the patient’s body weight had decreased from 82 to 50 
kg (height 1.62 m). In view of extensive strictures in the duodenum and jejunum 
(fig. 11.1), another laparotomy was performed shortly after her referral. This re­
vealed a markedly distended duodenum with severe stenoses in the duodenum and 
proximal 70 cm of the jejunum. The wall of the proximal jejunum was swollen and 
several large lymph nodes were palpable in the mesentery. After resection of the 
proximal jejunum, a gastrojejunostomy was established in view of the non-resect- 
able lesions in the duodenum. Pathological examination of the resected intestine 
disclosed many ulcers of varying width and depth. Their floors and surroundings 
consisted of a cellular inflammatory infiltrate containing numerous granulocytes,
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Fig. 11.1. X-ray film of a barium-meal in a patiënt with ulcerative duodenojejunitis (pa­
tiënt no. 46; for case history see text).
lymphocytes, plasma cells and eosinophils. The submucosa showed extensive oe­
dema and proliferation o f  connective tissue, but there were no signs o f  granuloma 
formation or transmural inflammatory reaction. The muscularis m ucosae was in­
tact throughout. The m ucosa o f  the resected specimen showed short to absent villi 
in the proximal part, which seemed less abnormal at more distal levels. The en- 
larged mesenteric nodes showed a marked increase in plasma cells and eosinophils, 
again without granuloma formation. There were no signs o f  malignancy, moreover. 
Severe diarrhoea developed after the operation, and a few m onths later the patiënt 
showed symptoms o f  tetany and stridor. The corrected serum calcium level was 
only 1.59 mmole/1. A  biopsy specimen from the iliac crest showed marked osteo­
malacia. For other biochemical data we refer to table 11.1. In view o f  a flat mucosa  
in the biopsy specimen from the proximal jejunum, 40 cm past the gastro-entero- 
stomy, a gluten-free diet was prescribed. A bout a year later the patiënt feit sub- 
jectively improved, but no significant objective improvement was observed (table 
11.1). Her massive enteric protein leakage showed a favourable reaction on fat
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Table 11.1. Effect of additional treatment with glucocorticosteroids (25 mg prednisone) 
in a patiënt with ulcerative duodenojejunitis, poorly responding to a gluten-free diet 
(patiënt no. 46).
PARAMETER NO DIET ON DIET
(15 mths)
ON DIET (18 mths) 
& PREDNISONE
(30 mg; 3 mths)
Body weight (kg) 60.5 61.2 67.9
Fat absorption (%) 83 82 85
Serum cholesterol (mmole/1) 4.2 4.2 5.0
Serum albumin (g/1) 39.6 35.8 39.0
Enteric plasma leakage (ml/24 hrs) 140 200 30
D-xylose excretion (g/5 hrs) 0.7 7.0 6.8
Haemoglobin (mmole/1) 6.9 5.3 8.2
Plasma calcium (corr) (mmole/1) 1.62 2.23 2.38
restriction o f  the diet, which might indicate an obstructed intestinal lymph drainage 
(table 6.2). After prescription o f  glucocorticosteroids in combination with the 
gluten-free diet marked improvement o f  the body weight and enteric protein loss 
was observed within a few months (table 11.1).
Patiënt no. 48 (who, as the number indicates, presented after completion o f  our 
series) had tw o children long identified as coeliac patients. H e had been in good  
health all his life, but at age 69 experienced an acute attack o f  abdominal pain with 
restlessness and vomiting, necessitating analgesic injections. After a symptom-free 
period o f  about 6 months, the patiënt again developed symptoms o f  upper ab­
dominal pain with vomiting o f  bile-coloured fluid, and watery diarrhoea, 4  times 
daily. Physical examination o f  the emaciated patiënt (50.5 kg while 1.76 m tall) 
revealed no abnormalities other than a slightly atrophic tongue. The abdomen was 
not distended and no masses were palpable. Laboratory findings included anaemia 
(haem oglobin 6.0 mmole/1), marked hypoalbuminaemia (serum albumin 26.7 g/1), 
a decreased D -xylose test (2.3 g in 5 hours) and increased indicanuria (daily average 
300 m g). Radiographs o f  the small intestine revealed a fistula between the proximal 
jejunum and the transverse colon. A t about ths sam e site there was a fistula be­
tween the first and the second jejunal loop  (fig. 11.2). A t operation the fistular 
process proved to be readily resectable and the norm al continuity o f  jejunal loops 
and transverse colon was restored. Pathological exam ination o f  the resected spe­
cim en revealed no specific inflammatory lesions or any indication o f  a malignant 
process. The same applied to  the enlarged mesenteric lymph nodes. However, a 
flat jejunal mucosa was found in the proximal as well as in the distal resection area. 
Severe diarrhoea developed in the post-operative phase and the patiënt was given 
a gluten-free diet. The diarrhoea then disappeared and the body weight increased 
by 13 kg in 4 months. His jejunal biopsy specimen showed at that moment a con­
voluted mucosa, which became flat again after 3 m onths on a normal diet.
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Fig. 11.2. X-ray film of a barium-meal in a coeliac patiënt with a jejunocolic fistula (pa­
tiënt no. 48; for case history see text). The fistula (F) between jejunum (J) and transverse 
colon (TC) is well visible (S stands for stomach, D  for duodenum, and SF for splenic 
flexure).
11.2.3 Comment
Analysis of the various published case histories of patients with malabsorp­
tion and ulcers of the small intestine, leads to the impression that these 
patients form a very heterogeneous group. In part this is also expressed in 
the various names used by authors to decribe this condition, for example: 
‘intestinal ulcerations’, ‘recurrent benign ulcers’, ‘severe mucosal damage’ 
‘chronic ulcerative jejunoileitis’ and ‘non-granulomatous jejunoileitis’.
In about half of the cases there were anamnestic indications that the 
patients were suffering from coeliac sprue (55, 141, 142, 143, 195, 769). 
Several patients showed no or only an insufficiënt response to gluten with-
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drawal, but improved after additional glucocorticosteroid medication 
(444, 479). In a substantial number of cases there were no more criteria of 
coeliac sprue present other than a flat mucosa in the proximal jejunum (49, 
153, 438, 780). In some cases, the localization of the villous abnormalities 
was not typical of coeliac sprue (143, 555). There was also considerable 
variation in the localization and morphology of the intestinal ulcers. In some 
cases they were found mostly in the ileum or even in the colon (49, 142, 143, 
827), being either superficial (49, 141, 143, 555) or very deep (55, 143). The 
cellular infiltrate in the floor or wall of the ulcers also varied, consisting of 
lymphoid cells (55, 143, 555), plasma cells or even polymorphonuclear cells 
(55, 143). In some cases there was a minimal cellular reaction (49) or only 
dense fibrinous tissue (142, 555) at the ulcer sites.
There are many known causes of ulceration in the small intestine (143, 
896). It is difficult to exclude that in some published cases ulcers have been 
due to one of these causes. The high frequency of intestinal ulceration in 
coeliac patients suggests, however, a relationship with coeliac sprue (55, 56). 
In view of the differences in localization and nature of the ulcers, the aetio- 
logy may have been different also. As long as there is no clear understanding 
of the underlying cause or mechanisms, it seems hardly sensible to regard 
all these patients with intestinal ulcers as a single separate group. It must be 
stated on the other hand, that coeliacs whose damaged mucosa shows 
ulceration, differ from other coeliacs in that they often do not respond to 
gluten withdrawal until after additional glucocorticosteroid medication 
(patiënt no. 46). Another striking characteristic of these patients is the high 
rate of complications such as perforations, haemorrhages and obstruction, 
which are often fatal (56). The development of the fistula between jejunum 
and colon in our patiënt no. 48 may well have resulted from perforation of a 
jejunal ulcer. This complication seems rather unique. In view of the high rate 
of complications and the regular necessity of additional glucocorticosteroid 
medication, it does seem justifiable to regard coeliac patients with ulcers of 
the small intestine as a separate category.
11.3 ‘COLLAGENOUS’ SPRUE
11.3.1 Introduction
Some patients with coeliac sprue show a marked increase in the amount of 
subepithelial collagen in the lamina propria. In view of this phenomenon, 
Weinstein et al. (900) decided to distinguish, within the group of patients
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with atypical coeliac sprue or ‘unclassified sprue’, a subgroup of patients 
suffering from ‘collagenous’ sprue. They introduced this entity with re- 
ference to the case history of a female patiënt with a severe malabsorption 
syndrome who failed to respond to gluten withdrawal prescribed on the basis 
o f a flat jejunal mucosa. A wide variety of other therapeutic measures like- 
wise failed to influence the downhill course of her condition. A striking 
feature in this case was the Progressive deposition of collagen in the sub- 
epithelial tissue of the small intestine. The aetiology of this unusual form of 
Progressive malabsorption, which led to the patient’s death, remained unex- 
plained. Collagen deposition has been demonstrated in jejunal biopsy 
specimens from coeliac patients by several other investigators, and was also 
found in the jejunal biopsies of some of our patients.
11.3.2 Personal observations
Our series of 47 patients included 3 cases in whom unmistakable collagen 
deposition in the subepithelial tissue was noticed (fig. 11.3). The width of 
the collagen band in these cases ranged from 10 (jim to 40 fi.m. The case 
histories of these patients were presented in section 9.3 and 9.4, as the course 
of their disease was complicated (patients no. 2, 17 and 34). Apart from one 
patiënt who died shortly after the institution of the diet (patiënt no. 34) 
multiple repeat biopsy specimens were later obtained in the other cases. In 
one patiënt the subepithelial collagen deposits had completely disappeared 
at the repeat biopsy after 4 years on a gluten-free diet. The remaining patiënt 
still showed a distinct collagen band 5 years after gluten withdrawal, although 
the width of the band had diminished somewhat.
Post-mortem examination of two patients with refractory sprue (section 
11.4) revealed no sign of subepithelial collagen deposition anywhere in the 
small intestine.
11.3.3 Comment
Collagen deposition in the lamina propria is regularly observed in coeliac 
patients. Gluten provocation in a treated coeliac patiënt is followed within 
48 hours by the appearance o f minute amounts of collagen beneath the 
basement membrane (784). A distinctly recognizable amount of collagen 
may be found in no fewer than one third of the intestinal biopsies o f un­
treated coeliac patients (96, 160, 420). A wide subepithelial collagen band is 
fairly rare, although Bossart et al. (96) observed it in 8% of their untreated 
coeliacs. Other investigators have also reported the presence o f subepithelial 
collagen deposits (49,143, 409). It is to be noted, however, that the very large
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Fig. 11.3. Subepithelial collagen 
deposition in 3 coeliac patients (patients 
no. 2, 34 and 17 respectively).
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amount of collagen found in their patiënt by Weinstein et al. (900) has 
rarely been described (141, 221, 420). We observed a marked collagenous 
band in 3 of our patients (fig. 11.3). The amount of collagen deposited seems 
to be determined in part by the severity and duration of the epithelial 
damage, for in therapy-resistent cases the collagen deposits are sometimes 
seen to increase (96, 141, 900). Studies involving frequent jejunal biopsies 
show that the collagen can disappear within 2-6 months after gluten with­
drawal. The presence of collagen beneath the epithelium o f the small in­
testine seems of little prognostic value. Several patients respond well to 
gluten withdrawal, with or without temporary glucocorticosteroid medica- 
tion (52, 409, 444). Patients who prefer to continue without dietary restric­
tion can also prove to be doing quite well (96). For the rest, subepithelial 
collagen deposits are by no means found only in coeliac patients. It is some­
times also observed in tropical sprue (96,756).
For the above mentioned reasons we regard it as unwarranted to segregate 
patients on the basis of subepithelial collagen deposition, for such a classifi- 
cation gives no information on the nature, treatment or prognosis of the 
intestinal lesions.
11.4 REFRACTORY SPRUE
11.4.1 Introduction
Refractory sprue, although relatively rare, is not unique judging from the 
number of published case histories (table 11.2). The names given to this condi­
tion range from ‘unresponsive coeliac disease’, ‘collagenous sprue’ or 
‘unclassified sprue’ to ‘ulcerative jejunoileitis’, ‘intestinal atrophy’ and ‘fatal 
malabsorption syndrome’. We prefer the name refractory sprue, which is 
non-committal about a possible relationship to coeliac sprue and does not 
emphasize the occurrence of certain morphological phenomena. The patients 
in question may well belong to a heterogeneous group, having as common 
denominator the failure to respond to any kind of treatment, clearly ex- 
pressed by the adjective ‘refractory’.
11.4.2 Personal observations
Patiënt A had been in good health until age 42, apart from several episodes of un- 
explained weight loss which had spontaneously ceased. At the age of 42 she was 
treated with large doses of glucocorticosteroids for complaints of malaise, anaemia 
and weight loss. These complaints were thought to be caused by adrenocortical 
hypofunction. She responded well to this therapy, and gained 18 kg body weight. 
Two years later she was treated by local irradiation for suspected reticulumcell
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Table 11.2. Incidence of refractory sprue.
-  Cases collected from literature -
AUTHORS PREVIOUS HISTORY OF 
COELIAC SPRUE
REPORTED NUMBER 
OF CASES
Himes et al. (1957) doubtful 1
Kelleyet al. (1958) doubtful 1
Hourihane (1963) no details 1
Shiner (1963) no details 1
Smitskampet al. (1965) present 1
Pink et al. (1967) no details
Stewart et al. (1967) no details 1
Cooke (1968) no details
C.P.C. (1968) present 1
Jeffries et al. (1968) absent 1
Barryetal. (1970) doubtful 1
C .P.C .(1970) absent 1
Weinstein et al. (1970) doubtful 1
Krondletal. (1971) no details 1
C .P.C .(1972) doubtful 1
Doe et al. (1972) doubtful 1
Marcheetal. (1974) doubtful 1
Modigliani et al. (1975) no details 1
Own series doubtful 2
sarcoma near the left sacro-iliac joint. Only a year later, at age 45, she complained 
of watery diarrhoea (20 times per day) and regular vomiting, resulting in a weight 
loss of 12 kg. She was referred to our department for more extensive investigations. 
Examination revealed a severe hypoalbuminaemia (30 g/1) and marked steatorrhoea 
(fat absorption coëfficiënt 55%). Serum calcium and magnesium concentrations 
were decreased (1.51 mmole/l after correction, and 0.30 mmole/l, respectively). 
Since after ACTH stimulation the plasma cortisol level of 250 [xg/1 increased by 
factor 4, hypoadrenocorticism was excluded. A gluten-free diet was prescribed as 
the biopsy specimen from the proximal jejunum showed a flat mucosa. The diar­
rhoea, however, did not cease. Continuous intravenous administration of glucose 
solution, plasma, minerals and vitamins during some weeks was complicated by 
sepsis. Subsequent parenteral glucocorticosteroid administration during the course 
of several weeks failed to prevent the patient’s death, only 5 months after the diar­
rhoea started. The post-mortem was performed within 2 hours of death. The small 
intestine, which feit thin over its entire length, was resected. Neither the mesenteric 
blood vessels nor the abdominal lymph nodes were abnormal. The liver showed 
extreme fatty degeneration but no tumour metastases; the pancreas was entirely 
normal. No signs of malignancy were observed in and around the left sacro-iliac 
joint. The very thin mucosa of the small intestine showed no villi from the pylorus 
to the ileocaecal valve. The enterocytes were cubical. A striking finding was the 
small number of crypts, in which little mitotic activity was discemible (fig. 11.4.a). 
Nowhere in the mucosa of the small intestine were ulcerations or subepithelial 
collagen found.
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BFig. 11.4. Post-mortem specimen of the smal] intestine from 2 patients with refractory 
sprue (patients A and B ; for case histories see text). The thinness of the intestinal wall and 
paucity of mucosal crypts are apparent.
Patiënt B began to pass frequent pulpy stools at age 54 and lost 6 kg body weight. 
He also feit tired and listless. When questioned he stated that as a child he had 
sometimes suffered from meteorism, diarrhoea, anaemia, and retardation of growth. 
The abdominal symptoms which had now developed were so severe that hospitali- 
zation was necessary. The patiënt was vomiting and produced large amounts of 
watery faeces (1-5 kg per day). The body weight had decreased to 50 kg (height
1.68 m). Biochemical tests revealed a normal haemoglobin concentration but a 
markedly decreased serum folate level (less than 1 ng/ml). The serum albumin 
concentration was markedly decreased (19 g/1), due to an increased enteric protein
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loss (500 ml plasma per day). There was moderate steatorrhoea (absorption coëffi­
ciënt 68 %), decreased excretion of D-xylose (2 g in 5 hours) and vitamin Bla 
(0.6% in 48 hours). The number of micro-organisms in the proximal jejunum was 
not increased, while urinary indican excretion was normal. The ‘breath’test for 
bile acid deconjugation showed an increased peak value (5.25 x 10-5 of the ad- 
ministered dose), probably'due to reduced reabsorption of bile acids in the ileum. 
Cholestyramine had no effect on the diarrhoea. Gluten withdrawal prescribed in 
view of a flat jejunal mucosa with marked inflammatory changes and superficial 
erosions, had no effect, no more than 3 weeks of an elementary diet or parenteral 
administration of fluids, plasma, minerals and vitamins. The Progressive deteriora- 
tion of the patient’s condition was accelerated by disturbed liver function and sepsis. 
The patiënt died cachectic, 7 months after the onset of diarrhoea. At the post- 
mortem, performed within 2 hours of death, a palpably thin small intestine was 
resected. A small amount of serous fluid was found in the abdominal cavity. The 
liver showed extensive steatosis and signs of cholangitis. The pancreas was normal, 
apart from slight atrophy of the exocrine glands. The spleen was atrophic. The 
mesenteric blood vessels seemed normal. The abdominal lymph nodes were mark- 
edly enlarged; microscopy revealed a chronic inflammatory infiltrate with an in- 
crease of connective tissue. No signs of a specific inflammatory or malignant pro­
cess were found. The mucosa of the small intestine was flat over its entire length, 
and lined by cubical to high-cylindrical enterocytes. The lamina propria contained 
a dense inflammatory infiltrate consisting of granulocytes as well as plasma cells 
and lymphocytes. In this patiënt the number of mucosal crypts was also extremely 
reduced with a minimal mitotic activity (fig. 11.4.b).
11.4.3 Comment
The confrontation with patients suffering from refractory sprue comes 
usually as a surprise. As a rule there are hardly any indications that one is 
dealing with refractory sprue, and the non-responsiveness of the patiënt to a 
gluten-free diet is usually unexpected. The symptomatology of refractory 
sprue, after all, is virtually identical to that of coeliac sprue. Only a few 
symptoms stand out in patients with refractory sprue, such as abdominal 
pain and signs of intestinal obstruction (55, 141, 221), although these are 
sometimes also observed in cases with uncomplicated coeliac sprue. Some 
patients show variable skin lesions (141, 221, 555) or fingerclubbing (142), 
but these symptoms are hardly characteristic (table 8.1). The severe hypoal­
buminaemia observed in nearly all patients also does not differ significantly 
from that in gluten-sensitive sprue (52). According to Creamer (182), 
radiographs of the small intestine in refractory sprue are characteristic in 
that they show a tubular intestine without mucosal plication. This phenom- 
enon, known as moulage, can also occur in other intestinal diseases, in- 
cluding coeliac sprue (434, 563).
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As the designation indicates, patients with refractory sprue fail to respond 
to all therapeutic measures. Efforts to influence the downhill course by even 
unconventional measures such as administration of pancreatic enzymes 
(682, 900), salazosulphapyridine (141, 900), tuberculostatics (49), broad- 
spectrum antibiotics (233, 555, 900) or cytostatics (555), proved to be quite 
unsuccessful. The patients ultimately die from complications, or from ca- 
chexia due to extensive malabsorption.
In nearly all published cases with refractory sprue a post-mortem was 
performed, which sometimes revealed an extremely thin-walled and atrophic 
small intestine (682, 900), as it was found in our two patients. Enlarged mes- 
enteric lymph nodes were regularly observed (52), consisting of fibrotic 
tissue (142, 143), or cavities containing accumulated chyle or other lipid 
material (555). In a few cases the post-mortem did reveal other pathological 
abnormalities, such as a malignant process (section 9.4.4), evidence of ab- 
dominal tuberculosis (253), pancreatic lesions (682) or signs of malignant 
lymphoma formation in the small intestine (421), well-known causes to 
bring on a therapy-resistent malabsorption syndrome. The significance of 
extraintestinal vasculitis, cryoglobulinaemia, discrete thrombosis or ob- 
structed lymph flow found in some patients, has remained obscure (143, 
221, 555). The same applies to the mycelia or bacteria found in some 
intestinal ulcers (49, 55).
There are several hypotheses on the pathogenesis of refractory sprue. 
Some authors hold that these patients are hypersensitive to several antigens 
or allergens other than gluten, which originate from the food, intestinal 
bacteria, or result from degradation of the mucosa of the small intestine 
(233, 444). The increased permeability of the intestinal mucosa found in all 
untreated coeliac patients (267, 590) could play a role in this respect, al­
though this fails to explain why only a few coeliac patients are affected. 
According to another theory are the longstanding mucosal lesions too ex­
tensive and severe to permit any recovery (141, 182). There are several other, 
purely speculative hypotheses (141,142,143, 603, 809).
In our own two cases we were struck by the extreme atrophy of the in­
testinal wall over the entire length. Histological examination of the intestinal 
mucosa revealed the features of an exhausted regeneration: a small number 
of crypts in which little mitotic activity was discernible (fig. 11.4). Others 
have reported similar findings (49, 420, 601, 682, 900), or published illustra- 
tions showing an intestinal mucosa with similar features (141, 143, 555). 
That a decreased production of enterocytes is present in such patients was 
demonstrated by Barry et al. (52) by DNA determination in perfusion fluid 
from intestinal loops. We share the latter investigators’ suspicion that crypt
230
hypoplasia is a primary phenomenon in patients with refractory sprue. The 
flat mucosa in these patients, resembling that in coeliac sprue, is nothing but 
the end-result of this hypoplasia. Analogous to comparing the turnover 
pattern of the intestinal epithelium in coeliac patients with haemolytic 
anaemia (89, 186), one might compare the pattern in refractory sprue with 
aplastic anaemia. Although this hypothesis might explain the morphogenesis 
of the intestinal mucosa in these patients, it fails to explain the cause of this 
primary crypt hypoplasia.
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CHAPTER 12
METHODS AND PROCEDURES
12.1 BIOCHEMICAL ASSAYS
12.1.1 Determinations in blood
Albumin concentration in serum was determined electrophoretically 
with cellulose acetate as vehicle (483). Since this method involves the use of 
amido-black which binds more strongly to albumin than to the globulin 
fractions, the values given are relatively high.
Controls (n =  32): 45.8-55.1 g/1.
Alkaline phosphatase activity in serum was determined according to 
Bessey et al. (65), using 2-amino-2-methylpropanolol buffer.
Controls (n =  29): 45-90 U /l
(6.5-13 KAU/1).
Amino acid analysis in serum was carried out with the aid of a Beekman 
Multichrom amino acid analyser. The normal range of the various essential 
amino acids in 23 Controls is listed in table 7.8.
Calcium concentration in plasma was measured with the aid of an atom ab­
sorption spectrophotometer.
Controls (n =  24): 2.35-2.50 mmole/1 
(4.70-5.00 mEq/1).
Cholesterol concentration in serum was determined in accordance with 
the principle of Liebermann-Burchard as modified according to Huang et al. 
(424).
Controls (n =  37): 4.0-7.2 mmole/1
(150-275 mg/lOOml).
Folate concentration in serum was determined by means of a biological 
assay with Lactobacillus casei, as described by Waters et al. (893).
Controls (n =  25): 6.8-26.2 [j.mole/1 
(3.0-11.5 ng/ml).
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Haemoglobin concentration in blood was colorimetrically determined 
after conversion to cyanmethaemoglobin according to Van Kampen et al. 
(456).
Female Controls (n =  47): 7.9-9.8 mmole/1 (12.7-15.8 g/100 ml).
Male Controls (n =  54): 8.7-10.9 mmole/1 (14.0-17.6 g/100 ml).
Iron concentration in serum was determined colorimetrically as described 
by Ramsay (696).
Controls (n =  102): 8.9-24.7 fi.mole/1 
(50-138 fxg/100 ml)
Iron binding capacity (total) of serum was determined as described by 
Ramsay (697).
Controls (n =  102): 50-85 jxmole/1
(280-476 (ig/100 ml)
Magnesium concentration in serum was measured with the aid of an atom 
absorption spectrophotometer.
Controls (n =  25): 0.80-0.95 mmole/1 
(1.60-1.90 mEq/1).
Thrombotest was measured in venous blood after incubation in throm- 
botest reagent as described by Owren (654).
Controls (n =  22): 60-100%.
Vitamin A concentration in serum was determined according to Paterson 
et al. (661).
Controls (n =  54): cf Fig. 7.10.
Vitamin B12 concentration in serum was determined by a microbiological 
assay with Lactobacillus Leichmanii, as described by Matthews (565). 
Controls (n =  24): 220-440 [i.mole/1 
(300-600 pg/ml)
Vitamin E  concentration in serum was spectrophotometrically determined 
according to Hashim et al. (368).
Controls'(n =  25): 25-35 fxmole/1
(1075-1500 [ig/100 ml).
12.1.2 Determinations in urine
Amino acid excretion was determined in 24-hour urine with the aid of a 
Beekman Multichrom amino acid analyser.
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Hydroxyproline excretion was measured in 24-hour urine during collagen 
restriction. Measurements were done colorimetrically as described by 
Prockop et al. (692).
Controls (n =  23): 150-400 umole/24 hrs 
(19.5-52.5 mg/24 hrs).
Indican excretion was determined in 24-hour urine according to Müting 
et al. (622).
Controls (n =  33): 180-480 u.mole/24 hrs 
(45-120 mg/24 hrs).
12.1.3 Absorption tests
Calcium absorption was determined by measuring the radioactivity in 
plasma after oral administration of 10 jxCi 47Ca in the form of calcium 
citrate together with 200 ml cow’s milk, 1 hour after breakfast. Blood samples 
were obtained after 10, 20, 30, 45, 60, 120, 180 and 240 minutes. Radio­
activity was measured in a well-type scintillation detector and expressed as 
per cent of the dose administered per litre of plasma. Radioactivity in the 
organism was determined 1 hour after administration of the 47Ca, with the 
aid of a whole-body counter. Retention of 47Ca in the organism was deter­
mined after 1, 7, 14 and 21 days, and expressed as per cent of the activity 
measured in the body 1 hour after administration of the dose.
Fat absorption coëfficiënt was calculated by relating the amount of fat in 
the faeces to the oral intake. This was done in the course of a 5-day balance 
period during which a diet with a fixed amount of fat (60-100 g) was used. 
Faeces was marked with carmine red before and after this 5-day period. 
The faecal fat was determined according to Van de Kamer et al. (452). 
Lower limit of normal range: 95%.
Glucose tolerance test was carried out with 100 g glucose. The blood sugar 
concentration was measured by the potassium ferricyanide method according 
to HofTman (407). Blood samples were obtained from the fasting subject 
and 30,60, 90 and 120 minutes after glucose ingestion.
Controls (n =  22): cf Fig. 7.2.
Iron retention was determined by measuring 59 Fe activity with the aid of 
a whole-body counter after oral administration of 2 fiCi 59Fe in a 50 ml 
solution of 0.2 mmole ferroammonium sulphate and 2 mmole ascorbic 
acid in 0.004 n HC1 to the fasting subject. Radioactivity measured 3 weeks
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after administration of the 59Fe was expressed as per cent of the activity 
present in the body 1 hour after administration of the dose.
Lactose tolerance test was carried out with 50 g lactose. The blood sugar 
concentration was determined according to Hoffman (407) in the fasting 
subject and 10, 20, 30, 45, 60 and 90 minutes after lactose ingestion. 
Maximal increase in blood sugar concentration in Controls (n =  22):
1.2-3.8 mmole/1 (22-68 mg/lOOml).
Maltose tolerance test was carried out with 50 g maltose.
Sucrose tolerance test was carried out with 50 g sucrose.
Vitamin A tolerance test was carried out after oral administration of 
600,000 IU (=  320 mg) vitamin A palmitate in aqueous solution (ArovitR) 
to the fasting subject. Blood samples were obtained from the fasting subject 
and 3, 6 and 9 hours after administration of the dose. The serum vitamin A 
concentration was determined according to Paterson et al. (661).
Maximal increase in serum vitamin A concentration in Controls (n =  24): 
1.8-21.0 [xmole/1 (170-2000 (Ag/100ml).
Vitamin S12 absorption was determined according to Schilling (758), 
using 0.5 [xCi 57 Co vitamin B12 (1.1 |J-g vitamin B12). Together with oral 
administration to the fasting patiënt, 1 mg vitamin B12 was injected i.m. 
Radioactivity was measured in the urine of the 48-hour period after inges­
tion. Patients in whom achlorhydria was not excluded in advance, were 
given intrinsic factor as well.
Controls (n =  28): 15-35% of dose excreted in 48 hours.
Xylose absorption was studied by measuring the excretion of D-xylose in 
the 5-hour urine after ingestion of 25 g D-xylose while fasting. The D-xylose 
was determined colorimetrically as described by Roe et al. (712).
Controls (n =  25): 33.5-62 mmole/5 hrs 
(5.0-9.3 g/5 hrs).
12.1.4 Other determinations
Albumin synthesis rate was determined after administration of 14C- 
labelled carbonate according to McFarlane (575), as described by Haf- 
kenscheid et al. (349).
Controls (n =  15): 22.3 ±  6.8 g/175cm/24hrs.
Breath test with (glyco-l-u C) cholic acid, for demonstration of the 
presence of an abnormal intestinal flora, was carried out by determining the
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amount of 14C 02 in expiratory air after ingestion of 5 fiCi 14C-labelled 
glycocholic acid with a Standard breakfast. Radioactivity was determined in 
the breath samples collected every hour (up to 10 hours after ingestion) with 
the aid of a fluid scintillation counter, and expressed as proportion of the 
dose administered per mmole expiratory C 02 (295, 777).
Upper limit of normal range: 1.5 x 10-5 of dose per mmole expiratory
co2.
Enteric plasma protein leakage was determined by measuring the radio­
activity of faeces and determining the plasma disappearance curve after 
intravenous administration of 50 (iCi 51CrCl3 as described by Van Tongeren 
et al. (848).
Upper limit of normal range: 30 ml plasma/24 hrs.
Intestinal juice cultures were carried out by aspirating a sample from the 
first jejunal loop in the fasting subject, transporting it immediately under 
strictly anaerobic conditions and inoculating it on a medium previously 
rendered free of oxygen.
Bacteria were counted by a dilution technique and counts were checked 
on the basis of a Gram preparation of the original jejunal juice.
Upper limit of normal range: 103 micro-organisms per ml.
Phosphate reabsorption was determined by measuring the ratio between 
phosphate and creatinine excretion in a 2-hour urine portion as described 
by Bijvoet et al. (67).
12.2 STATISTICAL ANALYSES
12.2.1 Calculation o f normal values
In order to ensure correct interpretation of the values found in patients, 
virtually every biochemical test was also done in a group of Controls, con- 
sisting partly of healthy staff-members and partly of out-patients in whom no 
abnormalities had been found. The number of control values always ex- 
ceeded 20, with a maximum of 102.
Since it was not always clear whether a normal distribution of control 
values existed, a distribution-free method as described by Mainland (545) 
and Elveback et al. (248) was used. By this method the inside limits for the 
2.5 and 97.5 percentile lines with 90% confidence were calculated. The 
values found were interpreted as limits of the normal range, represented by 
the shaded area in each figure.
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12.2.2 Calculation o f  significances
In an effort to establish whether the biochemical determinations and the 
results of the absorption tests showed differences between individuals with a 
flat mucosa and those with a convoluted pattern in the jejunal biopsy spe­
cimen, the Mann-Whitney test (552) was applied. This test was preferred 
because the samples did not impress as having been drawn from a normally 
distributed population, and because the variances were usually unequal. 
For the same reasons, Wilcoxon’s signed-rank test (916) was used in com- 
paring results before and after gluten withdrawal. In order to characterize 
the relation between various parameters, Pearson’s correlation coëfficiënt 
was calculated if necessary.
12.3 BIOPSY OF THE SMALL INTESTINE
Prior to 1970, the capsule of Crosby et al. (185) was used for taking biopsies 
of the small intestine. Later the multiple biopter according to Becker, as 
described by Haex et al (347), or that according to Quinton-Flick-Rubin 
(278) was used. Immediately before taking biopsies, the exact position of the 
capsule was determined under fluoroscopic control.
The biopsy specimens were rinsed with physiological saline, and subse- 
quently spread on paper with the submucosal surface adherent to the paper 
towelling. This was immediately followed by fixation in formalin, and also 
in Bouin’s fluid to facilitate stereomicroscopic evaluation and photography.
At stereomicroscopy, the biopsy specimens were named according to the 
most conspicuous type of villus: finger-shaped, leaf-shaped, convoluted or 
flat.
The biopsies were carefully embedded in paraffin in order to avoid tangen- 
tial cutting. The histological sections were stained with haematoxylin-eosin 
and PAS; for better evaluation of the presence of collagen with van Gieson 
elastin stain, and for detection of ceroid according to Ziehl-Neelsen or with 
auramin-rhodamin.
Lactase activity in biopsy specimens was determined as described by 
Dahlqvist (190) and expressed as Units per gramme wet weight of tissue. 
Lower limit of normal range .1.5 Unit.
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SURVEY OF REFERENCES TO PATIENTS
PATIËNT YEAR OF SEX CASE TEXT TABLE
BIRTH HISTORY
# 1 1929 m 6.3, 7.8 
7.10
# 2 1912 m p 207 pp 202, 204, 
206, 209, 219. 
224
6.4, 7.10
# 3 1923 m
# 4 1932 m
# 5 1910 m p 202 pp 90, 202, 
204
6.3, 6.4, 7.8, 
7.10, 9.4
# 6 1924 m
# 7 1945 f 6.4
# 8 1922 f
# 9 1926 m 7.13
# 10 1921 m 7.10, 7.13
# 11 1931 m
# 12 1934 f
# 13 1925 f 6.3, 7.10
# 14 1943 f
# 15 1938 f
# 16 1939 f
# 17 1921 f p 200 pp 202, 204, 
219, 224
6.2
# 18 1938 f
# 19 1932 f
# 20 1940 f 6.2, 6.3, 
7.8, 7.10
# 21 1914 f p 204 p 204 6.4
# 22 1930 f 6.4
# 23 1925 f
# 24 1944 f
* 25 1915 m
# 26 1912 m 6.3, 7.8
# 27 1914 f p 205 pp 204, 206 6.3, 7.8, 7.16
# 28 1904 m 6.3, 7.10
# 29 1926 f 6.3, 7.10, 
7.13
# 30 1925 f 6.3, 7.8,
7.10
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31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
YEAR OF 
BIRTH
SEX CASE TEXT
HISTORY
TABLE FIGURE
1887
1949
1943
1903
1932
1934 
1921 
1938 
1918 
1931 
1926
1935
1933 
1938 
1912 
1912
1925
m p 206
p 219 
p 207
9.1
6.3, 7.13
pp 90, 204, 7.10 
224
9.1
6.4
6.4
pp 202, 204, 6.2.11.1
223
p. 204
6.4, 11.3 
9.2
11.1
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Abdominal pain 88, 92, 113, 182, 186, 
192,204, 208 
Abortion (cf Miscarriage)
Absorption {cf substances concerned) 
Absorption net 58
-  total 58,59 
Achlorhydria 78,96,168
Active transport 54, 57, 72, 79,82, 83 
Adenylcyclase 46,111 
Adrenocortical insufficiency 181,184 
Albumin serum level 95, 136-139, 143, 
145,150,181,213-215
-  synthesis 138,143 
Aldosterone 61,77
Alkaline phosphatase iso-enzymes 154
-  -  serum level 147,150,154,155 
Amenorrhoea (cf Menstrual disorders) 
Amino acid absorption 72,141
-  essential 139,142,143
-  excretion 149,152,154
-  serum levels 139,142,143
-  supply for synthesis 73,97,142,143
-  transport 72,141
-  (cf Protein)
AMPcyclic 46,47,111 
Amylase 30,42,61,62,117
Anaemia 1, 2, 81, 84, 88, 160-166, 169, 
171,172,177,178,181,183,192,213, 214 
Anaerobic culturing (cf Intestinal 'juice 
culture)
Anorexia (cf Nausea)
Antibiotics (cf Treatment)
Antibodies copro 51
-  gliadin/gluten 16,191
-  parietal cells 96
-  reticulin 16,215 
Aphthae (cf Stomatitis)
APUD cells (cf Endocrine cells)
Artery (cf Blood vessels)
Ascites 95
Ascorbic acid (cf Vitamin C)
Associative diseases (cf Concomitant dis-
f»Q  C O C  |
ATP 46,54,56,58,74,75  
Autonomie nervous system anatomy 19,
33, 34,92
-  disorders 90-92
-  function 30-32, 35-38,42,43,45,47
Bacterial flora abnormal 91, 92, 99, 103, 
104, 107-109, 112, 121, 142, 170, 175,
177.183.204.205
-  growth-factors 48, 50-52,99,109
-  location and categories 50,51
-  metabolic effects 51, 80, 91, 92, 108,
112, 142, 170, 175, 176, 181, 182, 199,
204.205
-  normal function 33, 47, 52, 61, 70, 80,
81,175
Basement membrane 25, 57, 66,224
Bicarbonate absorption 43,60
-  secretion 30,42,43,45,46, 60,61 
Bile acid absorption 31,44, 67,132
conjugation 43,44
-  deficiency 132
-  degradation 44,91,104,107,108,112
-  faecalloss 44,132
-  function 43, 51,57,64, 67, 68
-  recirculation 44
-  secretion 30, 41, 43, 44, 46, 51, 59, 66,
67, 74,78,81, 83,91,132,133,153, 159
-  structure 64
-  synthesis 43,67
Biopsy (cf Intestinal biopsy, Rectal biopsy) 
Blind loop syndrome 108 
Blood vessels anatomy 19, 36, 37
-  circulation 35-39,44,46,91,92
-  function 31, 36-38,41, 57,92,95
-  structural abnormalities 92 
Bodylength 181
-  (cflnfantilism)
Body weight 2, 100, 160, 178, 180-182, 
184,192,201,208 
Bonefracture 88,149,178,184
-  histology 149,150,154,155
-  pain 144,149,184
-  marrow study 162 
Borborygmi 1,113,182
Breath test (14C glycocholic acid) 103, 
104,107,108 
Brown bowel syndrome 134 
Brush border digestion 62,67,72,117
-  enzyme activity 15, 25, 54, 62, 63, 67,
68.72.115.117.118.141
-  enzyme deficiency 15,112,199
-  function 22, 48, 53, 54, 58, 62, 63, 72,
77.81.82.141
-  lesions 25, 111, 117, 118, 133, 141, 165,
175,198
-  structure 22
Cachexia (cf Body weight)
Calcitonin 61
Calcium absorption 74, 75, 147, 152-154 
balance 75,145,147,152-154
-  body stores 73
-deficiency 144,152,156,185,186
-  dietary sources 74
-  faecal loss 73,75,152,184  
-fu n ction  42,73,81,170
-  intake 74, 75, 77,152
-  plasma level 144, 145, 149, 150, 153, 
155-157,184
-  renal excretion 73,152
-  requirements 74,75,153
-  secretion 42, 43, 45, 46, 60, 61, 74, 
152-154,183
-  solubilization 74
-  transport 69,77,152
Calcium47 studies 147, 150, 152, 153
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Candidate hormones 45,46,98  
Capillaries (cf Blood vessels)
Carbohydrate absorption 63, 108, 112, 
117,119
-  dietary forms 61
-  digestion 61-63,117,118
-  fermentation 113,182
-  function 61
-  intake 61 
Carotene 134
Causative factors (cf Coeliac sprue)
Ceroid pigment 25, 69,90,91,134  
Childhood history (cf Coeliac sprue) 
Chloride absorption 43, 46, 59-61, 110, 
112
-  dietary sources 59
-  intake 59
-  renal excretion 59
-  loss 59,103
-  requirements 59
-  secretion 43, 60,111,112 
Chlorosis 1,160,183 
Cholecystokinin 30, 33, 42, 43, 45, 46, 61,
70,97, 98,140 
Cholesterol absorption 67,133
-  dietary sources 67
-  endogenous sources 67
-  function 67
-  hydrolization 67
-  intake 63,67
-  re-esterification 67
-  serum level 67,122,126,135,213
-  solubilization 67
-  synthesis 67,127 
Cholesterol-esterase 42,67 
Chylomicron formation 66, 68,133 
-transport 39,40,66,68,132,133  
Chymotrypsin 42,71 
Circulation (cf Blood vessels)
Clinical picture (cf Coeliac sprue) 
Coagulation (cf Haemorrhagic disorders) 
Coeliac sprue causative factors 10,13, 14,
90
-  childhood history 4,6-9,187
-  clinical picture 1, 6, 88, 121, 144, 149, 
160,178
-  complications 204-208,215,223
-  definition 4-8,86,121,223
-  expressiveness 4-7,178 
-la ten t 5 ,6 ,9
-  pathogenesis 13-17
-  prognosis 187,190
-  refractory (cf Refractory sprue)
-  spontaneous course 8,187-190
-  terminology 1 ,3 ,4 ,6 ,121 ,218 ,224
-  (cf Incidence cf c.s.)
Collagen, subepithelial 25,223-227 
Colon function 31, 61,80 
Concomitant diseases 87, 94, 96, 97, 191,
201,210,216
Constipation 182,192 
Contact time, mucosal 53, 91,112 
Corticosteroids (cf Treatment)
Counterflow hypothesis 38,39,92  
Crypt histology 21,25,98
-  hyperplasia 8,27,98
-  hypoplasia 27,230,231
-  length 25,28
-  mitotic activity 25,27,28,48,100
-  secretory function 58,112
Dermatitis herpetiformis incidence 210, 
213,215
-  intestinal lesions 5, 87, 211, 213-215
-  malabsorption 213-215
-  pathogenesis 215
-  skin lesions 178,185,211,215 
Diagnostic criteria (cf Coeliac sprue) 
Diarrhoea 1, 84, 88, 93, 110, 112, 113,
164,178,182,192,199,201,202, 204,206 
Dietary restriction disaccharides 199
-  eggs 199
-  gluten (cf Gluten-free diet)
-  LCT-fat 93,95,158,199-201 
Digestion (cf substances concerned) 
Disaccharidases (cf Brush border) 
Duodenojejunoileitis, non-granulomatous
87 191 219-222 
D-xylose test 108,109, 115, 116, 119, 120, 
191,205,213,214 
Dyspepsia 113 
Dyspnoea 183
Electrolytes (cf substances concerned) 
Endocrine cell function 30, 32, 35, 37,
42-47,58,61,91, 97-99
-  localization 21,42,44-46, 70,97,98
-  nomenclature 44
Endogenous loss (cf substances concerned.) 
Enterocyte cell-membrane 55
-  exfoliation 26, 27, 48, 49, 67, 76, 79,
82, 83, 99,100,102, 133,142,159,165
-  intracellular enzyme activity 54, 72, 77, 
82
-  lesions 21, 25, 26, 102, 108, 133, 152, 
154,165,170,175,197,198
-  life-span 26, 27, 47, 48, 99, 100, 175, 
176,198,231
-  production 27
-  ultrastructure 21, 22, 26, 47, 66, 81, 82, 
174
Enterohepatic circulation 44,81
Enterokinase 42, 71,140
Erosions intestinal (cf Intestinal ulceration)
-  subperiostal 149,153
Exfoliative enteropathy (cf Enterocyte 
exfoliation)
Extrusion zone 21,26,48,49  
Exudative enteropathy (cf Protein leakage)
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Facilitated diffusion 55,57, 63 
Faecal weight 110,112,182 
Fat absorption 109, 132, 133, 135, 157,
158,199
-  absorption coëfficiënt 122,126,134
-  emulsification 132
-  faecal loss (cf Steatorrhoea)
- function 63
-  hydrolysis 132,133
-  intake 63
-  solubilization 108,132
-  (cf Triglycerides)
Fatty acids (cf Triglycerides)
Ferritin 79
Flatulence 1,113,182,192  
Folate absorption 82, 83,174,175
-  body stores 82
-  chemical forms 81
-  complex formation 82
-  conjugase 82,174,175
-  consumption 175
-  conversion 82,175
-  deconjugation 82,174
-  deficiency 82, 160, 161, 171, 172, 175, 
183,185
-  dietary sources 81
-  digestion 54
-  endogenous loss 83,103
-  function 82
-  intake 81,175
-  requirements 81,175
-  serum levels 161,172,173,175,213,214 
-synthesis 81,175
-  transport 82, 175
Folie acid tolerance test 191 
Fructose 62,119
Galactose 62
Gall-bladder emptying 30, 43, 46, 97, 98, 
132
-  function 43
Gastric evacuation 30,99,107,118,120
-  function 30,41, 59, 80 
-m u cosa  41,80
-  secretion 30, 36, 41, 42, 45, 51, 59, 64,
70, 74, 76, 78, 80, 81, 91, 95, 96, 99, 153, 
159,170
-  ulcer disease 96 
Gastrin 36,42,45,80,96  
Gliadin 13-15,17,190 
Gliadin antibodies (cf Antibodies)
Glossitis 84,171,183,192  
Glucose absorption 119
-  blood level 113,115,118,120
-  tolerance test 113,120 
Gluten definition 13 
-in ta k e  5,11,215
-  introduction 8,11,12
-  provocation 5-7,27,187,224  
Gluten-free diet adherence 5, 109, 169,
191-194,197-199,205,208,226
-  history 2, 3,190
-  nature 190
-  response 5-7, 87, 92, 93, 97, 98, 102-
104, 107, 112, 116, 119, 120, 126, 127,
135, 139, 149, 150, 152, 154, 155, 157,
159, 163, 165, 169, 172, 177, 183, 185,
186, 190, 192-194, 197-199, 202-204, 208,
218, 222-224, 226
Gluten-intolerance permanent 6
-  transient 6 ,9  
Glutenin 13 
Glycocalyx 22,48,62  
Goblet cells 21,31,47,48,99  
Growth hormone 75
-  retardation (cf Infantilism)
Haem absorption 78,79 
Haematopoietic factors 77-83, 160-176, 
183
Haemoglobin concentration (cf Anaemia)
-  degradation 54,78 
Haemorrhagic disorders 70, 83, 135, 177,
178,183 
Hairloss 185 
Headache 183
Historical description (cf Coeliac sprue) 
Hormone (cf Endocrine cell)
Howell Jolly bodies 183 
Hydrochloric acid 30,41,42,46,74
-  -  (cf gastric secretion)
Hydrogen secretion 60, 61 
Hydroxyproline excretion 149, 150, 154,
155
Hydroxytryptamine 33,44,98  
Hypeiparathyreoidism 149, 153-155, 184, 
185
Hyperphagia 183 
Hypotension 181,206
Deus 90,185,186 
Immunocytes (cf Lamina propria) 
Immunoglobulins, serum levels 16 
Immunologie disorders 15, 16, 109, 198 
Incidence of c.s. age groups 2, 8, 9, 88, 
187
-  familial occurrence 9,10
-  geographical distribution 10,11
-  racial distribution 11
-  sex 1,87
Indicanuria 103, 104, 107,108,142, 168 
Infantilism 2,181,185
-  (cf Body length)
Infertility 185,186
Innervation (cf Autonomie nervous system) 
Insulin 46,80,118,120  
Intake (cf substances concerned)
Intercellular space 22,49, 56, 57, 66,102 
Intestinal biopsy 2, 5, 6, 8, 10, 19, 23, 25,
86, 87, 91, 141, 187, 197, 198, 203, 211,
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213-215,224
-  juice culture 103,104,107,108
-  pseudo-obstruction 92
-  ulceration 218,219-223,230 
Intrinsic factor 41,80,81,170
Iron absorption 77, 78, 79, 83, 163, 164, 
165
-  body stores 77,79 
-deficiency 78,160-164,183,185
-  dietary sources 77
-  function 77
-  homeostasis 79,80
-  intake 77,78
-  loss 100,103,165
-  release 79
-  serum level 77, 162, 163, 165, 213, 214
-  solubilization 77-79, 165
-  storage 79
-  transport 79,165 
Iron58 studies 79,163,164
Lactase (cf Brush border)
Lactose digestion 62
-  intake 61
-intolerance 112,113,116,118,199
-  tolerance test 113,116,118 
Lactulose test 191
Lamina propria 16,20,25,27, 57 
Laparotomy 90,94  
Latent sprue 5, 9,215 
Lecithin 64
Leucocyte antigens 10,11 
Linoleicacid 63,185 
Lipase 30,42, 64,132 
Lipid (cf Fat)
Lipolyse (cf Fat hydrolysis)
Lipoprotein 66,133
Liver function disorders 70,139,147,154, 
182
Lymphangiectasia, intestinal 93, 95, 133 
Lymphatics anatomy 19, 39-41, 66, 94
-  drainage 40, 41, 93-95, 102, 133, 201, 
206
-  function 31, 39,40, 66, 67, 72, 94-95 
Lymph follicles, intestinal 39, 40, 95 
Lymphocytes in peripheral blood 16,
93-95
-  interepithelial 5,16,25,28,215  
Lymphoma (cf Malignancies)
Magnesium absorption 76, 77,158
-  balance 76
-  body stores 76 
-deficiency 75-77,156,158,186
-  dietary sources 76
-  excretion 76,159 
-fu n ction  75,76,81,170
-  homeostasis 76,77
-  intake 76
-  loss 76,159
-secretion  43,76,159
-  serum level 76,156-159,184
-  solubilization 76,158 
Magnesium28 studies 76 
Malaise 85,178,186 
Malignancies 206-208,230 
Maltose digestion 62
-  intake 62
-  tolerance test 115 
Menstrual disorders 185 
Mesenteric lymph nodes 94,95, 201, 206 
Meteorism 113,182,192,204 
Micellar concentration 64,97,132
-  formation 30,41,64-68,108 
Micro-organisms (cf Bacterial flora) 
Microvilli (cf Brush border)
Miscarriages 185
Morphology of intestinal mucosa (cf 
Enterocyte, Mucosa, Villus)
Motility, intestinal 31-34, 41, 44-46, 50,
54, 89-92, 103, 107,109, 112,134,182 
Mucosal lesions 7, 8, 86, 93, 98, 102-104, 
109, 154, 164, 174, 175, 178, 197-199, 
203,206,211,213,214,223
-  morphogenesis in c.s. 26-28
-  morphometry 28,29,198
-  permeability 54,102,198,230 
Mucus, intestinal 31, 41, 42, 47, 48, 51,
73,99
Muscular disorders 75, 83, 85, 184 
Muscularis mucosae 20, 25, 34, 41, 91, 
134
-  propria 25, 31, 34,41,90,91,134  
Myocardial disease 90,93
Nail abnormalities 185 
Nausea 92, 143, 181-183, 192, 203, 206, 
208
Neurological disorders 83, 84, 91, 92, 
149,169,171,184,186 
Niacin 84,177,184,186 
Nitrogen (cf Protein)
Nycturia 181
Obesitas 181,192
-  index (cf Quetelet index)
Oedema 181,192,206 
Oligopeptides (cf Protein)
Osteitis fibrosa 149,153 
Osteomalacia 69, 149, 150, 152, 154, 155,
178,184,192 
Osteoporosis 149,154,155,184 
Oxaluria 206
Pallor (cf Chlorosis)
Pancreatic insufficiency 96,97,183
-  lesions 96, 97,194, 230
-  secretion 30, 36, 41-43, 45, 46, 51, 59, 
61,64, 67,68,70,72,74,78,91,96,98,99, 
117,133, 140,153,159
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Paneth cell 21 
Pantothenic acid 85,177 
Parasympathetic (cf Autonomie nervous 
system)
Parathormone 75,77 
Parenteral feeding 201,206 
Pepsin 30,41,42,70,80  
Peptidase 30, 31, 42, 70, 71, 78, 140, 141 
Perfusion studies 27, 49, 57, 59, 73, 82,
100, 110-112, 119, 152, 153, 176, 230 
Peristalsis (cf Motility)
Phosphate clearance 69,149,153 
Phospholipase 42,68 
Phospholipid absorption 68
- deficiency 132
-  dietary sources 67
-  function 66,68
-  hydrolysis 68
-  intake 63,67
- synthesis 66,67 
Pigmentation 184 
Pinocytosis 49,66  
Plexus, nervous 34,92
-  , vascular 36 
Plication (cf Small intestine)
Polyglutamate (cf Folate)
Portal blood, transport 66,68,72,73  
Post-mortem examination 94,224 
Potassium absorption 46, 59-61, 110-112
-  dietary sources 59
-  excretion 59
-  intake 59
-  loss 59,103
-  requirements 59 
-secretion  43,61,111,112
serum level 90 
Protein absorption 53, 54, 72, 73, 97, 102, 
108,112,139,141,142
-  degradation 50,70,102,142
-  dietary sources 70
-  digestion 54, 70-72, 102, 139, 140, 142
-  endogenous loss 49, 50,73,95,100,103, 
142
-  faecal loss 73, 97, 100, 103, 140-143
-  intake 70,143
-  leakage 48-50, 73, 93-95, 100, 102, 103,
108, 133, 137-139, 142, 145, 165, 181, 201
-  nitrogen balance 70,140,185
-  serum level 49,184
-  synthesis 73
-  transport 72 
Prothrombin time 70,135 
Psychic disorders 75,186 
Pyrexia 181,208 
Pyridoxine (cf Vitamin B6)
Quetelet index 181
Radiological changes, intestinal 8, 89, 90, 
182,229
-  , skeletal 149,154,183 
Rectal biopsy 91,134
Refractory sprue clinical symptoms 229
- incidence 194,229
-  post-mortem investigations 97, 224, 
230
-  prognosis 230
-  terminology 6,218,227
-  theory 218,230
-  treatment 201,229,230
Renal function disorders 121, 153, 206 
Replacement therapy calcium 195, 201
-  folie acid 163,172,195,201
-  intrinsic factor 168,170
-  iron 163,195,201
-  pancreatic enzymes 133,169
-  vitamin A 201
-  vitamin B j2 163,195,201
-  vitamin D  150, 153, 154, 195, 201
-  vitamin E 201
-  vitamin K 201
Reticulin antibodies (cf Antibodies) 
Riboflavin 84,177,183 
Rickets 69,75,184
Saliva 30,41,61
Schilling test 166, 168-171, 194, 205, 213, 
214
Secretin 30, 33, 42, 43, 45, 46, 61, 96-98, 
140
Serotonin (cf Hydroxytryptamine)
Skeletal deformities 184
Skin lesions 63, 83, 84,184,185,208
Small intestine abnormalities 23
-  anatomy 18,19, 89,92, 94,102
-  functional reserve 53, 54, 59
-  length 18
-  luminal width 19, 23, 54, 89, 91, 92,182
-  surface area 19,27,31, 33,53, 111,119,
133,141,165,175
Sodium absorption 43, 46, 57, 59, 60, 61, 
110-112
-  dietary sources 59
-  intake 59
-  intracellular concentration 56, 57
-  loss 59,103
-  requirements 59 
-secretion  42,43,56-58,111,112
-  translocation (cf Translocation)
Solvent drag 39, 57, 60 
Splenic atrophy 16,183 
Starch in faeces 113,117
-  intake 61
Steatorrhoea 1, 95, 100, 108, 121, 122,
133, 145, 164, 168, 182, 207, 213, 214 
Stomatitis 1, 84, 88, 171, 178, 183, 192 
Sucrose digestion 62
-  intake 61
-  tolerance test 115
278
Sympathetic (cf Autonomie nervous sys­
tem)
Symptomatology (cf Coeliac sprue)
Target cells 183
Tetany 75,88,144,157,158,184,192  
Thiamine 83, 84, 177, 181, 185, 186 
Thrombotest 70,126,127,135 
Thyroid hormone 75 
Tight junction 49,55,57,102  
Transcobalamin 81 
Transferrin 77
Transit time 54, 61, 89-91, 107, 112, 117, 
121,158
Translocation process 54, 55, 57, 58, 60, 
63,72
Transport carriers 54, 55, 57, 63, 72, 76,
79, 82,117,141,175 
Treatment ahtibiotics 91, 92, 107, 109,
168,170,175,183
-  azathioprine 203
-  corticosteroids 5, 8, 15, 16, 165, 201- 
203,206,218,223, 226
-  fungistatics 107
-  (cf Dietary restriction, Replacement 
therapy)
Triglyceride absorption 53, 64,66,93, 133
-  emulsification 64,66
-  hydrolysis 64,66
-  intake 63
-  long-chain 63,93
-  medium- chain 63, 64,66
-  re-esterification 66,133
-  short-chain 63
-  solubilization 64,66 
T ropical sprue 1,2,226  
Trypsin 42,71,97,140  
Tuberculosis 95,230
Unclassified sprue (cf Coeliac sprue) 
Unstirred layer 33, 55, 56,91
Vasoconstriction/-dilatation (cf Blood ves­
sels)
Vertigo 75,183 
Villikinin 33 
Villus aspect 19,20,28
-  atrophy 5-8, 23, 25, 86,91,93, 197,198, 
213-215,223
-  histology 21, 25 
-m otility  33,41,91
Vitamin A  absorption 133
-  body stores 68
-  deficiency 68,186
-  dietary sources 68
-  precursors 68
-  serum level 68,124,127,133,134
-  synthesis 68
-  tolerance test 125,127,134,135 
Vitamin B x (cf Thiamine)
Vitamin B 2 (cf Riboflavin)
Vitamin B a (cf Niacin)
Vitamin B 6 84,177, 186 
Vitamin B 12 absorption 31, 80, 81, 108,
109,170,171,183
-  body stores 80,171 
consumption 170
-deficiency 161,169,171,183
-  degradation 80,170 
dietary sources 80
-  endogenous loss 81,100,103 
function 80
-  hydrolysis 80
-  intake 80
-  requirements 80
-  serum level 81, 162, 166, 171, 186, 214
-  synthesis 80
-  transport 81
Vitamin C 83,176,177,183 
Vitamin D  absorption 133, 153, 154, 183
-  deficiency 69, 152, 154, 183, 184 
dietary sources 69
-fu n ction  69,75,77,153  
metabolism 67, 69, 75
-  resistance 69,153
-  serum level 153 
Vitamin E absorption 133 
-deficiency 69,91,134
-  dietary sources 69
-  function 69
-  serum level 125,127,133-135 
Vitamin K  70,133,183 
Vomiting (cf Nausea)
Water absorption 43, 46, 59-61, 110-112
-  intake 59
-  loss 59
-  requirements 59
-  secretion 43,45,97,111,112  
Weight loss (cf Body weight)
Xylose (cf D-xylose)
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STELLINGEN
BEHORENDE BIJ HET 
PROEFSCHRIFT OMTRENT 
MALABSORPTION IN COELIAC SPRUE 
IN HET OPENBAAR TE VERDEDIGEN 
OP VRUDAG 24 JUNI 1977 
DES NAMIDDAGS TE 2 UUR
DOOR
ONNO JACOBUS JAN CLUYSENAER
GEBOREN TE GRONINGEN
1. De ene zijn brood is de andere zijn dood.
2. Bij spruw in de mond dient darmspruw overwogen te worden.
3. Een abnormale bacterieflora in de dunne darm speelt een wezenlijke rol 
in de symptomatologie van darmspruw. Er bestaan aanwijzingen dat 
deze abnormale flora een luxerende factor is bij het manifest worden 
van darmspruw op latere leeftijd.
4. Het serum albuminegehalte is een ideale parameter om het effect van 
een glutenvrij dieet bij spruwlijders na te gaan.
5. Er bestaan aanwijzingen dat een vitamine E gebrek aanleiding kan 
geven tot een paralytische ileus. Een dergelijk vitaminegebrek kan men 
behalve door bepalen van de vitamine E spiegel in het bloed ook op het 
spoor komen middels een rectumbiopsie.
6. Microscopisch onderzoek van faeces op de vertering en absorptie van 
vet is van grote waarde voor het vaststellen van steatorrhoea.
7. Spondylodiscitis bij de ziekte van Bechterew berust in eerste aanleg niet 
op osteolytische defecten, maar is eerder een gevolg van pseudarthrose 
na fracturering van de geankyloseerde wervelkolom.
8. Bij het uitdelen van geneesmiddelen in de kliniek wordt er onvoldoende 
rekening gehouden met de vullingstoestand van de maag.
9. Men zal ernstig moeten overwegen om röntgenfoto’s en andere non- 
verbale medische bescheiden aan de patiënt zelf in bewaring te geven. 
Hierdoor wordt soelaas geboden aan uitpuilende archieven en druk­
bezette administratieve diensten, terwijl voorkomen wordt dat deze 
bescheiden vernietigd raken of onvindbaar opgeborgen worden.
10. Bij het voorschrijven van een vermageringsdieet dient men zich tevoren 
op de hoogte te stellen van de schoonheidsidealen van zowel patiënt als 
echtelijke wederhelft.
11. Aan het gebruik van deodorantspray kleeft een luchtje.



